ASSAY_ID ASSAY PROJECT PLATE WELL WELL_TYPE RAW_VALUE_A BSUB_VALUE_A Z_SCORE_A RAW_VALUE_B BSUB_VALUE_B Z_SCORE_B COMPOSITE_Z REPRODUCIBILITY CHEMBANK_ID VIRTUAL_ID SMILES 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 A01 compound treatment 9.0256 -0.70062 -0.3793 10.9396 1.2088 0.5405 0.114 0.1726 3188092 PK04_102001 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(CCO)nn4)C(=O)N(CC=C)c5ccccc53 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 A02 compound treatment 10.1069 0.38067 0.2061 9.4189 -0.31188 -0.1395 0.0471 0.1893 3188093 PK04_102002 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4ccccc4)c5ccc(cc53)N6CCCCC6=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 A03 compound treatment 10.0749 0.34871 0.1888 8.882 -0.84878 -0.3795 -0.1349 -0.3182 3069304 PK04_102003 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(CC=C)c4ccccc43 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 A04 compound treatment 15.8804 6.1542 3.3316 10.1694 0.43864 0.1961 2.4945 0.7474 3188094 PK04_102004 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(CCO)nn4)C(=O)N(Cc5ccc(cc5)N6C(=O)c7cccc8cccc6c78)c9ccccc93 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 A05 compound treatment 15.8273 6.1011 3.3029 10.0067 0.27592 0.1234 2.4227 0.733 3069305 PK04_102005 COc1ccc(cc1)[Si](C)(C)[C@H](CC(=O)N2CCC[C@H]2CO)/C=C/C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 A06 compound treatment 10.4264 0.70019 0.3791 10.2582 0.52744 0.2358 0.4348 0.9739 3188095 PK04_102006 COc1ccc(cc1)C(=O)Nc2cccc(CN3C(=O)[C@]4(O[C@H](CCn5cc(nn5)[C@H](O)c6ccccc6)[C@H]([C@@H]4C)[Si](C)(C)c7ccc(OC)cc7)c8ccccc38)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 A07 compound treatment 11.5298 1.8036 0.9764 9.3487 -0.38205 -0.1708 0.5696 0.5747 3069306 PK04_102007 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(CCO)nn4)C(=O)N(c5ccccc53)c6ccccc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 A08 compound treatment 12.1832 2.457 1.3301 13.7862 4.0554 1.8133 2.2227 0.9884 3188096 PK04_102008 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4ccc(NC(=O)C)cc4)c5ccccc53 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 A09 compound treatment 10.693 0.96679 0.5234 11.1407 1.4099 0.6304 0.8159 0.9957 3188097 PK04_102009 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(C)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 A10 compound treatment 9.9403 0.21405 0.1159 10.1307 0.39997 0.1788 0.2084 0.9779 3069307 PK04_102010 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4ccccc4)c5ccc(cc53)N6CCOC6=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 A11 compound treatment 17.4723 7.746 4.1934 9.2419 -0.48885 -0.2186 2.8106 0.6693 3188098 PK04_102011 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(nn4)[C@H](O)c5ccccc5)C(=O)N(c6ccccc63)c7ccccc7 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 A12 compound treatment 10.3541 0.62788 0.3399 11.0617 1.331 0.5951 0.6612 0.9647 3069308 PK04_102012 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4cccc(c4)N(C=O)c5ccccc5)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 A13 mock treatment 9.087 -0.63928 -0.3461 11.6377 1.9069 0.8526 0.3582 0.3893 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 A14 mock treatment 8.6092 -1.117 -0.6047 10.2175 0.48674 0.2176 -0.2737 -0.4259 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 A15 compound treatment 14.8586 5.1324 2.7784 12.3661 2.6353 1.1783 2.7979 0.9271 3188099 PK04_102013 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(c4ccccc43)c5ccccc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 A16 compound treatment 11.9205 2.1943 1.1879 9.6529 -0.077846 -0.0348 0.8154 0.6861 3188100 PK04_102014 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(CCO)nn4)C(=O)N(Cc5cccc(c5)N6C(=O)c7cccc8cccc6c78)c9ccccc93 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 A17 compound treatment 11.3385 1.6123 0.8728 11.3226 1.5919 0.7118 1.1205 0.9949 3069309 PK04_102015 COc1ccc(cc1)C(=O)Nc2ccc3N(Cc4ccccc4)C(=O)[C@]5(O[C@H](CCO)[C@H]([C@@H]5C)[Si](C)(C)c6ccc(OC)cc6)c3c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 A18 compound treatment 12.1305 2.4043 1.3016 24.0587 14.328 6.4065 5.4505 0.8337 3188101 PK04_102016 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4ccc(NC(=O)[C@H](C)O)cc4)c5ccccc53 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 A19 compound treatment 38.2389 28.513 15.4355 41.2259 31.495 14.0826 20.8725 0.999 3069310 PK04_102017 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(CC=C)c4ccc(cc43)N5C(=O)COc6ccccc56 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 A20 compound treatment 12.0331 2.3069 1.2488 9.1585 -0.57228 -0.2559 0.7021 0.5508 3188102 PK04_102018 COc1ccc(cc1)C(=O)Nc2ccc3N(Cc4ccccc4)C(=O)[C@@]5(O[C@@H](CCO)[C@@H]([C@H]5C)[Si](C)(C)c6ccc(OC)cc6)c3c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 A21 compound treatment 8.9858 -0.74047 -0.4009 8.6102 -1.1206 -0.5011 -0.6378 -0.9939 3188103 PK04_102019 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(nn4)[C@H](O)c5ccccc5)C(=O)N(Cc6ccc(cc6)N7C(=O)c8cccc9cccc7c89)c%10ccccc%103 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 A22 compound treatment 14.737 5.0108 2.7126 19.9585 10.228 4.5732 5.1518 0.9689 3069311 PK04_102020 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4ccc(NC(=O)[C@H](C)O)cc4)c5ccccc53 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 A23 compound treatment 9.0536 -0.67259 -0.3641 9.9403 0.20951 0.0937 -0.1912 -0.5086 3188104 PK04_102021 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(nn4)[C@H](O)c5ccccc5)C(=O)N(CC=C)c6ccc(cc63)N7CCOC7=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 A24 compound treatment 9.9566 0.23041 0.1247 11.4884 1.7576 0.7859 0.6439 0.8092 3188105 PK04_102022 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(nn4)[C@H](O)c5ccccc5)C(=O)N(CC=C)c6ccc(cc63)N7CCOC7=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 B01 compound treatment 8.6097 -1.1165 -0.6044 10.1109 0.38018 0.17 -0.3072 -0.4893 3069350 PK04_102023 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(CC=C)c4ccc(cc43)N5CCC5=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 B02 compound treatment 9.4579 -0.2683 -0.1452 8.4859 -1.2449 -0.5566 -0.4963 -0.8627 3188106 PK04_102024 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4ccc(cc4)N5CCC5=O)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 B03 compound treatment 9.1029 -0.62333 -0.3374 7.4002 -2.3305 -1.0421 -0.9755 -0.8906 3069351 PK04_102025 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(Cc5ccc(cc5)N6CCCCC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 B04 compound treatment 11.2305 1.5043 0.8144 10.4158 0.68509 0.3063 0.7925 0.9108 3188107 PK04_102026 COc1ccc(cc1)C(=O)Nc2cccc(CN3C(=O)[C@]4(O[C@H](CC(=O)N5Cc6ccccc6C[C@H]5CO)[C@H]([C@@H]4C)[Si](C)(C)c7ccc(OC)cc7)c8ccccc38)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 B05 compound treatment 11.2917 1.5654 0.8475 9.843 0.11221 0.0502 0.6347 0.7477 3188221 PK04_102027 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(Cc5ccc(cc5)N6C(=O)c7cccc8cccc6c78)c9ccccc93 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 B06 compound treatment 9.502 -0.22422 -0.1214 9.7931 0.062354 0.0279 -0.0661 -0.5309 3069352 PK04_102028 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N(CCO)Cc4ccccc4)C(=O)N(Cc5cccc(I)c5)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 B07 compound treatment 11.7406 2.0143 1.0905 10.4298 0.69904 0.3126 0.9921 0.8746 3188222 PK04_102029 COc1ccc(cc1)C(=O)Nc2ccc(CN3C(=O)[C@]4(O[C@H](CC(=O)N(CCO)Cc5ccccc5)[C@H]([C@@H]4C)[Si](C)(C)c6ccc(OC)cc6)c7ccccc37)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 B08 compound treatment 10.7047 0.9785 0.5297 11.6075 1.8767 0.8391 0.9679 0.9754 3069353 PK04_102030 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N(CCO)Cc4ccccc4)C(=O)N(Cc5ccc(I)cc5)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 B09 compound treatment 9.1052 -0.62102 -0.3362 9.2237 -0.50705 -0.2267 -0.398 -0.9816 3188223 PK04_102031 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N(CCO)Cc4ccccc4)C(=O)N(Cc5cccc(c5)N6CCOC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 B10 compound treatment 12.1885 2.4623 1.333 10.2394 0.50861 0.2274 1.1034 0.816 3188224 PK04_102032 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(Cc6cccc(c6)N7CCOC7=O)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 B11 compound treatment 9.7553 0.029078 0.0157 8.7419 -0.98891 -0.4422 -0.3015 -0.6815 3069354 PK04_102033 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(Cc5ccc(cc5)N6C(=O)c7cccc8cccc6c78)c9ccccc93 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 B12 compound treatment 7.6086 -2.1176 -1.1464 11.4824 1.7516 0.7832 -0.2568 -0.185 3188225 PK04_102034 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(Cc6cccc(c6)N7CCCCC7=O)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 B13 mock treatment 9.993 0.26676 0.1444 10.3867 0.65596 0.2933 0.3095 0.9467 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 B14 mock treatment 9.2156 -0.51059 -0.2764 10.0549 0.32416 0.1449 -0.093 -0.2978 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 B15 compound treatment 10.9561 1.2299 0.6658 10.3427 0.61195 0.2736 0.6643 0.9228 3188226 PK04_102035 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N(CCO)Cc4ccccc4)C(=O)N(Cc5ccc(cc5)N6C(=O)c7cccc8cccc6c78)c9ccccc93 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 B16 compound treatment 10.2704 0.5442 0.2946 9.2889 -0.44188 -0.1976 0.0686 0.1934 3069355 PK04_102036 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(Cc5cccc(I)c5)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 B17 compound treatment 12.1296 2.4034 1.3011 10.841 1.1102 0.4964 1.271 0.9127 3188227 PK04_102037 COc1ccc(cc1)C(=O)Nc2ccc(CN3C(=O)[C@]4(O[C@H](CC(=O)N5Cc6ccccc6C[C@H]5CO)[C@H]([C@@H]4C)[Si](C)(C)c7ccc(OC)cc7)c8ccccc38)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 B18 compound treatment 10.9451 1.2189 0.6599 11.4699 1.7391 0.7776 1.0165 0.9967 3069356 PK04_102038 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N(CCO)Cc4ccccc4)C(=O)N(Cc5cccc(I)c5)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 B19 compound treatment 9.5934 -0.13284 -0.0719 9.4333 -0.29743 -0.133 -0.1449 -0.9583 3188228 PK04_102039 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(Cc5cccc(c5)N6CCC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 B20 compound treatment 10.2295 0.50327 0.2724 9.6515 -0.079234 -0.0354 0.1676 0.61 3188229 PK04_102040 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(CCO)nn4)C(=O)N(Cc5cccc(c5)N6CCC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 B21 compound treatment 9.0514 -0.67487 -0.3653 10.871 1.1403 0.5099 0.1022 0.1629 3069357 PK04_102041 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(nn4)[C@H](O)c5ccccc5)C(=O)N(C)c6c3cc(C)cc6Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 B22 compound treatment 34.3246 24.598 13.3165 13.7049 3.9742 1.777 10.6727 0.7944 3188230 PK04_102042 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(Cc6cccc(I)c6)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 B23 compound treatment 11.3747 1.6484 0.8924 9.1772 -0.55358 -0.2475 0.456 0.4924 3069358 PK04_102043 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(Cc6cccc(c6)N7C(=O)COc8ccccc78)c9ccccc93 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 B24 compound treatment 8.5312 -1.195 -0.6469 9.2917 -0.43906 -0.1963 -0.5963 -0.882 3188231 PK04_102044 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(Cc5ccc(I)cc5)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 C01 compound treatment 8.6196 -1.1067 -0.5991 9.9486 0.2178 0.0974 -0.3548 -0.5845 3188232 PK04_102045 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(c5ccccc53)c6ccccc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 C02 compound treatment 13.9242 4.198 2.2726 10.466 0.73525 0.3288 1.8395 0.8011 3069359 PK04_102046 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4ccccc4)c5ccc(cc53)N6C(=O)COc7ccccc67 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 C03 compound treatment 7.7724 -1.9539 -1.0577 8.3658 -1.3649 -0.6103 -1.1795 -0.9659 3188233 PK04_102047 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(c6ccccc63)c7ccccc7 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 C04 compound treatment 15.3053 5.579 3.0203 20.5644 10.834 4.8441 5.5609 0.9741 3188234 PK04_102048 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(nn4)[C@H](O)c5ccccc5)C(=O)N(Cc6ccc(cc6)N7CCOC7=O)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 C05 compound treatment 9.9516 0.22538 0.122 8.1157 -1.615 -0.7221 -0.4244 -0.5794 3069360 PK04_102049 COc1ccc(cc1)[Si](C)(C)[C@H](CCn2cc(nn2)[C@H](O)c3ccccc3)/C=C/C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 C06 compound treatment 18.0587 8.3324 4.5108 17.184 7.4532 3.3326 5.5461 0.9889 3188235 PK04_102050 COc1ccc(cc1)C(=O)Nc2cccc(CN3C(=O)[C@]4(O[C@H](CCO)[C@H]([C@@H]4C)[Si](C)(C)c5ccc(OC)cc5)c6ccccc36)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 C07 compound treatment 8.1731 -1.5531 -0.8408 8.3419 -1.3888 -0.621 -1.0336 -0.9889 3069393 PK04_102051 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(nn4)[C@H](O)c5ccccc5)C(=O)N(CC=C)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 C08 compound treatment 9.228 -0.49824 -0.2697 9.9975 0.26674 0.1193 -0.1064 -0.3607 3188236 PK04_102052 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4ccccc4)c5ccc(cc53)N6C(=O)c7ccccc7Oc8ccccc68 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 C09 compound treatment 24.8419 15.116 8.183 13.9078 4.177 1.8677 7.1069 0.8467 3069394 PK04_102053 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(C)c4c3cc(C)cc4Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 C10 compound treatment 10.5132 0.78697 0.426 10.8865 1.1558 0.5168 0.6667 0.9954 3188352 PK04_102054 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4ccc(cc4)N5C(=O)COc6ccccc56)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 C11 mock treatment 9.8648 0.13862 0.075 10.0628 0.33206 0.1485 0.1581 0.95 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 C12 mock treatment 12.0595 2.3333 1.2631 9.1267 -0.60403 -0.2701 0.7022 0.5436 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 C13 compound treatment 9.5571 -0.16913 -0.0916 9.1077 -0.62305 -0.2786 -0.2617 -0.8925 3188353 PK04_102055 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(nn4)[C@H](O)c5ccccc5)C(=O)N(C)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 C14 compound treatment 33.7768 24.051 13.0199 22.1559 12.425 5.5557 13.135 0.9279 3069395 PK04_102056 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(CC=C)c4ccc(cc43)N5C(=O)c6ccccc6Oc7ccccc57 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 C15 mock treatment 11.1241 1.3979 0.7568 12.0117 2.281 1.0199 1.2563 0.9892 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 C16 mock treatment 8.4809 -1.2453 -0.6742 9.3776 -0.35319 -0.1579 -0.5884 -0.8497 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 C17 compound treatment 11.2598 1.5335 0.8302 12.6682 2.9374 1.3134 1.5158 0.9755 3188354 PK04_102057 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4cccc(c4)N5C(=O)c6cccc7cccc5c67)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 C18 compound treatment 10.2275 0.50123 0.2713 9.9039 0.17315 0.0774 0.2466 0.874 3069396 PK04_102058 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(CC=C)c4ccc(NC(=O)[C@H](C)O)cc43 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 C19 compound treatment 11.2425 1.5162 0.8208 11.4596 1.7288 0.773 1.127 0.9996 3188355 PK04_102059 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4cccc(c4)N5C(=O)COc6ccccc56)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 C20 compound treatment 10.1486 0.42236 0.2286 10.4121 0.6813 0.3046 0.3771 0.99 3188356 PK04_102060 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4cccc(c4)N5C(=O)c6ccccc6Oc7ccccc57)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 C21 compound treatment 9.8886 0.16234 0.0879 9.9169 0.1861 0.0832 0.121 0.9996 3069397 PK04_102061 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(CCO)nn4)C(=O)N(Cc5ccc(cc5)N6CCOC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 C22 compound treatment 10.1844 0.4582 0.248 10.7034 0.97267 0.4349 0.4829 0.9645 3188357 PK04_102062 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4ccccc4)c5ccc(cc53)N6C(=O)COc7ccccc67 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 C23 compound treatment 11.5212 1.795 0.9717 9.6286 -0.10216 -0.0457 0.6548 0.6731 3188358 PK04_102063 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4ccc(cc4)N5C(=O)c6cccc7cccc5c67)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 C24 compound treatment 9.5103 -0.2159 -0.1169 12.1968 2.4661 1.1027 0.6971 0.6286 3069398 PK04_102064 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(CCO)nn4)C(=O)N(Cc5ccc(cc5)N6C(=O)c7cccc8cccc6c78)c9ccccc93 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 D01 compound treatment 9.5341 -0.19213 -0.104 11.5598 1.829 0.8178 0.5047 0.6122 3188359 PK04_102065 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N(CCO)Cc4ccccc4)C(=O)N(Cc5cccc(c5)N6CCC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 D02 compound treatment 10.9502 1.2239 0.6626 9.4274 -0.3034 -0.1357 0.3726 0.5509 3069399 PK04_102066 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(Cc6ccc(I)cc6)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 D03 compound treatment 8.8216 -0.90466 -0.4897 9.0866 -0.64417 -0.288 -0.55 -0.968 3188360 PK04_102067 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(Cc6ccc(cc6)N7CCC7=O)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 D04 compound treatment 9.5826 -0.14359 -0.0777 9.4054 -0.32531 -0.1455 -0.1578 -0.9569 3188361 PK04_102068 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(Cc5cccc(c5)N6CCOC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 D05 compound treatment 10.611 0.8848 0.479 8.3496 -1.3811 -0.6176 -0.098 -0.1254 3069400 PK04_102069 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N(CCO)Cc4ccccc4)C(=O)N(Cc5cccc(c5)N6CCC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 D06 compound treatment 11.4502 1.7239 0.9333 9.4152 -0.31553 -0.1411 0.5602 0.5935 3188362 PK04_102070 C[C@H](C=C)[C@H](O)c1ccc(O)c2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 D07 compound treatment 12.1491 2.4229 1.3116 8.1209 -1.6098 -0.7198 0.4185 0.2797 3188363 PK04_102071 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(nn4)[C@H](O)c5ccccc5)C(=O)N(Cc6ccc(cc6)N7CCC7=O)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 D08 compound treatment 8.6956 -1.0306 -0.5579 8.3446 -1.3861 -0.6198 -0.8328 -0.9986 3069401 PK04_102072 CO[C@H](C=C)[C@H](O)c1ccc(OC)c(O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 D09 compound treatment 10.5271 0.80088 0.4336 9.8671 0.13633 0.061 0.3497 0.7987 3188364 PK04_102073 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N(CCO)Cc4ccccc4)C(=O)N(Cc5cccc(c5)N6CCOC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 D10 compound treatment 11.4884 1.7622 0.954 10.3384 0.60768 0.2717 0.8667 0.8738 3069402 PK04_102074 CO[C@H](C=C)[C@H](OC(=O)Nc1ccc(OC)cc1)c2ccc(O)c(F)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 D11 mock treatment 11.1865 1.4603 0.7905 10.6566 0.92583 0.414 0.8517 0.9544 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 D12 mock treatment 10.7451 1.0189 0.5516 9.3065 -0.42428 -0.1897 0.2559 0.4387 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 D13 compound treatment 9.6962 -0.03 -0.0162 10.4258 0.69509 0.3108 0.2083 0.6692 3069403 PK04_102075 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(CCO)nn4)C(=O)N(CC=C)c5ccc(cc53)N6CCC6=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 D14 compound treatment 36.3577 26.631 14.4171 13.3346 3.6039 1.6114 11.3339 0.7813 3188365 PK04_102076 CSc1ccc(NC(=O)O[C@@H]([C@@H](C)C=C)c2ccc(O)c3ccccc23)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 D15 mock treatment 8.1785 -1.5478 -0.8379 11.4182 1.6874 0.7545 -0.059 -0.0523 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 D16 mock treatment 9.9561 0.22985 0.1244 21.6293 11.899 5.3203 3.85 0.7234 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 D17 compound treatment 10.8023 1.076 0.5825 15.8551 6.1243 2.7384 2.3482 0.8388 3188366 PK04_102077 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(Cc5ccc(cc5)N6CCC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 D18 compound treatment 9.4188 -0.30743 -0.1664 9.2641 -0.46668 -0.2087 -0.2652 -0.9937 3069404 PK04_102078 C[C@@H](C=C)[C@@H](O)c1ccc(OCCO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 D19 compound treatment 8.6966 -1.0296 -0.5574 9.9894 0.25863 0.1156 -0.3124 -0.5487 3188367 PK04_102079 COc1ccc(cc1)C(=O)Nc2cccc(CN3C(=O)[C@]4(O[C@H](CC(=O)N5CCC[C@H]5CO)[C@H]([C@@H]4C)[Si](C)(C)c6ccc(OC)cc6)c7ccccc37)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 D20 compound treatment 50.4831 40.757 22.064 42.5903 32.86 14.6926 25.9909 0.9805 3069405 PK04_102080 COc1ccc(NC(=O)O[C@H]([C@H](C)C=C)c2ccc(O)c3ccccc23)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 D21 compound treatment 8.7095 -1.0168 -0.5504 9.4652 -0.2656 -0.1188 -0.4732 -0.8403 3188368 PK04_102081 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(Cc6ccc(cc6)N7CCOC7=O)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 D22 compound treatment 11.4683 1.7421 0.9431 9.9234 0.19261 0.0861 0.7278 0.7685 3069440 PK04_102082 COc1ccc(NC(=O)O[C@@H]([C@@H](C)C=C)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 D23 compound treatment 9.9579 0.23166 0.1254 10.0728 0.34201 0.1529 0.1968 0.9951 3188485 PK04_102083 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(Cc6cccc(c6)N7CCOC7=O)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 D24 compound treatment 11.7612 2.0349 1.1016 8.5853 -1.1455 -0.5122 0.4168 0.3431 3069441 PK04_102084 O[C@H](CC=C)c1ccc(O)c(F)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 E01 mock treatment 10.6531 0.9269 0.5018 8.4904 -1.2404 -0.5546 -0.0374 -0.05 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 E02 mock treatment 11.0759 1.3497 0.7306 9.4631 -0.26771 -0.1197 0.432 0.5835 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 E03 compound treatment 8.3831 -1.3432 -0.7271 8.2722 -1.4586 -0.6522 -0.9753 -0.9985 3069442 PK04_102085 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(nn4)[C@H](O)c5ccccc5)C(=O)N(c6ccccc63)c7ccccc7 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 E04 compound treatment 27.2685 17.542 9.4966 11.2973 1.5666 0.7005 7.2104 0.7572 3188486 PK04_102086 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(CC=C)c4ccc(cc43)N5CCCCC5=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 E05 compound treatment 20.3251 10.599 5.7377 10.4787 0.74798 0.3344 4.2937 0.7471 3188487 PK04_102087 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(c6ccccc63)c7ccccc7 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 E06 compound treatment 10.0056 0.2794 0.1513 8.8462 -0.88455 -0.3955 -0.1727 -0.4079 3069443 PK04_102088 COc1ccc(cc1)C(=O)Nc2ccc3N(CC=C)C(=O)[C@@]4(O[C@@H](CCn5cc(nn5)[C@H](O)c6ccccc6)[C@@H]([C@H]4C)[Si](C)(C)c7ccc(OC)cc7)c3c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 E07 compound treatment 10.3202 0.59398 0.3216 8.5412 -1.1896 -0.5319 -0.1487 -0.2393 3188488 PK04_102089 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(CCO)nn4)C(=O)N(c5ccccc53)c6ccccc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 E08 compound treatment 10.7376 1.0114 0.5475 9.8534 0.12263 0.0548 0.4259 0.7741 3188489 PK04_102090 COc1ccc(cc1)C(=O)Nc2cccc(CN3C(=O)[C@]4(O[C@H](CCn5cc(CCO)nn5)[C@H]([C@@H]4C)[Si](C)(C)c6ccc(OC)cc6)c7ccccc37)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 E09 mock treatment 9.8112 0.08502 0.046 8.3574 -1.3734 -0.6141 -0.4017 -0.6523 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 E10 mock treatment 9.8772 0.15098 0.0817 10.047 0.31622 0.1414 0.1578 0.9661 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 E11 compound treatment 9.6455 -0.080765 -0.0437 10.2596 0.52888 0.2365 0.1363 0.5668 3069444 PK04_102091 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N(CCO)Cc4ccccc4)C(=O)N(C)c5ccccc53 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 E12 compound treatment 8.7211 -1.0051 -0.5441 10.1531 0.4223 0.1888 -0.2512 -0.4362 3188490 PK04_102092 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4ccc(cc4)N(C=O)c5ccccc5)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 E13 compound treatment 10.583 0.85679 0.4638 8.4721 -1.2586 -0.5628 -0.07 -0.0959 3069445 PK04_102093 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N(CCO)Cc4ccccc4)C(=O)N(C)c5c3cc(C)cc5Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 E14 compound treatment 8.4967 -1.2295 -0.6656 10.3509 0.62014 0.2773 -0.2746 -0.3808 3188491 PK04_102094 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4ccc(cc4)N(C=O)c5ccccc5)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 E15 compound treatment 10.2471 0.52083 0.282 10.2614 0.53062 0.2373 0.3671 0.9963 3188492 PK04_102095 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(C)c6c3cc(C)cc6Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 E16 compound treatment 10.5093 0.78304 0.4239 9.2986 -0.43216 -0.1932 0.1631 0.3501 3069446 PK04_102096 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(nn4)[C@H](O)c5ccccc5)C(=O)N(Cc6cccc(c6)N7C(=O)c8cccc9cccc7c89)c%10ccccc%103 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 E17 mock treatment 8.7285 -0.99773 -0.5401 9.9019 0.17111 0.0765 -0.3278 -0.6009 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 E18 mock treatment 10.2712 0.54494 0.295 9.8959 0.1651 0.0738 0.2608 0.8576 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 E19 compound treatment 11.2299 1.5036 0.814 11.2318 1.5011 0.6712 1.0502 0.9954 3188493 PK04_102097 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4cccc(c4)N5CCCCC5=O)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 E20 compound treatment 8.9309 -0.79528 -0.4305 8.8422 -0.8886 -0.3973 -0.5854 -0.9992 3188494 PK04_102098 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(nn4)[C@H](O)c5ccccc5)C(=O)N(Cc6ccc(cc6)N7CCOC7=O)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 E21 compound treatment 9.6896 -0.03664 -0.0198 12.1297 2.3989 1.0726 0.7445 0.6939 3069448 PK04_102099 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4ccc(cc4)N5CCOC5=O)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 E22 compound treatment 9.6409 -0.085292 -0.0462 11.0469 1.3161 0.5885 0.3835 0.6496 3188495 PK04_102100 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(CC=C)c4ccc(cc43)N5CCOC5=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 E23 compound treatment 11.3015 1.5752 0.8528 9.7983 0.067569 0.0302 0.6244 0.7317 3069450 PK04_102101 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4ccc(cc4)N5CCOC5=O)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 E24 compound treatment 9.9674 0.2412 0.1306 10.7572 1.0264 0.459 0.4169 0.8736 3188496 PK04_102102 COc1ccc(cc1)C(=O)Nc2ccc3N(CC=C)C(=O)[C@]4(O[C@H](CCn5cc(CCO)nn5)[C@H]([C@@H]4C)[Si](C)(C)c6ccc(OC)cc6)c3c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 F01 mock treatment 8.685 -1.0413 -0.5637 9.4983 -0.23242 -0.1039 -0.4721 -0.8236 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 F02 mock treatment 11.8408 2.1146 1.1448 12.3171 2.5864 1.1564 1.6272 1.0 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 F03 compound treatment 8.0695 -1.6568 -0.8969 10.6591 0.9283 0.4151 -0.3407 -0.3447 3188497 PK04_102103 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(nn4)[C@H](O)c5ccccc5)C(=O)N(CC=C)c6ccc(cc63)N7CCC7=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 F04 compound treatment 33.1886 23.462 12.7015 56.749 47.018 21.0235 23.8472 0.9709 3069264 PK04_102104 C[C@H](C=C)[C@@H](O)c1ccc(O)c2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 F05 compound treatment 8.6676 -1.0587 -0.5731 9.2506 -0.48021 -0.2147 -0.5571 -0.9102 3069265 PK04_102105 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(Cc5ccc(cc5)N6CCOC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 F06 compound treatment 15.1933 5.4671 2.9596 17.0013 7.2705 3.2509 4.3915 0.9989 3188498 PK04_102106 CSc1ccc(NC(=O)O[C@H]([C@@H](C)C=C)c2ccc(O)c3ccccc23)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 F07 compound treatment 13.6021 3.8758 2.0982 9.1019 -0.62881 -0.2812 1.2848 0.6069 3188499 PK04_102107 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4ccc(cc4)N5CCC5=O)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 F08 compound treatment 10.1492 0.42299 0.229 9.0584 -0.67238 -0.3006 -0.0507 -0.1341 3069441 PK04_102108 O[C@H](CC=C)c1ccc(O)c(F)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 F09 mock treatment 10.1345 0.40825 0.221 9.2621 -0.46868 -0.2096 0.0081 0.0266 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 F10 mock treatment 10.2866 0.56035 0.3033 9.3947 -0.33602 -0.1502 0.1083 0.3198 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 F11 compound treatment 9.5479 -0.17834 -0.0965 10.5733 0.84254 0.3767 0.1981 0.5094 3188500 PK04_102109 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N(CCO)Cc4ccccc4)C(=O)N(Cc5ccc(cc5)N6C(=O)c7cccc8cccc6c78)c9ccccc93 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 F12 compound treatment 9.6972 -0.029032 -0.0157 10.1023 0.37158 0.1661 0.1064 0.6374 3069270 PK04_102110 CO[C@@H](C=C)[C@@H](O)c1ccc(OCCO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 F13 compound treatment 9.336 -0.39018 -0.2112 10.3459 0.6151 0.275 0.0451 0.1301 3188501 PK04_102111 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(CCO)nn4)C(=O)N(C)c5c3cc(C)cc5Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 F14 compound treatment 11.1489 1.4227 0.7702 8.0748 -1.6559 -0.7404 0.021 0.0197 3188502 PK04_102112 CSc1ccc(NC(=O)O[C@H]([C@@H](C)C=C)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 F15 compound treatment 8.4015 -1.3247 -0.7171 8.7644 -0.96639 -0.4321 -0.8126 -0.9706 3188623 PK04_102113 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(Cc5cccc(c5)N6C(=O)c7cccc8cccc6c78)c9ccccc93 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 F16 compound treatment 13.7911 4.0649 2.2006 9.7333 0.002521 0.0011 1.5568 0.7075 3069312 PK04_102114 CO[C@H](C=C)[C@H](OC(=O)Nc1ccc(SC)cc1)c2ccc(O)c(F)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 F17 mock treatment 8.9713 -0.75494 -0.4087 11.9035 2.1727 0.9715 0.398 0.3776 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 F18 mock treatment 11.3331 1.6069 0.8699 8.9164 -0.8144 -0.3641 0.3576 0.3792 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 F19 compound treatment 9.6555 -0.070737 -0.0383 10.7232 0.99241 0.4437 0.2867 0.6437 3188624 PK04_102115 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(Cc6cccc(c6)N7CCC7=O)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 F20 compound treatment 9.5997 -0.12651 -0.0685 9.7208 -0.010001 -0.0045 -0.0516 -0.7517 3069314 PK04_102116 CO[C@H](C=C)[C@H](O)c1ccc(O)c(F)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 F21 compound treatment 8.387 -1.3392 -0.725 8.9788 -0.75199 -0.3362 -0.7504 -0.939 3069316 PK04_102117 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(nn4)[C@H](O)c5ccccc5)C(=O)N(CC=C)c6ccc(cc63)N7CCC7=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 F22 compound treatment 34.3477 24.621 13.329 22.7034 12.973 5.8005 13.5266 0.9305 3188625 PK04_102118 O[C@@H](CC=C)c1ccc(O)c2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 F23 compound treatment 9.1765 -0.54976 -0.2976 8.7215 -1.0092 -0.4513 -0.5295 -0.9796 3188626 PK04_102119 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N(CCO)Cc4ccccc4)C(=O)N(Cc5ccc(cc5)N6CCOC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 F24 compound treatment 10.2677 0.54142 0.2931 10.0437 0.31293 0.1399 0.3062 0.9428 3069318 PK04_102120 CO[C@@H](C=C)[C@@H](OC(=O)Nc1ccc(OC)cc1)c2ccc(OC)c(O)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 G01 compound treatment 13.2761 3.5498 1.9217 15.8718 6.1411 2.7459 3.3005 0.9848 3069320 PK04_102121 COc1ccc(cc1)[Si](C)(C)[C@H](CCn2cc(CCO)nn2)/C=C/C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 G02 compound treatment 8.4789 -1.2473 -0.6752 9.4776 -0.25317 -0.1132 -0.5575 -0.8143 3188627 PK04_102122 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(CCO)nn4)C(=O)N(CC=C)c5ccc(cc53)N6CCOC6=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 G03 mock treatment 8.5376 -1.1887 -0.6435 9.3679 -0.36287 -0.1623 -0.5697 -0.8585 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 G04 mock treatment 10.0934 0.36716 0.1988 9.6324 -0.098399 -0.044 0.1094 0.5376 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 G05 compound treatment 10.1695 0.44329 0.24 9.1726 -0.55815 -0.2496 -0.0068 -0.0196 3069321 PK04_102123 COc1ccc(cc1)[Si](C)(C)[C@H](CC(=O)N2Cc3ccccc3C[C@H]2CO)/C=C/C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 G06 compound treatment 11.0794 1.3531 0.7325 10.5891 0.85829 0.3838 0.7893 0.9545 3188628 PK04_102124 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(CCO)nn4)C(=O)N(CC=C)c5ccc(cc53)N6C(=O)c7cccc8cccc6c78 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 G07 compound treatment 12.4909 2.7647 1.4967 9.8758 0.14505 0.0649 1.1042 0.7371 3069362 PK04_102125 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(C)c4ccccc43 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 G08 compound treatment 11.4738 1.7475 0.946 10.4061 0.67531 0.302 0.8825 0.8886 3188629 PK04_102126 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4ccccc4)c5ccc(cc53)N6CCOC6=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 G09 compound treatment 13.6033 3.8771 2.0989 11.6334 1.9026 0.8507 2.0857 0.9209 3188630 PK04_102127 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(CC=C)c4ccc(I)cc43 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 G10 compound treatment 10.0395 0.31326 0.1696 10.2119 0.4811 0.2151 0.272 0.9931 3188631 PK04_102128 COc1ccc(cc1)C(=O)Nc2cccc(CN3C(=O)[C@@]4(O[C@@H](CCn5cc(nn5)[C@H](O)c6ccccc6)[C@@H]([C@H]4C)[Si](C)(C)c7ccc(OC)cc7)c8ccccc38)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 G11 compound treatment 20.9334 11.207 6.0671 17.2961 7.5653 3.3827 6.682 0.9619 3069365 PK04_102129 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(C)c4c3cc(C)cc4Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 G12 compound treatment 9.4839 -0.24236 -0.1312 9.2107 -0.52007 -0.2325 -0.2572 -0.9633 3188632 PK04_102130 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(nn4)[C@H](O)c5ccccc5)C(=O)N(Cc6cccc(c6)N7C(=O)c8cccc9cccc7c89)c%10ccccc%103 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 G13 compound treatment 10.3345 0.6083 0.3293 9.7096 -0.021184 -0.0095 0.2262 0.6865 3069368 PK04_102131 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(CC=C)c4ccccc43 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 G14 compound treatment 12.9055 3.1793 1.7211 11.3608 1.6301 0.7289 1.7324 0.9269 3069370 PK04_102132 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4cccc(NC(=O)C)c4)c5ccccc53 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 G15 compound treatment 11.8995 2.1732 1.1765 10.5579 0.82712 0.3698 1.0934 0.8866 3188633 PK04_102133 COc1ccc(cc1)[Si](C)(C)[C@@H](CC(=O)N2Cc3ccccc3C[C@H]2CO)/C=C/C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 G16 compound treatment 10.2327 0.50648 0.2742 9.7434 0.012619 0.0056 0.1979 0.7215 3188634 PK04_102134 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4ccc(cc4)N5C(=O)COc6ccccc56)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 G17 compound treatment 13.6631 3.9368 2.1312 11.4868 1.7561 0.7852 2.0622 0.908 3188635 PK04_102135 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4cccc(NC(=O)[C@H](C)O)c4)c5ccccc53 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 G18 compound treatment 9.4355 -0.29073 -0.1574 9.1105 -0.62021 -0.2773 -0.3074 -0.964 3069408 PK04_102136 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(CCO)nn4)C(=O)N(CC=C)c5ccc(cc53)N6CCOC6=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 G19 mock treatment 8.6581 -1.0681 -0.5782 10.1997 0.46894 0.2097 -0.2606 -0.4237 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 G20 mock treatment 8.9953 -0.73097 -0.3957 9.4652 -0.26555 -0.1187 -0.3638 -0.8805 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 G21 compound treatment 26.1265 16.4 8.8784 28.9614 19.231 8.5987 12.3582 0.9999 3188636 PK04_102137 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(CC=C)c4ccc(cc43)N(C=O)c5ccccc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 G22 compound treatment 13.3401 3.6139 1.9564 12.603 2.8722 1.2843 2.2915 0.9792 3188637 PK04_102138 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(CCO)nn4)C(=O)N(Cc5cccc(c5)N6CCOC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 G23 compound treatment 7.6679 -2.0584 -1.1143 9.6468 -0.083944 -0.0375 -0.8145 -0.7305 3069412 PK04_102139 COc1ccc(cc1)C(=O)Nc2ccc3N(CC=C)C(=O)[C@@]4(O[C@@H](CCn5cc(CCO)nn5)[C@@H]([C@H]4C)[Si](C)(C)c6ccc(OC)cc6)c3c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 G24 compound treatment 12.0593 2.3331 1.263 12.079 2.3482 1.05 1.6356 0.9958 3188638 PK04_102140 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4ccc(cc4)N5CCCCC5=O)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 H01 compound treatment 10.4907 0.76444 0.4138 10.1939 0.46312 0.2071 0.439 0.9488 3188639 PK04_102141 COc1ccc(cc1)C(=O)Nc2ccc(CN3C(=O)[C@@]4(O[C@@H](CC(=O)N(CCO)Cc5ccccc5)[C@@H]([C@H]4C)[Si](C)(C)c6ccc(OC)cc6)c7ccccc37)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 H02 compound treatment 8.9782 -0.74801 -0.4049 11.2816 1.5508 0.6934 0.204 0.254 3069414 PK04_102142 CSc1ccc(NC(=O)O[C@H]([C@H](C)C=C)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 H03 mock treatment 8.9563 -0.76989 -0.4168 9.9689 0.2381 0.1065 -0.2194 -0.5101 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 H04 mock treatment 10.5046 0.77836 0.4214 8.5143 -1.2164 -0.5439 -0.0867 -0.1259 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 H05 compound treatment 10.2336 0.50738 0.2747 9.3759 -0.35488 -0.1587 0.082 0.2586 3188755 PK04_102143 COc1ccc(cc1)C(=O)Nc2ccc(CN3C(=O)[C@@]4(O[C@@H](CC(=O)N5Cc6ccccc6C[C@H]5CO)[C@@H]([C@H]4C)[Si](C)(C)c7ccc(OC)cc7)c8ccccc38)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 H06 compound treatment 14.4342 4.708 2.5487 8.7657 -0.96501 -0.4315 1.4971 0.5792 3188362 PK04_102144 C[C@H](C=C)[C@H](O)c1ccc(O)c2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 H07 compound treatment 8.0288 -1.6974 -0.9189 11.6462 1.9154 0.8565 -0.0442 -0.0352 3188756 PK04_102145 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(Cc6cccc(c6)N7CCCCC7=O)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 H08 compound treatment 10.1484 0.42218 0.2286 10.5199 0.7891 0.3528 0.4111 0.9779 3069452 PK04_102146 CSc1ccc(NC(=O)O[C@@H](CC=C)c2ccc(O)c(F)c2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 H09 compound treatment 10.9474 1.2212 0.6611 9.7127 -0.018071 -0.0081 0.4617 0.6984 3188757 PK04_102147 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(Cc6ccc(cc6)N7CCOC7=O)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 H10 compound treatment 24.7243 14.998 8.1193 27.8577 18.127 8.1052 11.4725 1.0 3069454 PK04_102148 COc1ccc(NC(=O)O[C@@H]([C@@H](C)C=C)c2ccc(O)c3ccccc23)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 H11 compound treatment 12.9209 3.1947 1.7295 10.4676 0.73683 0.3295 1.4559 0.8269 3188758 PK04_102149 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(CCO)nn4)C(=O)N(Cc5cccc(c5)N6CCOC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 H12 compound treatment 13.6552 3.929 2.127 15.9251 6.1944 2.7697 3.4625 0.9915 3069456 PK04_102150 COc1ccc(NC(=O)O[C@H](CC=C)c2ccc(O)c(F)c2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 H13 compound treatment 9.6952 -0.03107 -0.0168 9.0631 -0.66763 -0.2985 -0.223 -0.7458 3188759 PK04_102151 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(Cc5cccc(c5)N6C(=O)COc7ccccc67)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 H14 compound treatment 63.4241 53.698 29.0697 27.0866 17.356 7.7604 26.0428 0.8656 3069458 PK04_102152 CSc1ccc(NC(=O)O[C@@H](CC=C)c2ccc(O)c3ccccc23)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 H15 compound treatment 9.4082 -0.31798 -0.1721 10.456 0.72524 0.3243 0.1076 0.293 3188760 PK04_102153 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(CCO)nn4)C(=O)N(CC=C)c5ccc(cc53)N6CCC6=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 H16 compound treatment 9.343 -0.3832 -0.2074 10.2563 0.52554 0.235 0.0195 0.0621 3069460 PK04_102154 COc1ccc(NC(=O)O[C@H](CC=C)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 H17 compound treatment 10.7041 0.97791 0.5294 13.4626 3.7318 1.6686 1.5542 0.8878 3188761 PK04_102155 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4ccccc4)c5ccc(cc53)N6CCC6=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 H18 compound treatment 16.8231 7.0968 3.8419 18.8875 9.1568 4.0943 5.6118 0.9995 3069461 PK04_102156 COc1ccc(NC(=O)O[C@H](CC=C)c2ccc(O)c3ccccc23)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 H19 mock treatment 9.7676 0.04136 0.0224 10.6564 0.92566 0.4139 0.3085 0.7443 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 H20 mock treatment 8.0883 -1.6379 -0.8867 10.5449 0.81414 0.364 -0.3696 -0.3856 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 H21 compound treatment 10.8966 1.1704 0.6336 9.946 0.21527 0.0963 0.5161 0.8053 3188762 PK04_102157 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(Cc5cccc(c5)N6CCCCC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 H22 compound treatment 32.8532 23.127 12.5199 28.0097 18.279 8.1732 14.6322 0.9786 3069504 PK04_102158 O[C@H](CC=C)c1ccc(O)c2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 H23 compound treatment 8.2413 -1.4849 -0.8039 8.0444 -1.6863 -0.754 -1.1016 -0.9995 3188763 PK04_102159 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N(CCO)Cc4ccccc4)C(=O)N(Cc5ccc(cc5)N6CCC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 H24 compound treatment 11.9422 2.2159 1.1996 12.2973 2.5665 1.1476 1.6597 0.9998 3069401 PK04_102160 CO[C@H](C=C)[C@H](O)c1ccc(OC)c(O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 I01 compound treatment 9.7601 0.033895 0.0183 11.2365 1.5057 0.6733 0.489 0.7261 3069507 PK04_102161 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N(CCO)Cc4ccccc4)C(=O)N(C)c5ccccc53 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 I02 compound treatment 10.9873 1.2611 0.6827 9.054 -0.67677 -0.3026 0.2688 0.3599 3188764 PK04_102162 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4ccccc4)c5ccc(cc53)N6C(=O)c7ccccc7Oc8ccccc68 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 I03 compound treatment 8.4322 -1.294 -0.7005 8.9053 -0.82544 -0.3691 -0.7563 -0.9552 3188765 PK04_102163 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(CCO)nn4)C(=O)N(C)c5ccccc53 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 I04 compound treatment 13.728 4.0017 2.1664 8.7641 -0.96669 -0.4322 1.2262 0.5551 3069594 PK04_102164 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4cccc(NC(=O)C)c4)c5ccccc53 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 I05 mock treatment 10.2302 0.50396 0.2728 9.2922 -0.43857 -0.1961 0.0542 0.1615 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 I06 mock treatment 9.2814 -0.44481 -0.2408 7.3736 -2.3572 -1.054 -0.9156 -0.8468 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 I07 compound treatment 11.36 1.6338 0.8845 9.4406 -0.29014 -0.1297 0.5337 0.597 3188766 PK04_102165 COc1ccc(cc1)[Si](C)(C)[C@@H](CCn2cc(nn2)[C@H](O)c3ccccc3)/C=C/C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 I08 compound treatment 10.5227 0.79647 0.4312 10.8768 1.1461 0.5124 0.6672 0.9963 3188767 PK04_102166 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(nn4)[C@H](O)c5ccccc5)C(=O)N(Cc6cccc(c6)N7CCOC7=O)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 I09 compound treatment 9.4022 -0.32404 -0.1754 7.8618 -1.869 -0.8357 -0.715 -0.8373 3069598 PK04_102167 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(C)c5ccccc53 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 I10 compound treatment 8.1979 -1.5283 -0.8274 11.3537 1.623 0.7257 -0.0719 -0.0653 3188768 PK04_102168 COc1ccc(cc1)C(=O)Nc2ccc(CN3C(=O)[C@@]4(O[C@@H](CCn5cc(CCO)nn5)[C@@H]([C@H]4C)[Si](C)(C)c6ccc(OC)cc6)c7ccccc37)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 I11 compound treatment 10.2347 0.50849 0.2753 9.5994 -0.13135 -0.0587 0.1531 0.544 3188769 PK04_102169 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(CC=C)c4ccc(I)cc43 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 I12 compound treatment 8.9676 -0.75863 -0.4107 8.5492 -1.1815 -0.5283 -0.664 -0.9922 3069636 PK04_102170 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4cccc(c4)N5CCOC5=O)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 I13 compound treatment 9.0897 -0.63655 -0.3446 9.9294 0.19866 0.0888 -0.1809 -0.5082 3188770 PK04_102171 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N(CCO)Cc4ccccc4)C(=O)N(c5ccccc53)c6ccccc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 I14 compound treatment 10.9136 1.1874 0.6428 10.1448 0.41403 0.1851 0.5854 0.8752 3188771 PK04_102172 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4ccc(cc4)N5C(=O)c6ccccc6Oc7ccccc57)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 I15 compound treatment 7.9847 -1.7415 -0.9428 10.3739 0.6431 0.2876 -0.4633 -0.4701 3069640 PK04_102173 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(CCO)nn4)C(=O)N(C)c5ccccc53 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 I16 compound treatment 8.158 -1.5682 -0.849 10.336 0.60521 0.2706 -0.409 -0.459 3188888 PK04_102174 COc1ccc(cc1)C(=O)Nc2ccc3N(CC=C)C(=O)[C@]4(O[C@H](CCO)[C@H]([C@@H]4C)[Si](C)(C)c5ccc(OC)cc5)c3c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 I17 compound treatment 10.5876 0.86138 0.4663 10.0687 0.33792 0.1511 0.4366 0.8906 3069645 PK04_102175 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(CC=C)c4ccc(NC(=O)C)cc43 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 I18 compound treatment 10.7959 1.0697 0.5791 9.7521 0.021374 0.0096 0.4162 0.7187 3188889 PK04_102176 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(nn4)[C@H](O)c5ccccc5)C(=O)N(CC=C)c6ccc(cc63)N7C(=O)c8cccc9cccc7c89 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 I19 compound treatment 11.7521 2.0258 1.0967 11.0503 1.3195 0.59 1.1927 0.9577 3069647 PK04_102177 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4cccc(c4)N5C(=O)c6cccc7cccc5c67)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 I20 compound treatment 11.1166 1.3903 0.7527 10.0021 0.27134 0.1213 0.618 0.8106 3188890 PK04_102178 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4ccc(cc4)N5C(=O)c6ccccc6Oc7ccccc57)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 I21 mock treatment 9.7804 0.054138 0.0293 9.1413 -0.58943 -0.2636 -0.1656 -0.6246 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 I22 mock treatment 9.0142 -0.71199 -0.3854 9.4599 -0.27088 -0.1211 -0.3582 -0.8866 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 I23 compound treatment 13.9274 4.2012 2.2743 16.9754 7.2446 3.2393 3.8988 0.985 3188891 PK04_102179 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(CC=C)c4ccc(cc43)N5C(=O)c6cccc7cccc5c67 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 I24 compound treatment 14.4419 4.7156 2.5528 14.813 5.0822 2.2724 3.412 0.9983 3069706 PK04_102180 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(CC=C)c4ccc(cc43)N(C=O)c5ccccc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 J01 compound treatment 8.677 -1.0492 -0.568 9.6429 -0.087856 -0.0393 -0.4294 -0.7542 3188892 PK04_102181 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N(CCO)Cc4ccccc4)C(=O)N(Cc5ccc(cc5)N6CCC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 J02 compound treatment 9.0373 -0.68888 -0.3729 10.5342 0.80346 0.3593 -0.0097 -0.0187 3069707 PK04_102182 CSc1ccc(NC(=O)O[C@@H](CC=C)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 J03 compound treatment 7.998 -1.7282 -0.9356 8.8329 -0.89789 -0.4015 -0.9454 -0.9287 3188893 PK04_102183 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N(CCO)Cc4ccccc4)C(=O)N(Cc5cccc(c5)N6CCCCC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 J04 compound treatment 10.5061 0.77986 0.4222 8.6162 -1.1145 -0.4983 -0.0539 -0.0825 3069711 PK04_102184 CO[C@H](C=C)[C@H](OC(=O)Nc1ccc(OC)cc1)c2ccc(OC)c(O)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 J05 mock treatment 10.3121 0.58586 0.3172 9.887 0.15621 0.0698 0.2737 0.8426 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 J06 mock treatment 7.8536 -1.8726 -1.0137 10.702 0.97121 0.4343 -0.4098 -0.3715 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 J07 compound treatment 12.9019 3.1756 1.7192 7.6317 -2.0991 -0.9386 0.5519 0.2818 3188894 PK04_102185 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(nn4)[C@H](O)c5ccccc5)C(=O)N(Cc6cccc(c6)N7CCC7=O)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 J08 compound treatment 9.2866 -0.43966 -0.238 13.6077 3.8769 1.7335 1.0575 0.6043 3069714 PK04_102186 COc1ccc(NC(=O)O[C@@H](CC=C)c2ccc(O)c3ccccc23)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 J09 compound treatment 9.5377 -0.18857 -0.1021 8.8999 -0.83088 -0.3715 -0.3349 -0.8692 3188895 PK04_102187 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(Cc6cccc(c6)N7CCC7=O)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 J10 compound treatment 9.1705 -0.55571 -0.3008 9.5897 -0.14101 -0.0631 -0.2573 -0.8371 3069716 PK04_102188 CO[C@@H](C=C)[C@@H](O)c1ccc(O)c(F)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 J11 compound treatment 9.0877 -0.63855 -0.3457 9.8314 0.10063 0.045 -0.2126 -0.6099 3188896 PK04_102189 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N(CCO)Cc4ccccc4)C(=O)N(Cc5ccc(cc5)N6CCOC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 J12 compound treatment 26.0373 16.311 8.8301 33.148 23.417 10.4707 13.6477 0.9964 3069744 PK04_102190 COc1ccc(NC(=O)O[C@H]([C@@H](C)C=C)c2ccc(O)c3ccccc23)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 J13 compound treatment 9.245 -0.48125 -0.2605 11.8664 2.1356 0.9549 0.491 0.4961 3188897 PK04_102191 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(Cc6cccc(c6)N7C(=O)c8cccc9cccc7c89)c%10ccccc%103 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 J14 compound treatment 9.9385 0.2123 0.1149 9.889 0.15824 0.0708 0.1313 0.9728 3069746 PK04_102192 OCCOc1ccc(cc1)[C@@H](O)CC=C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 J15 compound treatment 9.664 -0.062205 -0.0337 8.7107 -1.02 -0.4561 -0.3463 -0.7573 3069749 PK04_102193 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(CCO)nn4)C(=O)N(Cc5cccc(c5)N6CCC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 J16 compound treatment 9.0847 -0.64148 -0.3473 10.6349 0.90411 0.4043 0.0403 0.0756 3188898 PK04_102194 CO[C@H](C=C)[C@H](OC(=O)Nc1ccc(SC)cc1)c2ccc(OCCO)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 J17 compound treatment 10.2878 0.56158 0.304 8.8745 -0.85625 -0.3829 -0.0557 -0.114 3188899 PK04_102195 COc1ccc(cc1)C(=O)Nc2ccc(CN3C(=O)[C@]4(O[C@H](CC(=O)N5CCC[C@H]5CO)[C@H]([C@@H]4C)[Si](C)(C)c6ccc(OC)cc6)c7ccccc37)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 J18 compound treatment 19.968 10.242 5.5445 10.5032 0.77241 0.3454 4.1647 0.7497 3069504 PK04_102196 O[C@H](CC=C)c1ccc(O)c2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 J19 compound treatment 9.1106 -0.6156 -0.3333 8.891 -0.83973 -0.3755 -0.5012 -0.9982 3188900 PK04_102197 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(Cc6ccc(cc6)N7C(=O)c8cccc9cccc7c89)c%10ccccc%103 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 J20 compound treatment 14.1661 4.4399 2.4036 12.261 2.5303 1.1314 2.4996 0.9409 3069264 PK04_102198 C[C@H](C=C)[C@@H](O)c1ccc(O)c2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 J21 mock treatment 9.196 -0.53027 -0.2871 9.5906 -0.14014 -0.0627 -0.2473 -0.8416 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 J22 mock treatment 7.9067 -1.8195 -0.985 9.3656 -0.36512 -0.1633 -0.8119 -0.8132 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 J23 compound treatment 9.1607 -0.56556 -0.3062 9.0032 -0.72753 -0.3253 -0.4465 -0.9995 3069786 PK04_102199 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(Cc5ccc(cc5)N6CCC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 J24 compound treatment 8.8592 -0.86705 -0.4694 10.7533 1.0226 0.4572 -0.0086 -0.0131 3188901 PK04_102200 CSc1ccc(NC(=O)O[C@H](CC=C)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 K01 compound treatment 8.6333 -1.093 -0.5917 10.7557 1.0249 0.4583 -0.0943 -0.126 3069787 PK04_102201 COc1ccc(cc1)[Si](C)(C)[C@@H](CCn2cc(CCO)nn2)/C=C/C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 K02 compound treatment 11.0061 1.2799 0.6929 10.5986 0.86785 0.388 0.7643 0.9625 3188902 PK04_102202 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4ccccc4)c5ccc(NC(=O)[C@H](C)O)cc53 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 K03 compound treatment 9.0993 -0.62689 -0.3394 8.2885 -1.4422 -0.6449 -0.696 -0.9551 3188903 PK04_102203 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(nn4)[C@H](O)c5ccccc5)C(=O)N(C)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 K04 compound treatment 18.8002 9.074 4.9123 13.1373 3.4066 1.5232 4.5506 0.8848 3069790 PK04_102204 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4ccccc4)c5ccc(cc53)N(C=O)c6ccccc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 K05 compound treatment 9.907 0.18082 0.0979 9.1748 -0.55599 -0.2486 -0.1066 -0.3989 3188904 PK04_102205 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(C)c5c3cc(C)cc5Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 K06 compound treatment 20.2869 10.561 5.7171 18.7013 8.9705 4.011 6.8788 0.985 3189012 PK04_102206 COc1ccc(cc1)C(=O)Nc2ccc(CN3C(=O)[C@]4(O[C@H](CCO)[C@H]([C@@H]4C)[Si](C)(C)c5ccc(OC)cc5)c6ccccc36)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 K07 mock treatment 8.5037 -1.2226 -0.6618 9.0136 -0.71719 -0.3207 -0.6948 -0.9447 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 K08 mock treatment 10.5447 0.81848 0.4431 9.0093 -0.72142 -0.3226 0.0852 0.1555 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 K09 compound treatment 9.3128 -0.41339 -0.2238 8.4914 -1.2394 -0.5542 -0.5501 -0.9204 3069821 PK04_102207 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(nn4)[C@H](O)c5ccccc5)C(=O)N(CC=C)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 K10 compound treatment 10.0904 0.36416 0.1971 8.9391 -0.79165 -0.354 -0.1109 -0.2737 3189013 PK04_102208 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(CC=C)c4ccc(NC(=O)C)cc43 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 K11 compound treatment 7.8913 -1.835 -0.9934 9.1521 -0.57863 -0.2587 -0.8854 -0.8625 3069825 PK04_102209 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N4c5c3cc(OC)cc5C(=CC4(C)C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 K12 compound treatment 11.7735 2.0472 1.1083 13.6337 3.903 1.7452 2.0177 0.976 3189014 PK04_102210 COc1ccc(cc1)C(=O)Nc2ccc(CN3C(=O)[C@@]4(O[C@@H](CCO)[C@@H]([C@H]4C)[Si](C)(C)c5ccc(OC)cc5)c6ccccc36)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 K13 compound treatment 7.9614 -1.7648 -0.9554 8.7098 -1.021 -0.4565 -0.9984 -0.9429 3189015 PK04_102211 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(C)c5c3cc(C)cc5Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 K14 compound treatment 9.7523 0.026093 0.0141 9.4538 -0.27699 -0.1239 -0.0776 -0.6224 3069831 PK04_102212 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4cccc(c4)N5CCOC5=O)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 K15 mock treatment 8.7587 -0.96749 -0.5238 10.0188 0.28807 0.1288 -0.2793 -0.5178 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 K16 mock treatment 9.7202 -0.0060049 -0.0033 10.4889 0.75815 0.339 0.2374 0.7003 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 K17 compound treatment 11.3365 1.6103 0.8717 11.1407 1.4099 0.6304 1.0622 0.9873 3189016 PK04_102213 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(CC=C)c4ccc(cc43)N5C(=O)COc6ccccc56 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 K18 compound treatment 9.0563 -0.66995 -0.3627 8.5492 -1.1815 -0.5283 -0.63 -0.9832 3069867 PK04_102214 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4ccccc4)c5ccc(NC(=O)C)cc53 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 K19 compound treatment 9.3349 -0.39128 -0.2118 8.6576 -1.0731 -0.4798 -0.4891 -0.9324 3189017 PK04_102215 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4ccccc4)c5ccc(cc53)N6C(=O)c7cccc8cccc6c78 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 K20 compound treatment 9.1007 -0.62552 -0.3386 8.0337 -1.697 -0.7588 -0.776 -0.9339 3069873 PK04_102216 COc1ccc(cc1)C(=O)Nc2ccc3N(CC=C)C(=O)[C@@]4(O[C@@H](CCO)[C@@H]([C@H]4C)[Si](C)(C)c5ccc(OC)cc5)c3c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 K21 compound treatment 8.2424 -1.4839 -0.8033 11.5245 1.7938 0.8021 -9.0E-4 -8.0E-4 3189018 PK04_102217 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4ccc(cc4)N5C(=O)c6cccc7cccc5c67)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 K22 compound treatment 9.4076 -0.31865 -0.1725 10.1346 0.40387 0.1806 0.0057 0.0229 3189019 PK04_102218 COc1ccc(cc1)C(=O)Nc2ccc(CN3C(=O)[C@]4(O[C@H](CCn5cc(CCO)nn5)[C@H]([C@@H]4C)[Si](C)(C)c6ccc(OC)cc6)c7ccccc37)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 K23 mock treatment 10.0384 0.31215 0.169 10.7813 1.0505 0.4697 0.4516 0.9047 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 K24 mock treatment 10.7367 1.0105 0.547 9.1126 -0.61819 -0.2764 0.1914 0.3122 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 L01 compound treatment 8.909 -0.81719 -0.4424 10.1415 0.41074 0.1837 -0.183 -0.382 3069879 PK04_102219 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(Cc5cccc(c5)N6C(=O)c7cccc8cccc6c78)c9ccccc93 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 L02 compound treatment 10.2182 0.49197 0.2663 9.1275 -0.60323 -0.2697 -0.0024 -0.0063 3189020 PK04_102220 C[C@@H](C=C)[C@H](O)c1ccc(OCCO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 L03 compound treatment 8.4912 -1.235 -0.6686 8.3452 -1.3855 -0.6195 -0.9108 -0.9993 3189021 PK04_102221 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(Cc6ccc(cc6)N7C(=O)c8cccc9cccc7c89)c%10ccccc%103 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 L04 compound treatment 10.4048 0.67855 0.3673 8.29 -1.4408 -0.6442 -0.1958 -0.264 3069907 PK04_102222 C[C@H](C=C)[C@@H](O)c1ccc(OCCO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 L05 compound treatment 17.4485 7.7223 4.1805 13.3043 3.5736 1.5979 4.0859 0.913 3189022 PK04_102223 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(Cc6ccc(cc6)N7CCC7=O)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 L06 compound treatment 11.1906 1.4643 0.7927 10.784 1.0533 0.471 0.8936 0.9691 3069909 PK04_102224 C[C@@H](C=C)[C@@H](O)c1ccc(O)c2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 L07 mock treatment 9.5728 -0.15344 -0.0831 8.685 -1.0458 -0.4676 -0.3894 -0.8199 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 L08 mock treatment 10.7927 1.0665 0.5774 10.0969 0.3661 0.1637 0.524 0.8732 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 L09 compound treatment 9.3332 -0.393 -0.2128 9.8144 0.083649 0.0374 -0.124 -0.574 3189023 PK04_102225 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4cccc(c4)N5CCC5=O)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 L10 compound treatment 7.43 -2.2963 -1.2431 9.6371 -0.093701 -0.0419 -0.9086 -0.7305 3069912 PK04_102226 COc1ccc(NC(=O)O[C@H]([C@@H](C)C=C)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 L11 compound treatment 8.7653 -0.96094 -0.5202 8.3825 -1.3482 -0.6028 -0.7941 -0.9973 3189024 PK04_102227 COc1ccc(cc1)C(=O)Nc2cccc(CN3C(=O)[C@@]4(O[C@@H](CC(=O)N5CCC[C@H]5CO)[C@@H]([C@H]4C)[Si](C)(C)c6ccc(OC)cc6)c7ccccc37)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 L12 compound treatment 9.3747 -0.35154 -0.1903 9.6597 -0.071049 -0.0318 -0.157 -0.8139 3069746 PK04_102228 OCCOc1ccc(cc1)[C@@H](O)CC=C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 L13 compound treatment 9.44 -0.28626 -0.155 9.8142 0.083459 0.0373 -0.0832 -0.5219 3069917 PK04_102229 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(CC=C)c4ccc(cc43)N5CCC5=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 L14 compound treatment 10.4898 0.7636 0.4134 9.7994 0.068626 0.0307 0.314 0.7575 3069920 PK04_102230 O[C@@H](CC=C)c1ccc(O)c(F)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 L15 mock treatment 8.9224 -0.80384 -0.4352 12.127 2.3962 1.0714 0.4499 0.3891 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 L16 mock treatment 7.5504 -2.1759 -1.1779 9.627 -0.10373 -0.0464 -0.8657 -0.7344 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 L17 compound treatment 9.3829 -0.34335 -0.1859 9.0928 -0.63793 -0.2852 -0.3331 -0.9785 3189025 PK04_102231 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(Cc5cccc(c5)N6CCOC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 L18 compound treatment 10.1004 0.37416 0.2026 9.6113 -0.11951 -0.0534 0.1054 0.5033 3069953 PK04_102232 CO[C@H](C=C)[C@H](O)c1ccc(OCCO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 L19 compound treatment 8.7503 -0.97588 -0.5283 10.8616 1.1309 0.5056 -0.016 -0.0219 3189026 PK04_102233 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(CCO)nn4)C(=O)N(Cc5ccc(cc5)N6CCC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 L20 compound treatment 10.142 0.41578 0.2251 9.2212 -0.50953 -0.2278 -0.0019 -0.0061 3069956 PK04_102234 CO[C@@H](C=C)[C@@H](O)c1ccc(OC)c(O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 L21 compound treatment 9.1686 -0.55764 -0.3019 8.8531 -0.87769 -0.3924 -0.491 -0.9916 3189027 PK04_102235 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(Cc5cccc(c5)N6CCCCC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 L22 compound treatment 9.6413 -0.084922 -0.046 8.3171 -1.4137 -0.6321 -0.4795 -0.7565 3069961 PK04_102236 CO[C@H](C=C)[C@H](OC(=O)Nc1ccc(OC)cc1)c2ccc(OCCO)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 L23 mock treatment 11.4628 1.7366 0.9401 9.0669 -0.66386 -0.2968 0.4549 0.4614 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 L24 mock treatment 9.1592 -0.56699 -0.3069 8.7399 -0.99082 -0.443 -0.5303 -0.9839 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 M01 compound treatment 10.66 0.93377 0.5055 10.8435 1.1127 0.4975 0.7093 1.0 3069962 PK04_102237 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N(CCO)Cc4ccccc4)C(=O)N(c5ccccc53)c6ccccc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 M02 compound treatment 11.7614 2.0352 1.1018 10.536 0.80519 0.36 1.0336 0.8918 3188628 PK04_102238 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(CCO)nn4)C(=O)N(CC=C)c5ccc(cc53)N6C(=O)c7cccc8cccc6c78 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 M03 compound treatment 8.6816 -1.0446 -0.5655 11.3377 1.6069 0.7185 0.1082 0.1183 3189028 PK04_102239 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(C)c6c3cc(C)cc6Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 M04 compound treatment 13.8843 4.158 2.251 10.0962 0.36542 0.1634 1.7072 0.7564 3189141 PK04_102240 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(CC=C)c4ccc(cc43)N5CCCCC5=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 M05 compound treatment 12.5704 2.8442 1.5397 11.6471 1.9164 0.8569 1.6946 0.9617 3069277 PK04_102241 COc1ccc(cc1)[Si](C)(C)[C@@H](CC(=O)N(CCO)Cc2ccccc2)/C=C/C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 M06 compound treatment 11.365 1.6388 0.8872 8.3415 -1.3893 -0.6212 0.1881 0.1737 3189142 PK04_102242 COc1ccc(cc1)C(=O)Nc2cccc(CN3C(=O)[C@@]4(O[C@@H](CCn5cc(CCO)nn5)[C@@H]([C@H]4C)[Si](C)(C)c6ccc(OC)cc6)c7ccccc37)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 M07 compound treatment 10.8767 1.1505 0.6228 9.4174 -0.31339 -0.1401 0.3413 0.5347 3189143 PK04_102243 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N4c5c3cc(OC)cc5C(=CC4(C)C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 M08 compound treatment 11.8743 2.1481 1.1629 9.7424 0.011671 0.0052 0.826 0.7103 3069284 PK04_102244 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4ccccc4)c5ccc(NC(=O)[C@H](C)O)cc53 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 M09 mock treatment 9.0482 -0.678 -0.367 9.759 0.028194 0.0126 -0.2506 -0.6824 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 M10 mock treatment 9.8613 0.13504 0.0731 8.1246 -1.6061 -0.7182 -0.4561 -0.6319 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 M11 compound treatment 8.2523 -1.4739 -0.7979 10.2373 0.5065 0.2265 -0.4041 -0.4872 3189144 PK04_102245 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(C)c5ccccc53 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 M12 compound treatment 10.6845 0.95823 0.5187 10.8375 1.1068 0.4949 0.7167 0.9997 3189145 PK04_102246 COc1ccc(cc1)C(=O)Nc2ccc(CN3C(=O)[C@]4(O[C@H](CCn5cc(nn5)[C@H](O)c6ccccc6)[C@H]([C@@H]4C)[Si](C)(C)c7ccc(OC)cc7)c8ccccc38)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 M13 mock treatment 9.272 -0.45418 -0.2459 8.8868 -0.84392 -0.3773 -0.4407 -0.9785 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 M14 mock treatment 9.4276 -0.29864 -0.1617 10.3569 0.62612 0.28 0.0836 0.2587 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 M15 compound treatment 10.8066 1.0804 0.5849 8.8354 -0.89534 -0.4003 0.1305 0.1841 3189146 PK04_102247 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(CCO)nn4)C(=O)N(CC=C)c5ccccc53 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 M16 compound treatment 8.4053 -1.321 -0.7151 8.3323 -1.3985 -0.6253 -0.9478 -0.9978 3189147 PK04_102248 COc1ccc(cc1)C(=O)Nc2ccc(CN3C(=O)[C@@]4(O[C@@H](CCn5cc(nn5)[C@H](O)c6ccccc6)[C@@H]([C@H]4C)[Si](C)(C)c7ccc(OC)cc7)c8ccccc38)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 M17 compound treatment 9.7347 0.0084576 0.0046 8.6211 -1.1097 -0.4962 -0.3476 -0.7006 3069327 PK04_102249 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4ccccc4)c5ccc(NC(=O)C)cc53 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 M18 compound treatment 8.0035 -1.7227 -0.9326 8.9962 -0.73453 -0.3284 -0.8917 -0.9018 3189148 PK04_102250 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(CC=C)c4ccc(cc43)N5CCOC5=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 M19 compound treatment 10.2898 0.56359 0.3051 8.3952 -1.3356 -0.5972 -0.2065 -0.308 3069330 PK04_102251 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(nn4)[C@H](O)c5ccccc5)C(=O)N(Cc6ccc(cc6)N7C(=O)c8cccc9cccc7c89)c%10ccccc%103 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 M20 compound treatment 10.7869 1.0606 0.5742 11.4261 1.6953 0.758 0.942 0.9906 3189149 PK04_102252 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4cccc(c4)N5CCCCC5=O)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 M21 compound treatment 18.8901 9.1639 4.9609 8.9644 -0.76639 -0.3427 3.2656 0.6567 3189150 PK04_102253 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4cccc(c4)N5C(=O)c6ccccc6Oc7ccccc57)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 M22 compound treatment 8.4996 -1.2266 -0.664 11.0954 1.3647 0.6102 -0.0381 -0.0422 3189151 PK04_102254 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(nn4)[C@H](O)c5ccccc5)C(=O)N(Cc6cccc(c6)N7CCOC7=O)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 M23 compound treatment 9.3063 -0.41993 -0.2273 9.9628 0.23204 0.1038 -0.0874 -0.3497 3189152 PK04_102255 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4ccccc4)c5ccc(cc53)N6C(=O)c7cccc8cccc6c78 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 M24 compound treatment 25.603 15.877 8.595 26.2248 16.494 7.3751 11.2925 0.9971 3069375 PK04_102256 COc1ccc(cc1)C(=O)Nc2cccc(CN3C(=O)[C@@]4(O[C@@H](CCO)[C@@H]([C@H]4C)[Si](C)(C)c5ccc(OC)cc5)c6ccccc36)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 N01 compound treatment 9.8843 0.15802 0.0855 11.291 1.5603 0.6976 0.5538 0.7879 3189153 PK04_102257 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N(CCO)Cc4ccccc4)C(=O)N(Cc5cccc(c5)N6C(=O)c7cccc8cccc6c78)c9ccccc93 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 N02 compound treatment 8.9855 -0.7407 -0.401 8.7879 -0.94284 -0.4216 -0.5816 -0.9997 3069379 PK04_102258 CSc1ccc(NC(=O)O[C@@H]([C@H](C)C=C)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 N03 compound treatment 8.3491 -1.3771 -0.7455 8.1895 -1.5412 -0.6891 -1.0145 -0.9992 3189154 PK04_102259 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(nn4)[C@H](O)c5ccccc5)C(=O)N(Cc6ccc(cc6)N7CCC7=O)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 N04 compound treatment 9.9126 0.18641 0.1009 9.4208 -0.30997 -0.1386 -0.0266 -0.1554 3069716 PK04_102260 CO[C@@H](C=C)[C@@H](O)c1ccc(O)c(F)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 N05 compound treatment 16.68 6.9538 3.7645 9.3749 -0.3559 -0.1591 2.5494 0.6766 3069403 PK04_102261 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(CCO)nn4)C(=O)N(CC=C)c5ccc(cc53)N6CCC6=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 N06 compound treatment 9.5232 -0.20303 -0.1099 9.2785 -0.45229 -0.2022 -0.2207 -0.9589 3069417 PK04_102262 C[C@H](C=C)[C@H](O)c1ccc(OCCO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 N07 compound treatment 9.7884 0.062148 0.0336 9.5013 -0.22943 -0.1026 -0.0487 -0.4515 3189155 PK04_102263 COc1ccc(cc1)C(=O)Nc2cccc(CN3C(=O)[C@]4(O[C@H](CC(=O)N(CCO)Cc5ccccc5)[C@H]([C@@H]4C)[Si](C)(C)c6ccc(OC)cc6)c7ccccc37)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 N08 compound treatment 10.7863 1.06 0.5739 10.2856 0.55485 0.2481 0.5812 0.9296 3069421 PK04_102264 CO[C@@H](C=C)[C@@H](OC(=O)Nc1ccc(SC)cc1)c2ccc(OCCO)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 N09 mock treatment 10.3776 0.65133 0.3526 8.3813 -1.3494 -0.6034 -0.1773 -0.2537 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 N10 mock treatment 8.8444 -0.88187 -0.4774 8.1922 -1.5386 -0.688 -0.824 -0.9841 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 N11 compound treatment 15.2525 5.5263 2.9917 10.1381 0.40736 0.1821 2.2443 0.7488 3189156 PK04_102265 COc1ccc(cc1)C(=O)Nc2cccc(CN3C(=O)[C@@]4(O[C@@H](CC(=O)N5Cc6ccccc6C[C@H]5CO)[C@@H]([C@H]4C)[Si](C)(C)c7ccc(OC)cc7)c8ccccc38)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 N12 compound treatment 8.7224 -1.0039 -0.5435 8.9651 -0.76567 -0.3424 -0.6264 -0.9752 3069424 PK04_102266 CO[C@@H](C=C)[C@@H](OC(=O)Nc1ccc(OC)cc1)c2ccc(O)c(F)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 N13 mock treatment 9.3167 -0.40958 -0.2217 9.6392 -0.091571 -0.0409 -0.1857 -0.8238 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 N14 mock treatment 11.2502 1.5239 0.825 9.0098 -0.721 -0.3224 0.3554 0.4012 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 N15 compound treatment 10.7561 1.0298 0.5575 10.01 0.27924 0.1249 0.4825 0.8445 3189268 PK04_102267 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(Cc6cccc(c6)N7C(=O)c8cccc9cccc7c89)c%10ccccc%103 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 N16 compound treatment 10.4437 0.71744 0.3884 10.0798 0.34901 0.1561 0.385 0.9198 3069404 PK04_102268 C[C@@H](C=C)[C@@H](O)c1ccc(OCCO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 N17 compound treatment 9.2294 -0.49679 -0.2689 9.1563 -0.57449 -0.2569 -0.3718 -0.9997 3069428 PK04_102269 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(Cc5cccc(c5)N6CCC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 N18 compound treatment 9.5365 -0.18973 -0.1027 10.3185 0.58777 0.2628 0.1132 0.4012 3189269 PK04_102270 CO[C@@H](C=C)[C@@H](OC(=O)Nc1ccc(OC)cc1)c2ccc(OCCO)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 N19 compound treatment 9.75 0.023778 0.0129 10.6946 0.96381 0.431 0.3138 0.7279 3070277 PK04_102271 COc1ccc(cc1)C(=O)Nc2ccc(CN3C(=O)[C@@]4(O[C@@H](CC(=O)N5CCC[C@H]5CO)[C@@H]([C@H]4C)[Si](C)(C)c6ccc(OC)cc6)c7ccccc37)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 N20 compound treatment 10.5104 0.78421 0.4245 8.7985 -0.93223 -0.4168 0.0054 0.0092 3069270 PK04_102272 CO[C@@H](C=C)[C@@H](O)c1ccc(OCCO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 N21 compound treatment 9.4669 -0.2593 -0.1404 11.3516 1.6208 0.7247 0.4132 0.5597 3070278 PK04_102273 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4cccc(c4)N5CCC5=O)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 N22 compound treatment 10.4183 0.69207 0.3747 9.4857 -0.24506 -0.1096 0.1874 0.4802 3070279 PK04_102274 CSc1ccc(NC(=O)O[C@H](CC=C)c2ccc(O)c(F)c2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 N23 compound treatment 9.6379 -0.088342 -0.0478 8.3729 -1.3579 -0.6072 -0.4631 -0.7604 3070280 PK04_102275 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N(CCO)Cc4ccccc4)C(=O)N(Cc5cccc(c5)N6C(=O)COc7ccccc67)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 N24 compound treatment 10.005 0.27875 0.1509 10.1679 0.43712 0.1955 0.2449 0.9918 3189270 PK04_102276 CO[C@@H](C=C)[C@@H](OC(=O)Nc1ccc(SC)cc1)c2ccc(OC)c(O)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 O01 compound treatment 7.7681 -1.9581 -1.06 10.7047 0.97399 0.4355 -0.4416 -0.3853 3189271 PK04_102277 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(c5ccccc53)c6ccccc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 O02 compound treatment 10.2376 0.51136 0.2768 8.8507 -0.88004 -0.3935 -0.0825 -0.1715 3070281 PK04_102278 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4cccc(c4)N(C=O)c5ccccc5)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 O03 compound treatment 8.9992 -0.72699 -0.3936 10.3248 0.594 0.2656 -0.0905 -0.1906 3189272 PK04_102279 COc1ccc(cc1)[Si](C)(C)[C@@H](CC(=O)N2CCC[C@H]2CO)/C=C/C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 O04 compound treatment 24.5748 14.849 8.0383 11.1746 1.4438 0.6456 6.1405 0.7614 3189273 PK04_102280 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4cccc(NC(=O)[C@H](C)O)c4)c5ccccc53 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 O05 compound treatment 15.6238 5.8976 3.1927 12.082 2.3512 1.0513 3.001 0.8928 3070282 PK04_102281 COc1ccc(cc1)[Si](C)(C)[C@H](CC(=O)N(CCO)Cc2ccccc2)/C=C/C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 O06 compound treatment 25.5663 15.84 8.5751 38.7377 29.007 12.97 15.2347 0.9798 3189274 PK04_102282 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(CC=C)c4ccc(cc43)N5C(=O)c6cccc7cccc5c67 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 O07 compound treatment 11.6397 1.9134 1.0358 7.8492 -1.8816 -0.8413 0.1375 0.1031 3070283 PK04_102283 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N(CCO)Cc4ccccc4)C(=O)N(C)c5c3cc(C)cc5Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 O08 compound treatment 10.823 1.0968 0.5938 9.7575 0.026734 0.012 0.4283 0.7212 3189275 PK04_102284 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4ccccc4)c5ccc(cc53)N(C=O)c6ccccc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 O09 compound treatment 9.6858 -0.040402 -0.0219 12.0164 2.2857 1.022 0.7072 0.6918 3189276 PK04_102285 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(C)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 O10 compound treatment 9.5807 -0.14555 -0.0788 8.9358 -0.79498 -0.3555 -0.3071 -0.8434 3070284 PK04_102286 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(CCO)nn4)C(=O)N(Cc5ccc(cc5)N6CCOC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 O11 mock treatment 11.1116 1.3854 0.75 11.6464 1.9157 0.8566 1.136 0.9978 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 O12 mock treatment 10.1501 0.42387 0.2295 10.9999 1.2692 0.5675 0.5635 0.9206 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 O13 compound treatment 9.1743 -0.55193 -0.2988 11.2684 1.5376 0.6875 0.2749 0.3667 3189277 PK04_102287 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(C)c4ccccc43 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 O14 compound treatment 9.2838 -0.44247 -0.2395 9.9894 0.25862 0.1156 -0.0876 -0.3294 3189278 PK04_102288 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(CC=C)c4ccc(NC(=O)[C@H](C)O)cc43 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 O15 compound treatment 9.9465 0.22029 0.1193 9.716 -0.014764 -0.0066 0.0797 0.6669 3070285 PK04_102289 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(c4ccccc43)c5ccccc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 O16 compound treatment 15.6403 5.914 3.2016 9.9374 0.20664 0.0924 2.3292 0.7272 3189279 PK04_102290 COc1ccc(cc1)C(=O)Nc2ccc3N(CC=C)C(=O)[C@]4(O[C@H](CCn5cc(nn5)[C@H](O)c6ccccc6)[C@H]([C@@H]4C)[Si](C)(C)c7ccc(OC)cc7)c3c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 O17 compound treatment 8.8204 -0.90587 -0.4904 9.1372 -0.59357 -0.2654 -0.5344 -0.9584 3070286 PK04_102291 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(nn4)[C@H](O)c5ccccc5)C(=O)N(CC=C)c6ccc(cc63)N7C(=O)c8cccc9cccc7c89 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 O18 compound treatment 9.3376 -0.38866 -0.2104 9.7892 0.058426 0.0261 -0.1303 -0.6146 3189280 PK04_102292 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4ccccc4)c5ccc(cc53)N6CCCCC6=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 O19 compound treatment 9.8132 0.086998 0.0471 8.9852 -0.74554 -0.3334 -0.2024 -0.6012 3189281 PK04_102293 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(CCO)nn4)C(=O)N(Cc5cccc(c5)N6C(=O)c7cccc8cccc6c78)c9ccccc93 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 O20 compound treatment 10.3645 0.63826 0.3455 13.3363 3.6055 1.6121 1.3843 0.8396 3070287 PK04_102294 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4ccc(cc4)N5CCCCC5=O)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 O21 compound treatment 10.56 0.83381 0.4514 10.0684 0.33764 0.151 0.4259 0.8949 3189282 PK04_102295 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4cccc(c4)N5C(=O)COc6ccccc56)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 O22 compound treatment 11.0278 1.3015 0.7046 11.8999 2.1692 0.9699 1.1841 0.9877 3070288 PK04_102296 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(CC=C)c4ccc(cc43)N5C(=O)c6ccccc6Oc7ccccc57 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 O23 compound treatment 10.369 0.64277 0.348 10.879 1.1482 0.5134 0.6091 0.982 3189283 PK04_102297 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(CCO)nn4)C(=O)N(CC=C)c5ccc(cc53)N6C(=O)c7cccc8cccc6c78 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 O24 compound treatment 9.9398 0.21356 0.1156 10.2461 0.51532 0.2304 0.2447 0.9491 3189284 PK04_102298 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4ccc(NC(=O)C)cc4)c5ccccc53 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 P01 compound treatment 8.5856 -1.1406 -0.6175 9.5309 -0.19982 -0.0893 -0.4998 -0.8011 3070289 PK04_102299 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(CCO)nn4)C(=O)N(Cc5ccc(cc5)N6CCC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 P02 compound treatment 9.3574 -0.36885 -0.1997 9.3602 -0.37054 -0.1657 -0.2583 -0.9957 3069953 PK04_102300 CO[C@H](C=C)[C@H](O)c1ccc(OCCO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 P03 compound treatment 8.4094 -1.3168 -0.7129 8.8414 -0.88935 -0.3977 -0.7853 -0.962 3189285 PK04_102301 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(Cc6cccc(c6)N7C(=O)COc8ccccc78)c9ccccc93 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 P04 compound treatment 33.5241 23.798 12.8831 16.3886 6.6579 2.977 11.2148 0.8482 3070290 PK04_102302 C[C@@H](C=C)[C@H](O)c1ccc(O)c2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 P05 compound treatment 32.9139 23.188 12.5528 18.3677 8.6369 3.8619 11.6069 0.8838 3189394 PK04_102303 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(CCO)nn4)C(=O)N(C)c5c3cc(C)cc5Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 P06 compound treatment 10.9572 1.231 0.6664 10.6021 0.87135 0.3896 0.7467 0.9673 3069907 PK04_102304 C[C@H](C=C)[C@@H](O)c1ccc(OCCO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 P07 compound treatment 8.7903 -0.93595 -0.5067 10.0755 0.3447 0.1541 -0.2493 -0.4707 3189395 PK04_102305 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(nn4)[C@H](O)c5ccccc5)C(=O)N(Cc6cccc(c6)N7CCC7=O)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 P08 compound treatment 10.1467 0.42047 0.2276 11.1248 1.3941 0.6233 0.6017 0.9068 3069314 PK04_102306 CO[C@H](C=C)[C@H](O)c1ccc(O)c(F)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 P09 compound treatment 9.7486 0.02235 0.0121 9.2384 -0.49233 -0.2201 -0.1471 -0.6672 3070291 PK04_102307 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N(CCO)Cc4ccccc4)C(=O)N(Cc5cccc(c5)N6CCCCC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 P10 compound treatment 10.2235 0.49726 0.2692 18.6247 8.8939 3.9768 3.0024 0.7532 3189396 PK04_102308 CSc1ccc(NC(=O)O[C@@H]([C@@H](C)C=C)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 P11 mock treatment 8.9147 -0.81157 -0.4394 8.3863 -1.3444 -0.6011 -0.7357 -0.9881 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 P12 mock treatment 11.7972 2.0709 1.1211 8.0218 -1.7089 -0.7641 0.2524 0.1861 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 P13 compound treatment 9.6689 -0.057297 -0.031 9.6513 -0.079504 -0.0355 -0.0471 -0.9977 3189397 PK04_102309 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N(CCO)Cc4ccccc4)C(=O)N(Cc5cccc(c5)N6C(=O)c7cccc8cccc6c78)c9ccccc93 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 P14 compound treatment 8.8215 -0.90471 -0.4898 8.9993 -0.73148 -0.3271 -0.5776 -0.9807 3070292 PK04_102310 OCCOc1ccc(cc1)[C@H](O)CC=C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 P15 compound treatment 10.1738 0.44754 0.2423 9.9127 0.18197 0.0814 0.2289 0.8954 3070293 PK04_102311 COc1ccc(cc1)C(=O)Nc2cccc(CN3C(=O)[C@@]4(O[C@@H](CC(=O)N(CCO)Cc5ccccc5)[C@@H]([C@H]4C)[Si](C)(C)c6ccc(OC)cc6)c7ccccc37)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 P16 compound treatment 8.9105 -0.8157 -0.4416 9.2422 -0.4886 -0.2185 -0.4667 -0.9473 3070292 PK04_102312 OCCOc1ccc(cc1)[C@H](O)CC=C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 P17 compound treatment 10.9465 1.2203 0.6606 10.0282 0.29749 0.133 0.5612 0.8328 3189398 PK04_102313 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(Cc5ccc(cc5)N6CCOC6=O)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 P18 compound treatment 9.8634 0.13721 0.0743 10.4981 0.76736 0.3431 0.2951 0.8407 3070294 PK04_102314 CO[C@@H](C=C)[C@@H](OC(=O)Nc1ccc(SC)cc1)c2ccc(O)c(F)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 P19 compound treatment 9.5285 -0.19777 -0.1071 9.7614 0.030604 0.0137 -0.066 -0.6118 3189399 PK04_102315 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(Cc5cccc(c5)N6C(=O)COc7ccccc67)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 P20 compound treatment 9.0236 -0.70258 -0.3803 9.8638 0.133 0.0595 -0.2269 -0.5894 3070290 PK04_102316 C[C@@H](C=C)[C@H](O)c1ccc(O)c2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 P21 compound treatment 9.4401 -0.28609 -0.1549 10.6642 0.9334 0.4174 0.1856 0.4169 3189400 PK04_102317 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4ccccc4)c5ccc(cc53)N6CCC6=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 P22 compound treatment 10.4988 0.77252 0.4182 10.0181 0.2873 0.1285 0.3866 0.8836 3070295 PK04_102318 COc1ccc(NC(=O)O[C@@H]([C@H](C)C=C)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 P23 compound treatment 9.2442 -0.48198 -0.2609 12.6895 2.9587 1.3229 0.751 0.5569 3189401 PK04_102319 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(nn4)[C@H](O)c5ccccc5)C(=O)N(C)c6c3cc(C)cc6Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2102 P24 compound treatment 8.8443 -0.88198 -0.4775 11.7514 2.0206 0.9035 0.3012 0.2948 3414053 PK04_102320 OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3)([C@H](O2)c4ccccc4)C(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 A01 compound treatment 9.734 0.17957 0.0972 9.8112 0.48494 0.2168 0.2221 0.9345 3221174 PK04_130001 COC(=O)c1ccc(cc1)[C@@H]2C[C@H](OCCCCO)OC(=C2)C(=O)N[C@@H]3[C@H](O)Cc4ccccc34 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 A02 compound treatment 9.9618 0.40734 0.2205 8.8517 -0.47451 -0.2122 0.0059 0.0193 3211805 PK04_130002 CO[C@H](CCO)[C@H](OC(=O)Nc1ccc(SC)cc1)c2ccc(OCCO)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 A03 compound treatment 10.3011 0.74667 0.4042 8.276 -1.0503 -0.4696 -0.0463 -0.0746 3221177 PK04_130003 Cn1c(cc(=O)n1c2ccccc2)[C@@H]3C[C@H](OCCCCO)OC(=C3)C(=O)NCc4ccccc4F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 A04 compound treatment 9.3806 -0.17386 -0.0941 11.627 2.3007 1.0287 0.6609 0.6397 3080218 PK04_130004 OCCC[C@@H](O)c1ccc(OCCO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 A05 compound treatment 9.6972 0.14271 0.0773 9.8157 0.48949 0.2189 0.2094 0.9022 3221180 PK04_130005 OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)Nc2ccc(O)cc2)c3cccs3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 A06 compound treatment 9.6824 0.12795 0.0693 11.1857 1.8595 0.8314 0.6369 0.7634 3211801 PK04_130006 CSc1ccc(NC(=O)O[C@H](CCCO)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 A07 compound treatment 10.7521 1.1977 0.6484 10.179 0.85275 0.3813 0.7281 0.968 3221183 PK04_130007 OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)Nc2ccccc2O)c3cccs3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 A08 compound treatment 8.7155 -0.83893 -0.4542 10.9503 1.624 0.7262 0.1923 0.2246 3080220 PK04_130008 COc1ccc(NC(=O)O[C@@H](CC=C)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 A09 compound treatment 10.3338 0.77934 0.4219 10.2084 0.88217 0.3945 0.5772 0.9994 3221185 PK04_130009 OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)Nc2ccc(O)cc2)c3coc4ccccc4c3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 A10 compound treatment 10.3196 0.76516 0.4142 9.27 -0.056206 -0.0251 0.2751 0.663 3080222 PK04_130010 CO[C@H](CCO)[C@H](OC(=O)Nc1ccc(OC)cc1)c2ccc(OCCO)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 A11 compound treatment 10.0011 0.44663 0.2418 10.4215 1.0952 0.4897 0.5172 0.9471 3221188 PK04_130011 OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)NCc2ccc(Cl)cc2)c3coc4ccccc4c3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 A12 compound treatment 10.3588 0.80439 0.4355 9.9607 0.63443 0.2837 0.5085 0.9784 3211814 PK04_130012 C[C@H](CCO)[C@@H](O)c1ccc(OCCO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 A13 mock treatment 10.0546 0.50012 0.2707 9.5981 0.27186 0.1216 0.2774 0.9347 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 A14 mock treatment 9.8129 0.25847 0.1399 7.7032 -1.6231 -0.7257 -0.4142 -0.5605 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 A15 compound treatment 9.9887 0.43421 0.2351 11.011 1.6847 0.7533 0.6989 0.8856 3221191 PK04_130013 OCCCCCCNC(=O)C1=C[C@@H](C[C@H](OCCCCO)O1)c2coc3ccccc3c2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 A16 compound treatment 15.5486 5.9942 3.245 9.0538 -0.27249 -0.1218 2.2084 0.6801 3080206 PK04_130014 CSc1ccc(NC(=O)O[C@H](CCCO)c2ccc(O)c(F)c2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 A17 compound treatment 9.734 0.1796 0.0972 10.4671 1.1408 0.5101 0.4294 0.827 3221194 PK04_130015 Cn1c(cc(=O)n1c2ccccc2)[C@@H]3C[C@H](OCCCCO)OC(=C3)C(=O)N[C@@H]4[C@H](O)Cc5ccccc45 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 A18 compound treatment 11.9541 2.3996 1.2991 9.1753 -0.15094 -0.0675 0.8708 0.6695 3211690 PK04_130016 COc1ccc(NC(=O)O[C@H](CCCO)c2ccc(O)c(F)c2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 A19 compound treatment 10.807 1.2526 0.6781 9.6683 0.34208 0.153 0.5876 0.8454 3221197 PK04_130017 OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)NCc2ccccc2F)c3coc4ccccc4c3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 A20 compound treatment 9.2156 -0.3389 -0.1835 9.7588 0.43254 0.1934 0.007 0.0264 3189020 PK04_130018 C[C@@H](C=C)[C@H](O)c1ccc(OCCO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 A21 compound treatment 9.4992 -0.055239 -0.0299 9.493 0.16679 0.0746 0.0316 0.3931 2019329 PK04_130019 COC(=O)c1ccc(cc1)[C@@H]2C[C@H](OCCCCO)OC(=C2)C(=O)N3CCCCCCC3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 A22 compound treatment 10.5171 0.96263 0.5211 10.0016 0.67532 0.302 0.582 0.9663 3080190 PK04_130020 CO[C@@H](CCO)[C@@H](OC(=O)Nc1ccc(SC)cc1)c2ccc(OC)c(O)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 A23 compound treatment 8.3339 -1.2206 -0.6608 10.1785 0.85222 0.3811 -0.1978 -0.2593 3221200 PK04_130021 OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)N2CCCCCCC2)c3cccs3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 A24 compound treatment 10.605 1.0505 0.5687 10.186 0.85972 0.3844 0.674 0.9818 3211695 PK04_130022 CO[C@@H](CCO)[C@@H](O)c1ccc(O)c(F)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 B01 compound treatment 12.5654 3.0109 1.63 10.4189 1.0927 0.4886 1.4981 0.8804 3176327 PK04_130023 CN(C)CCCC[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCO)c3)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccc(I)cc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 B02 compound treatment 11.0855 1.531 0.8288 11.124 1.7977 0.8038 1.1545 0.9999 3221203 PK04_130024 C[C@@H]1[C@H]([C@H](CC(=O)N2Cc3ccccc3C[C@H]2CO)O[C@@]14C(=O)N(c5ccccc54)c6ccccc6)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 B03 compound treatment 10.284 0.72952 0.3949 10.6308 1.3045 0.5833 0.6917 0.982 3052745 PK04_130025 NCCCC[C@@H]1NC(=O)[C@@H]2C[C@@H]([C@@H](N2C1=O)c3cccc(OCCO)c3)C(=O)NCc4ccc(F)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 B04 compound treatment 12.2892 2.7348 1.4805 9.0422 -0.2841 -0.127 0.957 0.6441 3221205 PK04_130026 C[C@H]1[C@@H]([C@@H](CC(=O)N(CCO)Cc2ccccc2)O[C@]13C(=O)N(c4ccccc43)c5ccccc5)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 B05 compound treatment 13.7697 4.2153 2.282 9.0684 -0.2579 -0.1153 1.532 0.6705 3176512 PK04_130027 CC(C)C[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3ccc(O)cc3)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccccc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 B06 compound treatment 9.6695 0.11509 0.0623 9.3704 0.044176 0.0198 0.058 0.8877 3221207 PK04_130028 C[C@@H]1[C@H]([C@H](CCO)O[C@@]12C(=O)N(C)c3ccccc32)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 B07 compound treatment 12.6895 3.135 1.6972 13.6113 4.2851 1.916 2.5549 0.9982 3176123 PK04_130029 OCCOc1cccc(c1)[C@@H]2[C@@H](C[C@H]3N2C(=O)[C@H](Cc4ccccc4)NC3=O)C(=O)OCCOc5ccc(cc5)[C@H]6N7[C@@H]([C@@H](C(=O)OCC=C)[C@]68C(=O)Nc9ccccc98)C(=O)O[C@@H]([C@@H]7c%10ccccc%10)c%11ccccc%11 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 B08 compound treatment 10.9223 1.3678 0.7405 10.2598 0.93355 0.4174 0.8188 0.9632 3221209 PK04_130030 C[C@H]1[C@@H]([C@@H](CC(=O)N2CCC[C@H]2CO)O[C@]13C(=O)N(C)c4c3cc(C)cc4Br)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 B09 compound treatment 10.2468 0.69234 0.3748 8.2727 -1.0536 -0.4711 -0.0681 -0.1131 3052645 PK04_130031 CN(C)CCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3cccc(OCCO)c3)C(=O)CNC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 B10 compound treatment 9.5877 0.033294 0.018 9.1301 -0.1962 -0.0877 -0.0493 -0.5503 3221211 PK04_130032 C[C@@H]1[C@H]([C@H](CCn2cc(nn2)[C@H](O)c3ccccc3)O[C@@]14C(=O)N(C)c5ccccc54)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 B11 compound treatment 8.9815 -0.57291 -0.3101 8.7765 -0.54977 -0.2458 -0.3931 -0.9934 3052831 PK04_130033 CN(C)CCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3ccc(O)cc3)C(=O)[C@@H]4CCCN4C2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 B12 compound treatment 9.5206 -0.033856 -0.0183 10.2807 0.95442 0.4268 0.2888 0.6761 3221213 PK04_130034 C[C@H]1[C@@H]([C@@H](CC(=O)N2Cc3ccccc3C[C@H]2CO)O[C@]14C(=O)N(c5ccccc54)c6ccccc6)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 B13 mock treatment 9.0249 -0.52956 -0.2867 8.867 -0.45921 -0.2053 -0.3479 -0.9866 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 B14 mock treatment 10.2967 0.74227 0.4018 10.1857 0.85944 0.3843 0.5559 0.9998 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 B15 compound treatment 10.0594 0.50494 0.2734 9.6504 0.32418 0.145 0.2958 0.956 3176778 PK04_130035 C[N+](C)(C)CCCC[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3ccc(O)cc3)C(=O)NCc4ccc(F)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 B16 compound treatment 10.1447 0.59021 0.3195 9.4932 0.16696 0.0747 0.2787 0.8494 3221214 PK04_130036 C[C@@H]1[C@H]([C@H](CCO)O[C@@]12C(=O)N(CC=C)c3ccccc32)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 B17 compound treatment 9.3819 -0.17259 -0.0934 10.7745 1.4483 0.6476 0.3918 0.5989 3176195 PK04_130037 OCCOc1cccc(c1)[C@@H]2[C@@H](C[C@H]3N2C(=O)[C@@H]4CCCN4C3=O)C(=O)NCc5ccc(F)cc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 B18 compound treatment 10.4281 0.87365 0.473 9.0315 -0.2948 -0.1318 0.2412 0.4913 3221216 PK04_130038 C[C@H]1[C@@H]([C@@H](CCn2cc(CCO)nn2)O[C@]13C(=O)N(CC=C)c4ccccc43)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 B19 compound treatment 9.9584 0.40397 0.2187 8.7917 -0.53458 -0.239 -0.0144 -0.0444 3052584 PK04_130039 CN(C)CCCCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3cccc(OCCO)c3)C(=O)[C@H](Cc4ccccc4)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 B20 compound treatment 10.4241 0.86968 0.4708 8.3287 -0.99757 -0.446 0.0175 0.027 3221218 PK04_130040 C[C@@H]1[C@H]([C@H](CC(=O)N2CCC[C@H]2CO)O[C@@]13C(=O)N(C)c4ccccc43)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 B21 compound treatment 10.8736 1.3192 0.7142 12.7917 3.4655 1.5495 1.6007 0.9382 3176736 PK04_130041 CN(C)CCCC[C@@H]1NC(=O)[C@@H]2C[C@@H]([C@@H](N2C1=O)c3ccc(O)cc3)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccccc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 B22 compound treatment 13.509 3.9546 2.1408 10.3561 1.0299 0.4605 1.8394 0.84 3221220 PK04_130042 C[C@H]1[C@@H]([C@@H](CCO)O[C@]12C(=O)N(C)c3c2cc(C)cc3Br)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 B23 compound treatment 9.9348 0.3804 0.2059 7.9491 -1.3771 -0.6158 -0.2898 -0.4463 3052927 PK04_130043 C[N+](C)(C)CCCC[C@@H]1NC(=O)[C@@H]2C[C@@H]([C@@H](N2C1=O)c3ccc(O)cc3)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccccc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 B24 compound treatment 9.3923 -0.16211 -0.0878 8.5487 -0.77758 -0.3477 -0.3079 -0.8587 3221222 PK04_130044 C[C@H]1[C@@H]([C@@H](CCn2cc(CCO)nn2)O[C@]13C(=O)N(c4ccccc43)c5ccccc5)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 C01 compound treatment 12.337 2.7826 1.5064 9.7008 0.37456 0.1675 1.1836 0.7809 3221224 PK04_130045 COC(=O)c1ccc(cc1)[C@@H]2C[C@H](OCCCCO)OC(=C2)C(=O)NCc3ccc(Cl)cc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 C02 compound treatment 8.0025 -1.5519 -0.8401 11.6186 2.2924 1.025 0.1307 0.0986 3211914 PK04_130046 COc1ccc(NC(=O)O[C@H]([C@H](C)CCO)c2ccc(O)c3ccccc23)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 C03 compound treatment 10.0046 0.4502 0.2437 10.1129 0.78665 0.3517 0.4211 0.9839 3221227 PK04_130047 OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)N2CCOCCOCCOCCOCC2)c3cccs3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 C04 compound treatment 13.59 4.0355 2.1846 10.6891 1.3628 0.6094 1.9757 0.8711 3211809 PK04_130048 CSc1ccc(NC(=O)O[C@@H]([C@H](C)CCO)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 C05 compound treatment 10.9315 1.3771 0.7455 10.0648 0.73857 0.3302 0.7606 0.9329 2019446 PK04_130049 COC(CN(C)C(=O)C1=C[C@@H](C[C@H](OCCCCO)O1)c2coc3ccccc3c2=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 C06 compound treatment 10.47 0.91552 0.4956 12.2409 2.9146 1.3032 1.272 0.9123 3069417 PK04_130050 C[C@H](C=C)[C@H](O)c1ccc(OCCO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 C07 compound treatment 10.5454 0.9909 0.5364 9.2172 -0.10909 -0.0488 0.3448 0.6402 3221230 PK04_130051 COC(=O)c1ccc(cc1)[C@@H]2C[C@H](OCCCCO)OC(=C2)C(=O)Nc3ccc(O)cc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 C08 compound treatment 8.4895 -1.0649 -0.5765 10.1799 0.8536 0.3817 -0.1378 -0.1993 3080227 PK04_130052 CSc1ccc(NC(=O)O[C@H]([C@H](C)CCO)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 C09 compound treatment 10.1259 0.57148 0.3094 9.6728 0.34654 0.155 0.3283 0.9489 3221232 PK04_130053 OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)O)c2cccs2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 C10 compound treatment 7.8463 -1.7082 -0.9247 10.6949 1.3687 0.612 -0.2212 -0.1994 3080226 PK04_130054 COc1ccc(NC(=O)O[C@@H]([C@@H](C)CCO)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 C11 mock treatment 8.1375 -1.4169 -0.7671 11.9928 2.6665 1.1923 0.3007 0.2121 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 C12 mock treatment 8.0788 -1.4756 -0.7988 9.7187 0.39246 0.1755 -0.4408 -0.5389 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 C13 compound treatment 9.4966 -0.057884 -0.0313 8.5426 -0.78363 -0.3504 -0.2699 -0.7673 3221235 PK04_130055 Cn1c(cc(=O)n1c2ccccc2)[C@@H]3C[C@H](OCCCCO)OC(=C3)C(=O)NCCCCCCO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 C14 compound treatment 11.73 2.1756 1.1778 11.6933 2.367 1.0584 1.5812 0.9986 3080272 PK04_130056 OCCC[C@H](O)c1ccc(O)c2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 C15 mock treatment 11.6953 2.1409 1.159 7.9416 -1.3846 -0.6191 0.3817 0.2905 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 C16 mock treatment 10.3584 0.804 0.4352 9.5098 0.18359 0.0821 0.3658 0.8259 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 C17 compound treatment 9.1079 -0.44657 -0.2418 10.1933 0.86701 0.3877 0.1032 0.2258 3221238 PK04_130057 Cn1c(cc(=O)n1c2ccccc2)[C@@H]3C[C@H](OCCCCO)OC(=C3)C(=O)Nc4ccc(O)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 C18 compound treatment 9.1156 -0.43887 -0.2376 11.2204 1.8941 0.8469 0.4309 0.4898 3080228 PK04_130058 OCCC[C@@H](O)c1ccc(O)c2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 C19 compound treatment 9.5636 0.0091035 0.0049 9.9961 0.66982 0.2995 0.2153 0.7186 2019457 PK04_130059 Nc1ccccc1NC(=O)C2=C[C@@H](C[C@H](OCCCCO)O2)c3coc4ccccc4c3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 C20 compound treatment 9.3527 -0.20174 -0.1092 9.6151 0.28882 0.1291 0.0141 0.0833 3080205 PK04_130060 OCCC[C@@H](O)c1ccc(O)c(F)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 C21 compound treatment 9.2364 -0.31803 -0.1722 7.8255 -1.5007 -0.671 -0.5962 -0.8607 3221241 PK04_130061 OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)N[C@@H]2[C@H](O)Cc3ccccc23)c4cccs4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 C22 compound treatment 10.0101 0.45565 0.2467 8.48 -0.8463 -0.3784 -0.0932 -0.2062 3211908 PK04_130062 COc1ccc(NC(=O)O[C@@H]([C@H](C)CCO)c2ccc(O)c3ccccc23)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 C23 compound treatment 10.0148 0.46032 0.2492 13.6044 4.2782 1.9129 1.5288 0.7925 2019323 PK04_130063 COC(=O)c1ccc(cc1)[C@@H]2C[C@H](OCCCCO)OC(=C2)C(=O)Nc3ccccc3O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 C24 compound treatment 11.0784 1.5239 0.825 9.131 -0.19528 -0.0873 0.5216 0.6288 3211812 PK04_130064 C[C@@H](CCO)[C@H](O)c1ccc(OCCO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 D01 compound treatment 9.2216 -0.33286 -0.1802 11.5868 2.2606 1.0108 0.5873 0.572 3175965 PK04_130065 CC(=O)NCCCC[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCO)c3)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccc(I)cc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 D02 compound treatment 9.5039 -0.050571 -0.0274 9.6485 0.32229 0.1441 0.0825 0.5627 3221243 PK04_130066 COc1cc2c3N(C(=O)[C@@]42O[C@H](CCO)[C@H]([C@@H]4C)[Si](C)(C)F)C(C)(C)C=C(C)c3c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 D03 compound treatment 10.0587 0.50424 0.273 7.5218 -1.8044 -0.8068 -0.3775 -0.4432 3176379 PK04_130067 NCCCC[C@@H]1NC(=O)[C@@H]2C[C@@H]([C@@H](N2C1=O)c3cccc(OCCO)c3)C(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 D04 compound treatment 10.0433 0.48885 0.2646 9.1846 -0.14169 -0.0634 0.1423 0.523 3221245 PK04_130068 C[C@H]1[C@@H]([C@@H](CCO)O[C@]12C(=O)N(C)c3ccccc32)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 D05 compound treatment 8.8471 -0.7074 -0.383 9.9749 0.64864 0.29 -0.0657 -0.1368 3052839 PK04_130069 Oc1ccc(cc1)[C@@H]2[C@@H](C[C@H]3N2C(=O)[C@@H]4CCCN4C3=O)C(=O)OCCOc5ccc(cc5)[C@H]6N7[C@@H]([C@@H](C(=O)OCC=C)[C@]68C(=O)Nc9ccccc98)C(=O)O[C@@H]([C@@H]7c%10ccccc%10)c%11ccccc%11 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 D06 compound treatment 9.439 -0.11547 -0.0625 8.1403 -1.186 -0.5303 -0.4192 -0.785 3221246 PK04_130070 C[C@@H]1[C@H]([C@H](CC(=O)N2Cc3ccccc3C[C@H]2CO)O[C@@]14C(=O)N(C)c5c4cc(C)cc5Br)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 D07 compound treatment 8.0839 -1.4706 -0.7961 11.7011 2.3749 1.0619 0.1879 0.1416 3176048 PK04_130071 CC(C)C[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCO)c3)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccccc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 D08 compound treatment 9.6814 0.12693 0.0687 9.0684 -0.25785 -0.1153 -0.0329 -0.2454 3221248 PK04_130072 C[C@@H]1[C@H]([C@H](CC(=O)N2CCC[C@H]2CO)O[C@@]13C(=O)N(c4ccccc43)c5ccccc5)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 D09 compound treatment 8.567 -0.98745 -0.5346 11.3015 1.9752 0.8832 0.2465 0.2388 3175970 PK04_130073 CC(C)C[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCO)c3)C(=O)NCCCCN(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 D10 compound treatment 9.1604 -0.39406 -0.2133 9.7186 0.3923 0.1754 -0.0268 -0.0971 3221250 PK04_130074 C[C@H]1[C@@H]([C@@H](CC(=O)N2CCC[C@H]2CO)O[C@]13C(=O)N(c4ccccc43)c5ccccc5)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 D11 mock treatment 11.7182 2.1637 1.1713 9.4349 0.10865 0.0486 0.8626 0.7358 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 D12 mock treatment 11.7432 2.1888 1.1849 10.3355 1.0092 0.4513 1.1569 0.9125 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 D13 compound treatment 8.5437 -1.0108 -0.5472 7.7989 -1.5273 -0.6829 -0.8698 -0.994 3176675 PK04_130075 Oc1ccc(cc1)[C@@H]2[C@@H](C[C@H]3N2C(=O)CNC3=O)C(=O)NCc4ccc(F)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 D14 compound treatment 10.249 0.69454 0.376 10.2109 0.88469 0.3956 0.5456 0.9997 3221251 PK04_130076 C[C@@H]1[C@H]([C@H](CC(=O)N2Cc3ccccc3C[C@H]2CO)O[C@@]14C(=O)N(C)c5ccccc54)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 D15 mock treatment 10.1516 0.59712 0.3233 10.6427 1.3164 0.5886 0.6448 0.9602 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 D16 mock treatment 9.8418 0.28731 0.1555 12.4743 3.1481 1.4076 1.1053 0.7805 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 D17 compound treatment 11.1394 1.585 0.858 10.3915 1.0652 0.4763 0.9435 0.9614 3052531 PK04_130077 CC(=O)NCCCC[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCO)c3)C(=O)NCc4ccc(F)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 D18 compound treatment 8.8982 -0.65626 -0.3553 10.7421 1.4158 0.6331 0.1964 0.2706 3221253 PK04_130078 C[C@H]1[C@@H]([C@@H](CCn2cc(CCO)nn2)O[C@]13C(=O)N(C)c4ccccc43)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 D19 compound treatment 8.6006 -0.95385 -0.5164 9.2082 -0.11804 -0.0528 -0.4025 -0.7753 3052793 PK04_130079 CN(C)CCCCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3ccc(O)cc3)C(=O)[C@H](Cc4ccccc4)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 D20 compound treatment 9.4697 -0.084749 -0.0459 9.2191 -0.10711 -0.0479 -0.0663 -0.9998 3221255 PK04_130080 C[C@H]1[C@@H]([C@@H](CCn2cc(nn2)[C@H](O)c3ccccc3)O[C@]14C(=O)N(C)c5ccccc54)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 D21 compound treatment 9.5743 0.019816 0.0107 9.1021 -0.22411 -0.1002 -0.0633 -0.6278 3052828 PK04_130081 Oc1ccc(cc1)[C@H]2[C@H](C[C@@H]3N2C(=O)[C@H](Cc4ccccc4)NC3=O)C(=O)OCCOc5ccc(cc5)[C@H]6N7[C@@H]([C@@H](C(=O)OCC=C)[C@]68C(=O)Nc9ccccc98)C(=O)O[C@@H]([C@@H]7c%10ccccc%10)c%11ccccc%11 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 D22 compound treatment 9.6451 0.090651 0.0491 10.6638 1.3376 0.5981 0.4576 0.7626 3221256 PK04_130082 C[C@@H]1[C@H]([C@H](CCn2cc(CCO)nn2)O[C@@]13C(=O)N(c4ccccc43)c5ccccc5)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 D23 compound treatment 36.8775 27.323 14.7915 45.8795 36.553 16.3443 22.0163 0.9988 3052592 PK04_130083 OCCOc1cccc(c1)[C@H]2[C@H](C[C@@H]3N2C(=O)[C@H](Cc4ccccc4)NC3=O)C(=O)OCCOc5ccc(cc5)[C@H]6N7[C@@H]([C@@H](C(=O)OCC=C)[C@]68C(=O)Nc9ccccc98)C(=O)O[C@@H]([C@@H]7c%10ccccc%10)c%11ccccc%11 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 D24 compound treatment 10.7622 1.2077 0.6538 9.3439 0.017666 0.0079 0.4679 0.7156 3221257 PK04_130084 C[C@@H]1[C@H]([C@H](CCO)O[C@@]12C(=O)N(C)c3c2cc(C)cc3Br)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 E01 mock treatment 9.9801 0.4256 0.2304 8.077 -1.2492 -0.5586 -0.2321 -0.3841 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 E02 mock treatment 11.3345 1.7801 0.9636 9.3862 0.059921 0.0268 0.7003 0.7265 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 E03 compound treatment 7.7734 -1.781 -0.9642 10.8127 1.4865 0.6647 -0.2118 -0.1809 2019322 PK04_130085 COC(=O)c1ccc(cc1)[C@@H]2C[C@H](OCCCCO)OC(=C2)C(=O)Nc3ccccc3N 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 E04 compound treatment 10.3933 0.83884 0.4541 8.471 -0.85523 -0.3824 0.0507 0.0854 3080210 PK04_130086 CO[C@@H](CCO)[C@@H](OC(=O)Nc1ccc(OC)cc1)c2ccc(O)c(F)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 E05 compound treatment 9.0386 -0.51581 -0.2792 10.4424 1.1161 0.4991 0.1554 0.2718 3221259 PK04_130087 OCCCCCCNC(=O)C1=C[C@@H](C[C@H](OCCCCO)O1)c2cccs2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 E06 compound treatment 8.325 -1.2294 -0.6656 9.7489 0.42262 0.189 -0.337 -0.4871 3211802 PK04_130088 OCCC[C@H](O)c1ccc(OCCO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 E07 compound treatment 9.8413 0.28686 0.1553 9.7552 0.42893 0.1918 0.2454 0.9945 3221261 PK04_130089 Cn1c(cc(=O)n1c2ccccc2)[C@@H]3C[C@H](OCCCCO)OC(=C3)C(=O)NCc4ccc(Cl)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 E08 compound treatment 10.0524 0.49791 0.2695 9.0519 -0.27436 -0.1227 0.1039 0.3507 3080219 PK04_130090 COc1ccc(NC(=O)O[C@H](CCCO)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 E09 mock treatment 9.1997 -0.35471 -0.192 7.7133 -1.6129 -0.7212 -0.6457 -0.8652 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 E10 mock treatment 10.0379 0.48344 0.2617 9.5114 0.18518 0.0828 0.2436 0.8875 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 E11 compound treatment 8.3464 -1.2081 -0.654 10.1693 0.84306 0.377 -0.1959 -0.2595 3221264 PK04_130091 COC(CN(C)C(=O)C1=C[C@@H](C[C@H](OCCCCO)O1)c2cc(=O)n(c3ccccc3)n2C)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 E12 compound treatment 9.8477 0.29327 0.1588 10.0798 0.75358 0.337 0.3505 0.9411 3069920 PK04_130092 O[C@@H](CC=C)c1ccc(O)c(F)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 E13 compound treatment 9.5817 0.027281 0.0148 10.7283 1.4021 0.6269 0.4537 0.7236 3221266 PK04_130093 Cn1c(cc(=O)n1c2ccccc2)[C@@H]3C[C@H](OCCCCO)OC(=C3)C(=O)Nc4ccccc4N 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 E14 compound treatment 10.3101 0.75569 0.4091 11.2658 1.9396 0.8672 0.9025 0.9412 3211678 PK04_130094 CO[C@H](CCO)[C@H](OC(=O)Nc1ccc(OC)cc1)c2ccc(OC)c(O)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 E15 compound treatment 8.6685 -0.8859 -0.4796 10.1831 0.85689 0.3831 -0.0682 -0.1111 3221269 PK04_130095 Cn1c(cc(=O)n1c2ccccc2)[C@@H]3C[C@H](OCCCCO)OC(=C3)C(=O)N4CCOCCOCCOCCOCC4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 E16 compound treatment 9.5204 -0.034014 -0.0184 10.4868 1.1605 0.5189 0.3539 0.6816 3211906 PK04_130096 CSc1ccc(NC(=O)O[C@@H]([C@H](C)C=C)c2ccc(O)c3ccccc23)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 E17 mock treatment 10.0479 0.49348 0.2671 10.9611 1.6348 0.731 0.7058 0.9069 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 E18 mock treatment 9.7275 0.17306 0.0937 9.0316 -0.29463 -0.1317 -0.0269 -0.1664 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 E19 compound treatment 8.4828 -1.0717 -0.5801 9.3846 0.058386 0.0261 -0.3918 -0.6746 2019458 PK04_130097 OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)Nc2ccccc2O)c3coc4ccccc4c3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 E20 compound treatment 8.7269 -0.82755 -0.448 8.5028 -0.82344 -0.3682 -0.5771 -0.9953 3211804 PK04_130098 COc1ccc(NC(=O)O[C@@H](CCCO)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 E21 compound treatment 9.2623 -0.29211 -0.1581 9.5623 0.23607 0.1056 -0.0372 -0.1956 3221271 PK04_130099 OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)NCc2ccccc2F)c3cccs3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 E22 compound treatment 10.8831 1.3287 0.7193 10.4522 1.1259 0.5034 0.8646 0.9848 3211680 PK04_130100 CO[C@@H](CCO)[C@@H](OC(=O)Nc1ccc(OC)cc1)c2ccc(OC)c(O)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 E23 compound treatment 9.1695 -0.38499 -0.2084 8.5001 -0.82615 -0.3694 -0.4086 -0.9633 2019464 PK04_130101 OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)N2CCCCCCC2)c3coc4ccccc4c3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 E24 compound treatment 8.6171 -0.93731 -0.5074 8.1209 -1.2054 -0.539 -0.7399 -0.9995 3211909 PK04_130102 CSc1ccc(NC(=O)O[C@H]([C@@H](C)CCO)c2ccc(O)c3ccccc23)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 F01 mock treatment 10.2266 0.67217 0.3639 9.4388 0.11257 0.0503 0.2929 0.7973 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 F02 mock treatment 9.265 -0.28942 -0.1567 10.1799 0.85365 0.3817 0.1591 0.3856 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 F03 compound treatment 7.9966 -1.5578 -0.8433 9.7555 0.42929 0.192 -0.4606 -0.5325 3176785 PK04_130103 NCCCC[C@@H]1NC(=O)[C@@H]2C[C@@H]([C@@H](N2C1=O)c3ccc(O)cc3)C(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 F04 compound treatment 8.3809 -1.1735 -0.6353 10.4147 1.0885 0.4867 -0.1051 -0.1313 3221273 PK04_130104 C[C@H]1[C@@H]([C@@H](CC(=O)N2Cc3ccccc3C[C@H]2CO)O[C@]14C(=O)N(C)c5c4cc(C)cc5Br)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 F05 compound treatment 10.5539 0.99946 0.5411 8.7083 -0.61798 -0.2763 0.1872 0.3081 3176500 PK04_130105 CC(=O)NCCCC[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3ccc(O)cc3)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccccc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 F06 compound treatment 10.144 0.58954 0.3192 10.0746 0.74831 0.3346 0.4623 0.9997 3221274 PK04_130106 C[C@@H]1[C@H]([C@H](CCn2cc(CCO)nn2)O[C@@]13C(=O)N(CC=C)c4ccccc43)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 F07 compound treatment 8.5109 -1.0436 -0.565 10.9768 1.6505 0.738 0.1224 0.1317 3052886 PK04_130107 CN(C)CCCC[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3ccc(O)cc3)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccccc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 F08 compound treatment 8.8098 -0.74465 -0.4031 8.494 -0.83221 -0.3721 -0.5482 -0.9992 3221275 PK04_130108 C[C@@H]1[C@H]([C@H](CCO)O[C@@]12C(=O)N(c3ccccc32)c4ccccc4)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 F09 mock treatment 8.8404 -0.71407 -0.3866 9.1666 -0.15967 -0.0714 -0.3238 -0.8238 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 F10 mock treatment 9.5366 -0.017824 -0.0096 9.1565 -0.16978 -0.0759 -0.0605 -0.7906 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 F11 compound treatment 7.1993 -2.3552 -1.275 10.5817 1.2554 0.5613 -0.5046 -0.3622 3052654 PK04_130109 CN(C)CCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3cccc(OCCO)c3)C(=O)[C@H](CCCCN(C)C)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 F12 compound treatment 8.6306 -0.92382 -0.5001 8.5721 -0.75415 -0.3372 -0.5921 -0.9816 3221277 PK04_130110 C[C@H]1[C@@H]([C@@H](CC(=O)N(CCO)Cc2ccccc2)O[C@]13C(=O)N(C)c4ccccc43)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 F13 compound treatment 7.8791 -1.6753 -0.907 9.2573 -0.068979 -0.0308 -0.6631 -0.7307 3052647 PK04_130111 OCCOc1cccc(c1)[C@@H]2[C@@H](C[C@H]3N2C(=O)CNC3=O)C(=O)NCc4ccc(F)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 F14 compound treatment 10.3396 0.7851 0.425 9.1344 -0.19186 -0.0858 0.2399 0.5532 3221279 PK04_130112 C[C@H]1[C@@H]([C@@H](CC(=O)N2Cc3ccccc3C[C@H]2CO)O[C@]14C(=O)N(C)c5ccccc54)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 F15 compound treatment 7.7857 -1.7688 -0.9575 10.6347 1.3085 0.5851 -0.2634 -0.2347 3176113 PK04_130113 OCCOc1cccc(c1)[C@@H]2[C@@H](C[C@H]3N2C(=O)[C@H](Cc4ccccc4)NC3=O)C(=O)NCc5ccc(F)cc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 F16 compound treatment 8.1493 -1.4052 -0.7607 9.1055 -0.22074 -0.0987 -0.6077 -0.7922 3221280 PK04_130114 C[C@H]1[C@@H]([C@@H](CCn2cc(nn2)[C@H](O)c3ccccc3)O[C@]14C(=O)N(CC=C)c5ccccc54)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 F17 mock treatment 8.2272 -1.3273 -0.7185 8.0668 -1.2595 -0.5632 -0.9063 -0.9927 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 F18 mock treatment 10.8808 1.3263 0.718 11.1914 1.8652 0.834 1.0974 0.9972 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 F19 compound treatment 10.4605 0.906 0.4905 10.5207 1.1945 0.5341 0.7245 0.9991 3052888 PK04_130115 CN(C)CCCCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3ccc(O)cc3)C(=O)[C@H](CCCC[N+](C)(C)C)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 F20 compound treatment 8.4044 -1.15 -0.6226 8.9197 -0.40654 -0.1818 -0.5688 -0.877 3221282 PK04_130116 C[C@H]1[C@@H]([C@@H](CCO)O[C@]12C(=O)N(c3ccccc32)c4ccccc4)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 F21 compound treatment 9.2246 -0.32983 -0.1786 10.8561 1.5298 0.684 0.3574 0.5056 3176499 PK04_130117 CC(=O)NCCCC[C@@H]1NC(=O)[C@@H]2C[C@@H]([C@@H](N2C1=O)c3ccc(O)cc3)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccccc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 F22 compound treatment 10.9394 1.385 0.7498 8.4324 -0.89386 -0.3997 0.2475 0.2914 3221283 PK04_130118 C[C@@H]1[C@H]([C@H](CC(=O)N(CCO)Cc2ccccc2)O[C@@]13C(=O)N(C)c4ccccc43)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 F23 compound treatment 8.748 -0.80641 -0.4366 10.0024 0.67613 0.3023 -0.0949 -0.1787 3175968 PK04_130119 CC(=O)NCCCC[C@@H]1NC(=O)[C@@H]2C[C@@H]([C@@H](N2C1=O)c3cccc(OCCO)c3)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccccc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 F24 compound treatment 11.0962 1.5418 0.8346 12.7715 3.4452 1.5405 1.6795 0.9586 3221284 PK04_130120 C[C@@H]1[C@H]([C@H](CC(=O)N2CCC[C@H]2CO)O[C@@]13C(=O)N(C)c4c3cc(C)cc4Br)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 G01 compound treatment 10.7117 1.1573 0.6265 9.9352 0.60892 0.2723 0.6355 0.9303 2019328 PK04_130121 COC(=O)c1ccc(cc1)[C@@H]2C[C@H](OCCCCO)OC(=C2)C(=O)N3CCOCCOCCOCCOCC3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 G02 compound treatment 11.7137 2.1593 1.1689 14.3273 5.0011 2.2362 2.4078 0.9542 3211907 PK04_130122 COc1ccc(NC(=O)O[C@@H]([C@H](C)C=C)c2ccc(O)c3ccccc23)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 G03 mock treatment 8.9661 -0.58839 -0.3185 8.5827 -0.7436 -0.3325 -0.4603 -0.9998 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 G04 mock treatment 9.9588 0.40433 0.2189 11.4137 2.0875 0.9334 0.8148 0.8499 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 G05 compound treatment 9.6251 0.070636 0.0382 8.9934 -0.33288 -0.1488 -0.0782 -0.5089 3221285 PK04_130123 COC(=O)c1ccc(cc1)[C@@H]2C[C@H](OCCCCO)OC(=C2)C(=O)NCCCCCCO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 G06 compound treatment 10.1282 0.57379 0.3106 10.3392 1.013 0.4529 0.5399 0.9831 3211815 PK04_130124 COc1ccc(NC(=O)O[C@H]([C@H](C)C=C)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 G07 compound treatment 11.0534 1.499 0.8115 9.0262 -0.30002 -0.1341 0.4789 0.5823 3221287 PK04_130125 COC(=O)c1ccc(cc1)[C@@H]2C[C@H](OCCCCO)OC(=C2)C(=O)NCc3ccccc3F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 G08 compound treatment 9.4611 -0.093374 -0.0505 10.2513 0.92503 0.4136 0.2567 0.6161 3211803 PK04_130126 CSc1ccc(NC(=O)O[C@@H](CCCO)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 G09 compound treatment 7.2771 -2.2773 -1.2329 10.0878 0.76155 0.3405 -0.631 -0.4933 3221289 PK04_130127 Cn1c(cc(=O)n1c2ccccc2)[C@@H]3C[C@H](OCCCCO)OC(=C3)C(=O)N4CCCCCCC4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 G10 compound treatment 10.3492 0.79476 0.4302 9.2223 -0.10397 -0.0465 0.2714 0.6271 3211807 PK04_130128 CO[C@@H](CCO)[C@@H](OC(=O)Nc1ccc(SC)cc1)c2ccc(OCCO)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 G11 compound treatment 8.1536 -1.4009 -0.7584 8.2827 -1.0435 -0.4666 -0.8662 -0.9728 2019311 PK04_130129 COC(CN(C)C(=O)C1=C[C@@H](C[C@H](OCCCCO)O1)c2ccc(cc2)C(=O)OC)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 G12 compound treatment 8.3605 -1.194 -0.6464 8.4314 -0.89486 -0.4001 -0.74 -0.9734 3211818 PK04_130130 COc1ccc(NC(=O)O[C@H](CCCO)c2ccc(O)c3ccccc23)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 G13 compound treatment 9.6521 0.097696 0.0529 8.7303 -0.596 -0.2665 -0.151 -0.5559 3221292 PK04_130131 Cn1c(cc(=O)n1c2ccccc2)[C@@H]3C[C@H](OCCCCO)OC(=C3)C(=O)Nc4ccccc4O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 G14 compound treatment 8.8376 -0.71684 -0.3881 8.7267 -0.59956 -0.2681 -0.464 -0.9837 3080207 PK04_130132 OCCC[C@H](O)c1ccc(O)c(F)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 G15 compound treatment 8.6942 -0.86028 -0.4657 9.4965 0.17021 0.0761 -0.2755 -0.5838 2019470 PK04_130133 OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)O)c2coc3ccccc3c2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 G16 compound treatment 8.9306 -0.62381 -0.3377 9.5705 0.24423 0.1092 -0.1616 -0.4552 3080225 PK04_130134 COc1ccc(NC(=O)O[C@H]([C@@H](C)CCO)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 G17 compound treatment 8.8443 -0.71017 -0.3845 9.6963 0.37006 0.1655 -0.1548 -0.37 3221294 PK04_130135 OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)N[C@@H]2[C@H](O)Cc3ccccc23)c4coc5ccccc5c4=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 G18 compound treatment 9.1185 -0.43594 -0.236 11.4853 2.159 0.9654 0.5157 0.519 3211806 PK04_130136 CO[C@@H](CCO)[C@@H](O)c1ccc(OCCO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 G19 mock treatment 8.74 -0.81446 -0.4409 8.1458 -1.1804 -0.5278 -0.685 -0.996 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 G20 mock treatment 8.8838 -0.67061 -0.363 7.5401 -1.7862 -0.7987 -0.8214 -0.9363 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 G21 compound treatment 9.6475 0.093016 0.0504 11.1935 1.8672 0.8349 0.626 0.7484 2019463 PK04_130137 OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)N2CCOCCOCCOCCOCC2)c3coc4ccccc4c3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 G22 compound treatment 10.9516 1.3972 0.7564 7.9833 -1.3429 -0.6005 0.1102 0.1141 3080280 PK04_130138 COc1ccc(NC(=O)O[C@H]([C@@H](C)CCO)c2ccc(O)c3ccccc23)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 G23 compound treatment 8.2953 -1.2592 -0.6817 8.4824 -0.84381 -0.3773 -0.7488 -0.9611 3221297 PK04_130139 Cn1c(cc(=O)n1c2ccccc2)[C@@H]3C[C@H](OCCCCO)OC(=C3)C(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 G24 compound treatment 8.9896 -0.56486 -0.3058 9.6498 0.32356 0.1447 -0.1139 -0.3368 3211912 PK04_130140 C[C@H](CCO)[C@@H](O)c1ccc(O)c2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 H01 compound treatment 9.7692 0.21475 0.1163 9.9823 0.65608 0.2934 0.2896 0.9179 3052931 PK04_130141 NCCCC[C@@H]1NC(=O)[C@@H]2C[C@@H]([C@@H](N2C1=O)c3ccc(O)cc3)C(=O)NCc4ccc(F)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 H02 compound treatment 10.0417 0.48724 0.2638 7.8539 -1.4723 -0.6583 -0.279 -0.3934 3221300 PK04_130142 C[C@@H]1[C@H]([C@H](CCn2cc(CCO)nn2)O[C@@]13C(=O)N(C)c4ccccc43)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 H03 mock treatment 10.4946 0.94016 0.509 7.539 -1.7872 -0.7991 -0.2052 -0.2166 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 H04 mock treatment 10.7664 1.212 0.6561 8.4684 -0.85783 -0.3836 0.1927 0.2536 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 H05 compound treatment 10.8827 1.3283 0.7191 7.7666 -1.5597 -0.6974 0.0153 0.0153 3176330 PK04_130143 CN(C)CCCC[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCO)c3)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccccc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 H06 compound treatment 8.6516 -0.9029 -0.4888 10.6955 1.3692 0.6122 0.0873 0.1114 3221301 PK04_130144 C[C@@H]1[C@H]([C@H](CC(=O)N(CCO)Cc2ccccc2)O[C@@]13C(=O)N(c4ccccc43)c5ccccc5)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 H07 compound treatment 9.7411 0.18663 0.101 8.1852 -1.141 -0.5102 -0.2893 -0.5563 3176685 PK04_130145 Oc1ccc(cc1)[C@@H]2[C@@H](C[C@H]3N2C(=O)CNC3=O)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccccc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 H08 compound treatment 8.8973 -0.65718 -0.3558 9.0553 -0.27093 -0.1211 -0.3372 -0.8973 3221302 PK04_130146 C[C@H]1[C@@H]([C@@H](CC(=O)N2CCC[C@H]2CO)O[C@]13C(=O)N(C)c4ccccc43)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 H09 compound treatment 8.7532 -0.80124 -0.4338 9.0266 -0.29968 -0.134 -0.4015 -0.8843 3052879 PK04_130147 CN(C)CCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3ccc(O)cc3)C(=O)[C@H](CCCCN(C)C)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 H10 compound treatment 10.0105 0.4561 0.2469 8.3638 -0.96248 -0.4304 -0.1297 -0.2614 3221303 PK04_130148 C[C@H]1[C@@H]([C@@H](CC(=O)N(CCO)Cc2ccccc2)O[C@]13C(=O)N(C)c4c3cc(C)cc4Br)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 H11 compound treatment 9.0381 -0.51637 -0.2795 8.3715 -0.95474 -0.4269 -0.4995 -0.9789 3176775 PK04_130149 CN(C)CCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3ccc(O)cc3)C(=O)[C@H](CCCC[N+](C)(C)C)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 H12 compound treatment 9.2952 -0.25926 -0.1404 8.5871 -0.73917 -0.3305 -0.3329 -0.9272 3221305 PK04_130150 COc1cc2c3N(C(=O)[C@]42O[C@@H](CCO)[C@@H]([C@H]4C)[Si](C)(C)O)C(C)(C)C=C(C)c3c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 H13 compound treatment 9.1237 -0.43077 -0.2332 8.733 -0.59321 -0.2652 -0.3525 -0.9979 3052783 PK04_130151 CC(C)C[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3ccc(O)cc3)C(=O)NCc4ccc(F)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 H14 compound treatment 8.1949 -1.3595 -0.736 8.3027 -1.0235 -0.4577 -0.844 -0.9739 3221307 PK04_130152 C[C@@H]1[C@H]([C@H](CCn2cc(nn2)[C@H](O)c3ccccc3)O[C@@]14C(=O)N(CC=C)c5ccccc54)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 H15 compound treatment 9.4173 -0.13718 -0.0743 9.436 0.10975 0.0491 -0.0178 -0.2001 3176626 PK04_130153 Oc1ccc(cc1)[C@@H]2[C@@H](C[C@H]3N2C(=O)[C@@H]4CCCN4C3=O)C(=O)NCc5ccc(F)cc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 H16 compound treatment 8.8446 -0.70989 -0.3843 8.1708 -1.1555 -0.5167 -0.6371 -0.9894 3221308 PK04_130154 C[C@H]1[C@@H]([C@@H](CCO)O[C@]12C(=O)N(CC=C)c3ccccc32)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 H17 compound treatment 10.5762 1.0218 0.5531 9.1295 -0.19679 -0.088 0.3289 0.5872 3176501 PK04_130155 CC(C)C[C@@H]1NC(=O)[C@@H]2C[C@@H]([C@@H](N2C1=O)c3ccc(O)cc3)C(=O)NCCCCCCN(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 H18 compound treatment 8.9406 -0.61389 -0.3323 10.506 1.1797 0.5275 0.138 0.2213 3221309 PK04_130156 C[C@@H]1[C@H]([C@H](CC(=O)N(CCO)Cc2ccccc2)O[C@@]13C(=O)N(C)c4c3cc(C)cc4Br)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 H19 mock treatment 8.6618 -0.89261 -0.4832 10.1604 0.83418 0.373 -0.0779 -0.1277 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 H20 mock treatment 10.5067 0.95222 0.5155 10.844 1.5178 0.6787 0.8444 0.9908 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 H21 compound treatment 8.8335 -0.72093 -0.3903 10.6311 1.3048 0.5834 0.1366 0.1946 3052741 PK04_130157 C[N+](C)(C)CCCC[C@@H]1NC(=O)[C@@H]2C[C@@H]([C@@H](N2C1=O)c3cccc(OCCO)c3)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccccc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 H22 compound treatment 8.6672 -0.88724 -0.4803 8.6688 -0.65743 -0.294 -0.5475 -0.9722 3221310 PK04_130158 C[C@@H]1[C@H]([C@H](CCn2cc(nn2)[C@H](O)c3ccccc3)O[C@@]14C(=O)N(c5ccccc54)c6ccccc6)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 H23 compound treatment 35.0697 25.515 13.8128 17.2658 7.9395 3.55 12.2774 0.8609 3176203 PK04_130159 OCCOc1cccc(c1)[C@H]2[C@H](C[C@@H]3N2C(=O)[C@@H]4CCCN4C3=O)C(=O)OCCOc5ccc(cc5)[C@H]6N7[C@@H]([C@@H](C(=O)OCC=C)[C@]68C(=O)Nc9ccccc98)C(=O)O[C@@H]([C@@H]7c%10ccccc%10)c%11ccccc%11 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 H24 compound treatment 9.2085 -0.34599 -0.1873 10.3243 0.99801 0.4462 0.1831 0.3783 3221312 PK04_130160 C[C@H]1[C@@H]([C@@H](CCn2cc(nn2)[C@H](O)c3ccccc3)O[C@]14C(=O)N(c5ccccc54)c6ccccc6)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 I01 compound treatment 10.5098 0.95536 0.5172 9.0246 -0.30167 -0.1349 0.2703 0.5058 3221313 PK04_130161 OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)NCc2ccc(Cl)cc2)c3cccs3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 I02 compound treatment 9.5548 3.2352E-4 2.0E-4 9.0684 -0.25781 -0.1153 -0.0814 -0.706 3080209 PK04_130162 CO[C@H](CCO)[C@H](OC(=O)Nc1ccc(OC)cc1)c2ccc(O)c(F)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 I03 compound treatment 8.9058 -0.64868 -0.3512 9.1436 -0.1827 -0.0817 -0.3061 -0.8489 3221314 PK04_130163 Nc1ccccc1NC(=O)C2=C[C@@H](C[C@H](OCCCCO)O2)c3cccs3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 I04 compound treatment 9.8445 0.29 0.157 9.2049 -0.12139 -0.0543 0.0726 0.4372 3069956 PK04_130164 CO[C@@H](C=C)[C@@H](O)c1ccc(OC)c(O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 I05 mock treatment 9.3846 -0.16982 -0.0919 9.5587 0.23242 0.1039 0.0085 0.0611 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 I06 mock treatment 7.845 -1.7094 -0.9254 8.8647 -0.46155 -0.2064 -0.8003 -0.8441 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 I07 compound treatment 8.1837 -1.3707 -0.7421 8.3511 -0.97513 -0.436 -0.833 -0.9679 3221316 PK04_130165 COC(CN(C)C(=O)C1=C[C@@H](C[C@H](OCCCCO)O1)c2cccs2)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 I08 compound treatment 9.1918 -0.36264 -0.1963 9.1498 -0.17645 -0.0789 -0.1946 -0.9198 3211693 PK04_130166 CO[C@H](CCO)[C@H](O)c1ccc(O)c(F)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 I09 compound treatment 8.6193 -0.93513 -0.5062 8.6006 -0.72564 -0.3245 -0.5874 -0.9769 2019335 PK04_130167 COC(=O)c1ccc(cc1)[C@@H]2C[C@H](OCCCCO)OC(=C2)C(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 I10 compound treatment 9.8792 0.32479 0.1758 7.5185 -1.8078 -0.8083 -0.4472 -0.5406 3080278 PK04_130168 CSc1ccc(NC(=O)O[C@@H]([C@H](C)CCO)c2ccc(O)c3ccccc23)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 I11 compound treatment 9.0177 -0.5368 -0.2906 8.5285 -0.79779 -0.3567 -0.4577 -0.9948 3221318 PK04_130169 COc1cc2c[n+](Cc3cc4OCOc4cc3Br)ccc2cc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 I12 compound treatment 9.1278 -0.42662 -0.231 9.3246 -0.0016587 -7.0E-4 -0.1638 -0.7094 3211911 PK04_130170 COc1ccc(NC(=O)O[C@@H]([C@@H](C)CCO)c2ccc(O)c3ccccc23)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 I13 compound treatment 8.3034 -1.251 -0.6772 10.3321 1.0058 0.4497 -0.1609 -0.1979 3221319 PK04_130171 COc1cc2c[n+](Cc3sc4ccccc4c3Cl)ccc2cc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 I14 compound treatment 7.0957 -2.4587 -1.331 7.8957 -1.4305 -0.6396 -1.3935 -0.9436 3080208 PK04_130172 COc1ccc(NC(=O)O[C@@H](CCCO)c2ccc(O)c(F)c2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 I15 compound treatment 10.8625 1.3081 0.7081 8.3169 -1.0093 -0.4513 0.1816 0.2163 3221320 PK04_130173 COc1cc2c[n+](Cc3ccc(o3)[N+](=O)[O-])ccc2cc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 I16 compound treatment 9.4758 -0.078614 -0.0426 9.7746 0.44833 0.2005 0.1117 0.5448 3080223 PK04_130174 CO[C@@H](CCO)[C@@H](OC(=O)Nc1ccc(OC)cc1)c2ccc(OCCO)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 I17 compound treatment 7.2012 -2.3533 -1.2739 10.8889 1.5626 0.6987 -0.4068 -0.2799 3221321 PK04_130175 COc1cc2c[n+](Cc3cccc(OC(F)(F)F)c3)ccc2cc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 I18 compound treatment 17.5295 7.975 4.3173 14.5027 5.1764 2.3146 4.6894 0.9573 3080282 PK04_130176 CSc1ccc(NC(=O)O[C@H]([C@H](C)C=C)c2ccc(O)c3ccccc23)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 I19 compound treatment 9.5445 -0.0099965 -0.0054 9.5925 0.26628 0.1191 0.0804 0.6743 3221322 PK04_130177 COP(=O)(OC)/N=C\1/CC(=CC(N1Cc2cccc(OC(F)(F)F)c2)c3cccs3)CCCO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 I20 compound treatment 9.4851 -0.069311 -0.0375 9.0961 -0.23015 -0.1029 -0.0993 -0.9065 3211594 PK04_130178 CO[C@H](C=C)[C@H](OC(=O)Nc1ccc(SC)cc1)c2ccc(OC)c(O)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 I21 mock treatment 10.219 0.66454 0.3598 10.5009 1.1746 0.5252 0.6258 0.983 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 I22 mock treatment 9.5216 -0.032889 -0.0178 8.3935 -0.93272 -0.4171 -0.3075 -0.7366 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 I23 compound treatment 10.6953 1.1409 0.6176 8.8171 -0.50913 -0.2277 0.2758 0.4189 3221324 PK04_130179 COP(=O)(OC)/N=C\1/CC(=CC(N1Cc2cc3OCOc3cc2Br)c4cccs4)CCCO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 I24 compound treatment 10.6515 1.097 0.5939 9.6374 0.31112 0.1391 0.5183 0.8497 3211811 PK04_130180 CSc1ccc(NC(=O)O[C@H]([C@@H](C)CCO)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 J01 compound treatment 10.7158 1.1613 0.6287 7.8847 -1.4415 -0.6446 -0.0112 -0.0125 3176788 PK04_130181 CN(C)CCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3ccc(O)cc3)C(=O)[C@H](CCCCN)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 J02 compound treatment 10.8448 1.2903 0.6985 10.2768 0.95057 0.425 0.7945 0.9716 3221326 PK04_130182 C[C@@H]1[C@H]([C@H](CCO)O[C@@]12C(=O)N(Cc3ccccc3)c4ccc(cc42)N5CCOC5=O)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 J03 compound treatment 8.6163 -0.93816 -0.5079 8.7938 -0.53242 -0.2381 -0.5275 -0.9404 3176789 PK04_130183 NCCCCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3ccc(O)cc3)C(=O)[C@H](CCCCN)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 J04 compound treatment 13.0625 3.5081 1.8991 9.2034 -0.12285 -0.0549 1.304 0.6864 3221328 PK04_130184 C[C@H]1[C@@H]([C@@H](CCO)O[C@]12C(=O)N(Cc3cccc(c3)N(C=O)c4ccccc4)c5ccccc52)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 J05 mock treatment 9.8337 0.27927 0.1512 8.9135 -0.41273 -0.1845 -0.0236 -0.0989 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 J06 mock treatment 8.9775 -0.57697 -0.3123 8.6397 -0.68654 -0.307 -0.4379 -1.0 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 J07 compound treatment 7.3365 -2.2179 -1.2007 8.8458 -0.48044 -0.2148 -1.0009 -0.8206 3052827 PK04_130185 Oc1ccc(cc1)[C@@H]2[C@@H](C[C@H]3N2C(=O)[C@H](Cc4ccccc4)NC3=O)C(=O)OCCOc5ccc(cc5)[C@H]6N7[C@@H]([C@@H](C(=O)OCC=C)[C@]68C(=O)Nc9ccccc98)C(=O)O[C@@H]([C@@H]7c%10ccccc%10)c%11ccccc%11 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 J08 compound treatment 9.0743 -0.48016 -0.2599 8.9244 -0.40186 -0.1797 -0.3109 -0.9837 3221330 PK04_130186 C[C@H]1[C@@H]([C@@H](CCO)O[C@]12C(=O)N(CC=C)c3ccc(cc32)N4CCOC4=O)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 J09 compound treatment 7.8131 -1.7414 -0.9427 7.2689 -2.0574 -0.9199 -1.3171 -0.9999 3052794 PK04_130187 CN(C)CCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3ccc(O)cc3)C(=O)[C@H](Cc4ccccc4)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 J10 compound treatment 8.766 -0.78841 -0.4268 8.2586 -1.0676 -0.4774 -0.6394 -0.9984 3221332 PK04_130188 C[C@@H]1[C@H]([C@H](CCO)O[C@@]12C(=O)N(CC=C)c3ccc(cc32)N4C(=O)c5cccc6cccc4c56)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 J11 compound treatment 8.7816 -0.77289 -0.4184 8.2809 -1.0454 -0.4674 -0.6264 -0.9985 3176437 PK04_130189 CN(C)CCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3ccc(O)cc3)C(=O)[C@H](CCCCNC(=O)C)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 J12 compound treatment 8.0749 -1.4796 -0.801 10.2677 0.9415 0.421 -0.2687 -0.297 3221334 PK04_130190 C[C@@H]1[C@H]([C@H](CCO)O[C@@]12C(=O)N(CC=C)c3ccc(cc32)N4CCOC4=O)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 J13 compound treatment 8.2845 -1.2699 -0.6875 9.1796 -0.14663 -0.0656 -0.5325 -0.771 3176038 PK04_130191 CC(C)C[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCO)c3)C(=O)NCc4ccc(F)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 J14 compound treatment 7.9039 -1.6506 -0.8935 9.2402 -0.086094 -0.0385 -0.6591 -0.7369 3221335 PK04_130192 C[C@H]1[C@@H]([C@@H](CCO)O[C@]12C(=O)N(Cc3cccc(c3)N4CCC4=O)c5ccccc52)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 J15 compound treatment 9.1799 -0.37453 -0.2028 10.3325 1.0062 0.4499 0.1748 0.3542 3052796 PK04_130193 Oc1ccc(cc1)[C@@H]2[C@@H](C[C@H]3N2C(=O)[C@H](Cc4ccccc4)NC3=O)C(=O)NCc5ccc(F)cc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 J16 compound treatment 8.5184 -1.0361 -0.5609 9.2615 -0.064709 -0.0289 -0.4171 -0.7426 3221337 PK04_130194 C[C@H]1[C@@H]([C@@H](CCO)O[C@]12C(=O)N(Cc3ccccc3)c4ccc(cc42)N5CCCCC5=O)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 J17 compound treatment 8.0274 -1.5271 -0.8267 9.7708 0.44458 0.1988 -0.444 -0.5222 3176331 PK04_130195 CN(C)CCCCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3cccc(OCCO)c3)C(=O)[C@H](CCCC[N+](C)(C)C)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 J18 compound treatment 10.7486 1.1942 0.6465 9.9352 0.60896 0.2723 0.6497 0.9261 3221339 PK04_130196 C[C@H]1[C@@H]([C@@H](CCO)O[C@]12C(=O)N(Cc3ccccc3)c4ccc(cc42)N5CCC5=O)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 J19 compound treatment 8.752 -0.8024 -0.4344 8.7356 -0.59064 -0.2641 -0.4939 -0.9715 3176671 PK04_130197 CN(C)CCCCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3ccc(O)cc3)C(=O)CNC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 J20 compound treatment 8.6225 -0.93198 -0.5045 8.4088 -0.91741 -0.4102 -0.6468 -0.9947 3221341 PK04_130198 C[C@H]1[C@@H]([C@@H](CCO)O[C@]12C(=O)N(Cc3cccc(c3)N4C(=O)c5ccccc5Oc6ccccc46)c7ccccc72)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 J21 mock treatment 9.0026 -0.55184 -0.2987 7.8322 -1.4941 -0.668 -0.6836 -0.9342 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 J22 mock treatment 10.6368 1.0824 0.5859 8.1781 -1.1481 -0.5134 0.0513 0.0659 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 J23 compound treatment 9.3393 -0.21516 -0.1165 9.1511 -0.17511 -0.0783 -0.1377 -0.9813 3176271 PK04_130199 OCCOc1cccc(c1)[C@H]2[C@H](C[C@@H]3N2C(=O)CNC3=O)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccccc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 J24 compound treatment 9.6414 0.086944 0.0471 9.7346 0.40835 0.1826 0.1624 0.8612 3221343 PK04_130200 C[C@H]1[C@@H]([C@@H](CCO)O[C@]12C(=O)N(CC=C)c3ccc(cc32)N4C(=O)c5ccccc5Oc6ccccc46)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 K01 compound treatment 8.8441 -0.7103 -0.3845 11.0256 1.6993 0.7598 0.2654 0.3116 3221345 PK04_130201 COP(=O)(OC)/N=C\1/CC(=CC(N1Cc2cccc(OC(F)(F)F)c2)c3cccs3)c4ccc(CO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 K02 compound treatment 8.8204 -0.73404 -0.3974 11.0112 1.685 0.7534 0.2518 0.2956 3211905 PK04_130202 C[C@H](CCO)[C@H](O)c1ccc(O)c2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 K03 compound treatment 9.325 -0.22944 -0.1242 9.1842 -0.14203 -0.0635 -0.1327 -0.9515 3221347 PK04_130203 COc1ccc(CN2CCc3cc(OC)c(O)cc3C2C#Cc4ccccc4)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 K04 compound treatment 8.8883 -0.66612 -0.3606 9.3059 -0.020371 -0.0091 -0.2614 -0.7247 3211691 PK04_130204 CSc1ccc(NC(=O)O[C@@H](CCCO)c2ccc(O)c(F)c2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 K05 compound treatment 8.3885 -1.1659 -0.6312 8.6157 -0.71056 -0.3177 -0.671 -0.9495 3221348 PK04_130205 COc1cc2CCN(C)C(C#Cc3ccccc3)c2cc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 K06 compound treatment 8.4923 -1.0622 -0.575 9.0345 -0.29171 -0.1304 -0.4988 -0.846 3211813 PK04_130206 CSc1ccc(NC(=O)O[C@@H]([C@@H](C)CCO)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 K07 mock treatment 9.2026 -0.35185 -0.1905 8.6931 -0.63316 -0.2831 -0.3349 -0.9814 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 K08 mock treatment 8.3447 -1.2097 -0.6549 9.6491 0.32288 0.1444 -0.361 -0.5383 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 K09 compound treatment 8.6037 -0.95076 -0.5147 8.5573 -0.76898 -0.3438 -0.6071 -0.9808 3221349 PK04_130207 COc1cc2CCN(Cc3ccc(o3)[N+](=O)[O-])C(C#Cc4ccccc4)c2cc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 K10 compound treatment 10.6177 1.0632 0.5756 10.3057 0.97945 0.4379 0.7167 0.9909 3211817 PK04_130208 CSc1ccc(NC(=O)O[C@H](CC=C)c2ccc(O)c3ccccc23)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 K11 compound treatment 8.9465 -0.6079 -0.3291 8.8632 -0.46303 -0.207 -0.3791 -0.9751 3221350 PK04_130209 COCC#CC1N(Cc2ccc(OC)cc2)CCc3cc(OC)c(O)cc13 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 K12 compound treatment 10.6172 1.0628 0.5753 8.8087 -0.51759 -0.2314 0.2432 0.3921 3080279 PK04_130210 C[C@@H](CCO)[C@@H](O)c1ccc(O)c2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 K13 compound treatment 8.2083 -1.3461 -0.7287 8.9417 -0.38455 -0.1719 -0.6369 -0.8506 3221351 PK04_130211 COCC#CC1N(C)CCc2cc(OC)c(O)cc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 K14 compound treatment 8.3215 -1.233 -0.6675 12.1545 2.8282 1.2646 0.4222 0.2953 3080188 PK04_130212 CO[C@H](CCO)[C@H](O)c1ccc(OC)c(O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 K15 mock treatment 7.6592 -1.8953 -1.026 8.8451 -0.4812 -0.2152 -0.8776 -0.8372 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 K16 mock treatment 8.9087 -0.6457 -0.3496 9.2324 -0.093824 -0.042 -0.2768 -0.7863 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 K17 compound treatment 8.3098 -1.2447 -0.6738 10.0097 0.68344 0.3056 -0.2604 -0.3519 3221353 PK04_130213 COCC#CC1N(Cc2ccc(o2)[N+](=O)[O-])CCc3cc(OC)c(O)cc13 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 K18 compound treatment 9.2777 -0.27675 -0.1498 7.7205 -1.6058 -0.718 -0.6136 -0.8366 3080221 PK04_130214 CO[C@H](CCO)[C@H](O)c1ccc(OCCO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 K19 compound treatment 9.7136 0.15918 0.0862 9.5421 0.21581 0.0965 0.1292 0.9984 3221354 PK04_130215 COc1ccc(CN2CCc3cc(OC)c(O)cc3C2C#C)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 K20 compound treatment 8.566 -0.98844 -0.5351 8.9863 -0.34 -0.152 -0.4859 -0.8734 3211696 PK04_130216 CO[C@@H](CCO)[C@@H](OC(=O)Nc1ccc(SC)cc1)c2ccc(O)c(F)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 K21 compound treatment 8.7244 -0.83007 -0.4494 8.0137 -1.3125 -0.5869 -0.7327 -0.9913 3221356 PK04_130217 COc1cc2CCN(C)C(C#C)c2cc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 K22 compound treatment 10.2625 0.70807 0.3833 8.2157 -1.1105 -0.4966 -0.0801 -0.1276 3211816 PK04_130218 COc1ccc(NC(=O)O[C@H]([C@H](C)CCO)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 K23 mock treatment 7.9298 -1.6247 -0.8795 7.7904 -1.5359 -0.6867 -1.1075 -0.9925 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 K24 mock treatment 9.2297 -0.32478 -0.1758 10.283 0.95675 0.4278 0.1782 0.3852 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 L01 compound treatment 10.0207 0.46623 0.2524 10.5302 1.2039 0.5383 0.5591 0.9404 3176382 PK04_130219 CN(C)CCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3cccc(OCCO)c3)C(=O)[C@H](CCCCN)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 L02 compound treatment 10.1019 0.54747 0.2964 11.276 1.9497 0.8718 0.826 0.8971 3221357 PK04_130220 C[C@@H]1[C@H]([C@H](CCO)O[C@@]12C(=O)N(CC=C)c3ccc(cc32)N4CCCCC4=O)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 L03 compound treatment 11.5049 1.9504 1.0559 10.6139 1.2877 0.5758 1.1537 0.9593 3176383 PK04_130221 NCCCCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3cccc(OCCO)c3)C(=O)[C@H](CCCCN)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 L04 compound treatment 9.5589 0.004451 0.0024 8.0544 -1.2718 -0.5687 -0.4004 -0.7041 3221359 PK04_130222 C[C@H](O)C(=O)Nc1ccc2N(CC=C)C(=O)[C@]3(O[C@H](CCO)[C@H]([C@@H]3C)[Si](C)(C)F)c2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 L05 compound treatment 10.4406 0.88613 0.4797 14.8029 5.4767 2.4488 2.0708 0.8299 3052642 PK04_130223 OCCOc1cccc(c1)[C@@H]2[C@@H](C[C@H]3N2C(=O)[C@@H]4CCCN4C3=O)C(=O)OCCOc5ccc(cc5)[C@H]6N7[C@@H]([C@@H](C(=O)OCC=C)[C@]68C(=O)Nc9ccccc98)C(=O)O[C@@H]([C@@H]7c%10ccccc%10)c%11ccccc%11 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 L06 compound treatment 8.2767 -1.2778 -0.6917 7.9483 -1.378 -0.6161 -0.9248 -0.9983 3221361 PK04_130224 C[C@H]1[C@@H]([C@@H](CCO)O[C@]12C(=O)N(CC=C)c3ccc(cc32)N4CCC4=O)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 L07 mock treatment 8.5569 -0.99751 -0.54 8.3057 -1.0206 -0.4563 -0.7045 -0.9965 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 L08 mock treatment 8.1742 -1.3803 -0.7472 8.7224 -0.60386 -0.27 -0.7193 -0.9053 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 L09 compound treatment 8.3832 -1.1713 -0.6341 7.9515 -1.3748 -0.6147 -0.883 -0.9999 3176673 PK04_130225 CN(C)CCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3ccc(O)cc3)C(=O)CNC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 L10 compound treatment 7.5565 -1.9979 -1.0816 7.7176 -1.6086 -0.7193 -1.2734 -0.9804 3221363 PK04_130226 COc1ccc(cc1)C(=O)Nc2cccc(CN3C(=O)[C@]4(O[C@H](CCO)[C@H]([C@@H]4C)[Si](C)(C)F)c5ccccc35)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 L11 compound treatment 8.9595 -0.59493 -0.3221 8.2661 -1.0601 -0.474 -0.5629 -0.9823 3052529 PK04_130227 CN(C)CCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3cccc(OCCO)c3)C(=O)[C@H](CCCCNC(=O)C)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 L12 compound treatment 7.8581 -1.6963 -0.9183 9.8947 0.56848 0.2542 -0.4696 -0.4928 3221365 PK04_130228 C[C@@H]1[C@H]([C@H](CCO)O[C@@]12C(=O)N(Cc3cccc(c3)N(C=O)c4ccccc4)c5ccccc52)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 L13 compound treatment 8.0275 -1.5269 -0.8266 8.5756 -0.75069 -0.3357 -0.8219 -0.9212 3052693 PK04_130229 CN(C)CCCC[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCO)c3)C(=O)NCc4ccc(F)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 L14 compound treatment 8.9462 -0.60823 -0.3293 7.6038 -1.7225 -0.7702 -0.7774 -0.9281 3221366 PK04_130230 C[C@@H]1[C@H]([C@H](CCO)O[C@@]12C(=O)N(Cc3ccccc3)c4ccc(NC(=O)C)cc42)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 L15 mock treatment 8.0556 -1.4989 -0.8114 8.3268 -0.9995 -0.4469 -0.8898 -0.9605 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 L16 mock treatment 9.2549 -0.29957 -0.1622 8.0798 -1.2465 -0.5573 -0.5088 -0.8765 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 L17 compound treatment 9.3019 -0.25257 -0.1367 9.8299 0.50369 0.2252 0.0626 0.2375 3176205 PK04_130231 CN(C)CCCCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3cccc(OCCO)c3)C(=O)CNC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 L18 compound treatment 9.1989 -0.35552 -0.1925 10.4801 1.1538 0.5159 0.2287 0.4153 3221368 PK04_130232 C[C@H]1[C@@H]([C@@H](CCO)O[C@]12C(=O)N(Cc3cccc(c3)N4CCOC4=O)c5ccccc52)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 L19 compound treatment 9.1314 -0.42309 -0.229 9.5781 0.25187 0.1126 -0.0823 -0.3225 3176125 PK04_130233 CN(C)CCCCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3cccc(OCCO)c3)C(=O)[C@@H]4CCCN4C2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 L20 compound treatment 9.3452 -0.2093 -0.1133 11.2021 1.8759 0.8388 0.513 0.6061 3221370 PK04_130234 COc1ccc(cc1)C(=O)Nc2ccc3N(CC=C)C(=O)[C@@]4(O[C@@H](CCO)[C@@H]([C@H]4C)[Si](C)(C)F)c3c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 L21 compound treatment 8.3164 -1.2381 -0.6702 10.208 0.88179 0.3943 -0.1951 -0.2509 3052877 PK04_130235 Oc1ccc(cc1)[C@H]2[C@H](C[C@@H]3N2C(=O)CNC3=O)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccccc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 L22 compound treatment 8.8243 -0.73014 -0.3953 9.228 -0.098219 -0.0439 -0.3105 -0.7809 3221372 PK04_130236 C[C@H]1[C@@H]([C@@H](CCO)O[C@]12C(=O)N(CC=C)c3ccc(NC(=O)C)cc32)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 L23 mock treatment 9.8227 0.26824 0.1452 10.7616 1.4354 0.6418 0.5565 0.8457 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 L24 mock treatment 9.5882 0.033766 0.0183 8.7047 -0.62158 -0.2779 -0.1836 -0.6592 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 M01 compound treatment 10.82 1.2656 0.6851 8.8122 -0.51402 -0.2298 0.3219 0.4455 3221374 PK04_130237 COc1cc2CCN(Cc3ccc(o3)[N+](=O)[O-])C(C#C)c2cc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 M02 compound treatment 9.8399 0.2855 0.1546 10.0312 0.70493 0.3152 0.3322 0.9462 3211810 PK04_130238 C[C@@H](CCO)[C@@H](O)c1ccc(OCCO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 M03 compound treatment 9.0502 -0.50429 -0.273 8.433 -0.89329 -0.3994 -0.4755 -0.9828 3221375 PK04_130239 CC(C)C(=C=CC[C@@H](O)c1ccc(OCCO)cc1)C[C@@H](O)c2cc(Cl)cc(Cl)c2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 M04 compound treatment 9.4898 -0.064636 -0.035 9.1863 -0.13994 -0.0626 -0.069 -0.9623 3080224 PK04_130240 COc1ccc(NC(=O)O[C@@H]([C@H](C)CCO)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 M05 compound treatment 7.4616 -2.0928 -1.133 8.7632 -0.56304 -0.2518 -0.9791 -0.8437 3221376 PK04_130241 COCC(=C=CC[C@@H](O)c1ccc(OCCO)cc1)C[C@@H](O)c2cc(Cl)cc(Cl)c2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 M06 compound treatment 9.9852 0.43071 0.2332 7.6577 -1.6685 -0.7461 -0.3627 -0.464 3211820 PK04_130242 COc1ccc(NC(=O)O[C@@H](CCCO)c2ccc(O)c3ccccc23)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 M07 compound treatment 9.8323 0.27783 0.1504 10.0061 0.67985 0.304 0.3213 0.9474 3221377 PK04_130243 CCCCC(=C=CC[C@@H](O)c1cccc(OCCO)c1)C[C@@H](O)c2cc(Cl)cc(Cl)c2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 M08 compound treatment 8.1335 -1.421 -0.7693 9.491 0.16475 0.0737 -0.4919 -0.6365 3211694 PK04_130244 CO[C@H](CCO)[C@H](OC(=O)Nc1ccc(SC)cc1)c2ccc(O)c(F)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 M09 mock treatment 11.4337 1.8792 1.0173 8.2651 -1.0611 -0.4745 0.3839 0.342 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 M10 mock treatment 9.1852 -0.36922 -0.1999 8.8004 -0.52583 -0.2351 -0.3076 -0.9967 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 M11 compound treatment 9.9062 0.35177 0.1904 8.963 -0.36321 -0.1624 0.0198 0.0792 3221378 PK04_130245 CC(C)C(=C=CC[C@@H](O)c1cccc(OCCO)c1)C[C@@H](O)c2cc(Cl)cc(Cl)c2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 M12 compound treatment 8.339 -1.2154 -0.658 9.3997 0.073426 0.0328 -0.442 -0.671 3080189 PK04_130246 CO[C@H](CCO)[C@H](OC(=O)Nc1ccc(SC)cc1)c2ccc(OC)c(O)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 M13 mock treatment 8.5758 -0.97868 -0.5298 9.2137 -0.11251 -0.0503 -0.4102 -0.7708 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 M14 mock treatment 8.8853 -0.66917 -0.3623 8.3428 -0.9835 -0.4398 -0.5671 -0.9954 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 M15 compound treatment 8.7836 -0.77089 -0.4173 8.7753 -0.55098 -0.2464 -0.4693 -0.9684 3221379 PK04_130247 COCC(=C=CC[C@@H](O)c1cccc(OCCO)c1)C[C@@H](O)c2cc(Cl)cc(Cl)c2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 M16 compound treatment 9.7915 0.23707 0.1283 11.8156 2.4893 1.1131 0.8778 0.7834 3211679 PK04_130248 CO[C@@H](CCO)[C@@H](O)c1ccc(OC)c(O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 M17 compound treatment 8.2644 -1.29 -0.6984 10.3761 1.0498 0.4694 -0.1619 -0.1924 3221380 PK04_130249 CCCCC(=C=CC[C@@H](O)c1ccccc1OCCO)C[C@@H](O)c2cc(Cl)cc(Cl)c2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 M18 compound treatment 7.8556 -1.6988 -0.9197 8.3948 -0.93141 -0.4165 -0.9448 -0.9358 3211808 PK04_130250 C[C@H](CCO)[C@H](O)c1ccc(OCCO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 M19 mock treatment 9.4233 -0.13113 -0.071 10.6523 1.3261 0.5929 0.3691 0.618 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 M20 compound treatment 8.9642 -0.59027 -0.3195 9.8251 0.49886 0.2231 -0.0682 -0.1751 3080271 PK04_130251 CSc1ccc(NC(=O)O[C@H](CCCO)c2ccc(O)c3ccccc23)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 M21 mock treatment 9.57 0.015516 0.0084 9.3219 -0.0043312 -0.0019 0.0046 0.5302 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 M22 compound treatment 8.8658 -0.68869 -0.3728 10.2593 0.93309 0.4172 0.0314 0.0561 3211910 PK04_130252 C[C@@H](CCO)[C@H](O)c1ccc(O)c2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 M23 mock treatment 8.1933 -1.3611 -0.7369 9.6707 0.34448 0.154 -0.4121 -0.5475 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 M24 compound treatment 11.7364 2.1819 1.1812 8.8961 -0.43013 -0.1923 0.6992 0.5843 3211692 PK04_130253 COc1ccc(NC(=O)O[C@@H](CC=C)c2ccc(O)c(F)c2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 N01 compound treatment 9.3861 -0.16831 -0.0911 11.4205 2.0943 0.9364 0.5977 0.6353 3176433 PK04_130254 NCCCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3cccc(OCCO)c3)C(=O)[C@H](CCCCN)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 N02 compound treatment 10.3366 0.78213 0.4234 9.4976 0.17131 0.0766 0.3536 0.8217 3221382 PK04_130255 C[C@@H]1[C@H]([C@H](CCO)O[C@@]12C(=O)N(Cc3ccccc3)c4ccc(cc42)N5CCCCC5=O)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 N03 compound treatment 9.3281 -0.22638 -0.1226 9.2655 -0.060751 -0.0272 -0.1059 -0.8434 3175967 PK04_130256 CC(=O)NCCCC[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCO)c3)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccccc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 N04 compound treatment 9.4516 -0.10281 -0.0557 8.9378 -0.38841 -0.1737 -0.1622 -0.8892 3221383 PK04_130257 C[C@H]1[C@@H]([C@@H](CCO)O[C@]12C(=O)N(Cc3ccccc3)c4ccc(cc42)N5C(=O)c6ccccc6Oc7ccccc57)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 N05 compound treatment 10.8039 1.2495 0.6764 8.8525 -0.47377 -0.2118 0.3285 0.4635 3052653 PK04_130258 OCCOc1cccc(c1)[C@@H]2[C@@H](C[C@H]3N2C(=O)CNC3=O)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccccc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 N06 compound treatment 10.0036 0.44913 0.2431 10.6504 1.3241 0.5921 0.5906 0.9227 3221385 PK04_130259 C[C@H]1[C@@H]([C@@H](CCO)O[C@]12C(=O)N(CC=C)c3ccc(cc32)N4C(=O)c5cccc6cccc4c56)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 N07 compound treatment 7.8283 -1.7262 -0.9345 8.7969 -0.52933 -0.2367 -0.8281 -0.8591 3052758 PK04_130260 CC(C)C[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3ccc(O)cc3)C(=O)NCCCCN(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 N08 compound treatment 8.4629 -1.0915 -0.5909 8.3375 -0.98876 -0.4421 -0.7304 -0.9898 3221386 PK04_130261 C[C@H]1[C@@H]([C@@H](CCO)O[C@]12C(=O)N(Cc3ccc(cc3)N4CCCCC4=O)c5ccccc52)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 N09 mock treatment 7.8087 -1.7457 -0.9451 7.7122 -1.6141 -0.7217 -1.1786 -0.9911 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 N10 mock treatment 10.8435 1.289 0.6978 9.2597 -0.066561 -0.0298 0.4724 0.6763 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 N11 compound treatment 9.0013 -0.55317 -0.2995 9.3757 0.049444 0.0221 -0.1961 -0.6531 3176332 PK04_130262 CN(C)CCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3cccc(OCCO)c3)C(=O)[C@H](CCCC[N+](C)(C)C)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 N12 compound treatment 8.0339 -1.5206 -0.8232 6.5014 -2.8249 -1.2631 -1.4752 -0.9785 3221388 PK04_130263 C[C@H]1[C@@H]([C@@H](CCO)O[C@]12C(=O)N(Cc3ccccc3)c4ccc(NC(=O)C)cc42)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 N13 mock treatment 7.9865 -1.5679 -0.8488 9.2702 -0.056066 -0.0251 -0.6179 -0.7277 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 N14 mock treatment 9.6038 0.049371 0.0267 9.125 -0.20126 -0.09 -0.0447 -0.4765 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 N15 compound treatment 8.9124 -0.6421 -0.3476 9.361 0.034699 0.0155 -0.2348 -0.6749 3176440 PK04_130264 CC(=O)NCCCC[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3ccc(O)cc3)C(=O)NCc4ccc(F)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 N16 compound treatment 9.7432 0.18871 0.1022 9.3957 0.069479 0.0311 0.0942 0.8822 3221389 PK04_130265 C[C@@H]1[C@H]([C@H](CCO)O[C@@]12C(=O)N(Cc3cccc(c3)N4C(=O)c5cccc6cccc4c56)c7ccccc72)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 N17 compound treatment 8.6475 -0.9069 -0.491 9.372 0.045746 0.0205 -0.3327 -0.6771 3174818 PK04_130266 CN(C)CCCCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3cccc(OCCO)c3)C(=O)[C@H](CCCCNC(=O)C)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 N18 compound treatment 9.4102 -0.14426 -0.0781 10.202 0.87577 0.3916 0.2217 0.5551 3221391 PK04_130267 C[C@H]1[C@@H]([C@@H](CCO)O[C@]12C(=O)N(Cc3ccccc3)c4ccc(cc42)N5CCOC5=O)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 N19 compound treatment 10.4152 0.86073 0.466 9.048 -0.27827 -0.1244 0.2415 0.5007 3052539 PK04_130268 CC(C)C[C@@H]1NC(=O)[C@@H]2C[C@@H]([C@@H](N2C1=O)c3cccc(OCCO)c3)C(=O)NCCCCCCN(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 N20 compound treatment 10.3988 0.84439 0.4571 14.4198 5.0936 2.2775 1.9337 0.8324 3221392 PK04_130269 C[C@@H]1[C@H]([C@H](CCO)O[C@@]12C(=O)N(Cc3ccccc3)c4ccc(cc42)N(C=O)c5ccccc5)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 N21 compound treatment 9.9242 0.36977 0.2002 8.5473 -0.77898 -0.3483 -0.1047 -0.2607 3052582 PK04_130270 CC(C)C[C@@H]1NC(=O)[C@@H]2C[C@@H]([C@@H](N2C1=O)c3cccc(OCCO)c3)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccccc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 N22 compound treatment 11.7553 2.2009 1.1914 7.9228 -1.4035 -0.6275 0.3987 0.2961 3221394 PK04_130271 C[C@H](O)C(=O)Nc1ccc(CN2C(=O)[C@@]3(O[C@@H](CCO)[C@@H]([C@H]3C)[Si](C)(C)F)c4ccccc24)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 N23 compound treatment 12.1794 2.625 1.421 9.7497 0.42344 0.1893 1.1387 0.7943 3052791 PK04_130272 CC(C)C[C@@H]1NC(=O)[C@@H]2C[C@@H]([C@@H](N2C1=O)c3ccc(O)cc3)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccccc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 N24 compound treatment 10.1726 0.6182 0.3347 8.624 -0.70222 -0.314 0.0146 0.0319 3221396 PK04_130273 C[C@H]1[C@@H]([C@@H](CCO)O[C@]12C(=O)N(Cc3cccc(NC(=O)C)c3)c4ccccc42)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 O01 mock treatment 10.6505 1.096 0.5933 10.6654 1.3391 0.5988 0.8429 1.0 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 O02 compound treatment 8.4496 -1.1048 -0.5981 10.1315 0.80522 0.36 -0.1683 -0.2411 3211913 PK04_130274 CSc1ccc(NC(=O)O[C@H]([C@H](C)CCO)c2ccc(O)c3ccccc23)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 O03 mock treatment 9.215 -0.33945 -0.1838 10.0089 0.68261 0.3052 0.0859 0.2411 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 O04 mock treatment 10.2506 0.69614 0.3769 12.8286 3.5024 1.566 1.3738 0.8529 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 O05 mock treatment 10.208 0.65358 0.3538 8.3873 -0.93898 -0.4198 -0.0467 -0.085 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 O06 mock treatment 9.428 -0.1264 -0.0684 9.968 0.6417 0.2869 0.1545 0.5238 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 O07 mock treatment 9.1429 -0.41159 -0.2228 9.8134 0.48711 0.2178 -0.0035 -0.0114 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 O08 mock treatment 9.9017 0.34728 0.188 10.0469 0.72061 0.3222 0.3608 0.9671 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 O09 mock treatment 8.6994 -0.855 -0.4629 9.3142 -0.012034 -0.0054 -0.3311 -0.7153 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 O10 mock treatment 9.2607 -0.29379 -0.159 9.005 -0.32126 -0.1436 -0.214 -0.9987 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 O11 mock treatment 8.1593 -1.3951 -0.7553 10.4151 1.0889 0.4869 -0.1898 -0.2112 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 O12 mock treatment 10.9435 1.3891 0.752 9.0422 -0.28409 -0.127 0.4419 0.5795 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 O13 mock treatment 9.4977 -0.056729 -0.0307 8.9954 -0.33085 -0.1479 -0.1263 -0.8361 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 O14 mock treatment 9.6119 0.057476 0.0311 9.4688 0.14253 0.0637 0.0671 0.9457 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 O15 mock treatment 11.1347 1.5803 0.8555 9.9093 0.58304 0.2607 0.7893 0.8825 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 O16 mock treatment 8.0294 -1.5251 -0.8256 9.5372 0.2109 0.0943 -0.5171 -0.6223 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 O17 mock treatment 10.9925 1.4381 0.7785 9.7072 0.38094 0.1703 0.6709 0.8419 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 O18 mock treatment 10.6367 1.0823 0.5859 9.4511 0.12482 0.0558 0.4537 0.771 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 O19 mock treatment 9.7782 0.22371 0.1211 8.3999 -0.92631 -0.4142 -0.2072 -0.4802 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 O20 mock treatment 9.756 0.20159 0.1091 10.6991 1.3729 0.6139 0.5112 0.82 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 O21 mock treatment 10.9426 1.3881 0.7515 9.8028 0.47658 0.2131 0.6821 0.8732 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 O22 mock treatment 10.0283 0.47381 0.2565 8.6295 -0.69673 -0.3115 -0.0389 -0.0964 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 O23 mock treatment 9.6007 0.046274 0.0251 9.155 -0.17121 -0.0766 -0.0364 -0.4521 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 O24 mock treatment 9.2547 -0.29973 -0.1623 8.7004 -0.62588 -0.2799 -0.3126 -0.9664 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 P01 compound treatment 9.5575 0.0030885 0.0017 8.4473 -0.87892 -0.393 -0.2767 -0.7041 3175838 PK04_130275 NCCCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3ccc(O)cc3)C(=O)[C@H](CCCCN)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 P02 compound treatment 10.897 1.3425 0.7268 10.8592 1.533 0.6854 0.9986 0.9996 3221398 PK04_130276 C[C@@H]1[C@H]([C@H](CCO)O[C@@]12C(=O)N(Cc3ccc(cc3)N4CCCCC4=O)c5ccccc52)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 P03 compound treatment 9.3777 -0.17677 -0.0957 9.5219 0.19565 0.0875 -0.0058 -0.0448 3052740 PK04_130277 C[N+](C)(C)CCCC[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCO)c3)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccccc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 P04 compound treatment 10.5478 0.99336 0.5378 11.0613 1.7351 0.7758 0.9288 0.984 3221399 PK04_130278 C[C@@H]1[C@H]([C@H](CCO)O[C@@]12C(=O)N(Cc3cccc(NC(=O)C)c3)c4ccccc42)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 P05 compound treatment 11.5653 2.0109 1.0886 9.2539 -0.072309 -0.0323 0.7469 0.6858 3176784 PK04_130279 C[N+](C)(C)CCCC[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3ccc(O)cc3)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccccc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 P06 compound treatment 10.3795 0.8251 0.4467 10.3036 0.97732 0.437 0.6248 0.9999 3221400 PK04_130280 C[C@@H]1[C@H]([C@H](CCO)O[C@@]12C(=O)N(Cc3ccccc3)c4ccc(cc42)N5C(=O)c6ccccc6Oc7ccccc57)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 P07 compound treatment 8.3912 -1.1632 -0.6297 8.9306 -0.3957 -0.1769 -0.5704 -0.872 3052752 PK04_130281 CC(=O)NCCCC[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3ccc(O)cc3)C(=O)NCCCC[N+](C)(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 P08 compound treatment 9.8578 0.3034 0.1642 9.6322 0.30597 0.1368 0.2129 0.9959 3221401 PK04_130282 C[C@@H]1[C@H]([C@H](CCO)O[C@@]12C(=O)N(Cc3ccccc3)c4ccc(cc42)N5CCC5=O)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 P09 compound treatment 10.4263 0.87188 0.472 11.4333 2.107 0.9421 0.9999 0.9489 3052788 PK04_130283 CC(C)C[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3ccc(O)cc3)C(=O)NCCCC[N+](C)(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 P10 compound treatment 12.0418 2.4874 1.3466 10.0819 0.75567 0.3379 1.1911 0.8579 3221402 PK04_130284 C[C@@H]1[C@H]([C@H](CCO)O[C@@]12C(=O)N(Cc3cccc(c3)N4CCCCC4=O)c5ccccc52)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 P11 mock treatment 9.4332 -0.12127 -0.0656 8.8189 -0.50733 -0.2268 -0.2068 -0.8758 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 P12 mock treatment 9.3818 -0.17264 -0.0935 9.0522 -0.27406 -0.1225 -0.1527 -0.9911 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 P13 compound treatment 11.3292 1.7748 0.9608 10.1814 0.85514 0.3824 0.9497 0.9185 3052846 PK04_130285 C[N+](C)(C)CCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3ccc(O)cc3)C(=O)CNC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 P14 compound treatment 9.918 0.36354 0.1968 8.9666 -0.35964 -0.1608 0.0255 0.1001 3221404 PK04_130286 C[C@H](O)C(=O)Nc1cccc(CN2C(=O)[C@]3(O[C@H](CCO)[C@H]([C@@H]3C)[Si](C)(C)F)c4ccccc24)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 P15 compound treatment 9.2525 -0.30196 -0.1635 9.2392 -0.087039 -0.0389 -0.1431 -0.8516 3052836 PK04_130287 C[N+](C)(C)CCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3ccc(O)cc3)C(=O)[C@@H]4CCCN4C2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 P16 compound treatment 8.0685 -1.4859 -0.8044 10.22 0.89372 0.3996 -0.2862 -0.3187 3221406 PK04_130288 C[C@H]1[C@@H]([C@@H](CCO)O[C@]12C(=O)N(Cc3cccc(c3)N4CCCCC4=O)c5ccccc52)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 P17 compound treatment 8.004 -1.5505 -0.8394 10.2851 0.95881 0.4287 -0.2904 -0.3081 3176730 PK04_130289 C[N+](C)(C)CCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3ccc(O)cc3)C(=O)[C@H](CCCC[N+](C)(C)C)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 P18 compound treatment 8.9676 -0.58685 -0.3177 9.7798 0.45359 0.2028 -0.0812 -0.2155 3221407 PK04_130290 C[C@H](O)C(=O)Nc1ccc(CN2C(=O)[C@]3(O[C@H](CCO)[C@H]([C@@H]3C)[Si](C)(C)F)c4ccccc24)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 P19 compound treatment 10.4123 0.85787 0.4644 10.3198 0.99356 0.4443 0.6425 0.9998 3052799 PK04_130291 C[N+](C)(C)CCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3ccc(O)cc3)C(=O)[C@H](Cc4ccccc4)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 P20 compound treatment 11.8224 2.2679 1.2278 8.74 -0.58628 -0.2621 0.6828 0.5439 3221408 PK04_130292 COc1ccc(cc1)C(=O)Nc2ccc(CN3C(=O)[C@]4(O[C@H](CCO)[C@H]([C@@H]4C)[Si](C)(C)F)c5ccccc35)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 P21 compound treatment 10.4445 0.89006 0.4818 10.3201 0.99383 0.4444 0.6549 0.9992 3176730 PK04_130293 C[N+](C)(C)CCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3ccc(O)cc3)C(=O)[C@H](CCCC[N+](C)(C)C)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 P22 compound treatment 9.2077 -0.34672 -0.1877 10.4628 1.1365 0.5082 0.2266 0.4183 3221410 PK04_130294 C[C@@H]1[C@H]([C@H](CCO)O[C@@]12C(=O)N(CC=C)c3ccc(cc32)N4CCC4=O)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 P23 compound treatment 8.7758 -0.7787 -0.4216 10.6727 1.3464 0.602 0.1276 0.1736 3176786 PK04_130295 NCCCC[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3ccc(O)cc3)C(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2130 P24 compound treatment 10.1483 0.59382 0.3215 10.0941 0.76781 0.3433 0.4701 0.9995 3221411 PK04_130296 C[C@H]1[C@@H]([C@@H](CCO)O[C@]12C(=O)N(Cc3cccc(c3)N4C(=O)COc5ccccc45)c6ccccc62)[Si](C)(C)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 A01 compound treatment 10.8494 1.5913 0.8615 9.7594 0.011459 0.0051 0.6128 0.7113 3213058 Ald1-H_000001 NNC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 A02 compound treatment 9.0559 -0.20216 -0.1094 11.2585 1.5105 0.6754 0.4002 0.5849 3213059 Ald1-H_000002 NNC(=O)CCCCCCC(=O)Nc1ccccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 A03 compound treatment 153.4178 144.16 78.0418 152.9338 143.19 64.0234 100.4553 0.9952 3213060 Ald1-H_000003 ONC(=O)CCCCCCC(=O)N/N=C/c1ccccc1OCC=C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 A04 compound treatment 9.6102 0.35215 0.1906 9.7209 -0.027128 -0.0121 0.1262 0.6608 3213062 Ald1-H_000004 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccccc2OCC=C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 A05 compound treatment 249.7515 240.49 130.1928 257.493 247.75 110.7755 170.3903 0.9968 3213064 Ald1-H_000005 COc1ccc(/C=N/NC(=O)CCCCCCC(=O)NO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 A06 compound treatment 8.6021 -0.65603 -0.3551 10.1505 0.4025 0.18 -0.1239 -0.3111 3213066 Ald1-H_000006 COc1ccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 A07 compound treatment 233.1113 223.85 121.1845 204.27 194.52 86.9776 147.1928 0.9868 3213068 Ald1-H_000007 ONC(=O)CCCCCCC(=O)N/N=C/c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 A08 compound treatment 10.6446 1.3865 0.7506 11.7546 2.0066 0.8972 1.1652 0.9961 3213070 Ald1-H_000008 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 A09 compound treatment 233.4663 224.21 121.3766 224.3783 214.63 95.9687 153.6864 0.9932 3213072 Ald1-H_000009 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc2OCCOc2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 A10 compound treatment 10.7503 1.4922 0.8078 10.9655 1.2175 0.5444 0.9562 0.9815 3213074 Ald1-H_000010 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccc3OCCOc3c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 A11 compound treatment 22.4072 13.149 7.1183 22.2957 12.548 5.6105 9.0007 0.9931 3213076 Ald1-H_000011 ONC(=O)CCCCCCC(=O)N/N=C/COCc1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 A12 compound treatment 9.8869 0.62882 0.3404 10.3267 0.57874 0.2588 0.4237 0.9908 3213078 Ald1-H_000012 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/COCc2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 A13 mock treatment 9.8681 0.60998 0.3302 12.2861 2.5381 1.1349 1.036 0.8765 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 A14 mock treatment 9.5177 0.25966 0.1406 12.2258 2.4779 1.1079 0.8828 0.7905 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 A15 compound treatment 200.5182 191.26 103.54 156.7123 146.96 65.7129 119.6799 0.9759 3213080 Ald1-H_000013 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc(cc1)c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 A16 compound treatment 8.4865 -0.77156 -0.4177 10.7502 1.0022 0.4481 0.0215 0.0351 3213082 Ald1-H_000014 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccc(cc2)c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 A17 compound treatment 126.6045 117.35 63.5263 142.0308 132.28 59.1483 86.744 0.9994 3213084 Ald1-H_000015 ONC(=O)CCCCCCC(=O)N/N=C/c1ccccc1Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 A18 compound treatment 11.2895 2.0314 1.0997 12.8207 3.0727 1.3739 1.7491 0.9939 3213086 Ald1-H_000016 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccccc2Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 A19 compound treatment 43.7199 34.462 18.6561 44.2683 34.52 15.4352 24.1062 0.9956 3213088 Ald1-H_000017 ONC(=O)CCCCCCC(=O)N/N=C/c1cccc(Br)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 A20 compound treatment 9.8243 0.56617 0.3065 9.8461 0.098107 0.0439 0.2477 0.8002 3213090 Ald1-H_000018 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2cccc(Br)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 A21 compound treatment 130.2283 120.97 65.488 102.8908 93.143 41.6474 75.7562 0.9761 3213092 Ald1-H_000019 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc(Br)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 A22 compound treatment 11.1749 1.9168 1.0377 11.2197 1.4717 0.6581 1.1991 0.9758 3213094 Ald1-H_000020 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccc(Br)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 A23 compound treatment 175.2047 165.95 89.8364 170.403 160.66 71.8345 114.3186 0.9939 3213096 Ald1-H_000021 ONC(=O)CCCCCCC(=O)N/N=C/C(=C/c1ccccc1)/Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 A24 compound treatment 12.2526 2.9946 1.6211 10.1709 0.42287 0.1891 1.28 0.7843 3213098 Ald1-H_000022 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/C(=C/c2ccccc2)/Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 B01 compound treatment 16.8092 7.5512 4.0879 10.0615 0.31354 0.1402 2.9897 0.7309 3213100 Ald1-H_000023 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2c(O)ccc3ccccc23 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 B02 compound treatment 93.6767 84.419 45.7006 93.0213 83.273 37.2344 58.6439 0.9948 3213102 Ald1-H_000024 ONC(=O)CCCCCCC(=O)N/N=C/c1c(O)ccc2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 B03 compound treatment 10.6599 1.4018 0.7589 11.0256 1.2776 0.5713 0.9405 0.9902 3213104 Ald1-H_000025 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccc(O)c3ccccc23 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 B04 compound treatment 31.0219 21.764 11.782 41.8663 32.118 14.3613 18.486 0.9952 3213106 Ald1-H_000026 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc(O)c2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 B05 compound treatment 9.5101 0.25205 0.1364 10.6799 0.93192 0.4167 0.3911 0.892 3213108 Ald1-H_000027 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccc([N+](=O)[O-])c(O)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 B06 compound treatment 9.1541 -0.10394 -0.0563 9.897 0.14897 0.0666 0.0073 0.0838 3213110 Ald1-H_000028 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc([N+](=O)[O-])c(O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 B07 compound treatment 9.0022 -0.2559 -0.1385 12.3899 2.642 1.1813 0.7374 0.6199 3213112 Ald1-H_000029 Oc1ccc([N+](=O)[O-])c(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 B08 compound treatment 11.5642 2.3061 1.2484 10.3131 0.56512 0.2527 1.0615 0.8333 3213114 Ald1-H_000030 ONC(=O)CCCCCCC(=O)N/N=C/c1cc(O)ccc1[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 B09 compound treatment 8.5495 -0.70863 -0.3836 12.1418 2.3938 1.0704 0.4856 0.4271 3213116 Ald1-H_000031 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccc(cc2)n3ccnc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 B10 compound treatment 10.3566 1.0985 0.5947 11.4011 1.6531 0.7392 0.9432 0.9942 3213118 Ald1-H_000032 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc(cc1)n2ccnc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 B11 compound treatment 18.9273 9.6692 5.2345 18.2868 8.5388 3.818 6.4011 0.988 3213120 Ald1-H_000033 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2c[nH]c3ccccc23 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 B12 compound treatment 108.0268 98.769 53.4691 120.3255 110.58 49.4431 72.7699 0.9992 3213122 Ald1-H_000034 ONC(=O)CCCCCCC(=O)N/N=C/c1c[nH]c2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 B13 mock treatment 10.0029 0.7448 0.4032 8.2404 -1.5076 -0.6741 -0.1915 -0.2439 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 B14 mock treatment 8.2641 -0.99394 -0.5381 9.3131 -0.43492 -0.1945 -0.518 -0.9054 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 B15 compound treatment 8.8323 -0.42577 -0.2305 10.2097 0.46168 0.2064 -0.017 -0.055 3213124 Ald1-H_000035 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccc(I)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 B16 compound treatment 187.4738 178.22 96.4783 147.584 137.84 61.6313 111.8004 0.9766 3213126 Ald1-H_000036 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc(I)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 B17 compound treatment 8.6679 -0.59014 -0.3195 9.5655 -0.18247 -0.0816 -0.2836 -0.8601 3213128 Ald1-H_000037 C/C=C(/C)\C=N\NC(=O)CCCCCCC(=O)Nc1ccccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 B18 compound treatment 203.6695 194.41 105.246 182.9452 173.2 77.4426 129.1803 0.9886 3213130 Ald1-H_000038 C/C=C(/C)\C=N\NC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 B19 compound treatment 8.8741 -0.38394 -0.2078 9.7013 -0.046696 -0.0209 -0.1617 -0.7742 3213132 Ald1-H_000039 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccccc2[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 B20 compound treatment 50.1387 40.881 22.131 40.6777 30.93 13.8298 25.4281 0.9744 3213134 Ald1-H_000040 ONC(=O)CCCCCCC(=O)N/N=C/c1ccccc1[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 B21 compound treatment 8.6643 -0.59374 -0.3214 13.7278 3.9799 1.7795 1.031 0.5702 3213136 Ald1-H_000041 Cc1ccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)o1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 B22 compound treatment 232.9818 223.72 121.1144 191.8775 182.13 81.4365 143.2251 0.9813 3213138 Ald1-H_000042 Cc1ccc(/C=N/NC(=O)CCCCCCC(=O)NO)o1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 B23 compound treatment 9.5659 0.30781 0.1666 13.3987 3.6508 1.6324 1.2721 0.7753 3213140 Ald1-H_000043 Cc1[nH]cnc1/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 B24 compound treatment 9.4221 0.16406 0.0888 10.4786 0.73059 0.3267 0.2938 0.8679 3213142 Ald1-H_000044 Cc1[nH]cnc1/C=N/NC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 C01 compound treatment 7.4396 -1.8185 -0.9845 10.7792 1.0313 0.4611 -0.3701 -0.3404 3213144 Ald1-H_000045 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc(Br)o1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 C02 compound treatment 10.9283 1.6702 0.9042 12.5706 2.8226 1.2621 1.5318 0.9866 3213146 Ald1-H_000046 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccc(Br)o2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 C03 compound treatment 204.9065 195.65 105.9156 218.8663 209.12 93.5041 141.0111 0.9981 3213148 Ald1-H_000047 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc(O)cc1Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 C04 compound treatment 39.4563 30.198 16.348 28.7759 19.028 8.5081 17.5759 0.9537 3213150 Ald1-H_000048 Oc1ccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)c(Br)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 C05 compound treatment 212.3875 203.13 109.9655 213.7407 203.99 91.2123 142.2542 0.9957 3213152 Ald1-H_000049 ONC(=O)CCCCCCC(=O)N/N=C/c1cc(O)ccc1Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 C06 compound treatment 12.8759 3.6178 1.9585 16.2235 6.4755 2.8954 3.4322 0.9819 3213154 Ald1-H_000050 Oc1ccc(Br)c(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 C07 compound treatment 21.1792 11.921 6.4536 27.9024 18.154 8.1175 10.3033 0.9935 3213156 Ald1-H_000051 COc1cc(Br)cc(/C=N/NC(=O)CCCCCCC(=O)NO)c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 C08 compound treatment 9.5058 0.24773 0.1341 8.2029 -1.5451 -0.6908 -0.3937 -0.5594 3213158 Ald1-H_000052 COc1cc(Br)cc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 C09 compound treatment 47.3896 38.131 20.6427 65.1243 55.376 24.7607 32.1051 0.9959 3213160 Ald1-H_000053 COc1ccc(Br)c(/C=N/NC(=O)CCCCCCC(=O)NO)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 C10 compound treatment 9.3659 0.10785 0.0584 8.9481 -0.79985 -0.3576 -0.2116 -0.5839 3213162 Ald1-H_000054 COc1ccc(Br)c(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 C11 mock treatment 10.5262 1.2681 0.6865 10.734 0.98601 0.4409 0.7972 0.9771 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 C12 mock treatment 8.184 -1.0741 -0.5815 8.3773 -1.3707 -0.6129 -0.8446 -0.9997 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 C13 compound treatment 42.2358 32.978 17.8527 39.435 29.687 13.2741 22.01 0.9894 3213164 Ald1-H_000055 COc1ccc(Br)cc1/C=N/NC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 C14 compound treatment 13.9512 4.6931 2.5406 13.1596 3.4116 1.5255 2.8752 0.9702 3213166 Ald1-H_000056 COc1ccc(Br)cc1/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 C15 mock treatment 9.1917 -0.066352 -0.0359 9.726 -0.022016 -0.0098 -0.0324 -0.8689 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 C16 mock treatment 9.1344 -0.12367 -0.067 9.7748 0.026797 0.012 -0.0389 -0.5715 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 C17 compound treatment 10.4656 1.2075 0.6537 14.2422 4.4942 2.0095 1.8832 0.8912 3213168 Ald1-H_000057 ONC(=O)CCCCCCC(=O)N/N=C/c1cc2OCOc2cc1Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 C18 compound treatment 9.1437 -0.11434 -0.0619 10.5584 0.81042 0.3624 0.2125 0.5779 3213170 Ald1-H_000058 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2cc3OCOc3cc2Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 C19 compound treatment 136.2038 126.95 68.7229 123.8653 114.12 51.0258 84.6752 0.9893 3213172 Ald1-H_000059 ONC(=O)CCCCCCC(=O)N/N=C/c1cccnc1Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 C20 compound treatment 13.8507 4.5926 2.4863 11.2861 1.5381 0.6878 2.2444 0.87 3213174 Ald1-H_000060 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2cccnc2Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 C21 compound treatment 85.3068 76.049 41.1695 84.1418 74.394 33.2641 52.6325 0.9944 3213176 Ald1-H_000061 ONC(=O)CCCCCCC(=O)N/N=C/c1ccncc1Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 C22 compound treatment 10.6192 1.3611 0.7368 10.3287 0.58076 0.2597 0.7046 0.9019 3213178 Ald1-H_000062 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccncc2Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 C23 compound treatment 76.6167 67.359 36.465 68.6906 58.943 26.3553 44.4207 0.9873 3213180 Ald1-H_000063 ONC(=O)CCCCCCC(=O)N/N=C/c1cc(Br)ccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 C24 compound treatment 12.8331 3.575 1.9354 9.2493 -0.49865 -0.223 1.2109 0.6215 3213182 Ald1-H_000064 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2cc(Br)ccc2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 D01 compound treatment 12.0332 2.7751 1.5023 10.2925 0.54456 0.2435 1.2345 0.8111 3213184 Ald1-H_000065 Cc1ccsc1/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 D02 compound treatment 252.0205 242.76 131.4211 260.4187 250.67 112.0837 172.1839 0.9969 3213186 Ald1-H_000066 Cc1ccsc1/C=N/NC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 D03 compound treatment 11.0015 1.7434 0.9438 9.5302 -0.21775 -0.0974 0.5985 0.6308 3213188 Ald1-H_000067 CC1(C)[C@@H]2C[C@H]1C(=CC2)/C=N/NC(=O)CCCCCCC(=O)Nc3ccccc3O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 D04 compound treatment 259.3698 250.11 135.3997 204.5412 194.79 87.0989 157.3303 0.9772 3213190 Ald1-H_000068 CC1(C)[C@@H]2C[C@H]1C(=CC2)/C=N/NC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 D05 compound treatment 10.951 1.6929 0.9165 10.6218 0.87378 0.3907 0.9243 0.9278 3213192 Ald1-H_000069 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2cccc3ccccc23 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 D06 compound treatment 222.2958 213.04 115.3294 204.0608 194.31 86.8841 142.9865 0.9903 3213194 Ald1-H_000070 ONC(=O)CCCCCCC(=O)N/N=C/c1cccc2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 D07 compound treatment 9.827 0.56888 0.308 10.3646 0.61659 0.2757 0.4127 0.9985 3213196 Ald1-H_000071 COc1cc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)c(cc1OC)[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 D08 compound treatment 178.62 169.36 91.6852 180.4557 170.71 76.3294 118.8043 0.9958 3213198 Ald1-H_000072 COc1cc(/C=N/NC(=O)CCCCCCC(=O)NO)c(cc1OC)[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 D09 compound treatment 10.0131 0.75502 0.4087 10.1145 0.36647 0.1639 0.4049 0.9195 3213200 Ald1-H_000073 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccc3ccccc3c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 D10 compound treatment 228.0213 218.76 118.429 198.9437 189.2 84.5961 143.5604 0.9864 3213202 Ald1-H_000074 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc2ccccc2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 D11 mock treatment 8.8547 -0.40339 -0.2184 9.5022 -0.24582 -0.1099 -0.2321 -0.9495 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 D12 mock treatment 9.1633 -0.0948 -0.0513 8.202 -1.546 -0.6913 -0.5251 -0.7575 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 D13 compound treatment 9.363 0.10492 0.0568 10.4324 0.68444 0.306 0.2566 0.8243 3213204 Ald1-H_000075 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccc(s2)[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 D14 compound treatment 136.3713 127.11 68.8136 140.236 130.49 58.3458 89.9153 0.9966 3213206 Ald1-H_000076 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc(s1)[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 D15 mock treatment 8.4461 -0.81202 -0.4396 9.8042 0.056249 0.0252 -0.2931 -0.6656 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 D16 mock treatment 8.8619 -0.39617 -0.2145 9.7369 -0.011068 -0.0049 -0.1552 -0.7232 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 D17 compound treatment 9.2107 -0.047417 -0.0257 9.4386 -0.30936 -0.1383 -0.116 -0.8243 3213208 Ald1-H_000077 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2c(F)c(F)c(F)c(F)c2F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 D18 compound treatment 57.5274 48.269 26.1309 65.4637 55.716 24.9125 36.0931 0.9997 3213210 Ald1-H_000078 ONC(=O)CCCCCCC(=O)N/N=C/c1c(F)c(F)c(F)c(F)c1F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 D19 compound treatment 8.5277 -0.73037 -0.3954 10.1945 0.44651 0.1997 -0.1384 -0.3125 3213212 Ald1-H_000079 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/CCC=C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 D20 compound treatment 14.6474 5.3893 2.9175 11.7096 1.9616 0.8771 2.6832 0.8807 3213214 Ald1-H_000080 ONC(=O)CCCCCCC(=O)N/N=C/CCC=C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 D21 compound treatment 11.8753 2.6172 1.4169 10.7062 0.95818 0.4284 1.3048 0.8815 3213216 Ald1-H_000081 CC(=C)[C@H]1CCC(=CC1)/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 D22 compound treatment 226.8615 217.6 117.8011 243.7405 233.99 104.6263 157.2799 0.9983 3213218 Ald1-H_000082 CC(=C)[C@H]1CCC(=CC1)/C=N/NC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 D23 compound treatment 12.179 2.9209 1.5813 9.3544 -0.39363 -0.176 0.9937 0.6245 3213220 Ald1-H_000083 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2cccc(Oc3ccccc3)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 D24 compound treatment 109.275 100.02 54.1449 112.6313 102.88 46.0027 70.815 0.9967 3213222 Ald1-H_000084 ONC(=O)CCCCCCC(=O)N/N=C/c1cccc(Oc2ccccc2)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 E01 mock treatment 8.7192 -0.53887 -0.2917 11.3311 1.5831 0.7079 0.2943 0.3843 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 E02 mock treatment 11.8161 2.5581 1.3848 9.2046 -0.54337 -0.243 0.8074 0.5743 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 E03 compound treatment 218.4683 209.21 113.2574 220.403 210.66 94.1913 146.6883 0.9958 3213224 Ald1-H_000085 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc(Br)s1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 E04 compound treatment 10.3446 1.0865 0.5882 10.6045 0.85648 0.383 0.6867 0.9784 3213226 Ald1-H_000086 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccc(Br)s2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 E05 compound treatment 113.6748 104.42 56.5267 125.084 115.34 51.5708 76.4365 0.999 3213228 Ald1-H_000087 COc1cc(/C=N/NC(=O)CCCCCCC(=O)NO)c(Br)cc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 E06 compound treatment 10.5691 1.311 0.7097 9.7002 -0.047816 -0.0214 0.4867 0.6855 3213230 Ald1-H_000088 COc1cc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)c(Br)cc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 E07 compound treatment 64.1262 54.868 29.7032 71.6822 61.934 27.693 40.5853 0.9994 3213232 Ald1-H_000089 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc(OCc2ccccc2)cc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 E08 compound treatment 8.4993 -0.75881 -0.4108 8.763 -0.98502 -0.4404 -0.6019 -0.9994 3213234 Ald1-H_000090 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccc(OCc3ccccc3)cc2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 E09 mock treatment 9.0109 -0.24717 -0.1338 11.2181 1.4701 0.6573 0.3702 0.5518 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 E10 mock treatment 9.5112 0.25316 0.137 9.8311 0.083152 0.0372 0.1232 0.8676 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 E11 compound treatment 87.1018 77.844 42.1413 101.9088 92.161 41.2083 58.9371 0.9999 3213236 Ald1-H_000091 CC(C)(C)OC(=O)NC1(CCCC1)/C=N/NC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 E12 compound treatment 9.2972 0.039135 0.0212 11.3624 1.6145 0.7219 0.5254 0.7275 3213238 Ald1-H_000092 CC(C)(C)OC(=O)NC1(CCCC1)/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 E13 compound treatment 40.3134 31.055 16.812 40.8156 31.068 13.8914 21.7106 0.9955 3213240 Ald1-H_000093 CC(C)(C)OC(=O)N1CCC[C@H]1/C=N/NC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 E14 compound treatment 9.1212 -0.13692 -0.0741 7.9925 -1.7555 -0.785 -0.6075 -0.7705 3213242 Ald1-H_000094 CC(C)(C)OC(=O)N1CCC[C@H]1/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 E15 compound treatment 131.5605 122.3 66.2093 148.8728 139.12 62.2076 90.8044 0.9995 3213244 Ald1-H_000095 CC(C)(C)OC(=O)Nc1cccc(/C=N/NC(=O)CCCCCCC(=O)NO)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 E16 compound treatment 10.1306 0.87255 0.4724 11.8287 2.0807 0.9303 0.9919 0.9506 3213246 Ald1-H_000096 CC(C)(C)OC(=O)Nc1cccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 E17 mock treatment 8.8251 -0.43294 -0.2344 11.9143 2.1663 0.9686 0.5192 0.521 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 E18 mock treatment 9.2529 -0.0052347 -0.0028 8.8874 -0.8606 -0.3848 -0.2741 -0.7123 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 E19 compound treatment 10.0941 0.83599 0.4526 10.6666 0.91863 0.4108 0.6105 0.9988 3213248 Ald1-H_000097 ONC(=O)CCCCCCC(=O)N/N=C/c1cccc(c1)C(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 E20 compound treatment 10.0422 0.78409 0.4245 11.0919 1.344 0.6009 0.7251 0.9855 3213250 Ald1-H_000098 OC(=O)c1cccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 E21 compound treatment 8.2186 -1.0395 -0.5628 10.2479 0.49988 0.2235 -0.2399 -0.3962 3213252 Ald1-H_000099 ONC(=O)CCCCCCC(=O)N/N=C/c1ccccc1C(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 E22 compound treatment 11.606 2.3479 1.2711 11.3101 1.5622 0.6985 1.3927 0.9602 3213254 Ald1-H_000100 OC(=O)c1ccccc1/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 E23 compound treatment 9.489 0.2309 0.125 9.0942 -0.65381 -0.2923 -0.1183 -0.3722 3213256 Ald1-H_000101 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc(cc1)C(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 E24 compound treatment 8.9434 -0.31466 -0.1703 9.6558 -0.092146 -0.0412 -0.1496 -0.8535 3213258 Ald1-H_000102 OC(=O)c1ccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 F01 mock treatment 13.5089 4.2508 2.3012 8.8866 -0.86138 -0.3852 1.3549 0.5807 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 F02 mock treatment 11.8731 2.615 1.4156 10.4859 0.7379 0.3299 1.2343 0.8492 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 F03 compound treatment 9.4808 0.22272 0.1206 10.9147 1.1667 0.5217 0.4541 0.8482 3213260 Ald1-H_000103 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2cn(c3ccccc23)S(=O)(=O)c4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 F04 compound treatment 38.7421 29.484 15.9614 42.0016 32.254 14.4217 21.4841 0.9987 3213262 Ald1-H_000104 ONC(=O)CCCCCCC(=O)N/N=C/c1cn(c2ccccc12)S(=O)(=O)c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 F05 compound treatment 10.3132 1.0552 0.5712 10.3307 0.58272 0.2606 0.5882 0.9368 3213264 Ald1-H_000105 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccccn2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 F06 compound treatment 135.112 125.85 68.1319 135.8657 126.12 56.3917 88.0515 0.9956 3213266 Ald1-H_000106 ONC(=O)CCCCCCC(=O)N/N=C/c1ccccn1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 F07 compound treatment 10.1677 0.90961 0.4924 10.6374 0.88944 0.3977 0.6294 0.9944 3213268 Ald1-H_000107 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2cccnc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 F08 compound treatment 44.1637 34.906 18.8964 47.4848 37.737 16.8735 25.2931 0.9984 3213270 Ald1-H_000108 ONC(=O)CCCCCCC(=O)N/N=C/c1cccnc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 F09 mock treatment 7.8645 -1.3936 -0.7544 9.291 -0.45702 -0.2044 -0.678 -0.8674 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 F10 mock treatment 10.4396 1.1815 0.6396 8.7562 -0.99173 -0.4434 0.1387 0.1782 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 F11 compound treatment 9.8772 0.61914 0.3352 9.863 0.11499 0.0514 0.2734 0.8062 3213272 Ald1-H_000109 Cc1ncc(CO)c(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 F12 compound treatment 11.14 1.8819 1.0188 8.6176 -1.1304 -0.5054 0.363 0.3192 3213274 Ald1-H_000110 Cc1ncc(CO)c(/C=N/NC(=O)CCCCCCC(=O)NO)c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 F13 compound treatment 10.79 1.5319 0.8293 12.4377 2.6897 1.2026 1.4368 0.9835 3213276 Ald1-H_000111 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccc[nH]2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 F14 compound treatment 34.9472 25.689 13.907 34.2324 24.484 10.9478 17.575 0.993 3213278 Ald1-H_000112 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc[nH]1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 F15 compound treatment 8.8083 -0.44976 -0.2435 10.8798 1.1318 0.5061 0.1857 0.3306 3213280 Ald1-H_000113 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccc(cc2)N3CCCC3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 F16 compound treatment 187.6968 178.44 96.599 182.0035 172.26 77.0215 122.7682 0.9937 3213282 Ald1-H_000114 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc(cc1)N2CCCC2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 F17 mock treatment 9.0363 -0.22177 -0.1201 9.9594 0.21142 0.0945 -0.018 -0.1181 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 F18 mock treatment 8.3325 -0.92558 -0.5011 10.2821 0.5341 0.2388 -0.1854 -0.3341 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 F19 compound treatment 8.6501 -0.60799 -0.3291 9.114 -0.63395 -0.2835 -0.4332 -0.9972 3213284 Ald1-H_000115 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccccc2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 F20 compound treatment 227.1002 217.84 117.9304 217.6927 207.94 92.9794 149.1357 0.9931 3213286 Ald1-H_000116 ONC(=O)CCCCCCC(=O)N/N=C/c1ccccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 F21 compound treatment 10.3248 1.0667 0.5775 12.4055 2.6575 1.1883 1.2486 0.9451 3213288 Ald1-H_000117 CCCCCCC/C=N/NC(=O)CCCCCCC(=O)Nc1ccccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 F22 compound treatment 11.3972 2.1391 1.158 12.068 2.32 1.0374 1.5524 0.9985 3213290 Ald1-H_000118 CCCCCCC/C=N/NC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 F23 compound treatment 11.7548 2.4967 1.3516 12.5253 2.7773 1.2418 1.8339 0.9991 3213292 Ald1-H_000119 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2nccs2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 F24 compound treatment 111.3025 102.04 55.2425 112.7943 103.05 46.0756 71.6427 0.9959 3213294 Ald1-H_000120 ONC(=O)CCCCCCC(=O)N/N=C/c1nccs1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 G01 compound treatment 166.255 157.0 84.9914 167.3812 157.63 70.4834 109.9372 0.9957 3213296 Ald1-H_000121 ONC(=O)CCCCCCC(=O)N/N=C/c1ccccc1Cl 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 G02 compound treatment 12.4188 3.1607 1.711 10.6641 0.91616 0.4096 1.4996 0.8523 3213298 Ald1-H_000122 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccccc2Cl 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 G03 mock treatment 8.7411 -0.51702 -0.2799 8.6229 -1.1251 -0.5031 -0.5536 -0.9617 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 G04 mock treatment 8.8492 -0.40884 -0.2213 9.9878 0.23987 0.1073 -0.0807 -0.328 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 G05 compound treatment 105.6404 96.382 52.1772 97.367 87.619 39.1775 64.5976 0.99 3213300 Ald1-H_000123 ONC(=O)CCCCCCC(=O)N/N=C/c1cccnc1Cl 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 G06 compound treatment 9.2838 0.025705 0.0139 10.5741 0.8261 0.3694 0.271 0.7332 3213302 Ald1-H_000124 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2cccnc2Cl 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 G07 compound treatment 238.5045 229.25 124.1041 210.373 200.63 89.7065 151.1869 0.9873 3213304 Ald1-H_000125 ONC(=O)CCCCCCC(=O)N/N=C/C=C/c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 G08 compound treatment 15.1666 5.9085 3.1986 10.7782 1.0302 0.4607 2.5875 0.8007 3213306 Ald1-H_000126 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/C=C/c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 G09 compound treatment 30.1812 20.923 11.3269 52.415 42.667 19.0779 21.4994 0.969 3213308 Ald1-H_000127 C[C@H](CCC=C(C)C)C/C=N/NC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 G10 compound treatment 10.6479 1.3898 0.7524 9.2016 -0.54639 -0.2443 0.3593 0.4542 3213310 Ald1-H_000128 C[C@H](CCC=C(C)C)C/C=N/NC(=O)CCCCCCC(=O)Nc1ccccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 G11 compound treatment 72.4231 63.165 34.1948 95.7725 86.025 38.4646 51.378 0.9983 3213312 Ald1-H_000129 C[C@@H](CCC=C(C)C)C/C=N/NC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 G12 compound treatment 10.4422 1.1842 0.6411 9.4603 -0.28768 -0.1286 0.3623 0.5542 3213313 Ald1-H_000130 C[C@@H](CCC=C(C)C)C/C=N/NC(=O)CCCCCCC(=O)Nc1ccccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 G13 compound treatment 27.8306 18.573 10.0544 23.1178 13.37 5.9781 11.3367 0.9692 3213314 Ald1-H_000131 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc(C#N)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 G14 compound treatment 10.1411 0.88301 0.478 9.4692 -0.2788 -0.1247 0.2499 0.5058 3213316 Ald1-H_000132 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccc(C#N)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 G15 compound treatment 16.762 7.5039 4.0623 20.4134 10.665 4.7689 6.2446 0.9968 3213318 Ald1-H_000133 ONC(=O)CCCCCCC(=O)N/N=C/C1CCCCC1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 G16 compound treatment 11.0325 1.7744 0.9606 8.1271 -1.6209 -0.7248 0.1667 0.1386 3213320 Ald1-H_000134 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/C2CCCCC2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 G17 compound treatment 90.7892 81.531 44.1375 85.1078 75.36 33.696 55.0366 0.9911 3213322 Ald1-H_000135 COc1ccc(/C=N/NC(=O)CCCCCCC(=O)NO)cc1Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 G18 compound treatment 9.3291 0.070968 0.0384 9.808 0.060014 0.0268 0.0461 0.9846 3213324 Ald1-H_000136 COc1ccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)cc1Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 G19 mock treatment 8.2498 -1.0083 -0.5459 10.1665 0.4185 0.1871 -0.2537 -0.4396 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 G20 mock treatment 10.2576 0.99953 0.5411 13.1292 3.3812 1.5119 1.4517 0.904 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 G21 compound treatment 10.4308 1.1727 0.6348 10.9612 1.2132 0.5425 0.8325 0.9969 3213326 Ald1-H_000137 ONC(=O)CCCCCCC(=O)N/N=C/c1cc(Br)cc(Br)c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 G22 compound treatment 9.0179 -0.24015 -0.13 9.1981 -0.54993 -0.2459 -0.2658 -0.9556 3213328 Ald1-H_000138 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2cc(Br)cc(Br)c2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 G23 compound treatment 81.9008 72.643 39.3256 89.0772 79.329 35.4709 52.8891 0.9987 3213330 Ald1-H_000139 CCCCN(CCCC)c1ccc(/C=N/NC(=O)CCCCCCC(=O)NO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 G24 compound treatment 8.7558 -0.50233 -0.2719 9.3934 -0.35462 -0.1586 -0.3044 -0.967 3213332 Ald1-H_000140 CCCCN(CCCC)c1ccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 H01 compound treatment 12.5401 3.282 1.7767 11.5213 1.7733 0.7929 1.817 0.9339 3213334 Ald1-H_000141 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2cccs2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 H02 compound treatment 248.039 238.78 129.2657 233.4675 223.72 100.0329 162.1386 0.992 3213336 Ald1-H_000142 ONC(=O)CCCCCCC(=O)N/N=C/c1cccs1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 H03 mock treatment 8.1147 -1.1434 -0.619 9.3579 -0.3901 -0.1744 -0.561 -0.8724 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 H04 mock treatment 8.9904 -0.26764 -0.1449 8.3157 -1.4323 -0.6404 -0.5553 -0.8457 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 H05 compound treatment 8.9749 -0.28319 -0.1533 10.3112 0.56317 0.2518 0.0697 0.2363 3213338 Ald1-H_000143 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccc(cc2)C(F)(F)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 H06 compound treatment 44.0027 34.745 18.8092 45.1667 35.419 15.8369 24.4985 0.9963 3213340 Ald1-H_000144 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc(cc1)C(F)(F)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 H07 compound treatment 9.0271 -0.23096 -0.125 9.4803 -0.2677 -0.1197 -0.173 -0.9998 3213342 Ald1-H_000145 Oc1ccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)c(O)c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 H08 compound treatment 8.0595 -1.1985 -0.6488 8.1941 -1.5539 -0.6948 -0.9501 -0.9994 3213344 Ald1-H_000146 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc(O)c(O)c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 H09 compound treatment 9.7735 0.51537 0.279 11.0083 1.2603 0.5635 0.5957 0.9474 3213346 Ald1-H_000147 Oc1cc(O)c(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)c(O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 H10 compound treatment 8.5832 -0.67484 -0.3653 8.9751 -0.77287 -0.3456 -0.5027 -0.9996 3213348 Ald1-H_000148 ONC(=O)CCCCCCC(=O)N/N=C/c1c(O)cc(O)cc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 H11 compound treatment 8.6711 -0.58698 -0.3178 9.3932 -0.35474 -0.1586 -0.3369 -0.9485 3213350 Ald1-H_000149 COc1cc(OC)c(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)c(OC)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 H12 compound treatment 10.4145 1.1564 0.626 9.7008 -0.047143 -0.0211 0.4278 0.6829 3213352 Ald1-H_000150 COc1cc(OC)c(/C=N/NC(=O)CCCCCCC(=O)NO)c(OC)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 H13 compound treatment 11.0122 1.7541 0.9496 8.8506 -0.89734 -0.4012 0.3877 0.3761 3213354 Ald1-H_000151 COc1cc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)cc(OC)c1OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 H14 compound treatment 9.5782 0.32015 0.1733 12.0157 2.2677 1.014 0.8395 0.8161 3213356 Ald1-H_000152 COc1cc(/C=N/NC(=O)CCCCCCC(=O)NO)cc(OC)c1OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 H15 compound treatment 9.1443 -0.11379 -0.0616 10.4756 0.72765 0.3254 0.1865 0.5632 3213358 Ald1-H_000153 CC(C)(C)/C=N/NC(=O)CCCCCCC(=O)Nc1ccccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 H16 compound treatment 98.3388 89.081 48.2245 88.1887 78.441 35.0736 58.9006 0.9878 3213360 Ald1-H_000154 CC(C)(C)/C=N/NC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 H17 compound treatment 10.1405 0.88242 0.4777 12.6374 2.8894 1.292 1.2513 0.9084 3213362 Ald1-H_000155 CC1=C(C/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)C(C)(C)CCC1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 H18 compound treatment 127.7168 118.46 64.1284 143.3897 133.64 59.7559 87.5995 0.9994 3213364 Ald1-H_000156 CC1=C(C/C=N/NC(=O)CCCCCCC(=O)NO)C(C)(C)CCC1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 H19 mock treatment 7.7761 -1.482 -0.8023 8.3896 -1.3584 -0.6074 -0.9968 -0.9906 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 H20 mock treatment 8.4059 -0.85217 -0.4613 9.7208 -0.027173 -0.0122 -0.3348 -0.7255 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 H21 compound treatment 9.2642 0.0061103 0.0033 9.1385 -0.60953 -0.2725 -0.1904 -0.6985 3213366 Ald1-H_000157 NC(=O)COc1ccccc1/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 H22 compound treatment 10.9067 1.6486 0.8925 11.7691 2.0211 0.9037 1.2701 1.0 3213368 Ald1-H_000158 NC(=O)COc1ccccc1/C=N/NC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 H23 compound treatment 9.3711 0.11299 0.0612 9.6843 -0.063703 -0.0285 0.0231 0.3425 3213370 Ald1-H_000159 NC(=O)COc1ccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 H24 compound treatment 9.8517 0.59367 0.3214 12.3531 2.6052 1.1649 1.0509 0.8697 3213372 Ald1-H_000160 NC(=O)COc1ccc(/C=N/NC(=O)CCCCCCC(=O)NO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 I01 compound treatment 158.3202 149.06 80.6958 161.8932 152.15 68.0295 105.1647 0.9964 3213374 Ald1-H_000161 COc1cc(Cl)c(/C=N/NC(=O)CCCCCCC(=O)NO)c(Cl)c1OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 I02 compound treatment 11.2648 2.0067 1.0863 10.6036 0.8556 0.3826 1.0387 0.9018 3213376 Ald1-H_000162 COc1cc(Cl)c(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)c(Cl)c1OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 I03 compound treatment 8.2797 -0.97836 -0.5296 11.1874 1.4394 0.6436 0.0806 0.0967 3213378 Ald1-H_000163 ONC(=O)CCCCCCC(=O)N/N=C/c1cc(Cl)cc(Cl)c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 I04 compound treatment 12.1622 2.9041 1.5722 8.8951 -0.85291 -0.3814 0.842 0.5205 3213380 Ald1-H_000164 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2cc(Cl)cc(Cl)c2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 I05 mock treatment 8.5009 -0.75719 -0.4099 9.5031 -0.24485 -0.1095 -0.3673 -0.8656 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 I06 mock treatment 9.9338 0.67576 0.3658 10.6773 0.92936 0.4156 0.5525 0.998 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 I07 compound treatment 9.6555 0.39741 0.2151 9.1269 -0.62107 -0.2777 -0.0442 -0.1259 3213382 Ald1-H_000165 ONC(=O)CCCCCCC(=O)N/N=C/c1cc(Br)cc([N+](=O)[O-])c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 I08 compound treatment 10.3111 1.053 0.5701 9.3573 -0.39071 -0.1747 0.2796 0.4689 3213384 Ald1-H_000166 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2cc(Br)cc([N+](=O)[O-])c2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 I09 compound treatment 9.8441 0.586 0.3172 11.7137 1.9658 0.879 0.8458 0.9052 3213386 Ald1-H_000167 CCN(CC)c1ccc(/C=N/NC(=O)CCCCCCC(=O)NO)c(O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 I10 compound treatment 9.0699 -0.18817 -0.1019 9.7388 -0.0092084 -0.0041 -0.0749 -0.7351 3213388 Ald1-H_000168 CCN(CC)c1ccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)c(O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 I11 compound treatment 241.0483 231.79 125.4812 229.1055 219.36 98.0825 158.0834 0.9926 3213390 Ald1-H_000169 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc2OCCc2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 I12 compound treatment 12.4842 3.2261 1.7465 9.087 -0.66099 -0.2956 1.026 0.5792 3213392 Ald1-H_000170 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccc3OCCc3c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 I13 compound treatment 11.6586 2.4005 1.2995 14.7224 4.9744 2.2242 2.4917 0.9672 3213394 Ald1-H_000171 ONC(=O)CCCCCCC(=O)N/N=C/c1cccc(O)c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 I14 compound treatment 9.1624 -0.095727 -0.0518 10.4073 0.65936 0.2948 0.1718 0.574 3213396 Ald1-H_000172 Oc1cccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 I15 compound treatment 10.0015 0.74338 0.4024 11.4792 1.7312 0.7741 0.8319 0.9536 3213398 Ald1-H_000173 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc(O)cc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 I16 compound treatment 9.5843 0.3262 0.1766 9.7683 0.020302 0.0091 0.1313 0.7425 3213400 Ald1-H_000174 Oc1ccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)c(O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 I17 compound treatment 12.0539 2.7958 1.5135 10.0258 0.27777 0.1242 1.158 0.7626 3213402 Ald1-H_000175 ONC(=O)CCCCCCC(=O)N/N=C/c1cc(O)ccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 I18 compound treatment 11.8498 2.5917 1.403 11.5287 1.7808 0.7962 1.5551 0.964 3213404 Ald1-H_000176 Oc1ccc(O)c(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 I19 compound treatment 12.3438 3.0857 1.6704 10.8888 1.1408 0.5101 1.5419 0.8828 3213406 Ald1-H_000177 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc(O)c(O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 I20 compound treatment 9.3485 0.090383 0.0489 8.8396 -0.90837 -0.4062 -0.2526 -0.6175 3213408 Ald1-H_000178 Oc1ccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)cc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 I21 mock treatment 8.6989 -0.55921 -0.3027 10.3606 0.6126 0.2739 -0.0204 -0.0499 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 I22 mock treatment 10.8822 1.6241 0.8792 10.4669 0.71895 0.3215 0.849 0.9069 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 I23 compound treatment 57.4527 48.195 26.0905 68.2241 58.476 26.1467 36.9373 1.0 3213410 Ald1-H_000179 COc1ccc(/C=N/NC(=O)CCCCCCC(=O)NO)c(OC)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 I24 compound treatment 9.161 -0.097055 -0.0525 17.7114 7.9634 3.5607 2.4807 0.6966 3213412 Ald1-H_000180 COc1ccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)c(OC)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 J01 compound treatment 10.8329 1.5749 0.8526 10.0935 0.34547 0.1545 0.7121 0.8218 3213414 Ald1-H_000181 Oc1ccccc1NC(=O)CCCCCCC(=O)NN=C2CCCCCCC2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 J02 compound treatment 45.6039 36.346 19.676 40.056 30.308 13.5518 23.4956 0.9834 3213415 Ald1-H_000182 ONC(=O)CCCCCCC(=O)NN=C1CCCCCCC1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 J03 compound treatment 9.7842 0.52614 0.2848 8.2162 -1.5317 -0.6849 -0.2829 -0.3814 3213416 Ald1-H_000183 Oc1ccccc1NC(=O)CCCCCCC(=O)NN=C2CCCCCC2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 J04 compound treatment 23.6539 14.396 7.7933 22.1355 12.388 5.5389 9.4273 0.986 3213417 Ald1-H_000184 ONC(=O)CCCCCCC(=O)NN=C1CCCCCC1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 J05 mock treatment 9.6403 0.38222 0.2069 9.2902 -0.45778 -0.2047 0.0016 0.0054 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 J06 mock treatment 8.2717 -0.98637 -0.534 8.7554 -0.99257 -0.4438 -0.6914 -0.9958 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 J07 compound treatment 9.4517 0.19357 0.1048 10.9895 1.2415 0.5551 0.4666 0.826 3213418 Ald1-H_000185 Oc1ccccc1NC(=O)CCCCCCC(=O)NN=C2CCCC2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 J08 compound treatment 18.3588 9.1007 4.9267 18.4999 8.7519 3.9133 6.2509 0.9935 3213419 Ald1-H_000186 ONC(=O)CCCCCCC(=O)NN=C1CCCC1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 J09 mock treatment 10.445 1.1869 0.6425 10.2138 0.46583 0.2083 0.6016 0.8907 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 J10 mock treatment 9.9978 0.73975 0.4005 8.4235 -1.3245 -0.5922 -0.1356 -0.1897 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 J11 compound treatment 10.5948 1.3367 0.7236 9.658 -0.089946 -0.0402 0.4833 0.6668 3213420 Ald1-H_000187 COc1cc(Br)c(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)cc1OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 J12 compound treatment 266.2113 256.95 139.1034 212.3578 202.61 90.5939 162.4205 0.9784 3213422 Ald1-H_000188 COc1cc(Br)c(/C=N/NC(=O)CCCCCCC(=O)NO)cc1OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 J13 compound treatment 10.0582 0.80009 0.4331 9.3446 -0.40333 -0.1803 0.1787 0.381 3213424 Ald1-H_000189 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/CCC2CCCCC2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 J14 compound treatment 23.7032 14.445 7.8199 17.6961 7.9481 3.5539 8.0425 0.9363 3213426 Ald1-H_000190 ONC(=O)CCCCCCC(=O)N/N=C/CCC1CCCCC1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 J15 compound treatment 12.0032 2.7451 1.4861 11.8172 2.0692 0.9252 1.705 0.974 3213428 Ald1-H_000191 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccc(cc2)N(c3ccccc3)c4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 J16 compound treatment 56.0797 46.822 25.3472 54.1221 44.374 19.8413 31.9531 0.9927 3213430 Ald1-H_000192 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc(cc1)N(c2ccccc2)c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 J17 compound treatment 9.3844 0.12634 0.0684 9.3367 -0.4113 -0.1839 -0.0817 -0.4163 3213432 Ald1-H_000193 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/C[P+](c2ccccc2)(c3ccccc3)c4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 J18 compound treatment 8.3793 -0.87879 -0.4757 9.4659 -0.28209 -0.1261 -0.4256 -0.8647 3213434 Ald1-H_000194 ONC(=O)CCCCCCC(=O)N/N=C/C[P+](c1ccccc1)(c2ccccc2)c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 J19 mock treatment 8.3341 -0.92395 -0.5002 9.1445 -0.60346 -0.2698 -0.5445 -0.958 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 J20 mock treatment 8.9136 -0.34452 -0.1865 9.8902 0.14219 0.0636 -0.0869 -0.4411 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 J21 mock treatment 11.3109 2.0528 1.1113 10.8495 1.1015 0.4925 1.1341 0.933 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 J22 mock treatment 9.5765 0.31841 0.1724 11.4379 1.6899 0.7556 0.6562 0.8467 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 J23 mock treatment 9.7735 0.51545 0.279 11.3987 1.6507 0.7381 0.7192 0.9115 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 J24 mock treatment 8.1736 -1.0845 -0.5871 10.1599 0.41194 0.1842 -0.2849 -0.463 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 K01 compound treatment 11.7363 2.4782 1.3416 10.0063 0.25829 0.1155 1.0303 0.7651 3213436 Ald1-H_000195 COc1cccc(OC)c1/C=N/NC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 K02 compound treatment 10.3703 1.1122 0.6021 9.6484 -0.099581 -0.0445 0.3943 0.653 3213438 Ald1-H_000196 COc1cccc(OC)c1/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 K03 compound treatment 84.419 75.161 40.6889 83.0766 73.329 32.7878 51.9559 0.9943 3213440 Ald1-H_000197 COc1ccc(/C=N/NC(=O)CCCCCCC(=O)NO)cc1OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 K04 compound treatment 11.7003 2.4422 1.3221 10.3737 0.62574 0.2798 1.1327 0.8382 3213442 Ald1-H_000198 COc1ccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)cc1OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 K05 compound treatment 8.9473 -0.3108 -0.1683 11.4269 1.6789 0.7507 0.4119 0.5353 3213444 Ald1-H_000199 COc1cc(O)cc(OC)c1/C=N/NC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 K06 compound treatment 9.7675 0.50941 0.2758 10.1246 0.37665 0.1684 0.3141 0.972 3213446 Ald1-H_000200 COc1cc(O)cc(OC)c1/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 K07 mock treatment 9.7733 0.51517 0.2789 7.7761 -1.9719 -0.8817 -0.4263 -0.4609 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 K08 mock treatment 9.3766 0.1185 0.0642 7.6902 -2.0578 -0.9201 -0.6052 -0.6562 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 K09 compound treatment 11.3932 2.1351 1.1558 11.6521 1.9041 0.8514 1.4193 0.9887 3213448 Ald1-H_000201 CC1(C)COC(CCC/C=N/NC(=O)CCCCCCC(=O)NO)OC1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 K10 compound treatment 9.2702 0.012073 0.0065 9.6036 -0.14441 -0.0646 -0.041 -0.6323 3213450 Ald1-H_000202 CC1(C)COC(CCC/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)OC1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 K11 compound treatment 10.555 1.2969 0.7021 9.0715 -0.67644 -0.3025 0.2826 0.3696 3213452 Ald1-H_000203 Cc1nnc(Sc2ccc(/C=N/NC(=O)CCCCCCC(=O)NO)o2)n1C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 K12 compound treatment 10.6753 1.4172 0.7672 8.4113 -1.3367 -0.5977 0.1199 0.1233 3213454 Ald1-H_000204 Cc1nnc(Sc2ccc(/C=N/NC(=O)CCCCCCC(=O)Nc3ccccc3O)o2)n1C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 K13 compound treatment 216.3448 207.09 112.1078 194.9073 185.16 82.7912 137.8144 0.9889 3213456 Ald1-H_000205 ONC(=O)CCCCCCC(=O)N/N=C/c1cc(Br)cs1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 K14 compound treatment 12.1731 2.915 1.5781 10.8463 1.0983 0.4911 1.4631 0.8853 3213458 Ald1-H_000206 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2cc(Br)cs2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 K15 mock treatment 7.9407 -1.3174 -0.7132 9.0831 -0.66489 -0.2973 -0.7145 -0.9247 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 K16 mock treatment 9.1042 -0.15392 -0.0833 10.0476 0.29959 0.134 0.0358 0.2269 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 K17 compound treatment 9.5494 0.29131 0.1577 10.2716 0.52357 0.2341 0.2771 0.9815 3213460 Ald1-H_000207 CC(C)(C)OC(=O)NC/C=N/NC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 K18 compound treatment 8.9193 -0.33878 -0.1834 10.1264 0.37843 0.1692 -0.01 -0.0402 3213462 Ald1-H_000208 CC(C)(C)OC(=O)NC/C=N/NC(=O)CCCCCCC(=O)Nc1ccccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 K19 compound treatment 223.081 213.82 115.7545 210.1355 200.39 89.6003 145.2078 0.992 3213464 Ald1-H_000209 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc-2c(Cc3ccccc32)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 K20 compound treatment 13.5867 4.3286 2.3433 10.7415 0.99349 0.4442 1.9711 0.8264 3213466 Ald1-H_000210 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccc-3c(Cc4ccccc43)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 K21 compound treatment 195.1263 185.87 100.621 176.6643 166.92 74.6341 123.9241 0.9892 3213468 Ald1-H_000211 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc(F)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 K22 compound treatment 11.8172 2.5591 1.3854 10.0431 0.29514 0.132 1.0729 0.771 3213470 Ald1-H_000212 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccc(F)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 K23 mock treatment 8.3388 -0.91926 -0.4976 8.3692 -1.3787 -0.6165 -0.7878 -0.9944 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 K24 mock treatment 11.0781 1.82 0.9853 12.1921 2.4441 1.0928 1.4694 0.9987 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 L01 compound treatment 9.9576 0.69949 0.3787 13.4324 3.6844 1.6474 1.4327 0.8475 3213472 Ald1-H_000213 OC[C@@H](O)[C@@H](O)[C@H](O)/C=N/NC(=O)CCCCCCC(=O)Nc1ccccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 L02 compound treatment 9.3302 0.07209 0.039 12.5482 2.8002 1.2521 0.9129 0.7288 3213474 Ald1-H_000214 OC[C@@H](O)[C@@H](O)[C@H](O)/C=N/NC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 L03 compound treatment 9.2906 0.032525 0.0176 8.5176 -1.2304 -0.5502 -0.3766 -0.6841 3213476 Ald1-H_000215 C[C@@H](O)[C@@H](O)[C@@H](O)C/C=N/NC(=O)CCCCCCC(=O)Nc1ccccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 L04 compound treatment 9.7407 0.48266 0.2613 11.3282 1.5803 0.7066 0.6844 0.9085 3213478 Ald1-H_000216 C[C@@H](O)[C@@H](O)[C@@H](O)C/C=N/NC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 L05 compound treatment 8.5166 -0.74144 -0.4014 9.6512 -0.096733 -0.0433 -0.3144 -0.7788 3213480 Ald1-H_000217 OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)/C=N/NC(=O)CCCCCCC(=O)Nc1ccccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 L06 compound treatment 9.2104 -0.047687 -0.0258 12.3221 2.5741 1.151 0.7956 0.6911 3213482 Ald1-H_000218 OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)/C=N/NC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 L07 mock treatment 8.4075 -0.85056 -0.4605 10.1134 0.36542 0.1634 -0.2101 -0.4299 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 L08 mock treatment 10.1174 0.85931 0.4652 9.4388 -0.30917 -0.1382 0.2312 0.4764 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 L09 compound treatment 10.1523 0.89425 0.4841 7.7292 -2.0188 -0.9027 -0.296 -0.289 3213484 Ald1-H_000219 OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)/C=N/NC(=O)CCCCCCC(=O)Nc1ccccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 L10 compound treatment 12.534 3.2759 1.7734 10.7618 1.0138 0.4533 1.5745 0.8602 3213485 Ald1-H_000220 OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)/C=N/NC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 L11 compound treatment 11.3104 2.0524 1.1111 9.1063 -0.64172 -0.2869 0.5827 0.5078 3213486 Ald1-H_000221 OC[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)/C=N/NC(=O)CCCCCCC(=O)Nc1ccccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 L12 compound treatment 9.2676 0.0095303 0.0052 9.6337 -0.11428 -0.0511 -0.0325 -0.6325 3213487 Ald1-H_000222 OC[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)/C=N/NC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 L13 compound treatment 10.6397 1.3816 0.7479 8.8854 -0.86258 -0.3857 0.2561 0.3044 3213488 Ald1-H_000223 C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)/C=N/NC(=O)CCCCCCC(=O)Nc1ccccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 L14 compound treatment 8.4332 -0.82489 -0.4466 10.1793 0.43132 0.1929 -0.1794 -0.3688 3213490 Ald1-H_000224 C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)/C=N/NC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 L15 mock treatment 8.5391 -0.71897 -0.3892 9.5635 -0.18453 -0.0825 -0.3336 -0.8384 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 L16 mock treatment 9.3592 0.10114 0.0548 7.9541 -1.7939 -0.8021 -0.5285 -0.6573 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 L17 compound treatment 9.1283 -0.12981 -0.0703 9.007 -0.74103 -0.3313 -0.284 -0.8384 3213492 Ald1-H_000225 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccc(Oc3ccccc3)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 L18 compound treatment 157.766 148.51 80.3958 160.6877 150.94 67.4905 104.5714 0.9962 3213494 Ald1-H_000226 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc(Oc2ccccc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 L19 compound treatment 10.1603 0.90218 0.4884 9.3839 -0.36413 -0.1628 0.2302 0.4472 3213496 Ald1-H_000227 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2cc[n+]([O-])cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 L20 compound treatment 10.5989 1.3408 0.7259 9.6136 -0.13443 -0.0601 0.4708 0.6463 3213498 Ald1-H_000228 ONC(=O)CCCCCCC(=O)N/N=C/c1cc[n+]([O-])cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 L21 compound treatment 12.9057 3.6476 1.9747 11.3438 1.5958 0.7135 1.9009 0.9053 3213500 Ald1-H_000229 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccc3ccccc3n2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 L22 compound treatment 242.225 232.97 126.1183 215.6118 205.86 92.0489 154.2675 0.988 3213502 Ald1-H_000230 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc2ccccc2n1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 L23 mock treatment 10.7087 1.4506 0.7853 10.8756 1.1276 0.5042 0.9118 0.9771 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 L24 mock treatment 9.8321 0.57403 0.3108 8.0776 -1.6704 -0.7469 -0.3084 -0.3812 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 M01 compound treatment 12.4826 3.2245 1.7456 11.528 1.78 0.7959 1.7971 0.9367 3213504 Ald1-H_000231 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc(O)c(F)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 M02 compound treatment 11.0552 1.7971 0.9729 12.1809 2.4329 1.0879 1.4572 0.9984 3213506 Ald1-H_000232 Oc1ccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)cc1F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 M03 compound treatment 49.6788 40.421 21.882 60.2918 50.544 22.5999 31.4535 0.9999 3213508 Ald1-H_000233 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc(F)c(Oc2ccccc2)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 M04 compound treatment 9.363 0.10494 0.0568 8.8692 -0.87879 -0.3929 -0.2377 -0.5987 3213510 Ald1-H_000234 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccc(F)c(Oc3ccccc3)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 M05 compound treatment 158.6877 149.43 80.8948 175.4853 165.74 74.107 109.6028 0.999 3213512 Ald1-H_000235 ONC(=O)CCCCCCC(=O)N/N=C/c1cc(F)ccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 M06 compound treatment 11.1637 1.9056 1.0316 10.656 0.90798 0.406 1.0165 0.9169 3213514 Ald1-H_000236 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2cc(F)ccc2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 M07 compound treatment 11.8302 2.5721 1.3924 10.8057 1.0577 0.473 1.319 0.897 3213516 Ald1-H_000237 ONC(=O)CCCCCCC(=O)N/N=C/c1coc2ccccc2c1=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 M08 compound treatment 8.546 -0.71209 -0.3855 9.6458 -0.10221 -0.0457 -0.3049 -0.7854 3213518 Ald1-H_000238 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2coc3ccccc3c2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 M09 mock treatment 8.4723 -0.78575 -0.4254 9.062 -0.68595 -0.3067 -0.5177 -0.9871 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 M10 mock treatment 8.5077 -0.75035 -0.4062 10.9085 1.1605 0.5189 0.0797 0.1209 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 M11 compound treatment 218.0352 208.78 113.023 239.0023 229.25 102.5076 152.4032 0.9988 3213520 Ald1-H_000239 CC(C)(C)OC(=O)Nc1ccc(/C=N/NC(=O)CCCCCCC(=O)NO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 M12 compound treatment 10.0643 0.80618 0.4364 10.9844 1.2364 0.5529 0.6995 0.9931 3213522 Ald1-H_000240 CC(C)(C)OC(=O)Nc1ccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 M13 mock treatment 9.9583 0.70018 0.379 8.6385 -1.1095 -0.4961 -0.0828 -0.1325 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 M14 mock treatment 7.9559 -1.3022 -0.7049 8.7983 -0.9497 -0.4246 -0.7987 -0.9706 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 M15 compound treatment 9.7561 0.498 0.2696 9.559 -0.18903 -0.0845 0.1309 0.4632 3213524 Ald1-H_000241 ONC(=O)CCCCCCC(=O)N/N=C/c1cccc(c1)B(O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 M16 compound treatment 9.425 0.16692 0.0904 11.0552 1.3072 0.5845 0.4772 0.8068 3213526 Ald1-H_000242 OB(O)c1cccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 M17 compound treatment 208.6453 199.39 107.9396 206.9992 197.25 88.198 138.6902 0.995 3213528 Ald1-H_000243 ONC(=O)CCCCCCC(=O)N/N=C/c1ccco1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 M18 compound treatment 10.1445 0.88642 0.4799 11.7816 2.0337 0.9093 0.9823 0.9554 3213530 Ald1-H_000244 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccco2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 M19 compound treatment 123.752 114.49 61.9821 121.0903 111.34 49.785 79.0313 0.9941 3213532 Ald1-H_000245 ONC(=O)CCCCCCC(=O)N/N=C/c1ccoc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 M20 compound treatment 11.2904 2.0323 1.1002 9.1499 -0.59808 -0.2674 0.5889 0.5201 3213534 Ald1-H_000246 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccoc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 M21 compound treatment 81.7317 72.474 39.2341 70.6001 60.852 27.2091 46.9824 0.984 3213536 Ald1-H_000247 ONC(=O)CCCCCCC(=O)N/N=C/c1cccc(O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 M22 compound treatment 11.3074 2.0493 1.1094 10.6584 0.91039 0.4071 1.0723 0.9074 3213538 Ald1-H_000248 Oc1cccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 M23 compound treatment 37.8989 28.641 15.5049 37.5871 27.839 12.4479 19.7656 0.9941 3213540 Ald1-H_000249 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc(O)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 M24 compound treatment 9.7811 0.52302 0.2831 10.8814 1.1334 0.5068 0.5586 0.9622 3213542 Ald1-H_000250 Oc1ccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 N01 compound treatment 10.1904 0.9323 0.5047 11.7144 1.9664 0.8793 0.9786 0.9653 3213544 Ald1-H_000251 Cc1ccccc1/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 N02 compound treatment 273.3723 264.11 142.98 241.1583 231.41 103.4717 174.2677 0.9874 3213546 Ald1-H_000252 Cc1ccccc1/C=N/NC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 N03 compound treatment 9.9397 0.68164 0.369 9.3913 -0.35668 -0.1595 0.1482 0.3686 3213548 Ald1-H_000253 COc1cc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)ccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 N04 compound treatment 17.2414 7.9833 4.3218 18.4877 8.7397 3.9078 5.8193 0.9987 3213550 Ald1-H_000254 COc1cc(/C=N/NC(=O)CCCCCCC(=O)NO)ccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 N05 compound treatment 9.6171 0.35905 0.1944 9.2005 -0.54743 -0.2448 -0.0356 -0.114 3213552 Ald1-H_000255 O[C@@H](/C=N/NC(=O)CCCCCCC(=O)Nc1ccccc1O)[C@@H](O)[C@@H](O)[C@H](O)C(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 N06 compound treatment 11.2204 1.9623 1.0623 10.5484 0.80039 0.3579 1.0042 0.8959 3213554 Ald1-H_000256 ONC(=O)CCCCCCC(=O)N/N=C/[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 N07 compound treatment 10.9563 1.6982 0.9193 9.0872 -0.66083 -0.2955 0.4411 0.4568 3213556 Ald1-H_000257 OC[C@@H](O)[C@H](O)[C@@H](O)/C=N/NC(=O)CCCCCCC(=O)Nc1ccccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 N08 compound treatment 16.6087 7.3506 3.9793 16.1354 6.3874 2.856 4.8333 0.9868 3213557 Ald1-H_000258 OC[C@@H](O)[C@H](O)[C@@H](O)/C=N/NC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 N09 mock treatment 10.5127 1.2546 0.6792 7.989 -1.759 -0.7865 -0.0759 -0.073 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 N10 mock treatment 10.2028 0.9447 0.5114 9.5563 -0.1917 -0.0857 0.301 0.5805 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 N11 compound treatment 10.9804 1.7223 0.9324 10.5313 0.78333 0.3503 0.907 0.9106 3213558 Ald1-H_000259 COc1ccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)cc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 N12 compound treatment 21.6381 12.38 6.702 18.8709 9.1229 4.0792 7.6234 0.9717 3213560 Ald1-H_000260 COc1ccc(/C=N/NC(=O)CCCCCCC(=O)NO)cc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 N13 mock treatment 9.5858 0.32771 0.1774 11.8917 2.1437 0.9585 0.8032 0.824 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 N14 mock treatment 9.745 0.48691 0.2636 9.3276 -0.42043 -0.188 0.0535 0.1651 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 N15 compound treatment 9.282 0.023865 0.0129 10.7594 1.0114 0.4522 0.3289 0.727 3213562 Ald1-H_000261 CCOc1cccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)c1OCC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 N16 compound treatment 232.273 223.01 120.7307 220.0342 210.29 94.0264 151.8562 0.9924 3213564 Ald1-H_000262 CCOc1cccc(/C=N/NC(=O)CCCCCCC(=O)NO)c1OCC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 N17 compound treatment 9.7996 0.54148 0.2931 9.4492 -0.29876 -0.1336 0.1128 0.3502 3213566 Ald1-H_000263 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2cc(I)cc(I)c2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 N18 compound treatment 9.5219 0.26383 0.1428 10.0371 0.28907 0.1293 0.1924 0.9988 3213568 Ald1-H_000264 ONC(=O)CCCCCCC(=O)N/N=C/c1cc(I)cc(I)c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 N19 compound treatment 10.2527 0.99461 0.5384 9.8768 0.1288 0.0576 0.4215 0.7783 3213570 Ald1-H_000265 CN(C)c1ccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 N20 compound treatment 215.7318 206.47 111.7759 213.3127 203.56 91.021 143.3991 0.9948 3213572 Ald1-H_000266 CN(C)c1ccc(/C=N/NC(=O)CCCCCCC(=O)NO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 N21 compound treatment 10.9228 1.6647 0.9012 9.5971 -0.15092 -0.0675 0.5895 0.6523 3213574 Ald1-H_000267 CCn1c2ccccc2c3cc(/C=N/NC(=O)CCCCCCC(=O)Nc4ccccc4O)ccc13 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 N22 compound treatment 47.2943 38.036 20.5912 54.2568 44.509 19.9015 28.6326 0.9999 3213576 Ald1-H_000268 CCn1c2ccccc2c3cc(/C=N/NC(=O)CCCCCCC(=O)NO)ccc13 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 N23 compound treatment 8.8938 -0.36429 -0.1972 9.1537 -0.59432 -0.2657 -0.3274 -0.9892 3213578 Ald1-H_000269 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccc(c(F)c2)c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 N24 compound treatment 129.2113 119.95 64.9375 131.8127 122.06 54.5794 84.5112 0.9963 3213580 Ald1-H_000270 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc(c(F)c1)c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 O01 compound treatment 57.0622 47.804 25.8791 67.9987 58.251 26.0459 36.7165 1.0 3213582 Ald1-H_000271 OCCOc1ccccc1/C=N/NC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 O02 compound treatment 10.305 1.0469 0.5668 11.2125 1.4646 0.6549 0.8638 0.9974 3213584 Ald1-H_000272 OCCOc1ccccc1/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 O03 compound treatment 25.4473 16.189 8.7642 30.672 20.924 9.3559 12.8128 0.9995 3213586 Ald1-H_000273 OCCOc1cccc(/C=N/NC(=O)CCCCCCC(=O)NO)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 O04 compound treatment 12.368 3.1099 1.6836 11.7579 2.0099 0.8987 1.8259 0.9568 3213588 Ald1-H_000274 OCCOc1cccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 O05 compound treatment 65.1259 55.868 30.2444 45.2741 35.526 15.885 32.6184 0.9548 3213590 Ald1-H_000275 OCCOc1ccc(/C=N/NC(=O)CCCCCCC(=O)NO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 O06 compound treatment 12.1357 2.8776 1.5578 11.3297 1.5817 0.7072 1.6016 0.9362 3213592 Ald1-H_000276 OCCOc1ccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 O07 compound treatment 107.4386 98.18 53.1507 109.9212 100.17 44.791 69.2552 0.9964 3213594 Ald1-H_000277 COc1ccc(/C=N/NC(=O)CCCCCCC(=O)NO)c(O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 O08 compound treatment 10.4774 1.2193 0.6601 11.2782 1.5303 0.6842 0.9506 0.9998 3213596 Ald1-H_000278 COc1ccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)c(O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 O09 compound treatment 140.9083 131.65 71.2697 142.2325 132.48 59.2385 92.2832 0.9958 3213598 Ald1-H_000279 COc1ccc(O)c(/C=N/NC(=O)CCCCCCC(=O)NO)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 O10 compound treatment 8.3637 -0.8944 -0.4842 9.2655 -0.48247 -0.2157 -0.4949 -0.9337 3213600 Ald1-H_000280 COc1ccc(O)c(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 O11 mock treatment 10.0391 0.78098 0.4228 12.661 2.913 1.3025 1.22 0.8909 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 O12 mock treatment 12.6395 3.3814 1.8306 9.0409 -0.70705 -0.3161 1.0708 0.5765 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 O13 compound treatment 14.9721 5.714 3.0933 17.1803 7.4323 3.3232 4.5372 0.9994 3213602 Ald1-H_000281 COc1cc(/C=C/C=N/NC(=O)CCCCCCC(=O)NO)ccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 O14 compound treatment 10.0211 0.76299 0.4131 10.6479 0.89996 0.4024 0.5766 0.9999 3213604 Ald1-H_000282 COc1cc(/C=C/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)ccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 O15 compound treatment 194.2353 184.98 100.1387 218.5522 208.8 93.3637 136.8269 0.9994 3213606 Ald1-H_000283 Cc1ccc(O)c(/C=N/NC(=O)CCCCCCC(=O)NO)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 O16 compound treatment 10.7179 1.4599 0.7903 9.3141 -0.43385 -0.194 0.4217 0.5182 3213608 Ald1-H_000284 Cc1ccc(O)c(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 O17 compound treatment 10.5852 1.3271 0.7184 10.0249 0.27688 0.1238 0.5956 0.8169 3213610 Ald1-H_000285 OCc1ccc(/C=N/NC(=O)CCCCCCC(=O)NO)o1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 O18 compound treatment 9.8276 0.56949 0.3083 10.2129 0.4649 0.2079 0.365 0.9816 3213612 Ald1-H_000286 OCc1ccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)o1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 O19 compound treatment 18.9314 9.6733 5.2367 23.443 13.695 6.1235 8.0329 0.997 3213614 Ald1-H_000287 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc2ccccc2c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 O20 compound treatment 10.7923 1.5342 0.8305 10.1236 0.37557 0.1679 0.706 0.8332 3213616 Ald1-H_000288 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccc3ccccc3c2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 O21 compound treatment 220.2527 210.99 114.2234 206.0218 196.27 87.7609 142.8245 0.9915 3213618 Ald1-H_000289 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc(o1)c2cccc(Cl)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 O22 compound treatment 10.6428 1.3847 0.7496 10.5784 0.83038 0.3713 0.7926 0.9475 3213620 Ald1-H_000290 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccc(o2)c3cccc(Cl)c3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 O23 compound treatment 11.0987 1.8406 0.9964 9.4211 -0.32687 -0.1462 0.6012 0.597 3213622 Ald1-H_000291 ONC(=O)CCCCCCC(=O)N/N=C/c1cc(Br)c(O)c(Br)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 O24 compound treatment 8.498 -0.7601 -0.4115 10.4706 0.7226 0.3231 -0.0625 -0.1195 3213624 Ald1-H_000292 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2cc(Br)c(O)c(Br)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 P01 compound treatment 9.5062 0.24816 0.1343 8.5832 -1.1647 -0.5208 -0.2733 -0.5081 3213626 Ald1-H_000293 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2ccc(o2)S(=O)(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 P02 compound treatment 9.8934 0.63534 0.3439 8.7571 -0.99092 -0.4431 -0.0701 -0.125 3213628 Ald1-H_000294 ONC(=O)CCCCCCC(=O)N/N=C/c1ccc(o1)S(=O)(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 P03 compound treatment 10.3187 1.0606 0.5742 12.261 2.513 1.1236 1.2005 0.9514 3213630 Ald1-H_000295 Cn1cc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)c3ccccc13 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 P04 compound treatment 253.7835 244.53 132.3755 252.2933 242.55 108.4505 170.2897 0.9951 3213632 Ald1-H_000296 Cn1cc(/C=N/NC(=O)CCCCCCC(=O)NO)c2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 P05 compound treatment 9.1314 -0.12666 -0.0686 9.269 -0.47894 -0.2142 -0.1999 -0.8891 3213634 Ald1-H_000297 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/c2cn(Cc3ccccc3)c4ccccc24 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 P06 compound treatment 120.4825 111.22 60.2121 114.102 104.35 46.6603 75.5702 0.9921 3213636 Ald1-H_000298 ONC(=O)CCCCCCC(=O)N/N=C/c1cn(Cc2ccccc2)c3ccccc13 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 P07 compound treatment 9.3643 0.10618 0.0575 8.7199 -1.0281 -0.4597 -0.2844 -0.6139 3213638 Ald1-H_000299 Oc1ccccc1NC(=O)CCCCCCC(=O)N/N=C/C2=CCCCC2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 P08 compound treatment 230.9003 221.64 119.9875 215.6207 205.87 92.0529 149.9353 0.9914 3213640 Ald1-H_000300 ONC(=O)CCCCCCC(=O)N/N=C/C1=CCCCC1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 P09 compound treatment 10.1657 0.90763 0.4914 9.3338 -0.41422 -0.1852 0.2165 0.4123 3213642 Ald1-H_000301 OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)/C=N/NC(=O)CCCCCCC(=O)Nc1ccccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 P10 compound treatment 10.8449 1.5868 0.859 9.4254 -0.32256 -0.1442 0.5054 0.5803 3213643 Ald1-H_000302 OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)/C=N/NC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 P11 mock treatment 9.0064 -0.2517 -0.1363 9.381 -0.36699 -0.1641 -0.2124 -0.9957 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 P12 mock treatment 11.627 2.3689 1.2824 7.6901 -2.0578 -0.9201 0.2562 0.1623 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 P13 compound treatment 13.2315 3.9734 2.151 13.2608 3.5128 1.5707 2.6317 0.9881 3213644 Ald1-H_000303 OC[C@@H](O)[C@@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@@H](O)/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 P14 compound treatment 12.2416 2.9835 1.6151 11.3493 1.6014 0.716 1.6484 0.933 3213646 Ald1-H_000304 OC[C@@H](O)[C@@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@@H](O)/C=N/NC(=O)CCCCCCC(=O)NO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 P15 compound treatment 10.2617 1.0036 0.5433 12.0011 2.2532 1.0075 1.0966 0.958 3213648 Ald1-H_000305 OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)[C@H](O)[C@@H](O)[C@H]1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 P16 compound treatment 9.792 0.53389 0.289 10.5486 0.80062 0.358 0.4575 0.9944 3213650 Ald1-H_000306 OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)/C=N/NC(=O)CCCCCCC(=O)NO)[C@H](O)[C@@H](O)[C@H]1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 P17 compound treatment 9.9099 0.65178 0.3528 10.8563 1.1083 0.4956 0.5999 0.9861 3213652 Ald1-H_000307 C/C(=N\NC(=O)CCCCCCC(=O)Nc1ccccc1O)/C[P+](c2ccccc2)(c3ccccc3)c4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 P18 compound treatment 10.8992 1.6412 0.8884 8.5642 -1.1838 -0.5293 0.254 0.2456 3213654 Ald1-H_000308 C/C(=N\NC(=O)CCCCCCC(=O)NO)/C[P+](c1ccccc1)(c2ccccc2)c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 P19 compound treatment 10.2099 0.95178 0.5153 12.4221 2.6741 1.1957 1.2098 0.9292 3213656 Ald1-H_000309 CN(C)CCCOc1ccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 P20 compound treatment 191.8015 182.54 98.8211 175.2428 165.49 73.9985 122.202 0.9898 3213658 Ald1-H_000310 CN(C)CCCOc1ccc(/C=N/NC(=O)CCCCCCC(=O)NO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 P21 compound treatment 10.0815 0.82339 0.4457 10.0596 0.31161 0.1393 0.4137 0.8859 3213660 Ald1-H_000311 CCOc1cc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)ccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 P22 compound treatment 16.6436 7.3855 3.9982 16.8461 7.0981 3.1738 5.0714 0.9935 3213662 Ald1-H_000312 CCOc1cc(/C=N/NC(=O)CCCCCCC(=O)NO)ccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 P23 compound treatment 10.276 1.018 0.5511 10.3284 0.5804 0.2595 0.5732 0.941 3213664 Ald1-H_000313 CN(CCO)c1ccc(/C=N/NC(=O)CCCCCCC(=O)Nc2ccccc2O)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2131 P24 compound treatment 22.9354 13.677 7.4043 21.7519 12.004 5.3674 9.0309 0.9875 3213666 Ald1-H_000314 CN(CCO)c1ccc(/C=N/NC(=O)CCCCCCC(=O)NO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 A01 compound treatment 10.6582 0.79695 0.4314 10.5225 0.60171 0.269 0.4953 0.9742 3213668 Ald1-H_000315 NNC(=O)CCCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 A02 compound treatment 9.999 0.13768 0.0745 11.3325 1.4117 0.6312 0.499 0.7851 3213669 Ald1-H_000316 NNC(=O)CCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 A03 compound treatment 10.5935 0.73222 0.3964 9.6858 -0.23502 -0.1051 0.206 0.5023 3213670 Ald1-H_000317 OC(=O)CCCCCCC(=O)N/N=C/c1ccccc1OCC=C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 A04 compound treatment 10.7018 0.84049 0.455 10.3371 0.41625 0.1861 0.4533 0.9222 3213672 Ald1-H_000318 OC(=O)CCCCCC(=O)N/N=C/c1ccccc1OCC=C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 A05 compound treatment 9.3511 -0.51018 -0.2762 10.1357 0.21485 0.0961 -0.1274 -0.4356 3213674 Ald1-H_000319 COc1ccc(/C=N/NC(=O)CCCCCCC(=O)O)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 A06 compound treatment 9.3857 -0.47555 -0.2574 9.1411 -0.7797 -0.3486 -0.4286 -0.9889 3213676 Ald1-H_000320 COc1ccc(/C=N/NC(=O)CCCCCC(=O)O)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 A07 compound treatment 9.9948 0.13353 0.0723 10.4673 0.54648 0.2444 0.2239 0.8787 3213678 Ald1-H_000321 OC(=O)CCCCCCC(=O)N/N=C/c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 A08 compound treatment 9.8873 0.025996 0.0141 11.9475 2.0267 0.9062 0.6507 0.718 3213680 Ald1-H_000322 OC(=O)CCCCCC(=O)N/N=C/c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 A09 compound treatment 11.1913 1.33 0.72 12.4697 2.5489 1.1397 1.315 0.9755 3213682 Ald1-H_000323 OC(=O)CCCCCCC(=O)N/N=C/c1ccc2OCCOc2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 A10 compound treatment 12.6236 2.7623 1.4954 8.5305 -1.3903 -0.6217 0.6178 0.3815 3213684 Ald1-H_000324 OC(=O)CCCCCC(=O)N/N=C/c1ccc2OCCOc2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 A11 compound treatment 9.1704 -0.69085 -0.374 10.5008 0.57995 0.2593 -0.0811 -0.1782 3213686 Ald1-H_000325 OC(=O)CCCCCCC(=O)N/N=C/COCc1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 A12 compound treatment 10.804 0.94266 0.5103 11.0617 1.1409 0.5101 0.7216 1.0 3213688 Ald1-H_000326 OC(=O)CCCCCC(=O)N/N=C/COCc1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 A13 mock treatment 8.9754 -0.88591 -0.4796 9.5538 -0.36705 -0.1641 -0.4552 -0.898 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 A14 mock treatment 10.0097 0.14843 0.0804 9.6936 -0.22725 -0.1016 -0.015 -0.116 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 A15 compound treatment 9.587 -0.27427 -0.1485 10.1086 0.18775 0.0839 -0.0456 -0.2675 3213690 Ald1-H_000327 OC(=O)CCCCCCC(=O)N/N=C/c1ccc(cc1)c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 A16 compound treatment 8.7512 -1.1101 -0.601 10.9393 1.0185 0.4554 -0.1029 -0.1365 3213692 Ald1-H_000328 OC(=O)CCCCCC(=O)N/N=C/c1ccc(cc1)c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 A17 compound treatment 9.7054 -0.15593 -0.0844 9.0699 -0.85095 -0.3805 -0.3287 -0.8435 3213694 Ald1-H_000329 OC(=O)CCCCCCC(=O)N/N=C/c1ccccc1Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 A18 compound treatment 10.1723 0.31103 0.1684 9.261 -0.65978 -0.295 -0.0895 -0.2636 3213696 Ald1-H_000330 OC(=O)CCCCCC(=O)N/N=C/c1ccccc1Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 A19 compound treatment 9.8146 -0.046651 -0.0253 11.2002 1.2794 0.572 0.3866 0.6752 3213698 Ald1-H_000331 OC(=O)CCCCCCC(=O)N/N=C/c1cccc(Br)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 A20 compound treatment 9.6943 -0.167 -0.0904 8.9924 -0.92845 -0.4151 -0.3575 -0.8414 3213700 Ald1-H_000332 OC(=O)CCCCCC(=O)N/N=C/c1cccc(Br)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 A21 compound treatment 11.8666 2.0053 1.0856 11.8054 1.8846 0.8427 1.3635 0.9922 3213702 Ald1-H_000333 OC(=O)CCCCCCC(=O)N/N=C/c1ccc(Br)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 A22 compound treatment 11.6201 1.7588 0.9521 9.793 -0.12781 -0.0571 0.6329 0.6635 3213704 Ald1-H_000334 OC(=O)CCCCCC(=O)N/N=C/c1ccc(Br)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 A23 compound treatment 11.2153 1.354 0.733 9.6643 -0.25653 -0.1147 0.4372 0.5893 3213706 Ald1-H_000335 OC(=O)CCCCCCC(=O)N/N=C/C(=C/c1ccccc1)/Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 A24 compound treatment 9.8057 -0.055589 -0.0301 10.8701 0.94928 0.4245 0.2789 0.6553 3213708 Ald1-H_000336 OC(=O)CCCCCC(=O)N/N=C/C(=C/c1ccccc1)/Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 B01 compound treatment 8.9376 -0.92369 -0.5 9.04 -0.88085 -0.3939 -0.6321 -0.993 3213710 Ald1-H_000337 OC(=O)CCCCCC(=O)N/N=C/c1c(O)ccc2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 B02 compound treatment 11.4424 1.5811 0.8559 9.2328 -0.68802 -0.3076 0.3877 0.4263 3213712 Ald1-H_000338 OC(=O)CCCCCCC(=O)N/N=C/c1c(O)ccc2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 B03 compound treatment 10.3159 0.45462 0.2461 8.7288 -1.192 -0.533 -0.2029 -0.3456 3213714 Ald1-H_000339 OC(=O)CCCCCC(=O)N/N=C/c1ccc(O)c2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 B04 compound treatment 9.3932 -0.46812 -0.2534 15.2176 5.2968 2.3684 1.4955 0.6279 3213716 Ald1-H_000340 OC(=O)CCCCCCC(=O)N/N=C/c1ccc(O)c2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 B05 compound treatment 8.7674 -1.0939 -0.5922 9.0251 -0.89571 -0.4005 -0.702 -0.9819 3213718 Ald1-H_000341 OC(=O)CCCCCC(=O)N/N=C/c1ccc([N+](=O)[O-])c(O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 B06 compound treatment 10.7332 0.87194 0.472 9.1198 -0.80104 -0.3582 0.0805 0.1359 3213720 Ald1-H_000342 OC(=O)CCCCCCC(=O)N/N=C/c1ccc([N+](=O)[O-])c(O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 B07 compound treatment 9.4382 -0.42306 -0.229 8.8158 -1.1051 -0.4941 -0.5113 -0.9389 3213722 Ald1-H_000343 OC(=O)CCCCCC(=O)N/N=C/c1cc(O)ccc1[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 B08 compound treatment 11.2204 1.3591 0.7357 11.1073 1.1865 0.5305 0.8954 0.9871 3213724 Ald1-H_000344 OC(=O)CCCCCCC(=O)N/N=C/c1cc(O)ccc1[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 B09 compound treatment 11.552 1.6907 0.9153 10.4898 0.56895 0.2544 0.8271 0.8706 3213726 Ald1-H_000345 OC(=O)CCCCCC(=O)N/N=C/c1ccc(cc1)n2ccnc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 B10 compound treatment 10.676 0.81473 0.4411 9.5971 -0.32369 -0.1447 0.2095 0.4514 3213728 Ald1-H_000346 OC(=O)CCCCCCC(=O)N/N=C/c1ccc(cc1)n2ccnc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 B11 compound treatment 11.2055 1.3442 0.7277 9.203 -0.71785 -0.321 0.2876 0.3616 3213730 Ald1-H_000347 OC(=O)CCCCCC(=O)N/N=C/c1c[nH]c2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 B12 compound treatment 10.8261 0.96476 0.5223 8.5542 -1.3667 -0.6111 -0.0628 -0.0781 3213732 Ald1-H_000348 OC(=O)CCCCCCC(=O)N/N=C/c1c[nH]c2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 B13 mock treatment 9.7378 -0.12353 -0.0669 10.9 0.97916 0.4378 0.2623 0.5922 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 B14 mock treatment 9.7674 -0.093854 -0.0508 8.5216 -1.3992 -0.6256 -0.4783 -0.762 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 B15 compound treatment 10.5555 0.69421 0.3758 9.773 -0.14777 -0.0661 0.219 0.574 3213734 Ald1-H_000349 OC(=O)CCCCCC(=O)N/N=C/c1ccc(I)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 B16 compound treatment 9.5874 -0.27392 -0.1483 10.1076 0.1868 0.0835 -0.0458 -0.2691 3213736 Ald1-H_000350 OC(=O)CCCCCCC(=O)N/N=C/c1ccc(I)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 B17 compound treatment 8.8635 -0.99775 -0.5401 9.713 -0.20779 -0.0929 -0.4476 -0.8167 3213738 Ald1-H_000351 C/C=C(/C)\C=N\NC(=O)CCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 B18 compound treatment 12.3046 2.4433 1.3227 9.4589 -0.46196 -0.2066 0.7892 0.5895 3213740 Ald1-H_000352 C/C=C(/C)\C=N\NC(=O)CCCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 B19 compound treatment 10.7481 0.88681 0.4801 9.2275 -0.69334 -0.31 0.1203 0.2104 3213742 Ald1-H_000353 OC(=O)CCCCCC(=O)N/N=C/c1ccccc1[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 B20 compound treatment 9.369 -0.49226 -0.2665 10.7889 0.86811 0.3882 0.086 0.1827 3213744 Ald1-H_000354 OC(=O)CCCCCCC(=O)N/N=C/c1ccccc1[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 B21 compound treatment 9.6757 -0.18556 -0.1005 9.1686 -0.75218 -0.3363 -0.3088 -0.8799 3213746 Ald1-H_000355 Cc1ccc(/C=N/NC(=O)CCCCCC(=O)O)o1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 B22 compound treatment 8.9573 -0.90396 -0.4894 10.3617 0.44085 0.1971 -0.2066 -0.3917 3213748 Ald1-H_000356 Cc1ccc(/C=N/NC(=O)CCCCCCC(=O)O)o1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 B23 compound treatment 10.1549 0.29357 0.1589 9.5159 -0.40489 -0.181 -0.0156 -0.0649 3213750 Ald1-H_000357 Cc1[nH]cnc1/C=N/NC(=O)CCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 B24 compound treatment 8.875 -0.98628 -0.5339 8.7206 -1.2002 -0.5366 -0.757 -1.0 3213752 Ald1-H_000358 Cc1[nH]cnc1/C=N/NC(=O)CCCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 C01 compound treatment 10.656 0.79475 0.4302 9.4374 -0.48337 -0.2161 0.1514 0.3144 3213754 Ald1-H_000359 OC(=O)CCCCCCC(=O)N/N=C/c1ccc(Br)o1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 C02 compound treatment 10.7167 0.85538 0.4631 11.6054 1.6846 0.7532 0.8601 0.9727 3213756 Ald1-H_000360 OC(=O)CCCCCC(=O)N/N=C/c1ccc(Br)o1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 C03 compound treatment 20.7997 10.938 5.9216 22.4264 12.506 5.5917 8.1411 0.9996 3213758 Ald1-H_000361 OC(=O)CCCCCCC(=O)N/N=C/c1ccc(O)cc1Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 C04 compound treatment 16.1883 6.327 3.4252 11.5932 1.6724 0.7478 2.9507 0.8417 3213760 Ald1-H_000362 OC(=O)CCCCCC(=O)N/N=C/c1ccc(O)cc1Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 C05 compound treatment 19.0225 9.1613 4.9595 14.8307 4.9099 2.1954 5.0593 0.9328 3213762 Ald1-H_000363 OC(=O)CCCCCCC(=O)N/N=C/c1cc(O)ccc1Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 C06 compound treatment 14.8248 4.9635 2.687 14.0845 4.1637 1.8617 3.2165 0.9839 3213764 Ald1-H_000364 OC(=O)CCCCCC(=O)N/N=C/c1cc(O)ccc1Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 C07 compound treatment 10.7045 0.84324 0.4565 11.1328 1.2119 0.5419 0.706 0.9964 3213766 Ald1-H_000365 COc1cc(Br)cc(/C=N/NC(=O)CCCCCCC(=O)O)c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 C08 compound treatment 8.739 -1.1223 -0.6076 8.4922 -1.4286 -0.6388 -0.8813 -0.9997 3213768 Ald1-H_000366 COc1cc(Br)cc(/C=N/NC(=O)CCCCCC(=O)O)c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 C09 compound treatment 9.7227 -0.13862 -0.075 9.9856 0.0648 0.029 -0.0326 -0.405 3213770 Ald1-H_000367 COc1ccc(Br)c(/C=N/NC(=O)CCCCCCC(=O)O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 C10 compound treatment 9.9888 0.12747 0.069 9.8309 -0.089877 -0.0402 0.0204 0.2552 3213772 Ald1-H_000368 COc1ccc(Br)c(/C=N/NC(=O)CCCCCC(=O)O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 C11 mock treatment 9.9661 0.10482 0.0567 10.6764 0.75558 0.3378 0.279 0.8145 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 C12 mock treatment 10.9458 1.0845 0.5871 10.1045 0.18366 0.0821 0.4732 0.7982 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 C13 compound treatment 11.477 1.6157 0.8747 12.8749 2.9541 1.3209 1.5525 0.98 3213774 Ald1-H_000369 COc1ccc(Br)cc1/C=N/NC(=O)CCCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 C14 compound treatment 10.1478 0.28655 0.1551 9.0524 -0.86843 -0.3883 -0.1649 -0.3943 3213776 Ald1-H_000370 COc1ccc(Br)cc1/C=N/NC(=O)CCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 C15 mock treatment 10.1259 0.26465 0.1433 9.4791 -0.44171 -0.1975 -0.0383 -0.1572 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 C16 mock treatment 11.7104 1.8491 1.001 10.1262 0.20542 0.0919 0.7728 0.7688 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 C17 compound treatment 9.5309 -0.33039 -0.1789 9.2662 -0.65462 -0.2927 -0.3334 -0.9721 3213778 Ald1-H_000371 OC(=O)CCCCCCC(=O)N/N=C/c1cc2OCOc2cc1Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 C18 compound treatment 10.0964 0.2351 0.1273 10.188 0.26718 0.1195 0.1745 0.9995 3213780 Ald1-H_000372 OC(=O)CCCCCC(=O)N/N=C/c1cc2OCOc2cc1Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 C19 compound treatment 10.6708 0.80953 0.4382 10.8732 0.95235 0.4258 0.611 0.9999 3213782 Ald1-H_000373 OC(=O)CCCCCCC(=O)N/N=C/c1cccnc1Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 C20 compound treatment 9.0465 -0.81482 -0.4411 8.6827 -1.2381 -0.5536 -0.7034 -0.9937 3213784 Ald1-H_000374 OC(=O)CCCCCC(=O)N/N=C/c1cccnc1Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 C21 compound treatment 12.3489 2.4876 1.3467 9.9618 0.040983 0.0183 0.9652 0.7167 3213786 Ald1-H_000375 OC(=O)CCCCCCC(=O)N/N=C/c1ccncc1Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 C22 compound treatment 10.5908 0.7295 0.3949 10.0071 0.086258 0.0386 0.3065 0.7725 3213788 Ald1-H_000376 OC(=O)CCCCCC(=O)N/N=C/c1ccncc1Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 C23 compound treatment 11.3949 1.5336 0.8302 10.8597 0.93884 0.4198 0.8839 0.9501 3213790 Ald1-H_000377 OC(=O)CCCCCCC(=O)N/N=C/c1cc(Br)ccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 C24 compound treatment 10.4683 0.60697 0.3286 10.2093 0.28849 0.129 0.3236 0.9166 3213792 Ald1-H_000378 OC(=O)CCCCCC(=O)N/N=C/c1cc(Br)ccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 D01 compound treatment 9.6144 -0.24694 -0.1337 9.4919 -0.42889 -0.1918 -0.2301 -0.9844 3213794 Ald1-H_000379 Cc1ccsc1/C=N/NC(=O)CCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 D02 compound treatment 9.6826 -0.17871 -0.0967 8.9402 -0.98063 -0.4385 -0.3785 -0.8429 3213796 Ald1-H_000380 Cc1ccsc1/C=N/NC(=O)CCCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 D03 compound treatment 10.4694 0.60808 0.3292 9.0361 -0.88469 -0.3956 -0.0469 -0.0912 3213798 Ald1-H_000381 CC1(C)[C@@H]2C[C@H]1C(=CC2)/C=N/NC(=O)CCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 D04 compound treatment 10.4508 0.58946 0.3191 9.3048 -0.61598 -0.2754 0.0309 0.0733 3213800 Ald1-H_000382 CC1(C)[C@@H]2C[C@H]1C(=CC2)/C=N/NC(=O)CCCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 D05 compound treatment 9.4473 -0.41401 -0.2241 9.1862 -0.73461 -0.3285 -0.3907 -0.9826 3213802 Ald1-H_000383 OC(=O)CCCCCC(=O)N/N=C/c1cccc2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 D06 compound treatment 10.9739 1.1126 0.6023 9.6513 -0.26947 -0.1205 0.3407 0.5547 3213804 Ald1-H_000384 OC(=O)CCCCCCC(=O)N/N=C/c1cccc2ccccc12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 D07 compound treatment 9.4755 -0.38581 -0.2089 8.8771 -1.0437 -0.4667 -0.4777 -0.9343 3213806 Ald1-H_000385 COc1cc(/C=N/NC(=O)CCCCCC(=O)O)c(cc1OC)[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 D08 compound treatment 10.6426 0.78134 0.423 8.6992 -1.2216 -0.5462 -0.0871 -0.1261 3213808 Ald1-H_000386 COc1cc(/C=N/NC(=O)CCCCCCC(=O)O)c(cc1OC)[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 D09 compound treatment 10.4711 0.60981 0.3301 9.0138 -0.907 -0.4056 -0.0533 -0.102 3213810 Ald1-H_000387 OC(=O)CCCCCC(=O)N/N=C/c1ccc2ccccc2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 D10 compound treatment 10.2445 0.38317 0.2074 9.6444 -0.27641 -0.1236 0.0593 0.2455 3213812 Ald1-H_000388 OC(=O)CCCCCCC(=O)N/N=C/c1ccc2ccccc2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 D11 mock treatment 10.3188 0.4575 0.2477 8.8858 -1.035 -0.4628 -0.1521 -0.2898 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 D12 mock treatment 9.287 -0.5743 -0.3109 8.2097 -1.7111 -0.7651 -0.7608 -0.9213 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 D13 compound treatment 10.5805 0.71917 0.3893 10.4838 0.56302 0.2517 0.4533 0.9777 3213814 Ald1-H_000389 OC(=O)CCCCCC(=O)N/N=C/c1ccc(s1)[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 D14 compound treatment 10.6556 0.79426 0.43 8.6951 -1.2257 -0.5481 -0.0835 -0.1199 3213816 Ald1-H_000390 OC(=O)CCCCCCC(=O)N/N=C/c1ccc(s1)[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 D15 mock treatment 10.1323 0.27104 0.1467 8.9059 -1.0149 -0.4538 -0.2171 -0.4553 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 D16 mock treatment 9.6694 -0.19193 -0.1039 9.2197 -0.70114 -0.3135 -0.2952 -0.8937 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 D17 compound treatment 10.0968 0.23551 0.1275 8.9503 -0.97049 -0.4339 -0.2167 -0.4791 3213818 Ald1-H_000391 OC(=O)CCCCCC(=O)N/N=C/c1c(F)c(F)c(F)c(F)c1F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 D18 compound treatment 10.7366 0.87527 0.4738 8.3625 -1.5583 -0.6968 -0.1576 -0.1871 3213820 Ald1-H_000392 OC(=O)CCCCCCC(=O)N/N=C/c1c(F)c(F)c(F)c(F)c1F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 D19 compound treatment 9.3982 -0.46305 -0.2507 9.6786 -0.24224 -0.1083 -0.2538 -0.9296 3213822 Ald1-H_000393 OC(=O)CCCCCC(=O)N/N=C/CCC=C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 D20 compound treatment 9.6593 -0.20195 -0.1093 8.3414 -1.5794 -0.7062 -0.5767 -0.807 3213824 Ald1-H_000394 OC(=O)CCCCCCC(=O)N/N=C/CCC=C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 D21 compound treatment 9.1948 -0.66646 -0.3608 9.6765 -0.24427 -0.1092 -0.3324 -0.8817 3213826 Ald1-H_000395 CC(=C)[C@H]1CCC(=CC1)/C=N/NC(=O)CCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 D22 compound treatment 11.6096 1.7483 0.9464 8.843 -1.0778 -0.4819 0.3285 0.3093 3213828 Ald1-H_000396 CC(=C)[C@H]1CCC(=CC1)/C=N/NC(=O)CCCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 D23 compound treatment 9.5062 -0.35505 -0.1922 10.276 0.3552 0.1588 -0.0236 -0.0947 3213830 Ald1-H_000397 OC(=O)CCCCCC(=O)N/N=C/c1cccc(Oc2ccccc2)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 D24 compound treatment 10.3214 0.46006 0.2491 10.4188 0.49798 0.2227 0.3336 0.9984 3213832 Ald1-H_000398 OC(=O)CCCCCCC(=O)N/N=C/c1cccc(Oc2ccccc2)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 E01 mock treatment 10.675 0.81368 0.4405 11.8085 1.8877 0.844 0.9083 0.954 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 E02 mock treatment 10.461 0.5997 0.3246 10.0161 0.09532 0.0426 0.2597 0.7931 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 E03 compound treatment 13.7813 3.92 2.1221 8.9866 -0.93425 -0.4177 1.2052 0.5572 3213834 Ald1-H_000399 OC(=O)CCCCCCC(=O)N/N=C/c1ccc(Br)s1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 E04 compound treatment 9.583 -0.27826 -0.1506 9.0669 -0.85388 -0.3818 -0.3765 -0.9173 3213836 Ald1-H_000400 OC(=O)CCCCCC(=O)N/N=C/c1ccc(Br)s1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 E05 compound treatment 10.4638 0.60246 0.3261 8.4336 -1.4873 -0.665 -0.2396 -0.3235 3213838 Ald1-H_000401 COc1cc(/C=N/NC(=O)CCCCCCC(=O)O)c(Br)cc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 E06 compound treatment 10.205 0.34371 0.1861 9.0704 -0.85043 -0.3803 -0.1373 -0.3243 3213840 Ald1-H_000402 COc1cc(/C=N/NC(=O)CCCCCC(=O)O)c(Br)cc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 E07 compound treatment 10.4928 0.63146 0.3418 10.8161 0.89524 0.4003 0.5248 0.9969 3213842 Ald1-H_000403 OC(=O)CCCCCCC(=O)N/N=C/c1ccc(OCc2ccccc2)cc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 E08 compound treatment 7.3277 -2.5336 -1.3716 9.9919 0.071043 0.0318 -0.9474 -0.6905 3213844 Ald1-H_000404 OC(=O)CCCCCC(=O)N/N=C/c1ccc(OCc2ccccc2)cc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 E09 mock treatment 12.7616 2.9003 1.5701 8.8281 -1.0927 -0.4886 0.7647 0.4651 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 E10 mock treatment 10.9827 1.1214 0.6071 10.6241 0.70324 0.3144 0.6516 0.9531 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 E11 compound treatment 9.7465 -0.11483 -0.0622 8.5884 -1.3325 -0.5958 -0.4652 -0.7767 3213846 Ald1-H_000405 CC(C)(C)OC(=O)NC1(CCCC1)/C=N/NC(=O)CCCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 E12 compound treatment 9.1655 -0.69582 -0.3767 10.1602 0.23935 0.107 -0.1907 -0.4869 3213848 Ald1-H_000406 CC(C)(C)OC(=O)NC1(CCCC1)/C=N/NC(=O)CCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 E13 compound treatment 10.8405 0.97922 0.5301 10.3924 0.47162 0.2109 0.524 0.9184 3213850 Ald1-H_000407 CC(C)(C)OC(=O)N1CCC[C@H]1/C=N/NC(=O)CCCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 E14 compound treatment 10.0421 0.18084 0.0979 10.3259 0.40504 0.1811 0.1973 0.9583 3213852 Ald1-H_000408 CC(C)(C)OC(=O)N1CCC[C@H]1/C=N/NC(=O)CCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 E15 compound treatment 10.1363 0.27502 0.1489 10.0923 0.1715 0.0767 0.1595 0.9524 3213854 Ald1-H_000409 CC(C)(C)OC(=O)Nc1cccc(/C=N/NC(=O)CCCCCCC(=O)O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 E16 compound treatment 10.3119 0.45063 0.2439 10.0608 0.13997 0.0626 0.2168 0.8606 3213856 Ald1-H_000410 CC(C)(C)OC(=O)Nc1cccc(/C=N/NC(=O)CCCCCC(=O)O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 E17 mock treatment 8.5851 -1.2762 -0.6909 8.9593 -0.96153 -0.4299 -0.7925 -0.974 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 E18 mock treatment 9.3432 -0.51808 -0.2805 10.7866 0.86583 0.3871 0.0754 0.1578 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 E19 compound treatment 10.3002 0.43895 0.2376 9.6896 -0.2312 -0.1034 0.0949 0.3663 3213858 Ald1-H_000411 OC(=O)CCCCCCC(=O)N/N=C/c1cccc(c1)C(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 E20 compound treatment 10.3519 0.49062 0.2656 9.3708 -0.55005 -0.2459 0.0139 0.0384 3213860 Ald1-H_000412 OC(=O)CCCCCC(=O)N/N=C/c1cccc(c1)C(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 E21 compound treatment 9.5193 -0.342 -0.1851 10.4136 0.49275 0.2203 0.0249 0.0864 3213862 Ald1-H_000413 OC(=O)CCCCCCC(=O)N/N=C/c1ccccc1C(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 E22 compound treatment 10.5741 0.71281 0.3859 9.0314 -0.88946 -0.3977 -0.0084 -0.0151 3213864 Ald1-H_000414 OC(=O)CCCCCC(=O)N/N=C/c1ccccc1C(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 E23 compound treatment 10.7384 0.87708 0.4748 9.8134 -0.10743 -0.048 0.3018 0.6323 3213866 Ald1-H_000415 OC(=O)CCCCCCC(=O)N/N=C/c1ccc(cc1)C(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 E24 compound treatment 8.2827 -1.5786 -0.8546 9.9609 0.04007 0.0179 -0.5916 -0.6921 3213868 Ald1-H_000416 OC(=O)CCCCCC(=O)N/N=C/c1ccc(cc1)C(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 F01 mock treatment 9.1596 -0.70174 -0.3799 9.0191 -0.90168 -0.4032 -0.5537 -0.9996 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 F02 mock treatment 9.9508 0.089534 0.0485 8.5692 -1.3516 -0.6043 -0.3931 -0.6483 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 F03 compound treatment 9.473 -0.38828 -0.2102 11.8867 1.9659 0.879 0.4729 0.5233 3213870 Ald1-H_000417 OC(=O)CCCCCC(=O)N/N=C/c1cn(c2ccccc12)S(=O)(=O)c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 F04 compound treatment 20.2522 10.391 5.6252 9.7093 -0.21148 -0.0946 3.9108 0.6951 3213872 Ald1-H_000418 OC(=O)CCCCCCC(=O)N/N=C/c1cn(c2ccccc12)S(=O)(=O)c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 F05 compound treatment 9.3535 -0.5078 -0.2749 9.848 -0.072777 -0.0325 -0.2174 -0.7853 3213874 Ald1-H_000419 OC(=O)CCCCCC(=O)N/N=C/c1ccccn1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 F06 compound treatment 10.3724 0.51112 0.2767 9.6074 -0.31343 -0.1401 0.0966 0.3113 3213876 Ald1-H_000420 OC(=O)CCCCCCC(=O)N/N=C/c1ccccn1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 F07 compound treatment 9.8964 0.035086 0.019 9.2312 -0.68965 -0.3084 -0.2046 -0.6623 3213878 Ald1-H_000421 OC(=O)CCCCCC(=O)N/N=C/c1cccnc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 F08 compound treatment 8.6715 -1.1898 -0.6441 10.3469 0.42606 0.1905 -0.3207 -0.4775 3213880 Ald1-H_000422 OC(=O)CCCCCCC(=O)N/N=C/c1cccnc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 F09 mock treatment 9.6122 -0.24913 -0.1349 10.0744 0.15362 0.0687 -0.0468 -0.3092 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 F10 mock treatment 10.3132 0.4519 0.2446 9.3249 -0.59589 -0.2664 -0.0154 -0.0426 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 F11 compound treatment 10.1661 0.30481 0.165 10.5074 0.58658 0.2623 0.3021 0.9751 3213882 Ald1-H_000423 Cc1ncc(CO)c(/C=N/NC(=O)CCCCCC(=O)O)c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 F12 compound treatment 9.4796 -0.38169 -0.2066 10.9526 1.0318 0.4613 0.1801 0.3563 3213884 Ald1-H_000424 Cc1ncc(CO)c(/C=N/NC(=O)CCCCCCC(=O)O)c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 F13 compound treatment 10.7979 0.93661 0.507 11.6395 1.7187 0.7685 0.9019 0.9796 3213886 Ald1-H_000425 OC(=O)CCCCCC(=O)N/N=C/c1ccc[nH]1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 F14 compound treatment 9.5463 -0.31496 -0.1705 8.5507 -1.3701 -0.6126 -0.5538 -0.8708 3213888 Ald1-H_000426 OC(=O)CCCCCCC(=O)N/N=C/c1ccc[nH]1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 F15 compound treatment 9.9705 0.10925 0.0591 9.0266 -0.89419 -0.3998 -0.2409 -0.596 3213890 Ald1-H_000427 OC(=O)CCCCCC(=O)N/N=C/c1ccc(cc1)N2CCCC2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 F16 compound treatment 10.5119 0.65065 0.3522 9.7706 -0.15021 -0.0672 0.2016 0.5621 3213892 Ald1-H_000428 OC(=O)CCCCCCC(=O)N/N=C/c1ccc(cc1)N2CCCC2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 F17 mock treatment 9.0718 -0.78947 -0.4274 10.2095 0.28868 0.1291 -0.2109 -0.4725 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 F18 mock treatment 9.5367 -0.32456 -0.1757 9.9937 0.072925 0.0326 -0.1012 -0.5662 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 F19 compound treatment 9.1358 -0.72552 -0.3928 9.1405 -0.7803 -0.3489 -0.5244 -0.9983 3213894 Ald1-H_000429 OC(=O)CCCCCC(=O)N/N=C/c1ccccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 F20 compound treatment 10.717 0.85571 0.4632 9.2939 -0.62687 -0.2803 0.1294 0.2389 3213896 Ald1-H_000430 OC(=O)CCCCCCC(=O)N/N=C/c1ccccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 F21 compound treatment 9.0466 -0.81473 -0.4411 11.3581 1.4372 0.6426 0.1425 0.1829 3213898 Ald1-H_000431 CCCCCCC/C=N/NC(=O)CCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 F22 compound treatment 11.8256 1.9643 1.0634 9.538 -0.38278 -0.1712 0.6309 0.5858 3213900 Ald1-H_000432 CCCCCCC/C=N/NC(=O)CCCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 F23 compound treatment 10.5295 0.66819 0.3617 11.1153 1.1945 0.5341 0.6334 0.982 3213902 Ald1-H_000433 OC(=O)CCCCCC(=O)N/N=C/c1nccs1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 F24 compound treatment 9.5073 -0.35398 -0.1916 8.9207 -1.0001 -0.4472 -0.4517 -0.9285 3213904 Ald1-H_000434 OC(=O)CCCCCCC(=O)N/N=C/c1nccs1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 G01 compound treatment 11.8078 1.9465 1.0537 9.1813 -0.73949 -0.3307 0.5113 0.463 3213906 Ald1-H_000435 OC(=O)CCCCCCC(=O)N/N=C/c1ccccc1Cl 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 G02 compound treatment 12.2196 2.3583 1.2767 8.5008 -1.42 -0.6349 0.4538 0.3183 3213908 Ald1-H_000436 OC(=O)CCCCCC(=O)N/N=C/c1ccccc1Cl 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 G03 mock treatment 9.0234 -0.83787 -0.4536 9.7267 -0.19412 -0.0868 -0.3821 -0.8274 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 G04 mock treatment 8.8488 -1.0125 -0.5481 8.2878 -1.633 -0.7302 -0.9039 -0.99 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 G05 compound treatment 9.8989 0.037609 0.0204 9.3887 -0.5321 -0.2379 -0.1538 -0.6442 3213910 Ald1-H_000437 OC(=O)CCCCCCC(=O)N/N=C/c1cccnc1Cl 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 G06 compound treatment 9.6956 -0.16571 -0.0897 10.0533 0.13248 0.0592 -0.0215 -0.2004 3213912 Ald1-H_000438 OC(=O)CCCCCC(=O)N/N=C/c1cccnc1Cl 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 G07 compound treatment 10.9254 1.0641 0.576 11.2223 1.3015 0.582 0.8188 1.0 3213914 Ald1-H_000439 OC(=O)CCCCCCC(=O)N/N=C/C=C/c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 G08 compound treatment 10.0509 0.18957 0.1026 12.0588 2.138 0.956 0.7485 0.7785 3213916 Ald1-H_000440 OC(=O)CCCCCC(=O)N/N=C/C=C/c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 G09 compound treatment 8.7048 -1.1565 -0.6261 10.9747 1.0538 0.4712 -0.1095 -0.1398 3213918 Ald1-H_000441 C[C@H](CCC=C(C)C)C/C=N/NC(=O)CCCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 G10 compound treatment 8.7318 -1.1295 -0.6114 8.6668 -1.2541 -0.5607 -0.8289 -0.9991 3213920 Ald1-H_000442 C[C@H](CCC=C(C)C)C/C=N/NC(=O)CCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 G11 compound treatment 11.6466 1.7853 0.9665 9.3561 -0.56473 -0.2525 0.5049 0.5054 3213922 Ald1-H_000443 C[C@@H](CCC=C(C)C)C/C=N/NC(=O)CCCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 G12 compound treatment 8.1751 -1.6862 -0.9128 8.9327 -0.9881 -0.4418 -0.9579 -0.9445 3213923 Ald1-H_000444 C[C@@H](CCC=C(C)C)C/C=N/NC(=O)CCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 G13 compound treatment 9.1045 -0.75675 -0.4097 8.2491 -1.6718 -0.7475 -0.8182 -0.9599 3213924 Ald1-H_000445 OC(=O)CCCCCCC(=O)N/N=C/c1ccc(C#N)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 G14 compound treatment 9.6479 -0.21341 -0.1155 9.1422 -0.77857 -0.3481 -0.3279 -0.8938 3213926 Ald1-H_000446 OC(=O)CCCCCC(=O)N/N=C/c1ccc(C#N)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 G15 compound treatment 8.8984 -0.96291 -0.5213 10.024 0.10314 0.0461 -0.336 -0.642 3213928 Ald1-H_000447 OC(=O)CCCCCCC(=O)N/N=C/C1CCCCC1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 G16 compound treatment 8.6625 -1.1988 -0.649 10.0068 0.085948 0.0384 -0.4317 -0.6641 3213930 Ald1-H_000448 OC(=O)CCCCCC(=O)N/N=C/C1CCCCC1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 G17 compound treatment 9.9745 0.11325 0.0613 10.861 0.94017 0.4204 0.3406 0.8017 3213932 Ald1-H_000449 COc1ccc(/C=N/NC(=O)CCCCCCC(=O)O)cc1Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 G18 compound treatment 10.1647 0.3034 0.1642 10.216 0.29522 0.132 0.2095 0.9941 3213934 Ald1-H_000450 COc1ccc(/C=N/NC(=O)CCCCCC(=O)O)cc1Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 G19 mock treatment 11.3375 1.4762 0.7992 9.9714 0.05054 0.0226 0.5811 0.7268 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 G20 mock treatment 11.0984 1.2371 0.6697 13.3467 3.4259 1.5318 1.5567 0.9311 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 G21 compound treatment 9.7831 -0.078191 -0.0423 10.6028 0.68202 0.305 0.1857 0.6032 3213936 Ald1-H_000451 OC(=O)CCCCCCC(=O)N/N=C/c1cc(Br)cc(Br)c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 G22 compound treatment 8.0967 -1.7646 -0.9553 11.034 1.1132 0.4977 -0.3235 -0.3004 3213938 Ald1-H_000452 OC(=O)CCCCCC(=O)N/N=C/c1cc(Br)cc(Br)c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 G23 compound treatment 10.8875 1.0262 0.5556 9.7646 -0.15621 -0.0698 0.3434 0.6134 3213940 Ald1-H_000453 CCCCN(CCCC)c1ccc(/C=N/NC(=O)CCCCCCC(=O)O)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 G24 compound treatment 10.4804 0.6191 0.3352 11.7228 1.802 0.8057 0.8067 0.9244 3213942 Ald1-H_000454 CCCCN(CCCC)c1ccc(/C=N/NC(=O)CCCCCC(=O)O)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 H01 compound treatment 9.8388 -0.022521 -0.0122 10.2761 0.3553 0.1589 0.1037 0.6509 3213944 Ald1-H_000455 OC(=O)CCCCCC(=O)N/N=C/c1cccs1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 H02 compound treatment 9.9481 0.086809 0.047 10.8986 0.97779 0.4372 0.3424 0.7786 3213946 Ald1-H_000456 OC(=O)CCCCCCC(=O)N/N=C/c1cccs1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 H03 mock treatment 10.6968 0.83548 0.4523 9.5978 -0.32302 -0.1444 0.2177 0.4585 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 H04 mock treatment 9.4882 -0.37311 -0.202 8.9567 -0.96412 -0.4311 -0.4477 -0.9403 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 H05 compound treatment 10.092 0.23074 0.1249 9.665 -0.25578 -0.1144 0.0075 0.044 3213948 Ald1-H_000457 OC(=O)CCCCCC(=O)N/N=C/c1ccc(cc1)C(F)(F)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 H06 compound treatment 9.5006 -0.36074 -0.1953 11.4177 1.4969 0.6693 0.3352 0.4808 3213950 Ald1-H_000458 OC(=O)CCCCCCC(=O)N/N=C/c1ccc(cc1)C(F)(F)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 H07 compound treatment 8.8769 -0.98438 -0.5329 8.9169 -1.0039 -0.4489 -0.6942 -0.9964 3213952 Ald1-H_000459 OC(=O)CCCCCC(=O)N/N=C/c1ccc(O)c(O)c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 H08 compound treatment 8.4385 -1.4228 -0.7703 9.4076 -0.5132 -0.2295 -0.7069 -0.8796 3213954 Ald1-H_000460 OC(=O)CCCCCCC(=O)N/N=C/c1ccc(O)c(O)c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 H09 compound treatment 9.5108 -0.35052 -0.1898 10.7392 0.81834 0.3659 0.1246 0.3022 3213956 Ald1-H_000461 OC(=O)CCCCCC(=O)N/N=C/c1c(O)cc(O)cc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 H10 compound treatment 8.4107 -1.4506 -0.7853 10.4101 0.48926 0.2188 -0.4006 -0.4914 3213958 Ald1-H_000462 OC(=O)CCCCCCC(=O)N/N=C/c1c(O)cc(O)cc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 H11 compound treatment 10.0547 0.19343 0.1047 11.1539 1.2331 0.5514 0.4639 0.8266 3213960 Ald1-H_000463 COc1cc(OC)c(/C=N/NC(=O)CCCCCC(=O)O)c(OC)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 H12 compound treatment 9.6941 -0.16721 -0.0905 9.8029 -0.11794 -0.0527 -0.1013 -0.9669 3213962 Ald1-H_000464 COc1cc(OC)c(/C=N/NC(=O)CCCCCCC(=O)O)c(OC)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 H13 compound treatment 8.2025 -1.6588 -0.898 9.7915 -0.12928 -0.0578 -0.6759 -0.7511 3213964 Ald1-H_000465 COc1cc(/C=N/NC(=O)CCCCCC(=O)O)cc(OC)c1OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 H14 compound treatment 9.4807 -0.38058 -0.206 10.0989 0.17807 0.0796 -0.0894 -0.4047 3213966 Ald1-H_000466 COc1cc(/C=N/NC(=O)CCCCCCC(=O)O)cc(OC)c1OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 H15 compound treatment 9.0014 -0.85989 -0.4655 9.6532 -0.26758 -0.1196 -0.4138 -0.8609 3213968 Ald1-H_000467 CC(C)(C)/C=N/NC(=O)CCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 H16 compound treatment 10.0246 0.16334 0.0884 9.5149 -0.40589 -0.1815 -0.0658 -0.326 3213970 Ald1-H_000468 CC(C)(C)/C=N/NC(=O)CCCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 H17 compound treatment 10.5718 0.71053 0.3846 10.2375 0.31664 0.1416 0.3721 0.9078 3213972 Ald1-H_000469 CC1=C(C/C=N/NC(=O)CCCCCC(=O)O)C(C)(C)CCC1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 H18 compound treatment 9.7193 -0.14196 -0.0769 9.1641 -0.75668 -0.3383 -0.2936 -0.8462 3213974 Ald1-H_000470 CC1=C(C/C=N/NC(=O)CCCCCCC(=O)O)C(C)(C)CCC1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 H19 mock treatment 9.0817 -0.77958 -0.422 10.15 0.22917 0.1025 -0.226 -0.5203 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 H20 mock treatment 9.9337 0.072446 0.0392 8.9701 -0.9507 -0.4251 -0.2729 -0.6392 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 H21 compound treatment 9.2016 -0.65967 -0.3571 10.9173 0.99646 0.4456 0.0625 0.1095 3213976 Ald1-H_000471 NC(=O)COc1ccccc1/C=N/NC(=O)CCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 H22 compound treatment 10.1264 0.26514 0.1435 10.4023 0.48153 0.2153 0.2537 0.9806 3213978 Ald1-H_000472 NC(=O)COc1ccccc1/C=N/NC(=O)CCCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 H23 compound treatment 13.2281 3.3669 1.8227 10.6493 0.72846 0.3257 1.5191 0.8205 3213980 Ald1-H_000473 NC(=O)COc1ccc(/C=N/NC(=O)CCCCCC(=O)O)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 H24 compound treatment 8.2679 -1.5934 -0.8626 8.8234 -1.0974 -0.4907 -0.9569 -0.9643 3213982 Ald1-H_000474 NC(=O)COc1ccc(/C=N/NC(=O)CCCCCCC(=O)O)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 I01 compound treatment 9.653 -0.20826 -0.1127 8.8252 -1.0956 -0.4899 -0.4261 -0.8477 3213984 Ald1-H_000475 COc1cc(Cl)c(/C=N/NC(=O)CCCCCCC(=O)O)c(Cl)c1OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 I02 compound treatment 10.0583 0.19702 0.1067 11.5804 1.6596 0.7421 0.6001 0.8005 3213986 Ald1-H_000476 COc1cc(Cl)c(/C=N/NC(=O)CCCCCC(=O)O)c(Cl)c1OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 I03 compound treatment 8.7833 -1.078 -0.5836 10.4754 0.55461 0.248 -0.2373 -0.3742 3213988 Ald1-H_000477 OC(=O)CCCCCCC(=O)N/N=C/c1cc(Cl)cc(Cl)c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 I04 compound treatment 8.6074 -1.2539 -0.6788 10.2394 0.31863 0.1425 -0.3792 -0.5468 3213990 Ald1-H_000478 OC(=O)CCCCCC(=O)N/N=C/c1cc(Cl)cc(Cl)c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 I05 mock treatment 9.1944 -0.66688 -0.361 9.813 -0.1078 -0.0482 -0.2894 -0.7945 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 I06 mock treatment 8.5434 -1.3179 -0.7135 8.7764 -1.1444 -0.5117 -0.8663 -0.9867 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 I07 compound treatment 9.9974 0.13615 0.0737 8.5764 -1.3444 -0.6011 -0.3729 -0.6158 3213992 Ald1-H_000479 OC(=O)CCCCCCC(=O)N/N=C/c1cc(Br)cc([N+](=O)[O-])c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 I08 compound treatment 9.585 -0.27633 -0.1496 9.6189 -0.3019 -0.135 -0.2012 -0.9987 3213994 Ald1-H_000480 OC(=O)CCCCCC(=O)N/N=C/c1cc(Br)cc([N+](=O)[O-])c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 I09 compound treatment 9.0313 -0.82997 -0.4493 10.2622 0.34139 0.1526 -0.2098 -0.4421 3213996 Ald1-H_000481 CCN(CC)c1ccc(/C=N/NC(=O)CCCCCCC(=O)O)c(O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 I10 compound treatment 10.5752 0.71393 0.3865 9.2782 -0.64264 -0.2873 0.0701 0.1456 3213998 Ald1-H_000482 CCN(CC)c1ccc(/C=N/NC(=O)CCCCCC(=O)O)c(O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 I11 compound treatment 10.2339 0.37256 0.2017 9.6996 -0.22119 -0.0989 0.0727 0.3236 3214000 Ald1-H_000483 OC(=O)CCCCCCC(=O)N/N=C/c1ccc2OCCc2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 I12 compound treatment 8.8143 -1.047 -0.5668 9.0478 -0.87299 -0.3903 -0.6768 -0.9834 3214002 Ald1-H_000484 OC(=O)CCCCCC(=O)N/N=C/c1ccc2OCCc2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 I13 compound treatment 10.5848 0.72347 0.3917 8.7021 -1.2187 -0.5449 -0.1084 -0.1615 3214004 Ald1-H_000485 OC(=O)CCCCCCC(=O)N/N=C/c1cccc(O)c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 I14 compound treatment 9.3942 -0.46708 -0.2529 8.3438 -1.577 -0.7051 -0.6774 -0.9043 3214006 Ald1-H_000486 OC(=O)CCCCCC(=O)N/N=C/c1cccc(O)c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 I15 compound treatment 9.9701 0.10877 0.0589 10.7195 0.79868 0.3571 0.2942 0.8127 3214008 Ald1-H_000487 OC(=O)CCCCCCC(=O)N/N=C/c1ccc(O)cc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 I16 compound treatment 10.0698 0.20852 0.1129 9.5092 -0.41162 -0.184 -0.0503 -0.2331 3214010 Ald1-H_000488 OC(=O)CCCCCC(=O)N/N=C/c1ccc(O)cc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 I17 compound treatment 11.4974 1.6361 0.8857 8.4228 -1.498 -0.6698 0.1527 0.1375 3214012 Ald1-H_000489 OC(=O)CCCCCCC(=O)N/N=C/c1cc(O)ccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 I18 compound treatment 10.5358 0.67453 0.3652 10.971 1.0502 0.4696 0.5903 0.9923 3214014 Ald1-H_000490 OC(=O)CCCCCC(=O)N/N=C/c1cc(O)ccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 I19 compound treatment 10.855 0.99373 0.538 10.3159 0.39513 0.1767 0.5053 0.8924 3214016 Ald1-H_000491 OC(=O)CCCCCCC(=O)N/N=C/c1ccc(O)c(O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 I20 compound treatment 10.206 0.34474 0.1866 10.3473 0.42652 0.1907 0.2668 0.9999 3214018 Ald1-H_000492 OC(=O)CCCCCC(=O)N/N=C/c1ccc(O)c(O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 I21 mock treatment 9.6137 -0.24759 -0.134 10.4573 0.53649 0.2399 0.0748 0.2724 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 I22 mock treatment 9.3217 -0.5396 -0.2921 10.0878 0.16702 0.0747 -0.1538 -0.5099 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 I23 compound treatment 9.1596 -0.7017 -0.3799 10.1042 0.18336 0.082 -0.2106 -0.542 3214020 Ald1-H_000493 COc1ccc(/C=N/NC(=O)CCCCCCC(=O)O)c(OC)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 I24 compound treatment 9.2395 -0.62183 -0.3366 12.088 2.1672 0.969 0.4472 0.4359 3214022 Ald1-H_000494 COc1ccc(/C=N/NC(=O)CCCCCC(=O)O)c(OC)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 J01 compound treatment 7.8077 -2.0536 -1.1117 10.415 0.49419 0.221 -0.6299 -0.5557 3214024 Ald1-H_000495 OC(=O)CCCCCC(=O)NN=C1CCCCCCC1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 J02 compound treatment 9.7391 -0.12215 -0.0661 8.9078 -1.013 -0.4529 -0.367 -0.8018 3214025 Ald1-H_000496 OC(=O)CCCCCCC(=O)NN=C1CCCCCCC1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 J03 compound treatment 10.3491 0.48779 0.2641 11.2541 1.3333 0.5962 0.6083 0.9329 3214026 Ald1-H_000497 OC(=O)CCCCCC(=O)NN=C1CCCCCC1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 J04 compound treatment 10.4202 0.55886 0.3025 10.2901 0.36929 0.1651 0.3307 0.9594 3214027 Ald1-H_000498 OC(=O)CCCCCCC(=O)NN=C1CCCCCC1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 J05 mock treatment 11.506 1.6447 0.8904 10.0258 0.105 0.0469 0.6628 0.7434 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 J06 mock treatment 11.1442 1.2829 0.6945 10.2192 0.29838 0.1334 0.5854 0.8278 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 J07 compound treatment 10.2467 0.38545 0.2087 11.3815 1.4606 0.6531 0.6094 0.8888 3214028 Ald1-H_000499 OC(=O)CCCCCC(=O)NN=C1CCCC1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 J08 compound treatment 9.2548 -0.60651 -0.3283 8.0551 -1.8657 -0.8342 -0.8221 -0.9169 3214029 Ald1-H_000500 OC(=O)CCCCCCC(=O)NN=C1CCCC1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 J09 mock treatment 8.6385 -1.2228 -0.662 9.3071 -0.61367 -0.2744 -0.6621 -0.924 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 J10 mock treatment 12.0887 2.2274 1.2058 9.5079 -0.41296 -0.1846 0.7221 0.5919 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 J11 compound treatment 11.3958 1.5345 0.8307 10.1582 0.23741 0.1062 0.6625 0.791 3214030 Ald1-H_000501 COc1cc(Br)c(/C=N/NC(=O)CCCCCC(=O)O)cc1OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 J12 compound treatment 13.2236 3.3623 1.8202 11.4975 1.5766 0.705 1.7856 0.9148 3214032 Ald1-H_000502 COc1cc(Br)c(/C=N/NC(=O)CCCCCCC(=O)O)cc1OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 J13 compound treatment 10.4078 0.54653 0.2959 10.2955 0.37465 0.1675 0.3277 0.9637 3214034 Ald1-H_000503 OC(=O)CCCCCC(=O)N/N=C/CCC1CCCCC1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 J14 compound treatment 10.6278 0.7665 0.4149 9.5568 -0.36404 -0.1628 0.1783 0.4 3214036 Ald1-H_000504 OC(=O)CCCCCCC(=O)N/N=C/CCC1CCCCC1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 J15 compound treatment 16.0147 6.1534 3.3312 17.2256 7.3048 3.2662 4.6651 1.0 3214038 Ald1-H_000505 OC(=O)CCCCCC(=O)N/N=C/c1ccc(cc1)N(c2ccccc2)c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 J16 compound treatment 18.6525 8.7912 4.7592 17.5069 7.5861 3.392 5.7637 0.9862 3214040 Ald1-H_000506 OC(=O)CCCCCCC(=O)N/N=C/c1ccc(cc1)N(c2ccccc2)c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 J17 compound treatment 10.2016 0.34027 0.1842 8.6836 -1.2372 -0.5532 -0.2609 -0.4475 3214042 Ald1-H_000507 OC(=O)CCCCCC(=O)N/N=C/C[P+](c1ccccc1)(c2ccccc2)c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 J18 compound treatment 9.9255 0.064244 0.0348 10.1074 0.18655 0.0834 0.0836 0.9248 3214044 Ald1-H_000508 OC(=O)CCCCCCC(=O)N/N=C/C[P+](c1ccccc1)(c2ccccc2)c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 J19 mock treatment 10.3138 0.45248 0.245 9.6012 -0.31959 -0.1429 0.0722 0.2545 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 J20 mock treatment 8.598 -1.2633 -0.6839 9.9722 0.051368 0.023 -0.4673 -0.683 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 J21 mock treatment 12.0499 2.1886 1.1848 10.0455 0.12467 0.0557 0.8772 0.7396 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 J22 mock treatment 10.7537 0.89236 0.4831 10.2489 0.32809 0.1467 0.4453 0.8821 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 J23 mock treatment 9.1339 -0.72736 -0.3938 0.0 -9.9208 -4.4359 -3.4151 -0.7669 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 J24 mock treatment 9.2465 -0.61474 -0.3328 9.9141 -0.0066699 -0.003 -0.2374 -0.7134 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 K01 compound treatment 9.117 -0.74428 -0.4029 9.4043 -0.51649 -0.2309 -0.4482 -0.9651 3214046 Ald1-H_000509 COc1cccc(OC)c1/C=N/NC(=O)CCCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 K02 compound treatment 10.2605 0.39916 0.2161 10.8509 0.93012 0.4159 0.4469 0.9535 3214048 Ald1-H_000510 COc1cccc(OC)c1/C=N/NC(=O)CCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 K03 compound treatment 9.0176 -0.84367 -0.4567 10.0152 0.094428 0.0422 -0.2931 -0.639 3214050 Ald1-H_000511 COc1ccc(/C=N/NC(=O)CCCCCCC(=O)O)cc1OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 K04 compound treatment 8.6282 -1.2331 -0.6675 9.129 -0.79179 -0.354 -0.7224 -0.956 3214052 Ald1-H_000512 COc1ccc(/C=N/NC(=O)CCCCCC(=O)O)cc1OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 K05 compound treatment 9.1808 -0.68046 -0.3684 9.4573 -0.46348 -0.2072 -0.407 -0.963 3214054 Ald1-H_000513 COc1cc(O)cc(OC)c1/C=N/NC(=O)CCCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 K06 compound treatment 8.9994 -0.86186 -0.4666 10.2941 0.37333 0.1669 -0.2119 -0.4276 3214056 Ald1-H_000514 COc1cc(O)cc(OC)c1/C=N/NC(=O)CCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 K07 mock treatment 9.1558 -0.70551 -0.3819 9.354 -0.56685 -0.2535 -0.4493 -0.9802 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 K08 mock treatment 8.5981 -1.2632 -0.6838 10.0019 0.08111 0.0363 -0.4579 -0.6687 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 K09 compound treatment 7.4803 -2.381 -1.289 9.0242 -0.89657 -0.4009 -1.1949 -0.8852 3214058 Ald1-H_000515 CC1(C)COC(CCC/C=N/NC(=O)CCCCCCC(=O)O)OC1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 K10 compound treatment 9.2123 -0.64895 -0.3513 9.811 -0.1098 -0.0491 -0.2831 -0.7982 3214060 Ald1-H_000516 CC1(C)COC(CCC/C=N/NC(=O)CCCCCC(=O)O)OC1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 K11 compound treatment 9.8472 -0.014056 -0.0076 10.8458 0.92502 0.4136 0.2871 0.694 3214062 Ald1-H_000517 Cc1nnc(Sc2ccc(/C=N/NC(=O)CCCCCCC(=O)O)o2)n1C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 K12 compound treatment 9.0519 -0.80935 -0.4381 8.7164 -1.2044 -0.5385 -0.6906 -0.9948 3214064 Ald1-H_000518 Cc1nnc(Sc2ccc(/C=N/NC(=O)CCCCCC(=O)O)o2)n1C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 K13 compound treatment 10.4346 0.57332 0.3104 9.6247 -0.2961 -0.1324 0.1258 0.373 3214066 Ald1-H_000519 OC(=O)CCCCCCC(=O)N/N=C/c1cc(Br)cs1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 K14 compound treatment 9.2143 -0.64699 -0.3503 10.406 0.48518 0.2169 -0.0943 -0.2288 3214068 Ald1-H_000520 OC(=O)CCCCCC(=O)N/N=C/c1cc(Br)cs1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 K15 mock treatment 9.396 -0.46532 -0.2519 8.2671 -1.6538 -0.7395 -0.701 -0.8974 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 K16 mock treatment 8.4948 -1.3665 -0.7398 10.3104 0.38963 0.1742 -0.3999 -0.5262 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 K17 compound treatment 8.8882 -0.97305 -0.5268 8.9143 -1.0065 -0.4501 -0.6907 -0.9969 3214070 Ald1-H_000521 CC(C)(C)OC(=O)NC/C=N/NC(=O)CCCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 K18 compound treatment 9.5263 -0.33497 -0.1813 10.5843 0.66344 0.2966 0.0815 0.2345 3214072 Ald1-H_000522 CC(C)(C)OC(=O)NC/C=N/NC(=O)CCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 K19 compound treatment 11.1235 1.2622 0.6833 11.1197 1.1989 0.5361 0.8622 0.9928 3214074 Ald1-H_000523 OC(=O)CCCCCCC(=O)N/N=C/c1ccc-2c(Cc3ccccc32)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 K20 compound treatment 10.3451 0.48384 0.2619 11.7226 1.8018 0.8056 0.7549 0.8911 3214076 Ald1-H_000524 OC(=O)CCCCCC(=O)N/N=C/c1ccc-2c(Cc3ccccc32)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 K21 compound treatment 10.3058 0.44449 0.2406 10.3444 0.42359 0.1894 0.3041 0.993 3214078 Ald1-H_000525 OC(=O)CCCCCCC(=O)N/N=C/c1ccc(F)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 K22 compound treatment 9.609 -0.25233 -0.1366 9.996 0.075223 0.0336 -0.0728 -0.5175 3214080 Ald1-H_000526 OC(=O)CCCCCC(=O)N/N=C/c1ccc(F)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 K23 mock treatment 11.7915 1.9302 1.0449 8.7466 -1.1742 -0.525 0.3676 0.3144 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 K24 mock treatment 9.4815 -0.37981 -0.2056 10.2228 0.30196 0.135 -0.0499 -0.2029 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 L01 mock treatment 9.7272 -0.13406 -0.0726 10.4327 0.51186 0.2289 0.1105 0.4603 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 L02 mock treatment 8.4735 -1.3878 -0.7513 9.7295 -0.19133 -0.0855 -0.5917 -0.7826 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 L03 mock treatment 10.4748 0.61354 0.3321 10.2546 0.33379 0.1492 0.3404 0.9348 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 L04 mock treatment 8.3658 -1.4955 -0.8096 8.6565 -1.2644 -0.5653 -0.9722 -0.9846 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 L05 mock treatment 9.1696 -0.69169 -0.3745 9.7664 -0.15441 -0.069 -0.3136 -0.8236 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 L06 mock treatment 8.9633 -0.89801 -0.4861 9.6177 -0.30309 -0.1355 -0.4396 -0.871 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 L07 mock treatment 11.2636 1.4023 0.7591 10.0267 0.1059 0.0473 0.5703 0.7498 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 L08 mock treatment 9.0156 -0.84572 -0.4578 12.3919 2.4711 1.1049 0.4575 0.3826 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 L09 mock treatment 9.9645 0.10323 0.0559 9.0187 -0.9021 -0.4034 -0.2457 -0.6034 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 L10 mock treatment 9.4721 -0.38922 -0.2107 9.5671 -0.35367 -0.1581 -0.2608 -0.99 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 L11 mock treatment 9.5426 -0.3187 -0.1725 9.3835 -0.53735 -0.2403 -0.2919 -0.9868 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 L12 mock treatment 8.7213 -1.14 -0.6171 9.8681 -0.052687 -0.0236 -0.453 -0.7336 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 L13 mock treatment 8.723 -1.1383 -0.6162 9.877 -0.043765 -0.0196 -0.4496 -0.7292 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 L14 mock treatment 10.4165 0.55524 0.3006 8.2656 -1.6552 -0.7401 -0.3108 -0.3891 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 L15 mock treatment 9.1813 -0.68001 -0.3681 8.217 -1.7038 -0.7618 -0.799 -0.9443 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 L16 mock treatment 8.1786 -1.6827 -0.9109 10.0422 0.1214 0.0543 -0.6057 -0.6638 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 L17 compound treatment 8.978 -0.88332 -0.4782 7.6354 -2.2854 -1.0219 -1.0607 -0.9402 3214082 Ald1-H_000527 OC(=O)CCCCCC(=O)N/N=C/c1ccc(Oc2ccccc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 L18 compound treatment 9.1413 -0.72003 -0.3898 9.4498 -0.47105 -0.2106 -0.4246 -0.9582 3214084 Ald1-H_000528 OC(=O)CCCCCCC(=O)N/N=C/c1ccc(Oc2ccccc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 L19 compound treatment 9.3758 -0.48552 -0.2628 10.7386 0.8178 0.3657 0.0727 0.1615 3214086 Ald1-H_000529 OC(=O)CCCCCC(=O)N/N=C/c1cc[n+]([O-])cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 L20 compound treatment 11.0881 1.2268 0.6642 10.8861 0.96526 0.4316 0.7748 0.9782 3214088 Ald1-H_000530 OC(=O)CCCCCCC(=O)N/N=C/c1cc[n+]([O-])cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 L21 compound treatment 8.8787 -0.98258 -0.5319 10.9675 1.0467 0.468 -0.0452 -0.0638 3214090 Ald1-H_000531 OC(=O)CCCCCC(=O)N/N=C/c1ccc2ccccc2n1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 L22 compound treatment 9.4739 -0.38742 -0.2097 10.9506 1.0298 0.4605 0.1773 0.3504 3214092 Ald1-H_000532 OC(=O)CCCCCCC(=O)N/N=C/c1ccc2ccccc2n1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 L23 mock treatment 11.0876 1.2263 0.6639 10.4729 0.55207 0.2468 0.644 0.9092 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 L24 mock treatment 9.1678 -0.69348 -0.3754 7.7041 -2.2168 -0.9912 -0.9663 -0.9117 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 M01 compound treatment 9.215 -0.64629 -0.3499 8.4726 -1.4482 -0.6475 -0.7053 -0.9582 3214094 Ald1-H_000533 OC(=O)CCCCCCC(=O)N/N=C/c1ccc(O)c(F)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 M02 compound treatment 11.6354 1.7741 0.9604 9.6952 -0.22561 -0.1009 0.6078 0.6294 3214096 Ald1-H_000534 OC(=O)CCCCCC(=O)N/N=C/c1ccc(O)c(F)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 M03 compound treatment 9.1507 -0.71063 -0.3847 10.0179 0.09712 0.0434 -0.2413 -0.6233 3214098 Ald1-H_000535 OC(=O)CCCCCCC(=O)N/N=C/c1ccc(F)c(Oc2ccccc2)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 M04 compound treatment 8.4804 -1.3808 -0.7475 11.8496 1.9288 0.8624 0.0813 0.0712 3214100 Ald1-H_000536 OC(=O)CCCCCC(=O)N/N=C/c1ccc(F)c(Oc2ccccc2)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 M05 compound treatment 9.438 -0.42334 -0.2292 10.355 0.4342 0.1941 -0.0248 -0.0825 3214102 Ald1-H_000537 OC(=O)CCCCCCC(=O)N/N=C/c1cc(F)ccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 M06 compound treatment 9.708 -0.15325 -0.083 12.0157 2.0949 0.9367 0.6037 0.642 3214104 Ald1-H_000538 OC(=O)CCCCCC(=O)N/N=C/c1cc(F)ccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 M07 compound treatment 9.7545 -0.1068 -0.0578 8.5908 -1.33 -0.5947 -0.4614 -0.7722 3214106 Ald1-H_000539 OC(=O)CCCCCCC(=O)N/N=C/c1coc2ccccc2c1=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 M08 compound treatment 8.3516 -1.5097 -0.8173 8.901 -1.0198 -0.456 -0.9003 -0.962 3214108 Ald1-H_000540 OC(=O)CCCCCC(=O)N/N=C/c1coc2ccccc2c1=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 M09 mock treatment 9.4324 -0.42887 -0.2322 10.2947 0.3739 0.1672 -0.046 -0.1606 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 M10 mock treatment 10.7224 0.86109 0.4662 8.6416 -1.2792 -0.572 -0.0748 -0.1014 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 M11 compound treatment 11.8453 1.984 1.074 11.0358 1.115 0.4985 1.112 0.9391 3214110 Ald1-H_000541 CC(C)(C)OC(=O)Nc1ccc(/C=N/NC(=O)CCCCCCC(=O)O)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 M12 compound treatment 9.934 0.072659 0.0393 9.1317 -0.78915 -0.3529 -0.2217 -0.6244 3214112 Ald1-H_000542 CC(C)(C)OC(=O)Nc1ccc(/C=N/NC(=O)CCCCCC(=O)O)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 M13 mock treatment 9.9454 0.084121 0.0455 9.6945 -0.22632 -0.1012 -0.0394 -0.3547 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 M14 mock treatment 9.9297 0.068424 0.037 10.2754 0.3546 0.1586 0.1383 0.8494 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 M15 compound treatment 8.8233 -1.038 -0.5619 9.1587 -0.76213 -0.3408 -0.6383 -0.9713 3214114 Ald1-H_000543 OB(O)c1cccc(/C=N/NC(=O)CCCCCCC(=O)O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 M16 compound treatment 8.8383 -1.023 -0.5538 9.9978 0.076998 0.0344 -0.3673 -0.6619 3214116 Ald1-H_000544 OB(O)c1cccc(/C=N/NC(=O)CCCCCC(=O)O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 M17 compound treatment 10.3144 0.45306 0.2453 9.178 -0.74278 -0.3321 -0.0614 -0.1488 3214118 Ald1-H_000545 OC(=O)CCCCCCC(=O)N/N=C/c1ccco1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 M18 compound treatment 9.0102 -0.85114 -0.4608 9.5328 -0.388 -0.1735 -0.4485 -0.9109 3214120 Ald1-H_000546 OC(=O)CCCCCC(=O)N/N=C/c1ccco1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 M19 compound treatment 9.28 -0.58129 -0.3147 11.1722 1.2514 0.5595 0.1731 0.2697 3214122 Ald1-H_000547 OC(=O)CCCCCCC(=O)N/N=C/c1ccoc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 M20 compound treatment 11.301 1.4397 0.7794 9.0931 -0.82776 -0.3701 0.2894 0.3354 3214124 Ald1-H_000548 OC(=O)CCCCCC(=O)N/N=C/c1ccoc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 M21 compound treatment 8.4562 -1.4051 -0.7606 10.2356 0.31483 0.1408 -0.4383 -0.5666 3214126 Ald1-H_000549 OC(=O)CCCCCCC(=O)N/N=C/c1cccc(O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 M22 compound treatment 9.6621 -0.19916 -0.1078 9.1365 -0.78428 -0.3507 -0.3242 -0.8837 3214128 Ald1-H_000550 OC(=O)CCCCCC(=O)N/N=C/c1cccc(O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 M23 compound treatment 8.5087 -1.3526 -0.7323 10.2876 0.36683 0.164 -0.4018 -0.5354 3214130 Ald1-H_000551 OC(=O)CCCCCCC(=O)N/N=C/c1ccc(O)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 M24 compound treatment 9.7379 -0.12336 -0.0668 9.2966 -0.62422 -0.2791 -0.2446 -0.8522 3214132 Ald1-H_000552 OC(=O)CCCCCC(=O)N/N=C/c1ccc(O)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 N01 compound treatment 10.3487 0.48739 0.2639 9.837 -0.083775 -0.0375 0.1601 0.6007 3214134 Ald1-H_000553 Cc1ccccc1/C=N/NC(=O)CCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 N02 compound treatment 11.1099 1.2486 0.676 10.0159 0.09511 0.0425 0.508 0.7501 3214136 Ald1-H_000554 Cc1ccccc1/C=N/NC(=O)CCCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 N03 compound treatment 10.2261 0.36484 0.1975 8.8341 -1.0867 -0.4859 -0.2039 -0.3888 3214138 Ald1-H_000555 COc1cc(/C=N/NC(=O)CCCCCC(=O)O)ccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 N04 compound treatment 13.2187 3.3574 1.8175 11.4448 1.524 0.6814 1.767 0.9103 3214140 Ald1-H_000556 COc1cc(/C=N/NC(=O)CCCCCCC(=O)O)ccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 N05 mock treatment 8.5222 -1.3391 -0.7249 9.5091 -0.41171 -0.1841 -0.6428 -0.8594 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 N06 mock treatment 10.7939 0.93262 0.5049 9.7877 -0.1331 -0.0595 0.3149 0.6195 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 N07 mock treatment 9.8983 0.037046 0.0201 9.6313 -0.28947 -0.1294 -0.0773 -0.5905 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 N08 mock treatment 9.0359 -0.82536 -0.4468 10.9377 1.0169 0.4547 0.0056 0.0087 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 N09 mock treatment 10.6612 0.79992 0.433 9.4357 -0.4851 -0.2169 0.1528 0.3156 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 N10 mock treatment 9.8054 -0.055886 -0.0303 8.749 -1.1718 -0.524 -0.3919 -0.7467 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 N11 compound treatment 10.855 0.99375 0.538 11.5632 1.6424 0.7344 0.8997 0.9883 3214142 Ald1-H_000557 COc1ccc(/C=N/NC(=O)CCCCCC(=O)O)cc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 N12 compound treatment 10.1418 0.28054 0.1519 9.5605 -0.36035 -0.1611 -0.0065 -0.0295 3214144 Ald1-H_000558 COc1ccc(/C=N/NC(=O)CCCCCCC(=O)O)cc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 N13 mock treatment 9.6185 -0.24275 -0.1314 10.9309 1.0101 0.4516 0.2264 0.4814 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 N14 mock treatment 9.518 -0.34326 -0.1858 9.8183 -0.10253 -0.0458 -0.1638 -0.8559 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 N15 compound treatment 10.7435 0.88222 0.4776 9.7107 -0.21013 -0.094 0.2713 0.5573 3214146 Ald1-H_000559 CCOc1cccc(/C=N/NC(=O)CCCCCC(=O)O)c1OCC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 N16 compound treatment 12.7147 2.8534 1.5447 9.8614 -0.059442 -0.0266 1.0735 0.6948 3214148 Ald1-H_000560 CCOc1cccc(/C=N/NC(=O)CCCCCCC(=O)O)c1OCC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 N17 compound treatment 9.7374 -0.12391 -0.0671 10.849 0.92816 0.415 0.246 0.5852 3214150 Ald1-H_000561 OC(=O)CCCCCC(=O)N/N=C/c1cc(I)cc(I)c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 N18 compound treatment 10.7311 0.86985 0.4709 10.3288 0.40799 0.1824 0.462 0.9148 3214152 Ald1-H_000562 OC(=O)CCCCCCC(=O)N/N=C/c1cc(I)cc(I)c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 N19 compound treatment 9.3093 -0.55197 -0.2988 11.1026 1.1818 0.5284 0.1624 0.2675 3214154 Ald1-H_000563 CN(C)c1ccc(/C=N/NC(=O)CCCCCC(=O)O)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 N20 compound treatment 11.342 1.4807 0.8016 8.4554 -1.4654 -0.6552 0.1035 0.1 3214156 Ald1-H_000564 CN(C)c1ccc(/C=N/NC(=O)CCCCCCC(=O)O)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 N21 compound treatment 9.0059 -0.85537 -0.4631 10.8918 0.97099 0.4342 -0.0204 -0.0322 3214158 Ald1-H_000565 CCn1c2ccccc2c3cc(/C=N/NC(=O)CCCCCC(=O)O)ccc13 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 N22 compound treatment 8.482 -1.3793 -0.7467 11.1392 1.2184 0.5448 -0.1428 -0.1545 3214160 Ald1-H_000566 CCn1c2ccccc2c3cc(/C=N/NC(=O)CCCCCCC(=O)O)ccc13 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 N23 compound treatment 8.5757 -1.2856 -0.696 10.1324 0.21154 0.0946 -0.4252 -0.6054 3214162 Ald1-H_000567 OC(=O)CCCCCC(=O)N/N=C/c1ccc(c(F)c1)c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 N24 compound treatment 9.8795 0.018251 0.0099 9.3144 -0.60638 -0.2711 -0.1847 -0.6809 3214164 Ald1-H_000568 OC(=O)CCCCCCC(=O)N/N=C/c1ccc(c(F)c1)c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 O01 compound treatment 9.1573 -0.70395 -0.3811 10.618 0.69717 0.3117 -0.049 -0.0996 3214166 Ald1-H_000569 OCCOc1ccccc1/C=N/NC(=O)CCCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 O02 compound treatment 9.6532 -0.20807 -0.1126 9.6247 -0.29615 -0.1324 -0.1733 -0.9968 3214168 Ald1-H_000570 OCCOc1ccccc1/C=N/NC(=O)CCCCCC(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 O03 compound treatment 9.7248 -0.1365 -0.0739 11.0204 1.0995 0.4916 0.2954 0.5942 3214170 Ald1-H_000571 OCCOc1cccc(/C=N/NC(=O)CCCCCCC(=O)O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 O04 compound treatment 11.2793 1.418 0.7677 10.1031 0.18229 0.0815 0.6005 0.7778 3214172 Ald1-H_000572 OCCOc1cccc(/C=N/NC(=O)CCCCCC(=O)O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 O05 compound treatment 9.5101 -0.35123 -0.1901 11.09 1.1692 0.5228 0.2352 0.4228 3214174 Ald1-H_000573 OCCOc1ccc(/C=N/NC(=O)CCCCCCC(=O)O)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 O06 compound treatment 9.9876 0.12629 0.0684 9.4368 -0.48401 -0.2164 -0.1047 -0.4612 3214176 Ald1-H_000574 OCCOc1ccc(/C=N/NC(=O)CCCCCC(=O)O)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 O07 compound treatment 9.2328 -0.62852 -0.3403 10.5351 0.61432 0.2747 -0.0464 -0.106 3214178 Ald1-H_000575 COc1ccc(/C=N/NC(=O)CCCCCCC(=O)O)c(O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 O08 compound treatment 11.7703 1.909 1.0335 10.4092 0.48841 0.2184 0.8852 0.838 3214180 Ald1-H_000576 COc1ccc(/C=N/NC(=O)CCCCCC(=O)O)c(O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 O09 compound treatment 9.7139 -0.14741 -0.0798 8.2306 -1.6902 -0.7557 -0.5908 -0.7775 3214182 Ald1-H_000577 COc1ccc(O)c(/C=N/NC(=O)CCCCCCC(=O)O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 O10 compound treatment 10.4222 0.56095 0.3037 7.5611 -2.3597 -1.0551 -0.5313 -0.4839 3214184 Ald1-H_000578 COc1ccc(O)c(/C=N/NC(=O)CCCCCC(=O)O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 O11 mock treatment 8.9244 -0.9369 -0.5072 10.0809 0.16007 0.0716 -0.308 -0.6014 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 O12 mock treatment 10.8745 1.0132 0.5485 9.5638 -0.35699 -0.1596 0.275 0.4813 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 O13 compound treatment 11.6588 1.7975 0.9731 9.7762 -0.14466 -0.0647 0.6424 0.6587 3214186 Ald1-H_000579 COc1cc(/C=C/C=N/NC(=O)CCCCCCC(=O)O)ccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 O14 compound treatment 11.9021 2.0408 1.1048 10.0203 0.099455 0.0445 0.8127 0.735 3214188 Ald1-H_000580 COc1cc(/C=C/C=N/NC(=O)CCCCCC(=O)O)ccc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 O15 compound treatment 11.3201 1.4588 0.7897 9.3381 -0.58271 -0.2606 0.3742 0.45 3214190 Ald1-H_000581 Cc1ccc(O)c(/C=N/NC(=O)CCCCCCC(=O)O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 O16 compound treatment 12.7057 2.8444 1.5398 13.0861 3.1653 1.4153 2.0896 0.9991 3214192 Ald1-H_000582 Cc1ccc(O)c(/C=N/NC(=O)CCCCCC(=O)O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 O17 compound treatment 9.276 -0.58525 -0.3168 9.5177 -0.40307 -0.1802 -0.3515 -0.9642 3214194 Ald1-H_000583 OCc1ccc(/C=N/NC(=O)CCCCCCC(=O)O)o1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 O18 compound treatment 9.2908 -0.5705 -0.3088 9.3489 -0.57191 -0.2557 -0.3992 -0.9956 3214196 Ald1-H_000584 OCc1ccc(/C=N/NC(=O)CCCCCC(=O)O)o1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 O19 compound treatment 9.5815 -0.27977 -0.1515 9.7442 -0.17659 -0.079 -0.1629 -0.9539 3214198 Ald1-H_000585 OC(=O)CCCCCCC(=O)N/N=C/c1ccc2ccccc2c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 O20 compound treatment 9.7221 -0.13922 -0.0754 9.1701 -0.75074 -0.3357 -0.2907 -0.8448 3214200 Ald1-H_000586 OC(=O)CCCCCC(=O)N/N=C/c1ccc2ccccc2c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 O21 compound treatment 11.5747 1.7134 0.9276 10.245 0.32423 0.145 0.7584 0.8078 3214202 Ald1-H_000587 OC(=O)CCCCCCC(=O)N/N=C/c1ccc(o1)c2cccc(Cl)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 O22 compound treatment 8.5561 -1.3052 -0.7066 11.0713 1.1505 0.5144 -0.1359 -0.1555 3214204 Ald1-H_000588 OC(=O)CCCCCC(=O)N/N=C/c1ccc(o1)c2cccc(Cl)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 O23 compound treatment 11.7944 1.9331 1.0465 10.0863 0.16552 0.074 0.7923 0.7552 3214206 Ald1-H_000589 OC(=O)CCCCCCC(=O)N/N=C/c1cc(Br)c(O)c(Br)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 O24 compound treatment 11.0448 1.1835 0.6407 9.6689 -0.25189 -0.1126 0.3734 0.574 3214208 Ald1-H_000590 OC(=O)CCCCCC(=O)N/N=C/c1cc(Br)c(O)c(Br)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 P01 compound treatment 10.4928 0.63155 0.3419 11.0262 1.1054 0.4943 0.5913 0.9838 3214210 Ald1-H_000591 OC(=O)CCCCCC(=O)N/N=C/c1ccc(o1)S(=O)(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 P02 compound treatment 11.7554 1.8941 1.0254 11.1354 1.2146 0.5431 1.1091 0.9558 3214212 Ald1-H_000592 OC(=O)CCCCCCC(=O)N/N=C/c1ccc(o1)S(=O)(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 P03 mock treatment 9.0775 -0.78383 -0.4243 65.3058 55.385 24.7646 17.2111 0.6949 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 P04 mock treatment 10.3648 0.50349 0.2726 11.4012 1.4804 0.662 0.6608 0.9231 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 P05 mock treatment 11.0818 1.2205 0.6607 10.6991 0.77825 0.348 0.7133 0.9551 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 P06 mock treatment 9.9915 0.13022 0.0705 13.6033 3.6825 1.6466 1.2142 0.7367 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 P07 mock treatment 9.6716 -0.18967 -0.1027 9.6703 -0.2505 -0.112 -0.1518 -0.9991 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 P08 mock treatment 9.6249 -0.23635 -0.128 9.4937 -0.42714 -0.191 -0.2255 -0.981 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 P09 mock treatment 9.6187 -0.24257 -0.1313 11.264 1.3432 0.6006 0.3318 0.5397 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 P10 mock treatment 11.6485 1.7872 0.9675 10.3916 0.47076 0.2105 0.833 0.8413 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 P11 mock treatment 10.2158 0.35446 0.1919 10.3112 0.39037 0.1745 0.2591 0.9989 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 P12 mock treatment 11.1549 1.2936 0.7003 8.3421 -1.5787 -0.7059 -0.0039 -0.004 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 P13 mock treatment 11.7482 1.8869 1.0215 12.352 2.4312 1.0871 1.491 0.9995 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 P14 mock treatment 13.4689 3.6076 1.953 10.0702 0.14939 0.0668 1.4282 0.7309 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 P15 mock treatment 9.866 0.0046886 0.0025 9.1929 -0.72794 -0.3255 -0.2284 -0.7016 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 P16 mock treatment 10.8681 1.0068 0.5451 9.6528 -0.26797 -0.1198 0.3007 0.5388 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 P17 mock treatment 10.0767 0.2154 0.1166 9.7687 -0.15208 -0.068 0.0344 0.2546 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 P18 mock treatment 9.3077 -0.55363 -0.2997 10.5478 0.62694 0.2803 -0.0137 -0.0334 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 P19 mock treatment 9.056 -0.80525 -0.4359 9.818 -0.10285 -0.046 -0.3408 -0.7774 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 P20 mock treatment 13.1295 3.2682 1.7692 12.2012 2.2804 1.0196 1.972 0.9657 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 P21 mock treatment 9.8952 0.033914 0.0184 12.5269 2.6061 1.1653 0.837 0.7182 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 P22 mock treatment 9.2426 -0.61871 -0.3349 12.6097 2.6889 1.2023 0.6133 0.4914 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 P23 mock treatment 10.7019 0.84061 0.4551 10.5265 0.60568 0.2708 0.5133 0.9693 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2132 P24 mock treatment 9.9999 0.13862 0.075 10.3024 0.38161 0.1706 0.1737 0.9319 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 A01 compound treatment 8.7071 -0.72323 -0.3915 10.7774 0.95729 0.428 0.0258 0.0445 3188507 BCB03_000320 CCCCCCc1nc(cc2CO[Si](C(C)C)(C(C)C)c21)c3ccc(o3)c4ccc(Cl)c(Cl)c4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 A02 compound treatment 10.6006 1.1703 0.6336 10.1148 0.29465 0.1317 0.5412 0.8363 3071186 BCB03_000321 COc1ccc(cc1)[C@H]2OC[C@@H]3CCC(=O)N23 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 A03 compound treatment 10.981 1.5507 0.8395 11.2032 1.383 0.6184 1.0309 0.9887 3070126 BCB03_000322 CCCCCCc1nc(cc2CO[Si](C(C)C)(C(C)C)c21)c3cc(C)c(OC)c(C)c3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 A04 compound treatment 8.8716 -0.55869 -0.3025 9.4922 -0.32786 -0.1466 -0.3175 -0.9447 3071252 BCB03_000323 COc1cccc(C[C@H]2C[C@@H](CO)NC2=O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 A05 compound treatment 10.529 1.0987 0.5948 8.9095 -0.91063 -0.4072 0.1327 0.1841 3070127 BCB03_000324 CCCCCCc1nc(cc2CO[Si](C(C)C)(C(C)C)c21)c3ccc(OC)nc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 A06 compound treatment 10.6699 1.2396 0.6711 10.0027 0.18259 0.0816 0.5322 0.7873 3071181 BCB03_000325 COc1cccc(C[C@H]2C[C@@H](CO[Si](C(C)C)(C(C)C)C(C)C)N3C(=O)[C@]4(O[C@@]23[C@H]5[C@@H]4C(=O)N(C)C5=O)C(=O)C)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 A07 compound treatment 11.2894 1.8591 1.0064 9.2075 -0.6126 -0.2739 0.518 0.4966 3070128 BCB03_000326 CCCCCCc1nc(Cc2cc(OC)c(OC)c(OC)c2)cc3CO[Si](C(C)C)(C(C)C)c31 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 A08 compound treatment 9.657 0.22668 0.1227 8.9745 -0.84557 -0.3781 -0.1806 -0.4543 3189172 BCB03_000327 COc1cccc(C[C@H]2C[C@@H](CO[Si](C(C)C)(C(C)C)C(C)C)N3C(=O)[C@@]4(O[C@]23[C@@H]5[C@H]4C(=O)N(C)C5=O)C(=O)C)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 A09 compound treatment 8.5636 -0.86667 -0.4692 10.1919 0.37181 0.1662 -0.2142 -0.4303 3070129 BCB03_000328 CCCCCCc1nc(cc2CO[Si](C(C)C)(C(C)C)c21)C3CC3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 A10 compound treatment 10.2928 0.86253 0.4669 10.1393 0.31917 0.1427 0.4311 0.8829 3071185 BCB03_000329 COc1ccc(cc1)[C@H]2OC[C@@H]3CC4(CC=CC4)C(=O)N23 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 A11 compound treatment 10.3484 0.91808 0.497 10.0573 0.2372 0.1061 0.4264 0.8391 3188514 BCB03_000330 CCCCCCc1nc(c2ccc(o2)c3ccc(Cl)c(Cl)c3)c(C)c4CO[Si](C(C)C)(C(C)C)c41 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 A12 compound treatment 8.7609 -0.66938 -0.3624 8.9785 -0.84162 -0.3763 -0.5223 -0.9998 3189173 BCB03_000331 NC(=N)NCc1cn(CCc2c[nH]c3ccccc23)nn1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 A13 mock treatment 10.1637 0.73336 0.397 8.1797 -1.6404 -0.7335 -0.2379 -0.2853 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 A14 mock treatment 9.3492 -0.081086 -0.0439 12.2715 2.4514 1.0961 0.744 0.6782 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 A15 compound treatment 9.592 0.16171 0.0875 11.9909 2.1708 0.9706 0.7482 0.7678 3070178 BCB03_000332 CCCCCCc1nc(c(C)c2CO[Si](C(C)C)(C(C)C)c21)c3cc(C)c(OC)c(C)c3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 A16 compound treatment 9.6899 0.25961 0.1405 9.7561 -0.064004 -0.0286 0.0791 0.5518 3071253 BCB03_000333 COC(=O)c1c(CC[C@@H](CO)NC(=O)N(C)Cc2ccccc2)oc(C(=O)OCC=C)c1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 A17 compound treatment 10.834 1.4037 0.7599 9.2154 -0.60472 -0.2704 0.3461 0.4291 3070179 BCB03_000334 CCCCCCc1nc(c(C)c2CO[Si](C(C)C)(C(C)C)c21)c3ccc(OC)nc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 A18 compound treatment 9.4642 0.033874 0.0183 9.473 -0.34707 -0.1552 -0.0968 -0.6192 3071184 BCB03_000335 COc1ccc(cc1)[C@H]2OC[C@@H]3C[C@@H](Cc4ccccc4)C(=O)N23 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 A19 compound treatment 9.1058 -0.32446 -0.1757 8.6543 -1.1658 -0.5213 -0.4928 -0.8959 3070180 BCB03_000336 CCCCCCc1nc(Cc2cc(OC)c(OC)c(OC)c2)c(C)c3CO[Si](C(C)C)(C(C)C)c31 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 A20 compound treatment 10.5741 1.1438 0.6192 10.9116 1.0915 0.4881 0.7829 0.9931 3071183 BCB03_000337 COc1ccc(cc1)[C@H]2OC[C@@H]3C[C@H](Cc4ccccc4)C(=O)N23 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 A21 compound treatment 9.5593 0.12897 0.0698 9.7479 -0.072199 -0.0323 0.0265 0.345 3070181 BCB03_000338 CCCCCCc1nc(C2CC2)c(C)c3CO[Si](C(C)C)(C(C)C)c31 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 A22 compound treatment 11.3173 1.887 1.0216 13.8156 3.9955 1.7865 1.9856 0.9648 3189417 BCB03_000339 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](CO)NC(=O)N[C@@H](Cc3ccccc3)Cn4cc(COC2=O)nn4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 A23 compound treatment 11.8208 2.3905 1.2941 10.0103 0.1902 0.085 0.9752 0.752 3188651 BCB03_000340 CCCCCCc1nc(cc2[C@@H](O[Si](C(C)C)(C(C)C)c21)c3ccccc3)c4ccc(o4)c5ccc(Cl)c(Cl)c5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 A24 compound treatment 11.1762 1.7459 0.9452 9.8111 -0.0090316 -0.004 0.6655 0.7041 3070196 BCB03_000341 CC(C)[C@@H](C(=O)O)n1cc(nn1)c2ccccn2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 B01 compound treatment 12.449 3.0187 1.6342 10.5967 0.77655 0.3472 1.4011 0.8386 3188662 BCB03_000342 COC(=O)[C@H](Cc1ccccc1)N2CC(=C[C@@H]2[C@@H](O)Cc3ccccc3)/C=C/C4CC4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 B02 compound treatment 9.9451 0.51482 0.2787 10.6602 0.84013 0.3757 0.4627 0.9892 3071724 BCB03_000343 BrC1=C[C@]23COC[C@H]3C[C@@H]1[C@]4(CO4)C2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 B03 compound treatment 10.151 0.72072 0.3902 9.4384 -0.38167 -0.1707 0.1552 0.3645 3188663 BCB03_000344 COC(=O)[C@H](Cc1ccccc1)N2CC(=C)[C@@H](/C=C/C=C)[C@@H]2[C@@H](O)Cc3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 B04 compound treatment 8.4833 -0.94699 -0.5127 9.1808 -0.63929 -0.2858 -0.5646 -0.9619 3071727 BCB03_000345 C[C@]12COC[C@@]2(C=C(Br)[C@@H]3C1)C(=O)[C@@]43CO4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 B05 compound treatment 11.326 1.8957 1.0262 11.0055 1.1854 0.53 1.1004 0.9527 3070955 BCB03_000346 COC(=O)[C@H](Cc1ccccc1)N2CC(C)(OC)O[C@@H](Cc3ccccc3)[C@H]2/C=C/C4CC4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 B06 compound treatment 10.6571 1.2268 0.6641 12.4922 2.6721 1.1948 1.3144 0.9616 3071766 BCB03_000347 CCCCC[C@H]1OC[C@@]2(C=C(Br)[C@@H]3CC12)C(=O)[C@@]43CO4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 B07 compound treatment 10.3717 0.94145 0.5097 10.6692 0.84911 0.3797 0.6288 0.9895 3188666 BCB03_000348 COC(=O)[C@H](Cc1ccccc1)N2CC3=C[C@@H](C4CC4)n5n([C@H]3[C@@H]2[C@@H](O)Cc6ccccc6)c(=O)n(C)c5=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 B08 compound treatment 8.4278 -1.0025 -0.5427 9.6554 -0.16472 -0.0737 -0.4358 -0.7958 3071767 BCB03_000349 CC1(C)OC[C@@]2(C=C(Br)[C@@H]3C[C@H]12)C(=O)[C@@]43CO4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 B09 compound treatment 9.8297 0.39942 0.2162 10.1375 0.31743 0.1419 0.2533 0.9792 3188667 BCB03_000350 O[C@@H](Cc1ccccc1)[C@@H](/C=C/C2CC2)N(CC#Cc3ccccc3)Cc4ccccc4Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 B10 compound treatment 9.5894 0.15908 0.0861 10.4664 0.6463 0.289 0.2652 0.8796 3071770 BCB03_000351 BrC1=C[C@]23COCC[C@H]3C[C@@H]1[C@@]4(CO4)C2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 B11 compound treatment 9.1851 -0.24523 -0.1328 8.9414 -0.87876 -0.3929 -0.3717 -0.8962 3188668 BCB03_000352 CCC#CCN(Cc1ccccc1Br)[C@H](/C=C/c2ccccc2)[C@@H](O)Cc3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 B12 compound treatment 9.5546 0.1243 0.0673 8.7679 -1.0522 -0.4705 -0.2851 -0.5999 3071774 BCB03_000353 C=CCC1=C[C@H]2[C@H]([C@H]3C=C[C@]2(CC=C)C(=O)[C@@]43CO4)[C@@]5(CO5)C1=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 B13 mock treatment 9.0838 -0.34651 -0.1876 10.0317 0.21162 0.0946 -0.0657 -0.3129 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 B14 mock treatment 9.783 0.35267 0.1909 11.9679 2.1478 0.9604 0.8141 0.8314 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 B15 compound treatment 9.3314 -0.098863 -0.0535 10.2227 0.40261 0.18 0.0895 0.4763 3070996 BCB03_000354 O[C@@H](Cc1ccccc1)[C@@H](/C=C/c2ccccc2)N(CC#C)Cc3ccccc3Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 B16 compound treatment 9.9252 0.49488 0.2679 8.8461 -0.974 -0.4355 -0.1185 -0.2318 3188527 BCB03_000355 CC1=C[C@]2(CO)C(=O)[C@]3(CO3)[C@H]1[C@@H]4[C@@]5(CO5)C(=O)C(=C[C@@]42C)CO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 B17 compound treatment 9.616 0.1857 0.1005 12.5051 2.685 1.2006 0.92 0.7636 3070997 BCB03_000356 CCCC/C=C/[C@H]([C@@H](O)Cc1ccccc1)N(CC#Cc2ccccc2)Cc3ccccc3Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 B18 compound treatment 12.4143 2.984 1.6154 16.1215 6.3014 2.8176 3.1346 0.9651 3070938 BCB03_000357 CC(C)Cc1ccc(CN2CC[C@H](C2)NS(=O)(=O)c3cc(F)ccc3C)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 B19 compound treatment 8.6719 -0.75835 -0.4105 8.4334 -1.3867 -0.62 -0.7287 -0.98 3071055 BCB03_000358 CCC#CCN(Cc1ccccc1Br)[C@H](/C=C/C2CC2)[C@@H](O)Cc3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 B20 compound treatment 9.9921 0.5618 0.3041 8.7798 -1.0403 -0.4652 -0.1139 -0.2049 3070939 BCB03_000359 Cc1ccc(F)cc1S(=O)(=O)N[C@@H]2CCN(Cc3ccc(cc3)c4ccccc4)C2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 B21 compound treatment 12.8211 3.3908 1.8356 12.947 3.1269 1.3982 2.2866 0.991 3188794 BCB03_000360 O[C@@H](Cc1ccccc1)[C@H](NCc2cccc(Cl)c2)/C=C/C3CC3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 B22 compound treatment 9.4483 0.018004 0.0097 10.64 0.81985 0.3666 0.2661 0.7257 3188531 BCB03_000361 Cc1ccc(F)cc1S(=O)(=O)N[C@@H]2CCN(Cc3ccc(Oc4ccccc4)cc3)C2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 B23 compound treatment 8.9618 -0.4685 -0.2536 11.5496 1.7294 0.7733 0.3675 0.4515 3188796 BCB03_000362 O[C@@H](Cc1ccccc1)[C@@H](/C=C/C2CC2)N(CC#Cc3ccccc3)Cc4cccc(Cl)c4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 B24 compound treatment 10.2943 0.86398 0.4677 9.6536 -0.16655 -0.0745 0.2781 0.5871 3188532 BCB03_000363 Cc1ccc(F)cc1S(=O)(=O)N[C@@H]2CCN(Cc3ccc(cc3)C(F)(F)F)C2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 C01 compound treatment 9.1387 -0.29165 -0.1579 9.132 -0.68816 -0.3077 -0.3292 -0.9519 3070235 BCB03_000364 CCCCCCc1nc(cc2[C@@H](O[Si](C(C)C)(C(C)C)c21)c3ccccc3)c4cc(C)c(OC)c(C)c4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 C02 compound treatment 8.969 -0.46129 -0.2497 11.4701 1.6499 0.7377 0.3451 0.4431 3189039 BCB03_000365 OC(=O)[C@H](Cc1ccccc1)n2cc(nn2)c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 C03 compound treatment 9.7443 0.31402 0.17 9.0408 -0.77935 -0.3485 -0.1262 -0.3255 3070236 BCB03_000366 CCCCCCc1nc(cc2[C@@H](O[Si](C(C)C)(C(C)C)c21)c3ccccc3)c4ccc(OC)nc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 C04 compound treatment 11.0525 1.6222 0.8782 10.1347 0.31463 0.1407 0.7205 0.8101 3070086 BCB03_000367 N[C@@H](Cc1ccccc1)C(=O)NCc2cn(CCCNC(=N)N)nn2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 C05 compound treatment 10.9712 1.5409 0.8342 10.7607 0.94056 0.4206 0.8872 0.9497 3188655 BCB03_000368 CCCCCCc1nc(Cc2cc(OC)c(OC)c(OC)c2)cc3[C@@H](O[Si](C(C)C)(C(C)C)c31)c4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 C06 compound treatment 10.6537 1.2234 0.6623 8.9086 -0.91149 -0.4076 0.1801 0.2316 3070191 BCB03_000369 N[C@@H](Cc1ccccc1)C(=O)NCc2cn(Cc3ccccc3)nn2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 C07 compound treatment 8.635 -0.79526 -0.4305 9.4528 -0.36731 -0.1642 -0.4206 -0.9127 3188656 BCB03_000370 CCCCCCc1nc(cc2[C@@H](O[Si](C(C)C)(C(C)C)c21)c3ccccc3)C4CC4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 C08 compound treatment 8.9179 -0.51236 -0.2774 7.8335 -1.9866 -0.8883 -0.8242 -0.8857 3071180 BCB03_000371 OC(=O)[C@H](Cc1ccccc1)n2cc(nn2)c3ccccn3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 C09 compound treatment 9.0656 -0.36475 -0.1975 10.1389 0.31882 0.1426 -0.0388 -0.1594 3188772 BCB03_000372 CCCCCCc1nc(CCCc2cc3[C@@H](O[Si](C(C)C)(C(C)C)c3c(CCCCCC)n2)c4ccccc4)cc5[C@@H](O[Si](C(C)C)(C(C)C)c51)c6ccccc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 C10 compound treatment 9.9697 0.53939 0.292 10.2202 0.40006 0.1789 0.333 0.9723 3070134 BCB03_000373 OC(=O)[C@H](Cc1ccccc1)n2cc(nn2)C3(O)CCCCC3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 C11 mock treatment 8.9555 -0.47483 -0.2571 9.0022 -0.81792 -0.3657 -0.4404 -0.9851 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 C12 mock treatment 8.9182 -0.51209 -0.2772 8.7611 -1.059 -0.4735 -0.5309 -0.9675 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 C13 compound treatment 8.5201 -0.91017 -0.4927 10.8665 1.0464 0.4679 -0.0176 -0.0259 3070242 BCB03_000374 CC(C)[Si]1(OCc2cc(nc(c21)c3ccccc3)c4ccc(o4)c5ccc(Cl)c(Cl)c5)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 C14 compound treatment 9.9347 0.50441 0.2731 9.314 -0.50609 -0.2263 0.0331 0.0933 3070089 BCB03_000375 CC(C)[C@@H](C(=O)O)n1cc(nn1)c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 C15 mock treatment 9.9726 0.54233 0.2936 10.7086 0.88853 0.3973 0.4885 0.9889 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 C16 mock treatment 9.7548 0.32452 0.1757 10.1208 0.30067 0.1344 0.2193 0.9913 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 C17 compound treatment 9.9452 0.51486 0.2787 9.9161 0.095938 0.0429 0.2274 0.8064 3070245 BCB03_000376 COc1c(C)cc(cc1C)c2cc3CO[Si](C(C)C)(C(C)C)c3c(n2)c4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 C18 compound treatment 10.3472 0.91687 0.4964 10.0263 0.20622 0.0922 0.4162 0.8244 3071179 BCB03_000377 CC(C)[C@@H](C(=O)O)n1cc(nn1)C2(O)CCCCC2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 C19 compound treatment 10.8951 1.4648 0.793 10.68 0.85987 0.3845 0.8326 0.9448 3070527 BCB03_000378 COc1cc(Cc2cc3CO[Si](C(C)C)(C(C)C)c3c(n2)c4ccccc4)cc(OC)c1OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 C20 compound treatment 8.7763 -0.65399 -0.354 10.5088 0.68868 0.3079 -0.0326 -0.0695 3414058 BCB03_000379 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](CO)NC(=O)N(C)Cc3cn(C[C@H](Cc4ccccc4)NC2=O)nn3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 C21 compound treatment 9.6254 0.19514 0.1056 10.08 0.25988 0.1162 0.1569 0.9989 3070530 BCB03_000380 CC(C)[Si]1(OCc2cc(nc(c21)c3ccccc3)C4CC4)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 C22 compound treatment 9.7371 0.30682 0.1661 10.2776 0.45747 0.2045 0.2621 0.9947 3189555 BCB03_000381 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](CO)NC(=O)N(Cc3ccccc3)Cc4cn(C[C@H](Cc5ccccc5)NC2=O)nn4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 C23 compound treatment 8.8748 -0.55554 -0.3007 11.4096 1.5895 0.7107 0.2899 0.3756 3070081 BCB03_000382 CC(C)[Si]1(OCc2c1c(nc(c3ccc(o3)c4ccc(Cl)c(Cl)c4)c2C)c5ccccc5)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 C24 compound treatment 9.7148 0.28451 0.154 10.362 0.54186 0.2423 0.2802 0.9761 3189558 BCB03_000383 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](CO)NC(=O)N(Cc3ccccc3)Cc4cnnn4C[C@@H](Cc5ccccc5)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 D01 compound treatment 9.5897 0.15937 0.0863 10.4357 0.61558 0.2752 0.2556 0.8862 3071060 BCB03_000384 O[C@@H](Cc1ccccc1)[C@H](NCc2ccccc2Br)/C=C/c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 D02 compound treatment 10.5318 1.1015 0.5963 10.1755 0.35543 0.1589 0.534 0.8654 3070941 BCB03_000385 Cc1ccc(F)cc1S(=O)(=O)N[C@@H]2CCN(Cc3ccc4[nH]ccc4c3)C2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 D03 compound treatment 10.1573 0.72703 0.3936 10.3986 0.57846 0.2586 0.4612 0.9793 3188797 BCB03_000386 O[C@@H](Cc1ccccc1)[C@H]2C3C=CCCC=C3CN2Cc4cccc(Cl)c4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 D04 compound treatment 10.0106 0.58029 0.3141 11.1898 1.3696 0.6124 0.6552 0.9519 3070942 BCB03_000387 Cc1ccc(F)cc1S(=O)(=O)N[C@@H]2CCN(Cc3cccc4[nH]ccc34)C2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 D05 compound treatment 12.3796 2.9493 1.5966 10.4089 0.58882 0.2633 1.3152 0.8127 3188798 BCB03_000388 COC1(C)CN(Cc2ccccc2Br)[C@H](/C=C/c3ccccc3)[C@H](Cc4ccccc4)O1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 D06 compound treatment 11.0424 1.6121 0.8727 10.5894 0.76934 0.344 0.8603 0.9172 3070943 BCB03_000389 CC(C)Oc1ccc(cc1)C(=O)N2CC[C@H](C2)NS(=O)(=O)c3cc(F)ccc3C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 D07 compound treatment 10.2775 0.84717 0.4586 9.1946 -0.62556 -0.2797 0.1265 0.2355 3188799 BCB03_000390 CN1C(=O)C2C3[C@H]([C@@H](O)Cc4ccccc4)N(Cc5cccc(Cl)c5)CC3=CC(C6CC6)C2C1=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 D08 compound treatment 10.5867 1.1564 0.626 10.7095 0.88938 0.3977 0.7239 0.976 3188537 BCB03_000391 Cc1ccc(F)cc1S(=O)(=O)N[C@@H]2CCN(Cc3ccc(Br)cc3)C2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 D09 compound treatment 9.7469 0.31661 0.1714 11.185 1.3649 0.6103 0.5527 0.872 3071066 BCB03_000392 O[C@@H](Cc1ccccc1)[C@H](N(CC#C)CC2=CCCCC2)c3ccccc3Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 D10 compound treatment 10.282 0.8517 0.4611 10.2593 0.43923 0.1964 0.4649 0.9277 3070952 BCB03_000393 CC(C)Cc1ccc(CN2CC[C@@H](N)C2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 D11 mock treatment 7.6765 -1.7538 -0.9494 9.5061 -0.31404 -0.1404 -0.7706 -0.803 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 D12 mock treatment 10.233 0.80267 0.4345 12.057 2.2368 1.0002 1.0145 0.9303 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 D13 compound treatment 8.8254 -0.60489 -0.3275 9.6629 -0.15717 -0.0703 -0.2812 -0.8397 3071068 BCB03_000394 O=C(Cc1ccccc1)[C@H]2C3C=CCCC(=C3CN2Cc4ccccc4)c5ccccc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 D14 compound treatment 12.7302 3.2999 1.7864 12.4931 2.6729 1.1952 2.1083 0.9809 3070953 BCB03_000395 CC(C)Cc1ccc(CN2CC[C@H](C2)NS(=O)(=O)c3ccccc3)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 D15 mock treatment 7.9997 -1.4306 -0.7745 10.8322 1.0121 0.4525 -0.2277 -0.2538 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 D16 mock treatment 10.9065 1.4762 0.7991 9.0115 -0.80861 -0.3616 0.3094 0.3528 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 D17 compound treatment 11.1129 1.6826 0.9109 9.2202 -0.59996 -0.2683 0.4544 0.4785 3071112 BCB03_000396 O[C@@H](Cc1ccccc1)[C@H]2C3C=CCCC(=C3CN2Cc4cccc(Cl)c4)c5ccccc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 D18 compound treatment 10.1354 0.70506 0.3817 9.1926 -0.62747 -0.2806 0.0715 0.1509 3070954 BCB03_000397 CC(C)Cc1ccc(CN2CC[C@H](C2)NC(=O)c3ccccc3)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 D19 compound treatment 11.025 1.5947 0.8633 15.7188 5.8987 2.6375 2.4755 0.892 3188804 BCB03_000398 Clc1cccc(CN2CC3=CCCC=CC3[C@@H]2[C@H](Cc4ccccc4)OC(=O)C=C)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 D20 compound treatment 14.1003 4.67 2.5281 17.3966 7.5764 3.3877 4.1831 0.9896 3188664 BCB03_000399 CC(C)Cc1ccc(CN2CC[C@H](C2)NC(=O)Nc3ccccc3)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 D21 compound treatment 11.5848 2.1545 1.1664 11.3365 1.5164 0.678 1.3042 0.9667 3071454 BCB03_000400 CCC1=C2CN(Cc3ccccc3Br)[C@@H]([C@@H](O)Cc4ccccc4)C2C=CCC1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 D22 compound treatment 9.3665 -0.063848 -0.0346 11.1699 1.3498 0.6035 0.4023 0.6655 3188665 BCB03_000401 CC(C)Oc1ccc(CN2CC[C@H](C2)NS(=O)(=O)c3cc(F)ccc3C)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 D23 compound treatment 9.5545 0.12423 0.0673 9.7244 -0.095732 -0.0428 0.0173 0.2168 3071455 BCB03_000402 CCC1=C2CN(Cc3ccccc3)[C@H](C2C=CCC1)C(=O)Cc4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 D24 compound treatment 13.023 3.5927 1.9449 11.3221 1.502 0.6716 1.8501 0.8992 3070994 BCB03_000403 CC(C)Oc1ccc(CN2CC[C@@H](C2)NS(=O)(=O)c3cc(F)ccc3C)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 E01 mock treatment 10.1044 0.67406 0.3649 10.4183 0.59818 0.2675 0.4472 0.9883 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 E02 mock treatment 10.9068 1.4765 0.7993 9.7995 -0.020589 -0.0092 0.5587 0.6989 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 E03 compound treatment 9.4116 -0.018746 -0.0101 9.783 -0.037122 -0.0166 -0.0189 -0.9721 3189040 BCB03_000404 COc1c(C)cc(cc1C)c2nc(c3c(CO[Si]3(C(C)C)C(C)C)c2C)c4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 E04 compound treatment 9.2595 -0.17076 -0.0924 9.3994 -0.4207 -0.1881 -0.1984 -0.9465 3189560 BCB03_000405 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](CO)NC(=O)N(Cc3ccccc3)Cc4cn(C[C@@H]5CCCN5C2=O)nn4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 E05 compound treatment 12.0753 2.645 1.4319 9.0236 -0.79652 -0.3562 0.7607 0.5155 3189041 BCB03_000406 COc1ccc(cn1)c2nc(c3c(CO[Si]3(C(C)C)C(C)C)c2C)c4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 E06 compound treatment 8.56 -0.87029 -0.4711 9.4101 -0.40998 -0.1833 -0.4628 -0.9154 3189559 BCB03_000407 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](CO)NC(=O)N(Cc3ccccc3)Cc4cnnn4C[C@@H]5CCCN5C2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 E07 compound treatment 10.0816 0.65128 0.3526 14.9882 5.1681 2.3108 1.8833 0.8057 3189042 BCB03_000408 CC(C)[Si]1(O[C@H](c2cc(nc(c21)c3ccccc3)c4ccc(o4)c5ccc(Cl)c(Cl)c5)c6ccccc6)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 E08 compound treatment 9.0016 -0.42871 -0.2321 10.6773 0.8572 0.3833 0.1069 0.2386 3189043 BCB03_000409 N[C@@H](Cc1ccccc1)Cn2cc(nn2)C3(O)CCCCC3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 E09 mock treatment 9.45 0.019707 0.0107 11.1278 1.3077 0.5847 0.421 0.7199 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 E10 mock treatment 8.7521 -0.67821 -0.3672 10.8859 1.0657 0.4765 0.0773 0.1286 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 E11 compound treatment 10.3074 0.87711 0.4748 8.5574 -1.2627 -0.5646 -0.0635 -0.0861 3070137 BCB03_000410 COc1c(C)cc(cc1C)c2cc3[C@@H](O[Si](C(C)C)(C(C)C)c3c(n2)c4ccccc4)c5ccccc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 E12 compound treatment 8.9348 -0.49545 -0.2682 14.1992 4.3791 1.9581 1.1949 0.6046 3070143 BCB03_000411 N[C@@H](Cc1ccccc1)Cn2cc(nn2)c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 E13 compound treatment 8.4328 -0.99752 -0.54 11.4399 1.6197 0.7242 0.1303 0.1442 3189044 BCB03_000412 COc1ccc(cn1)c2cc3[C@@H](O[Si](C(C)C)(C(C)C)c3c(n2)c4ccccc4)c5ccccc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 E14 compound treatment 8.7098 -0.72048 -0.39 9.4091 -0.41099 -0.1838 -0.4057 -0.941 3189695 BCB03_000413 COC(=O)c1nc2oc1CC[C@@H](CO)NC(=O)N(C)Cc3cn(C[C@H](Cc4ccccc4)NC2=O)nn3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 E15 compound treatment 9.5961 0.16576 0.0897 12.3367 2.5166 1.1252 0.8591 0.7611 3189045 BCB03_000414 CC(C)[Si]1(O[C@H](c2cc(nc(c21)c3ccccc3)C4CC4)c5ccccc5)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 E16 compound treatment 8.3763 -1.054 -0.5706 9.8796 0.059518 0.0266 -0.3846 -0.6734 3071393 BCB03_000415 COC(=O)c1nc2oc1CC[C@@H](CO)NC(=O)N(C)Cc3cnnn3C[C@H](Cc4ccccc4)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 E17 mock treatment 8.9218 -0.50854 -0.2753 11.0571 1.237 0.5531 0.1964 0.3179 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 E18 mock treatment 11.0348 1.6045 0.8686 8.1488 -1.6714 -0.7473 0.0858 0.0749 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 E19 compound treatment 9.1389 -0.29143 -0.1578 10.7642 0.94407 0.4221 0.1869 0.4148 3189046 BCB03_000416 CC(C)[Si]1(OCc2cc(nc(CCc3ccccc3)c21)c4ccc(o4)c5ccc(Cl)c(Cl)c5)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 E20 compound treatment 10.7816 1.3513 0.7315 9.8211 9.7594E-4 4.0E-4 0.5176 0.7075 3071396 BCB03_000417 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](CO)NC(=O)NC3(CCCCC3)c4cn(C[C@H](C)NC2=O)nn4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 E21 compound treatment 9.113 -0.31733 -0.1718 11.0589 1.2388 0.5539 0.2702 0.4659 3189047 BCB03_000418 COc1c(C)cc(cc1C)c2cc3CO[Si](C(C)C)(C(C)C)c3c(CCc4ccccc4)n2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 E22 compound treatment 10.6956 1.2653 0.685 9.0019 -0.81824 -0.3659 0.2256 0.2906 3187595 BCB03_000419 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](CO)NC(=O)NC3(CCCCC3)c4cn(C[C@@H](NC2=O)C(C)C)nn4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 E23 compound treatment 9.1369 -0.2934 -0.1588 8.5128 -1.3073 -0.5845 -0.5256 -0.8678 3189169 BCB03_000420 COc1ccc(cn1)c2cc3CO[Si](C(C)C)(C(C)C)c3c(CCc4ccccc4)n2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 E24 compound treatment 8.7714 -0.65891 -0.3567 11.5398 1.7197 0.7689 0.2915 0.3439 3187594 BCB03_000421 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](CO)NC(=O)NC3(CCCCC3)c4cn(C[C@H](Cc5ccccc5)NC2=O)nn4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 F01 mock treatment 9.1018 -0.32849 -0.1778 13.5249 3.7048 1.6565 1.0456 0.6276 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 F02 mock treatment 11.6786 2.2483 1.2171 10.3343 0.5142 0.2299 1.0232 0.8261 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 F03 compound treatment 10.2184 0.78813 0.4267 9.5827 -0.23744 -0.1062 0.2266 0.5154 3071456 BCB03_000422 C/C=C\[C@@H](NCc1ccccc1Br)[C@@H](O)Cc2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 F04 compound treatment 9.3379 -0.092358 -0.05 10.1444 0.32425 0.145 0.0672 0.4379 3070995 BCB03_000423 Cc1ccc(F)cc1S(=O)(=O)N[C@@H]2CCN(Cc3ccc4OCOc4c3)C2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 F05 compound treatment 9.0782 -0.35213 -0.1906 9.2009 -0.61926 -0.2769 -0.3306 -0.9834 3071457 BCB03_000424 CC(=CCN[C@H](CO)c1ccccc1)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 F06 compound treatment 9.401 -0.029316 -0.0159 10.0447 0.22456 0.1004 0.0598 0.588 2133134 BCB03_000425 CCCCC(=O)N(CCN1CCOCC1)[C@@H]2CC(=C[C@H](Oc3c(I)cc(CO)cc3OC)[C@H]2O)C(=O)NCCO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 F07 compound treatment 10.9551 1.5248 0.8255 9.9429 0.12276 0.0549 0.6225 0.7525 3071458 BCB03_000426 CC(=CCN(CC#C)[C@H](CO)c1ccccc1)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 F08 compound treatment 10.0382 0.60794 0.3291 10.8243 1.0042 0.449 0.5502 0.9883 2133147 BCB03_000427 COc1cc(CO)cc(I)c1O[C@H]2C=C(C[C@H]([C@@H]2O)N(CCN3CCOCC3)C(=O)C4CCCO4)C(=O)NCCO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 F09 mock treatment 8.4745 -0.95582 -0.5174 7.5762 -2.2439 -1.0033 -1.0754 -0.9526 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 F10 mock treatment 8.5903 -0.84 -0.4547 8.404 -1.4161 -0.6332 -0.7693 -0.9868 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 F11 compound treatment 15.1416 5.7113 3.0919 16.13 6.3099 2.8214 4.1813 0.999 3187737 BCB03_000428 CC(=CCN(CC#Cc1ccccc1)[C@H](CO)c2ccccc2)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 F12 compound treatment 9.4162 -0.014058 -0.0076 10.0502 0.23007 0.1029 0.0674 0.653 3188671 BCB03_000429 COc1cc(CO)cc(I)c1O[C@H]2C=C(C[C@@H](NCCc3c[nH]c4ccccc34)[C@@H]2O)C(=O)NCCO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 F13 compound treatment 8.9719 -0.4584 -0.2482 10.2416 0.42151 0.1885 -0.0422 -0.1354 3071460 BCB03_000430 O=C1OC[C@@H](c2ccccc2)n3cc(/C=C/c4ccccc4)cc13 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 F14 compound treatment 9.3855 -0.044803 -0.0243 8.964 -0.85607 -0.3828 -0.2878 -0.7504 2129060 BCB03_000431 COc1cc(CO)cc(I)c1O[C@H]2C=C(C[C@@H](NCC3CCCCC3)[C@@H]2O)C(=O)NCCO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 F15 compound treatment 9.6174 0.18713 0.1013 9.0911 -0.72898 -0.326 -0.1588 -0.4654 3071461 BCB03_000432 CC(=C)C/1CN([C@H](CO)c2ccccc2)C(=O)\C1=C/c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 F16 compound treatment 9.8194 0.38909 0.2106 10.4275 0.60743 0.2716 0.341 0.9921 2129057 BCB03_000433 COc1cc(CO)cc(I)c1O[C@H]2C=C(C[C@@H](NC[C@@H]3CCCO3)[C@@H]2O)C(=O)NCCO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 F17 mock treatment 9.9937 0.56336 0.305 9.7277 -0.092402 -0.0413 0.1864 0.6058 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 F18 mock treatment 8.4275 -1.0028 -0.5429 8.877 -0.94314 -0.4217 -0.6821 -0.9922 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 F19 compound treatment 9.9402 0.50991 0.276 10.2915 0.47142 0.2108 0.3442 0.9911 3071462 BCB03_000434 OCC(/C=C/c1ccccc1)N(CC#C)C(C(=O)O)c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 F20 compound treatment 9.7337 0.30338 0.1642 11.1661 1.346 0.6018 0.5417 0.8683 2129061 BCB03_000435 COc1cc(CO)cc(I)c1O[C@H]2C=C(C[C@@H](NC3CCCCCC3)[C@@H]2O)C(=O)NCCO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 F21 compound treatment 8.0792 -1.3511 -0.7314 8.9369 -0.88321 -0.3949 -0.7965 -0.9581 3071463 BCB03_000436 C/C=C/CN([C@H](CO[Si](C)(C)C(C)(C)C)c1ccccc1)C(=O)C#Cc2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 F22 compound treatment 9.7097 0.27937 0.1512 10.4298 0.60964 0.2726 0.2997 0.9614 2129067 BCB03_000437 COc1cc(CO)cc(I)c1O[C@H]2C=C(C[C@@H](NCc3ccccc3F)[C@@H]2O)C(=O)NCCO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 F23 compound treatment 8.2742 -1.1561 -0.6259 11.2634 1.4433 0.6453 0.0138 0.0153 3071464 BCB03_000438 O=C1OC[C@H](N(CC#C)C1/C=C/c2ccccc2)c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 F24 compound treatment 9.5859 0.1556 0.0842 10.0477 0.22755 0.1017 0.1315 0.9956 2129068 BCB03_000439 COc1cc(CO)cc(I)c1O[C@H]2C=C(C[C@@H](NCc3ccc(F)cc3)[C@@H]2O)C(=O)NCCO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 G01 compound treatment 9.4049 -0.025383 -0.0137 9.4367 -0.38345 -0.1715 -0.131 -0.7613 3189170 BCB03_000440 COc1cc(Cc2cc3CO[Si](C(C)C)(C(C)C)c3c(CCc4ccccc4)n2)cc(OC)c1OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 G02 compound treatment 8.7109 -0.71937 -0.3894 9.8874 0.067261 0.0301 -0.2541 -0.6506 3187594 BCB03_000441 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](CO)NC(=O)NC3(CCCCC3)c4cn(C[C@H](Cc5ccccc5)NC2=O)nn4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 G03 mock treatment 10.1374 0.70707 0.3828 9.0326 -0.78753 -0.3521 0.0217 0.0417 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 G04 mock treatment 9.2554 -0.17494 -0.0947 10.6249 0.8048 0.3599 0.1875 0.5039 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 G05 compound treatment 9.5641 0.13378 0.0724 8.6161 -1.204 -0.5384 -0.3295 -0.6065 3189171 BCB03_000442 CC(C)[Si]1(OCc2cc(nc(CCc3ccccc3)c21)C4CC4)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 G06 compound treatment 11.7899 2.3597 1.2774 10.614 0.79389 0.355 1.1543 0.8706 3187597 BCB03_000443 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](CO)NC(=O)NC3(CCCCC3)c4cnnn4C[C@@H](NC2=O)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 G07 compound treatment 9.548 0.11768 0.0637 11.0691 1.2489 0.5584 0.4399 0.7827 3071182 BCB03_000444 CC(C)[Si]1(OCc2cc(CCCc3cc4CO[Si](C(C)C)(C(C)C)c4c(CCc5ccccc5)n3)nc(CCc6ccccc6)c21)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 G08 compound treatment 9.9696 0.53928 0.2919 9.8507 0.030626 0.0137 0.2161 0.7395 3189696 BCB03_000445 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](CO)NC(=O)NC3(CCCCC3)c4cn(C[C@@H](Cc5ccccc5)NC2=O)nn4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 G09 compound treatment 8.8592 -0.57113 -0.3092 9.5016 -0.31854 -0.1424 -0.3193 -0.9381 3189286 BCB03_000446 CC(C)[Si]1(O[C@H](c2cc(nc(CCc3ccccc3)c21)c4ccc(o4)c5ccc(Cl)c(Cl)c5)c6ccccc6)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 G10 compound treatment 9.2876 -0.14269 -0.0772 10.7577 0.93763 0.4192 0.2418 0.5673 3187593 BCB03_000447 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](CO)NC(=O)NC3(CCCCC3)c4cnnn4C[C@@H](Cc5ccccc5)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 G11 compound treatment 7.8066 -1.6237 -0.879 8.8108 -1.0094 -0.4513 -0.9407 -0.952 3189287 BCB03_000448 COc1c(C)cc(cc1C)c2cc3[C@@H](O[Si](C(C)C)(C(C)C)c3c(CCc4ccccc4)n2)c5ccccc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 G12 compound treatment 9.1296 -0.30074 -0.1628 8.853 -0.96712 -0.4324 -0.4209 -0.9109 3414059 BCB03_000449 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](CO)NC(=O)N[C@@H](Cc3ccccc3)Cn4cc(CN(Cc5ccccc5)C2=O)nn4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 G13 compound treatment 9.656 0.22569 0.1222 7.6482 -2.1719 -0.9711 -0.6003 -0.6133 3189288 BCB03_000450 COc1ccc(cn1)c2cc3[C@@H](O[Si](C(C)C)(C(C)C)c3c(CCc4ccccc4)n2)c5ccccc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 G14 compound treatment 8.6943 -0.73595 -0.3984 9.4589 -0.36119 -0.1615 -0.3959 -0.921 3414060 BCB03_000451 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](CO)NC(=O)N[C@@H](Cc3ccccc3)Cn4cc(nn4)C5(CCCCC5)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 G15 compound treatment 12.927 3.4967 1.893 14.4059 4.5858 2.0505 2.7885 0.9992 3189289 BCB03_000452 COc1cc(Cc2cc3[C@@H](O[Si](C(C)C)(C(C)C)c3c(CCc4ccccc4)n2)c5ccccc5)cc(OC)c1OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 G16 compound treatment 9.3633 -0.067023 -0.0363 9.562 -0.25809 -0.1154 -0.1073 -0.8866 3189561 BCB03_000453 CN1Cc2cn(C[C@H](Cc3ccccc3)NC(=O)c4cc(c(CC[C@@H](CO)NC1=O)o4)S(=O)(=O)c5ccc(C)cc5)nn2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 G17 compound treatment 9.3814 -0.048873 -0.0265 9.0135 -0.80664 -0.3607 -0.2737 -0.7569 3189171 BCB03_000454 CC(C)[Si]1(OCc2cc(nc(CCc3ccccc3)c21)C4CC4)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 G18 compound treatment 8.7146 -0.71567 -0.3874 9.8224 0.0022884 0.001 -0.2732 -0.7052 3189290 BCB03_000455 COc1ccc(cc1)[C@H]2OC[C@@H]3CC(CC=C)(CC=C)C(=O)N23 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 G19 mock treatment 9.7814 0.35113 0.1901 8.723 -1.0971 -0.4906 -0.2125 -0.4038 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 G20 mock treatment 10.3329 0.90262 0.4886 8.8764 -0.94375 -0.422 0.0471 0.073 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 G21 compound treatment 8.2431 -1.1872 -0.6427 11.1055 1.2853 0.5747 -0.0481 -0.0557 3071182 BCB03_000456 CC(C)[Si]1(OCc2cc(CCCc3cc4CO[Si](C(C)C)(C(C)C)c4c(CCc5ccccc5)n3)nc(CCc6ccccc6)c21)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 G22 compound treatment 8.7814 -0.64886 -0.3513 10.8025 0.9824 0.4393 0.0622 0.1106 3071255 BCB03_000457 NC(=N)NCC#C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 G23 compound treatment 8.8071 -0.62323 -0.3374 10.4926 0.67248 0.3007 -0.026 -0.0574 3188910 BCB03_000458 CC(C)[Si]1(OCc2cc(nc(c21)c3ccc(Oc4ccccc4)cc3)c5ccc(o5)c6ccc(Cl)c(Cl)c6)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 G24 compound treatment 8.9992 -0.43109 -0.2334 9.3701 -0.44996 -0.2012 -0.3073 -0.9973 3189419 BCB03_000459 OC(=O)CCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC#C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 H01 compound treatment 9.8688 0.43846 0.2374 10.7435 0.92334 0.4129 0.4598 0.9655 3071464 BCB03_000460 O=C1OC[C@H](N(CC#C)C1/C=C/c2ccccc2)c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 H02 compound treatment 9.817 0.38675 0.2094 8.8581 -0.96205 -0.4302 -0.1561 -0.3263 3071064 BCB03_000461 CCCC(=O)N(CCc1c[nH]c2ccccc12)[C@@H]3CC(=C[C@H](Oc4c(I)cc(CO)cc4OC)[C@H]3O)C(=O)NCCO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 H03 mock treatment 10.0417 0.61142 0.331 9.5263 -0.29378 -0.1314 0.1412 0.3964 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 H04 mock treatment 8.5104 -0.91986 -0.498 12.9173 3.0972 1.3849 0.6271 0.4261 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 H05 compound treatment 8.2567 -1.1736 -0.6353 8.4929 -1.3272 -0.5934 -0.8689 -0.9994 3071517 BCB03_000462 CC(=C)C1C(=C)CN([C@H](CO)c2ccccc2)C1=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 H06 compound treatment 9.6194 0.18909 0.1024 10.826 1.0058 0.4497 0.3904 0.8464 2133032 BCB03_000463 COc1cc(CO)cc(I)c1O[C@H]2C=C(C[C@H]([C@@H]2O)N(CC3CCCCC3)C(=O)c4ccc(cc4)C(F)(F)F)C(=O)NCCO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 H07 compound treatment 8.9962 -0.43413 -0.235 8.7058 -1.1143 -0.4983 -0.5185 -0.9412 3187880 BCB03_000464 CC(C)(C)OC(=O)N(CC#C)[C@H](CO)c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 H08 compound treatment 11.0709 1.6406 0.8881 9.5443 -0.27577 -0.1233 0.5408 0.6031 2133035 BCB03_000465 COc1cc(CO)cc(I)c1O[C@H]2C=C(C[C@H]([C@@H]2O)N(CC3CCCCC3)C(=O)c4cc5ccccc5oc4=O)C(=O)NCCO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 H09 compound treatment 12.7922 3.3619 1.82 12.3906 2.5705 1.1494 2.0996 0.9754 3071519 BCB03_000466 CC(=CCN([C@H](CO)c1ccccc1)C(=O)C#Cc2ccccc2)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 H10 compound treatment 9.8359 0.40563 0.2196 9.2691 -0.55099 -0.2464 -0.0189 -0.0574 2133267 BCB03_000467 COc1cc(CO)cc(I)c1O[C@H]2C=C(C[C@H]([C@@H]2O)N(Cc3ccc(F)cc3)C(=O)C4CCCO4)C(=O)NCCO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 H11 compound treatment 10.9746 1.5443 0.836 12.0197 2.1996 0.9835 1.2866 0.9967 3071520 BCB03_000468 OC[C@@H](N(C/C=C/c1ccccc1)CC#C)c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 H12 compound treatment 9.8786 0.4483 0.2427 10.4464 0.62627 0.28 0.3696 0.9975 2133153 BCB03_000469 COc1cc(CO)cc(I)c1O[C@H]2C=C(C[C@H]([C@@H]2O)N(CCN3CCOCC3)C(=O)C4CCOC4)C(=O)NCCO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 H13 compound treatment 9.562 0.13168 0.0713 10.3338 0.51371 0.2297 0.2128 0.8849 3071521 BCB03_000470 CC(C)(C)[Si](C)(C)OC[C@@H](N(C/C=C/c1ccccc1)CC#C)c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 H14 compound treatment 9.315 -0.11532 -0.0624 9.1522 -0.66792 -0.2987 -0.2553 -0.8368 2132929 BCB03_000471 CC/C=C/C(=O)N(C[C@@H]1CCCO1)[C@@H]2CC(=C[C@H](Oc3c(I)cc(CO)cc3OC)[C@H]2O)C(=O)NCCO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 H15 compound treatment 10.2531 0.82283 0.4454 10.7493 0.92918 0.4155 0.6088 0.9994 3071522 BCB03_000472 O=C1OC[C@H](N2CC(=CC21)/C=C/c3ccccc3)c4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 H16 compound treatment 10.6696 1.2393 0.6709 9.3415 -0.4786 -0.214 0.3231 0.4588 2133065 BCB03_000473 COc1cc(CO)cc(I)c1O[C@H]2C=C(C[C@H]([C@@H]2O)N(C3CCCCCC3)C(=O)c4cc5ccccc5oc4=O)C(=O)NCCO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 H17 compound treatment 10.6819 1.2516 0.6776 9.3431 -0.47704 -0.2133 0.3283 0.4621 3071523 BCB03_000474 OCC(/C=C/c1ccccc1)N(CC#C)Cc2ccccc2Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 H18 compound treatment 9.8552 0.42486 0.23 9.2955 -0.5246 -0.2346 -0.0032 -0.0098 2133224 BCB03_000475 CCCCC(=O)N(Cc1ccccc1F)[C@@H]2CC(=C[C@H](Oc3c(I)cc(CO)cc3OC)[C@H]2O)C(=O)NCCO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 H19 mock treatment 8.5063 -0.92404 -0.5002 8.0244 -1.7957 -0.8029 -0.9215 -0.9741 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 H20 mock treatment 10.2101 0.77979 0.4221 10.1859 0.36582 0.1636 0.4142 0.9148 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 H21 compound treatment 11.5542 2.1239 1.1498 11.0645 1.2444 0.5564 1.2065 0.9445 3071524 BCB03_000476 OCC1C=C(CN1Cc2ccccc2Br)/C=C/c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 H22 compound treatment 9.7573 0.327 0.177 9.8674 0.047241 0.0211 0.1401 0.7859 2133510 BCB03_000477 COc1cc(CO)cc(I)c1O[C@H]2C=C(C[C@H]([C@@H]2O)N(CCc3cccc(F)c3)C(=O)CCC4CCCC4)C(=O)NCCO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 H23 compound treatment 9.7687 0.33838 0.1832 11.3955 1.5754 0.7044 0.6276 0.8623 3414064 BCB03_000478 O=S1(=O)N2CCC[C@@H]2[C@@H](Oc3ccccc31)C#C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 H24 compound treatment 8.1739 -1.2564 -0.6802 9.5839 -0.23622 -0.1056 -0.5556 -0.8072 2128988 BCB03_000479 COc1cc(CO)cc(I)c1O[C@H]2C=C(C[C@@H]3O[C@@H]32)C(=O)NCCO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 I01 compound treatment 9.1526 -0.27769 -0.1503 11.2223 1.4022 0.627 0.337 0.5227 3070742 BCB03_000480 COc1c(C)cc(cc1C)c2cc3CO[Si](C(C)C)(C(C)C)c3c(n2)c4ccc(Oc5ccccc5)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 I02 compound treatment 10.6687 1.2384 0.6704 10.5533 0.73322 0.3278 0.7059 0.9459 3189420 BCB03_000481 COc1ccc(cc1)[C@H]2OC[C@@H]3C[C@](Cc4ccccc4)(C(=O)OCC=C)C(=O)N23 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 I03 compound treatment 8.5288 -0.90146 -0.488 10.0282 0.2081 0.093 -0.2793 -0.5622 3070750 BCB03_000482 COc1ccc(cn1)c2cc3CO[Si](C(C)C)(C(C)C)c3c(n2)c4ccc(Oc5ccccc5)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 I04 compound treatment 9.1455 -0.28485 -0.1542 9.692 -0.12813 -0.0573 -0.1496 -0.9091 1035256 BCB03_000483 C#CCNCc1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 I05 mock treatment 11.0174 1.5871 0.8592 10.1157 0.29559 0.1322 0.701 0.8064 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 I06 mock treatment 9.3177 -0.11264 -0.061 9.3065 -0.51361 -0.2297 -0.2055 -0.8649 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 I07 compound treatment 9.564 0.13371 0.0724 9.5788 -0.24129 -0.1079 -0.0251 -0.1932 3188915 BCB03_000484 CC(C)[Si]1(OCc2cc(nc(c21)c3ccc(Oc4ccccc4)cc3)C5CC5)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 I08 compound treatment 9.9303 0.50001 0.2707 8.7766 -1.0435 -0.4666 -0.1385 -0.2568 3071258 BCB03_000485 CC(C)[C@H](N=[N+]=[N-])C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC#C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 I09 compound treatment 9.1745 -0.25585 -0.1385 9.475 -0.34506 -0.1543 -0.207 -0.9985 3070808 BCB03_000486 CC(C)[Si]1(O[C@H](c2cc(nc(c21)c3ccc(Oc4ccccc4)cc3)C5CC5)c6ccccc6)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 I10 compound treatment 9.9989 0.56858 0.3078 9.2875 -0.53259 -0.2381 0.0493 0.1266 3189550 BCB03_000487 COc1cccc(C[C@]2(C[C@@H](CO)NC2=O)C(=O)OCc3ccccc3)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 I11 compound treatment 8.755 -0.67529 -0.3656 9.4886 -0.33152 -0.1482 -0.3633 -0.921 3070078 BCB03_000488 CC[C@@H]1O[Si](C(C)C)(C(C)C)c2c1cc(nc2c3ccc(Oc4ccccc4)cc3)c5cc(C)c(OC)c(C)c5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 I12 compound treatment 9.2606 -0.16974 -0.0919 9.6518 -0.16828 -0.0752 -0.1182 -0.9951 3189551 BCB03_000489 COc1cccc(C[C@@]2(C[C@@H](CO)NC2=O)C(=O)OCc3ccccc3)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 I13 compound treatment 8.3717 -1.0586 -0.5731 8.5803 -1.2398 -0.5544 -0.7972 -0.9999 3070690 BCB03_000490 CCCCCCc1nc(cc2CO[Si](C(C)C)(C(C)C)c21)C(=C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 I14 compound treatment 9.3225 -0.10782 -0.0584 8.9347 -0.8854 -0.3959 -0.3212 -0.8027 3071267 BCB03_000491 CN(C)S(=O)(=O)NCC#C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 I15 compound treatment 10.4022 0.97194 0.5262 15.855 6.0348 2.6984 2.2801 0.8294 3071259 BCB03_000492 CC(C)[Si](O[C@@H](c1cn(Cc2ccccc2)nn1)c3ccccc3)(C#Cc4ccccc4)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 I16 compound treatment 9.1219 -0.30839 -0.1669 10.6379 0.81782 0.3657 0.1405 0.3496 3189556 BCB03_000493 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](CO)NC(=O)N(Cc3ccccc3)Cc4cn(C[C@@H](Cc5ccccc5)NC2=O)nn4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 I17 compound treatment 9.4372 0.0068665 0.0037 15.9607 6.1406 2.7457 1.9441 0.7081 3071266 BCB03_000494 CC(C)[Si](O[C@@H](c1cn(Cc2ccccc2)nn1)c3ccccc3)(C#CCCc4ccccc4)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 I18 compound treatment 10.7058 1.2755 0.6905 9.5825 -0.23758 -0.1062 0.4131 0.5914 3188911 BCB03_000495 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](CO)NC(=O)N[C@H](Cc3ccccc3)Cn4cc(CN(C)C2=O)nn4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 I19 compound treatment 8.8811 -0.54923 -0.2973 10.9446 1.1245 0.5028 0.1453 0.2487 3189415 BCB03_000496 CCCCCCC#C[Si](O[C@@H](C#C)c1ccccc1)(C(C)C)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 I20 compound treatment 9.1122 -0.3181 -0.1722 10.0972 0.27708 0.1239 -0.0342 -0.161 3188912 BCB03_000497 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](CO)NC(=O)N[C@H](C)Cn3cc(CN(C)C2=O)nn3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 I21 mock treatment 10.8208 1.3905 0.7527 9.0957 -0.72443 -0.3239 0.3032 0.37 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 I22 mock treatment 8.6653 -0.76499 -0.4141 9.6327 -0.18742 -0.0838 -0.3521 -0.8333 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 I23 compound treatment 8.0644 -1.3659 -0.7394 11.0295 1.2094 0.5408 -0.1405 -0.1534 3189416 BCB03_000498 CCCCCCC#C[Si](OCC#CC)(C(C)C)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 I24 compound treatment 10.1701 0.73985 0.4005 10.4138 0.59367 0.2655 0.4709 0.98 3188913 BCB03_000499 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](CO)NC(=O)N[C@@H](Cc3ccccc3)Cn4cc(CN(C)C2=O)nn4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 J01 compound treatment 9.5482 0.11795 0.0639 11.204 1.3838 0.6188 0.4827 0.776 3071594 BCB03_000500 O=S1(=O)N2CCC[C@H]2[C@H](Oc3ccccc31)C#C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 J02 compound treatment 10.1798 0.74945 0.4057 10.2373 0.41716 0.1865 0.4188 0.9378 3187871 BCB03_000501 OCCNC(=O)C1=C[C@H](Oc2ccccc2I)[C@@H](O)[C@@H](C1)N(Cc3ccco3)C(=O)Cc4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 J03 compound treatment 9.8066 0.37635 0.2037 10.5113 0.69121 0.3091 0.3626 0.9796 3071530 BCB03_000502 CCOC(=O)[C@H]1C[C@H]2O[C@]32C[C@H]1C(=O)N4CCCC4[C@@H]3O[Si](C)(C)C(C)(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 J04 compound treatment 8.5596 -0.87067 -0.4713 10.2423 0.42221 0.1888 -0.1998 -0.3935 2129008 BCB03_000503 OCCNC(=O)C1=C[C@H](Oc2ccccc2I)[C@@H](O)[C@@H](C1)NCc3ccc(F)cc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 J05 mock treatment 9.558 0.12774 0.0692 7.7888 -2.0313 -0.9083 -0.5934 -0.6514 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 J06 mock treatment 9.5123 0.082052 0.0444 9.9208 0.10068 0.045 0.0632 1.0 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 J07 compound treatment 10.0559 0.62558 0.3387 9.783 -0.037129 -0.0166 0.2277 0.6716 3071528 BCB03_000504 CCOC(=O)[C@H]1CC=C2CC1C(=O)N3CCC[C@@H]3[C@@H]2O[Si](C)(C)C(C)(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 J08 compound treatment 9.1342 -0.29614 -0.1603 11.1141 1.294 0.5786 0.2958 0.4926 3187877 BCB03_000505 CC(C)C[C@@H]1NC(=O)[C@@]2(C3[C@H](Cc4ccccc4)NC2=O)C(/C=C/CC\C=C\CNC(=O)[C@@H](C)NC1=O)[C@@H]5O[C@]5(C)[C@H]3C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 J09 compound treatment 8.7867 -0.64355 -0.3484 10.3917 0.57157 0.2556 -0.0656 -0.1519 3071529 BCB03_000506 CCOC(=O)[C@@H]1CC2O[C@@]32C[C@@H]1C(=O)N4CCC[C@@H]4[C@H]3O[Si](C)(C)C(C)(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 J10 compound treatment 12.6818 3.2515 1.7602 11.2194 1.3993 0.6257 1.6871 0.9031 3188005 BCB03_000507 CC(C)C[C@@H]1NC(=O)C(NC(=O)[C@@]2(C3[C@H](Cc4ccccc4)NC2=O)C(/C=C/CC\C=C\CNC1=O)[C@@H]5O[C@]5(C)[C@H]3C)[C@@H](C)OCc6ccccc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 J11 compound treatment 9.3125 -0.1178 -0.0638 8.3163 -1.5038 -0.6724 -0.5206 -0.7707 3071527 BCB03_000508 CCOC(=O)[C@@H]1CC=C2CC1C(=O)N3CCC[C@@H]3[C@H]2O[Si](C)(C)C(C)(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 J12 compound treatment 9.9 0.46968 0.2543 9.8312 0.011073 0.005 0.1833 0.7207 3188007 BCB03_000509 CC(C)C[C@@H]1NC(=O)[C@@H](NC(=O)[C@@]2(C3[C@H](Cc4ccccc4)NC2=O)C(/C=C/CC\C=C\CNC1=O)[C@@H]5O[C@]5(C)[C@H]3C)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 J13 compound treatment 9.8141 0.38384 0.2078 8.9549 -0.86522 -0.3869 -0.1266 -0.2883 3071654 BCB03_000510 [O-][N+](=O)c1ccccc1S(=O)(=O)N2CCC[C@@H]2[C@H]3OCC=C3C(=C)C=C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 J14 compound treatment 11.4759 2.0456 1.1074 10.8009 0.98075 0.4385 1.0931 0.9178 3188008 BCB03_000511 C[C@H]1C2[C@H](Cc3ccccc3)NC(=O)[C@@]24C(/C=C/CC\C=C\CNC(=O)[C@@H]5CCCN5C(=O)[C@H](Cc6ccccc6)NC4=O)[C@@H]7O[C@@]71C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 J15 compound treatment 10.045 0.61474 0.3328 11.5381 1.7179 0.7682 0.7785 0.9299 3071597 BCB03_000512 Cc1ccc(cc1)S(=O)(=O)NC/C=C\C(=C)[C@H](O)[C@H]2CCCN2S(=O)(=O)c3ccccc3[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 J16 compound treatment 9.8307 0.40036 0.2167 10.5288 0.70872 0.3169 0.3773 0.9828 3188142 BCB03_000513 C[C@@H](OCc1ccccc1)C2NC(=O)[C@@]3(C4[C@H](Cc5ccccc5)NC3=O)C(/C=C/C\C=C/CNC(=O)[C@@H](C)NC2=O)[C@@H]6O[C@]6(C)[C@H]4C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 J17 compound treatment 9.1797 -0.25058 -0.1357 10.2556 0.43549 0.1947 0.0418 0.176 3071598 BCB03_000514 Cc1ccc(cc1)S(=O)(=O)NC/C=C/C(=C)[C@H](O)[C@H]2CCCN2S(=O)(=O)c3ccccc3[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 J18 compound treatment 11.1581 1.7278 0.9354 9.8806 0.060503 0.0271 0.6805 0.7273 3188271 BCB03_000515 CC(C)C[C@H]1NC(=O)CNC(=O)[C@@]2(C3[C@H](Cc4ccccc4)NC2=O)C(/C=C/C\C=C/CNC1=O)[C@@H]5O[C@]5(C)[C@H]3C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 J19 compound treatment 12.8917 3.4614 1.8738 12.5866 2.7665 1.237 2.1997 0.9797 3188138 BCB03_000516 Cc1ccc(cc1)S(=O)(=O)N(CCC=C)CC#C[C@H]2Oc3ccccc3S(=O)(=O)N4CCC[C@@H]24 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 J20 compound treatment 10.3832 0.95294 0.5159 11.8064 1.9863 0.8881 0.9928 0.9666 3188272 BCB03_000517 CC(C)C[C@H]1NC(=O)C(NC(=O)[C@@]2(C3[C@H](Cc4ccccc4)NC2=O)C(/C=C/C\C=C/CNC1=O)[C@@H]5O[C@]5(C)[C@H]3C)[C@@H](C)OCc6ccccc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 J21 mock treatment 9.1896 -0.24071 -0.1303 10.2011 0.38102 0.1704 0.0283 0.1321 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 J22 mock treatment 9.895 0.46467 0.2516 10.9619 1.1418 0.5105 0.5389 0.9468 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 J23 compound treatment 10.3163 0.886 0.4796 9.085 -0.73513 -0.3287 0.1067 0.1836 3071656 BCB03_000518 CN1C(=C)C2CC3C4C(C5CO[C@H]([C@H]6CCCN6S(=O)(=O)c7ccccc7[N+](=O)[O-])C5=C3CC2C1=O)C(=O)N(C)C4=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 J24 compound treatment 9.7555 0.32524 0.1761 10.0176 0.19751 0.0883 0.1869 0.9491 3188275 BCB03_000519 CC(C)C[C@H]1NC(=O)[C@H](C)NC(=O)[C@@]2(C3[C@H](Cc4ccccc4)NC2=O)C(/C=C/C\C=C/CNC1=O)[C@@H]5O[C@]5(C)[C@H]3C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 K01 compound treatment 17.7561 8.3258 4.5072 29.2533 19.433 8.6893 9.3313 0.9533 3071254 BCB03_000520 CC(C)[Si](O[C@@H](C#C)c1ccccc1)(C#Cc2ccccc2)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 K02 compound treatment 9.4243 -0.006031 -0.0033 10.2677 0.44764 0.2002 0.1392 0.6955 3220747 BCB03_000521 COC(=O)c1c(CC[C@@H](CO)NC(=O)N2CCCC2)oc(C(=O)Cc3ccccc3)c1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 K03 compound treatment 9.2703 -0.15996 -0.0866 10.431 0.61092 0.2732 0.1319 0.4604 3189418 BCB03_000522 CC#CCO[Si](C#Cc1ccccc1)(C(C)C)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 K04 compound treatment 12.1244 2.6941 1.4585 10.8292 1.0091 0.4512 1.3503 0.8845 3220749 BCB03_000523 COC(=O)c1c(CC[C@@H](CO)NC(=O)NCC(C)C)oc(C(=O)Cc2ccccc2)c1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 K05 compound treatment 9.6808 0.25048 0.1356 8.8416 -0.97846 -0.4375 -0.2135 -0.4661 3071256 BCB03_000524 CC(C)[Si](O[C@@H](C#C)c1ccccc1)(C#Cc2ccc(Oc3ccccc3)cc2)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 K06 compound treatment 8.7776 -0.65273 -0.3534 8.8525 -0.96758 -0.4326 -0.5558 -0.995 3220751 BCB03_000525 COC(=O)c1c(CC[C@@H](CO)NC(=O)Nc2ccc(OC)cc2)oc(C(=O)Cc3ccccc3)c1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 K07 mock treatment 8.3392 -1.0911 -0.5907 8.3771 -1.443 -0.6452 -0.8739 -0.999 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 K08 mock treatment 8.6928 -0.73754 -0.3993 9.743 -0.077084 -0.0345 -0.3067 -0.7653 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 K09 compound treatment 7.5934 -1.8369 -0.9944 9.7778 -0.042322 -0.0189 -0.7165 -0.7204 3071257 BCB03_000526 CC[C@@H](O[Si](C#Cc1ccc(Oc2ccccc2)cc1)(C(C)C)C(C)C)C#C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 K10 compound treatment 10.1317 0.70142 0.3797 9.2718 -0.54833 -0.2452 0.0951 0.2105 3220772 BCB03_000527 COC(=O)c1c(CC[C@@H](CO)NC(=O)NCCc2c[nH]c3ccccc23)oc(C(=O)Cc4ccccc4)c1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 K11 compound treatment 8.4436 -0.98666 -0.5341 9.3577 -0.46238 -0.2067 -0.5239 -0.9147 3189421 BCB03_000528 CC(C)[Si](Oc1ccccc1Br)(C#CCCCC#N)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 K12 compound treatment 10.3065 0.87615 0.4743 9.2284 -0.59176 -0.2646 0.1483 0.273 3220775 BCB03_000529 COC(=O)c1c(CC[C@@H](CO)NC(=O)Nc2nc[nH]n2)oc(C(=O)Cc3ccccc3)c1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 K13 compound treatment 11.0991 1.6688 0.9034 11.0315 1.2114 0.5416 1.0218 0.9701 3189422 BCB03_000530 CC[C@@H](O[Si](C#CCCCC#N)(C(C)C)C(C)C)C#C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 K14 compound treatment 9.2723 -0.15803 -0.0856 9.0269 -0.7932 -0.3547 -0.3113 -0.8532 3220649 BCB03_000531 COC(=O)c1c(CC[C@@H](CO)NC(=O)N[C@@H](Cc2ccccc2)Cn3cc(nn3)C4(O)CCCCC4)oc(C(=O)C)c1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 K15 mock treatment 16.6965 7.2662 3.9336 9.2028 -0.61732 -0.276 2.5863 0.6559 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 K16 mock treatment 8.7566 -0.67371 -0.3647 9.4732 -0.3469 -0.1551 -0.3676 -0.9274 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 K17 compound treatment 7.7798 -1.6505 -0.8935 9.1624 -0.65774 -0.2941 -0.8398 -0.8927 3189552 BCB03_000532 CC(C)[Si](O[C@@H](c1cn(Cc2ccccc2)nn1)c3ccccc3)(C#C[Si](C(C)C)(C(C)C)C(C)C)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 K18 compound treatment 9.3744 -0.055881 -0.0303 9.2048 -0.61528 -0.2751 -0.2159 -0.7802 3220651 BCB03_000533 COC(=O)c1c(CC[C@@H](CO)NC(=O)N[C@@H](Cc2ccccc2)Cn3cc(nn3)c4cncn4C)oc(C(=O)C)c1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 K19 compound treatment 8.8861 -0.54418 -0.2946 9.498 -0.32211 -0.144 -0.3102 -0.9458 3189553 BCB03_000534 CC[C@@H](O[Si](C#C[Si](C(C)C)(C(C)C)C(C)C)(C(C)C)C(C)C)c1cn(nn1)[C@H](CO)Cc2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 K20 compound treatment 9.2796 -0.1507 -0.0816 9.0631 -0.75703 -0.3385 -0.297 -0.8531 3220653 BCB03_000535 CCCCc1cn(C[C@H](Cc2ccccc2)NC(=O)N[C@H](CO)CCc3oc(C(=O)C)c(C(=O)OC)c3C(=O)OC)nn1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 K21 compound treatment 9.1352 -0.29507 -0.1597 8.7317 -1.0884 -0.4867 -0.4571 -0.8924 3189554 BCB03_000536 CC[C@@H](O[Si](C#C[Si](C(C)C)(C(C)C)C(C)C)(C(C)C)C(C)C)c1cn(Cc2cccc(Cl)c2)nn1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 K22 compound treatment 8.8494 -0.58089 -0.3145 10.4276 0.60744 0.2716 -0.0303 -0.0729 3220655 BCB03_000537 CCOC(=O)c1cn(C[C@H](Cc2ccccc2)NC(=O)N[C@H](CO)CCc3oc(C(=O)C)c(C(=O)OC)c3C(=O)OC)nn1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 K23 mock treatment 9.4485 0.018224 0.0099 10.111 0.29091 0.1301 0.099 0.7586 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 K24 mock treatment 8.7223 -0.70802 -0.3833 10.9833 1.1632 0.5201 0.0967 0.1497 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 L01 compound treatment 10.5741 1.1438 0.6192 10.1889 0.3688 0.1649 0.5545 0.8653 3071655 BCB03_000538 CN1C(=O)C2CC=C(CC2C1=O)C3=CCO[C@@H]3[C@H]4CCCN4S(=O)(=O)c5ccccc5[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 L02 compound treatment 11.6868 2.2565 1.2215 15.7111 5.891 2.6341 2.7263 0.939 3188392 BCB03_000539 C[C@H]1C2[C@H](Cc3ccccc3)NC(=O)[C@@]24C(/C=C/C\C=C/CNC(=O)[C@@H]5CCCN5C(=O)CNC4=O)[C@@H]6O[C@@]61C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 L03 compound treatment 11.4914 2.0611 1.1158 9.448 -0.37213 -0.1664 0.6713 0.5951 3188141 BCB03_000540 C=CC(=C)[C@H]1Oc2ccccc2S(=O)(=O)N3CCC[C@@H]13 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 L04 compound treatment 10.0545 0.6242 0.3379 9.2143 -0.60579 -0.2709 0.0474 0.1095 3188274 BCB03_000541 CC1=C2[C@@H](CCc3ccccc3)OB(O)C[C@@H]2[C@H]4[C@@H](C1)C(=O)N(Cc5ccccc5)C4=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 L05 compound treatment 8.5545 -0.87577 -0.4741 10.4082 0.58806 0.2629 -0.1493 -0.2754 3071592 BCB03_000542 CN1C(=O)C2CC=C(CC2C1=O)[C@H]3Oc4ccccc4S(=O)(=O)N5CCC[C@@H]35 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 L06 compound treatment 9.1153 -0.31502 -0.1705 9.641 -0.17907 -0.0801 -0.1772 -0.9406 3070931 BCB03_000543 CCCC[C@H]1OB(O)C[C@@H]2[C@H]3[C@@H](CC(=C12)C)C(=O)N(C)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 L07 mock treatment 8.6618 -0.76854 -0.4161 8.274 -1.5461 -0.6913 -0.783 -0.9705 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 L08 mock treatment 8.6412 -0.78905 -0.4272 8.7164 -1.1037 -0.4935 -0.651 -0.9974 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 L09 compound treatment 8.7095 -0.72076 -0.3902 9.6927 -0.12739 -0.057 -0.3162 -0.8018 3071592 BCB03_000544 CN1C(=O)C2CC=C(CC2C1=O)[C@H]3Oc4ccccc4S(=O)(=O)N5CCC[C@@H]35 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 L10 compound treatment 9.5515 0.12119 0.0656 9.4378 -0.38234 -0.171 -0.0745 -0.4068 3070933 BCB03_000545 CCCC[C@H]1OB(O)C[C@@H]2[C@H]3[C@@H](CC(=C12)COC)C(=O)N(C)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 L11 compound treatment 9.1026 -0.32775 -0.1774 9.5605 -0.25959 -0.1161 -0.2075 -0.9788 3071581 BCB03_000546 O=C1C2CC=C(CC2C(=O)c3ccccc13)[C@H]4Oc5ccccc5S(=O)(=O)N6CCC[C@@H]46 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 L12 compound treatment 9.1959 -0.23435 -0.1269 9.5227 -0.29739 -0.133 -0.1837 -0.9997 3188523 BCB03_000547 CCCC[C@H]1OB(O)C[C@@H]2[C@H]3[C@@H](CC(=C12)COc4ccccc4)C(=O)N(C)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 L13 compound treatment 9.1389 -0.29143 -0.1578 10.3319 0.51183 0.2289 0.0503 0.1808 3071582 BCB03_000548 O=C1c2ccccc2C(=O)c3cc(ccc13)[C@H]4Oc5ccccc5S(=O)(=O)N6CCC[C@@H]46 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 L14 compound treatment 9.5009 0.070564 0.0382 9.6279 -0.19223 -0.086 -0.0338 -0.359 3188524 BCB03_000549 CC1=C2[C@@H](CCc3ccccc3)OB(O)C[C@@H]2n4n(C1)c(=O)n(c5ccccc5)c4=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 L15 mock treatment 8.5758 -0.85452 -0.4626 8.2232 -1.5969 -0.714 -0.832 -0.9779 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 L16 mock treatment 8.8349 -0.59537 -0.3223 9.334 -0.4861 -0.2174 -0.3816 -0.9816 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 L17 compound treatment 9.5452 0.11492 0.0622 9.6558 -0.16431 -0.0735 -0.008 -0.0827 3071529 BCB03_000550 CCOC(=O)[C@@H]1CC2O[C@@]32C[C@@H]1C(=O)N4CCC[C@@H]4[C@H]3O[Si](C)(C)C(C)(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 L18 compound treatment 8.9005 -0.52982 -0.2868 7.8777 -1.9424 -0.8685 -0.817 -0.8932 3188525 BCB03_000551 COCC1=C2[C@@H](CCc3ccccc3)OB(O)C[C@@H]2n4n(C1)c(=O)n(c5ccccc5)c4=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 L19 compound treatment 9.031 -0.39933 -0.2162 12.2202 2.4001 1.0732 0.606 0.5535 3071527 BCB03_000552 CCOC(=O)[C@@H]1CC=C2CC1C(=O)N3CCC[C@@H]3[C@H]2O[Si](C)(C)C(C)(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 L20 compound treatment 17.9436 8.5133 4.6088 8.1833 -1.6368 -0.7319 2.7414 0.5875 3188526 BCB03_000553 OB1C[C@H]2C(=C(COc3ccccc3)Cn4n2c(=O)n(c5ccccc5)c4=O)[C@@H](CCc6ccccc6)O1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 L21 compound treatment 9.0335 -0.39678 -0.2148 11.5695 1.7494 0.7822 0.4012 0.4946 3071531 BCB03_000554 CCOC(=O)[C@@H]1[C@@H]2CN(CCC2=C[C@@H]3[C@@H](O[Si](C(C)C)(C(C)C)C(C)C)[C@@H]4CCCN4C(=O)[C@@H]13)S(=O)(=O)c5ccc(C)cc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 L22 compound treatment 8.2856 -1.1447 -0.6197 9.1173 -0.70283 -0.3143 -0.6604 -0.9505 3188538 BCB03_000555 CCCC[C@H]1OB(O)C[C@H]2C1=C(C)Cn3n2c(=O)n(c4ccccc4)c3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 L23 mock treatment 11.2596 1.8293 0.9903 10.2907 0.47056 0.2104 0.849 0.8386 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 L24 mock treatment 8.8892 -0.54111 -0.2929 10.4053 0.58516 0.2616 -0.0221 -0.0563 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 M01 compound treatment 9.2001 -0.23023 -0.1246 9.7086 -0.11148 -0.0498 -0.1234 -0.9191 3071269 BCB03_000556 CC[C@@H](O[Si](C#C[Si](C(C)C)(C(C)C)C(C)C)(C(C)C)C(C)C)c1cn(nn1)[C@H](C)c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 M02 compound treatment 9.6554 0.22513 0.1219 9.6155 -0.20462 -0.0915 0.0215 0.141 3220657 BCB03_000557 COC(=O)c1c(CC[C@@H](CO)NC(=O)N[C@@H](C)Cn2cc(nn2)c3ccccn3)oc(C(=O)C)c1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 M03 compound treatment 8.4336 -0.99675 -0.5396 11.1653 1.3452 0.6015 0.0438 0.0542 3189557 BCB03_000558 CCCC#C[Si](O[C@H](CC)c1cn(Cc2ccccc2)nn1)(C(C)C)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 M04 compound treatment 9.4387 0.0084265 0.0046 8.8329 -0.98722 -0.4414 -0.3089 -0.6998 3220659 BCB03_000559 COC(=O)c1c(CC[C@@H](CO)NC(=O)N[C@@H](C)Cn2cc(nn2)C3(O)CCCCC3)oc(C(=O)C)c1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 M05 compound treatment 8.5502 -0.88012 -0.4765 9.6826 -0.13753 -0.0615 -0.3804 -0.7918 3071329 BCB03_000560 CCCC#C[Si](O[C@H](CC)c1cn(nn1)[C@H](CO)Cc2ccccc2)(C(C)C)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 M06 compound treatment 9.4714 0.041062 0.0222 10.0756 0.25546 0.1142 0.0965 0.8292 3220661 BCB03_000561 COC(=O)c1c(CC[C@@H](CO)NC(=O)N[C@@H](C)Cn2cc(nn2)C3(O)CCCC3)oc(C(=O)C)c1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 M07 compound treatment 9.9584 0.52814 0.2859 9.8539 0.033783 0.0151 0.2129 0.7434 3071331 BCB03_000562 CCCC#C[Si](O[C@H](CC)c1cn(nn1)[C@H](C)c2ccccc2)(C(C)C)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 M08 compound treatment 8.7283 -0.70196 -0.38 10.9279 1.1078 0.4953 0.0815 0.1306 3220665 BCB03_000563 COC(=O)c1c(CC[C@@H](CO)NC(=O)N[C@H](Cn2cc(Cc3ccccc3)nn2)C(C)C)oc(C(=O)C)c1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 M09 mock treatment 9.5563 0.12595 0.0682 10.042 0.22193 0.0992 0.1184 0.9832 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 M10 mock treatment 8.1991 -1.2312 -0.6665 10.1397 0.31963 0.1429 -0.3703 -0.5431 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 M11 compound treatment 8.1962 -1.2341 -0.6681 9.7892 -0.030924 -0.0138 -0.4822 -0.7216 3071332 BCB03_000564 CCCCCCC#C[Si](O[C@@H](c1cn(Cc2ccccc2)nn1)c3ccccc3)(C(C)C)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 M12 compound treatment 9.4287 -0.001561 -8.0E-4 10.0492 0.22909 0.1024 0.0718 0.7012 3220667 BCB03_000565 COC(=O)c1c(CC[C@@H](CO)NC(=O)N[C@H](Cn2cc(nn2)C3(O)CCCCC3)C(C)C)oc(C(=O)C)c1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 M13 mock treatment 8.4668 -0.96352 -0.5216 8.3794 -1.4407 -0.6442 -0.8243 -0.9945 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 M14 mock treatment 8.7452 -0.68514 -0.3709 8.8915 -0.92859 -0.4152 -0.5559 -0.9984 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 M15 compound treatment 9.7804 0.35009 0.1895 10.658 0.83793 0.3747 0.3989 0.9501 3189692 BCB03_000566 CCCCCCC#C[Si](O[C@@H](c1cn(nn1)[C@H](CO)Cc2ccccc2)c3ccccc3)(C(C)C)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 M16 compound treatment 9.3749 -0.055396 -0.03 9.1753 -0.64483 -0.2883 -0.2251 -0.7765 3220669 BCB03_000567 COC(=O)c1c(CC[C@@H](CO)NC(=O)N[C@H](Cn2cc(nn2)c3cncn3C)C(C)C)oc(C(=O)C)c1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 M17 compound treatment 9.8738 0.44354 0.2401 10.6868 0.86668 0.3875 0.4438 0.9735 3189693 BCB03_000568 CCCCCCC#C[Si](O[C@@H](c1cn(Cc2cccc(Cl)c2)nn1)c3ccccc3)(C(C)C)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 M18 compound treatment 11.204 1.7737 0.9602 9.0469 -0.77321 -0.3457 0.4345 0.4258 3414054 BCB03_000569 COC(=O)c1c(CC[C@@H](CO)NC(=O)N2CCC[C@H]2Cn3cc(nn3)c4ccccn4)oc(C(=O)C)c1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 M19 compound treatment 9.678 0.24765 0.1341 12.2512 2.4311 1.087 0.8634 0.7883 3189694 BCB03_000570 CCCCCCC#C[Si](O[C@@H](c1cn(nn1)[C@H](C)c2ccccc2)c3ccccc3)(C(C)C)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 M20 compound treatment 9.0717 -0.35865 -0.1942 8.3616 -1.4585 -0.6522 -0.5984 -0.8795 3414055 BCB03_000571 COC(=O)c1c(CC[C@@H](CO)NC(=O)N2CCC[C@H]2Cn3cc(Cc4ccccc4)nn3)oc(C(=O)C)c1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 M21 compound treatment 9.0447 -0.38558 -0.2087 64.9202 55.1 24.6372 17.2735 0.7011 3071395 BCB03_000572 CC(C)[Si](O[C@@H](c1cn(Cc2ccccc2)nn1)c3ccccc3)(C#CCCCC#N)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 M22 compound treatment 12.1722 2.7419 1.4843 9.3411 -0.47899 -0.2142 0.8981 0.5989 3414056 BCB03_000573 COC(=O)c1c(CC[C@@H](CO)NC(=O)N2CCC[C@H]2Cn3cc(nn3)C4(O)CCCCC4)oc(C(=O)C)c1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 M23 compound treatment 9.2226 -0.20767 -0.1124 9.0523 -0.76783 -0.3433 -0.3223 -0.892 3189697 BCB03_000574 CC(C)[Si](O[C@@H](c1cn(nn1)[C@H](CO)Cc2ccccc2)c3ccccc3)(C#CCCCC#N)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 M24 compound treatment 10.2251 0.79481 0.4303 10.0128 0.19271 0.0862 0.3652 0.8322 3414057 BCB03_000575 CCCCc1cn(C[C@@H]2CCCN2C(=O)N[C@H](CO)CCc3oc(C(=O)C)c(C(=O)OC)c3C(=O)OC)nn1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 N01 compound treatment 10.3524 0.92208 0.4992 8.5913 -1.2288 -0.5495 -0.0356 -0.0479 3071585 BCB03_000576 OCCOCCO[C@H]1C[C@H]2C(=C[C@@H]1C(=O)[C@@]32CO3)Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 N02 compound treatment 10.0279 0.59757 0.3235 10.478 0.65787 0.2942 0.4367 0.9989 3215882 BCB03_000577 CCCC[C@H]1OB(O)C[C@H]2C1=C(COC)Cn3n2c(=O)n(c4ccccc4)c3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 N03 compound treatment 11.3748 1.9445 1.0526 9.01 -0.81007 -0.3622 0.4882 0.4386 3188130 BCB03_000578 OCCCCCCO[C@H]1C[C@H]2C(=C[C@@H]1C(=O)[C@@]32CO3)Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 N04 compound treatment 10.1161 0.68576 0.3712 9.2966 -0.5235 -0.2341 0.097 0.221 3215880 BCB03_000579 CCCC[C@H]1OB(O)C[C@H]2C1=C(COc3ccccc3)Cn4n2c(=O)n(c5ccccc5)c4=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 N05 compound treatment 11.5789 2.1486 1.1632 8.5006 -1.3195 -0.59 0.4053 0.3108 3071587 BCB03_000580 OCCCCO[C@H]1C[C@H]2C(=C[C@@H]1C(=O)[C@@]32CO3)Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 N06 compound treatment 9.1081 -0.32222 -0.1744 8.4964 -1.3237 -0.5919 -0.5419 -0.8782 3188542 BCB03_000581 CC1=C2[C@@H](CCc3ccccc3)OB(O)C[C@@H]2[C@H]4[C@@H](C1)C(=O)C=CC4=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 N07 compound treatment 11.7858 2.3555 1.2751 8.5932 -1.2269 -0.5486 0.5137 0.3701 3071588 BCB03_000582 BrC1=C[C@H]2[C@H](C[C@@H]1[C@@]3(CO3)C2=O)c4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 N08 compound treatment 8.7075 -0.72284 -0.3913 9.9925 0.17234 0.0771 -0.2222 -0.5572 3071661 BCB03_000583 COCC1=C2[C@@H](CCc3ccccc3)OB(O)C[C@@H]2[C@H]4[C@@H](C1)C(=O)N(Cc5ccccc5)C4=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 N09 mock treatment 9.0686 -0.36168 -0.1958 9.647 -0.17309 -0.0774 -0.1932 -0.9175 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 N10 mock treatment 10.3196 0.88935 0.4815 10.5958 0.77566 0.3468 0.5857 0.987 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 N11 compound treatment 10.1526 0.72228 0.391 9.2071 -0.61306 -0.2741 0.0827 0.1731 3071589 BCB03_000584 Cc1cccc(c1)[C@H]2C[C@H]3C(=C[C@@H]2C(=O)[C@@]43CO4)Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 N12 compound treatment 9.757 0.32672 0.1769 10.9232 1.1031 0.4932 0.4738 0.9043 3188543 BCB03_000585 COCC1=C2[C@@H](CCc3ccccc3)OB(O)C[C@@H]2[C@H]4[C@@H](C1)C(=O)C=CC4=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 N13 mock treatment 10.277 0.84668 0.4584 9.6428 -0.17735 -0.0793 0.268 0.5762 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 N14 mock treatment 9.1821 -0.24818 -0.1344 9.9805 0.16044 0.0717 -0.0443 -0.2907 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 N15 compound treatment 9.8607 0.43045 0.233 10.8321 1.012 0.4525 0.4848 0.9524 3071590 BCB03_000586 COc1ccc(cc1)[C@H]2C[C@H]3C(=C[C@@H]2C(=O)[C@@]43CO4)Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 N16 compound treatment 9.8676 0.43733 0.2368 9.5045 -0.3156 -0.1411 0.0676 0.2454 3070948 BCB03_000587 OB1C[C@@H]2[C@H]3[C@@H](CC(=C2[C@@H](CCc4ccccc4)O1)COc5ccccc5)C(=O)C=CC3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 N17 compound treatment 10.5118 1.0815 0.5855 9.2629 -0.55722 -0.2492 0.2378 0.3738 3071591 BCB03_000588 CO[C@@]1(C=C(Br)[C@@H]2C[C@@H]1c3ccccc3)C(=O)[C@@]42CO4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 N18 compound treatment 11.0643 1.634 0.8846 9.3015 -0.51858 -0.2319 0.4615 0.5047 3070949 BCB03_000589 CCCC[C@H]1OB(O)C[C@@H]2[C@H]3[C@@H](CC(=C12)C)C(=O)C=CC3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 N19 compound treatment 11.4391 2.0088 1.0875 11.3663 1.5461 0.6913 1.2578 0.9761 3188261 BCB03_000590 CO[C@@]1(C=C(Br)[C@@H]2C[C@@H]1c3cccc(C)c3)C(=O)[C@@]42CO4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 N20 compound treatment 9.1059 -0.3244 -0.1756 9.9682 0.14813 0.0662 -0.0773 -0.4121 3070950 BCB03_000591 CCCC[C@H]1OB(O)C[C@@H]2[C@H]3[C@@H](CC(=C12)COC)C(=O)C=CC3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 N21 compound treatment 9.6767 0.24641 0.1334 10.9292 1.1091 0.4959 0.445 0.8665 3071600 BCB03_000592 COc1ccc(cc1)[C@H]2C[C@H]3C(=C[C@]2(OC)C(=O)[C@@]43CO4)Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 N22 compound treatment 13.1134 3.6831 1.9939 9.3334 -0.4867 -0.2176 1.256 0.6262 3070951 BCB03_000593 CCCC[C@H]1OB(O)C[C@@H]2[C@H]3[C@@H](CC(=C12)COc4ccccc4)C(=O)C=CC3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 N23 compound treatment 8.811 -0.61931 -0.3353 10.1048 0.2847 0.1273 -0.1471 -0.4101 3071601 BCB03_000594 OCCOCCO[C@H]1C[C@H]2C(=C[C@@H]1C(=O)[C@@]32CO3)I 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 N24 compound treatment 9.6534 0.22309 0.1208 9.9454 0.12532 0.056 0.125 0.939 3071664 BCB03_000595 OB1C[C@@H]2[C@H]3[C@@H](CC(=C2[C@@H](CCc4ccccc4)O1)COc5ccccc5)C(=O)N(Cc6ccccc6)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 O01 compound treatment 10.738 1.3077 0.7079 10.143 0.32285 0.1444 0.6027 0.8341 3187592 BCB03_000596 CC(C)[Si](O[C@@H](c1cn(Cc2cccc(Cl)c2)nn1)c3ccccc3)(C#CCCCC#N)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 O02 compound treatment 8.9148 -0.51551 -0.2791 10.7508 0.93073 0.4162 0.0969 0.1935 3220705 BCB03_000597 CCc1oc(CC[C@@H](CO)NC(=O)NCCn2cc(nn2)C3(O)CCCCC3)c(C(=O)OC)c1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 O03 compound treatment 8.5561 -0.87416 -0.4732 9.1282 -0.69195 -0.3094 -0.5534 -0.9788 3071397 BCB03_000598 CC(C)[Si](O[C@@H](c1cn(nn1)[C@H](C)c2ccccc2)c3ccccc3)(C#CCCCC#N)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 O04 compound treatment 10.2225 0.79219 0.4289 10.6355 0.81543 0.3646 0.5611 0.9967 3220708 BCB03_000599 COC(=O)c1c(CC[C@@H](CO)NC(=O)NCCn2cc(nn2)C3(O)CCCC3)oc(C(=O)C)c1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 O05 compound treatment 10.458 1.0277 0.5564 10.479 0.65892 0.2946 0.6017 0.9558 3071398 BCB03_000600 CC(C)[Si](O[C@H](C)c1cn(Cc2ccccc2)nn1)(C#C[Si](C(C)C)(C(C)C)C(C)C)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 O06 compound treatment 9.5352 0.10494 0.0568 9.7341 -0.086027 -0.0385 0.013 0.1891 3220711 BCB03_000601 COC(=O)c1c(CC[C@@H](CO)NC(=O)N[C@H](Cc2ccccc2)Cn3cc(nn3)c4ccccn4)oc(C(=O)C)c1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 O07 compound treatment 9.9613 0.53098 0.2875 8.5759 -1.2442 -0.5563 -0.1901 -0.3036 3071399 BCB03_000602 CC(C)[Si](O[C@H](C)c1cn(nn1)[C@H](CO)Cc2ccccc2)(C#C[Si](C(C)C)(C(C)C)C(C)C)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 O08 compound treatment 8.2584 -1.1719 -0.6344 12.5889 2.7688 1.238 0.4268 0.3068 3220713 BCB03_000603 COC(=O)c1c(CC[C@@H](CO)NC(=O)N[C@H](Cc2ccccc2)Cn3cc(nn3)c4ccccc4N)oc(C(=O)C)c1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 O09 compound treatment 9.6097 0.1794 0.0971 9.5987 -0.2214 -0.099 -0.0013 -0.0096 3187596 BCB03_000604 CC(C)[Si](O[C@H](C)c1cn(Cc2cccc(Cl)c2)nn1)(C#C[Si](C(C)C)(C(C)C)C(C)C)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 O10 compound treatment 9.6077 0.17741 0.096 12.0753 2.2552 1.0084 0.7809 0.771 3220715 BCB03_000605 COC(=O)c1cn(C[C@@H](Cc2ccccc2)NC(=O)N[C@H](CO)CCc3oc(C(=O)C)c(C(=O)OC)c3C(=O)OC)nn1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 O11 mock treatment 9.5553 0.12505 0.0677 10.5224 0.70233 0.314 0.2699 0.8402 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 O12 mock treatment 9.9253 0.49496 0.268 9.5896 -0.23054 -0.1031 0.1166 0.4061 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 O13 compound treatment 9.0792 -0.35112 -0.1901 8.8799 -0.94019 -0.4204 -0.4317 -0.9356 3071400 BCB03_000606 CC(C)[Si](O[C@H](C)c1cn(nn1)[C@H](C)c2ccccc2)(C#C[Si](C(C)C)(C(C)C)C(C)C)C(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 O14 compound treatment 9.9245 0.49416 0.2675 10.0528 0.23274 0.1041 0.2627 0.9154 3220717 BCB03_000607 COC(=O)c1c(CC[C@@H](CO)NC(=O)N[C@@H](Cc2ccccc2)Cn3cc(nn3)c4ccccc4)oc(C(=O)N5CCOCC5)c1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 O15 compound treatment 9.5959 0.1656 0.0896 7.6563 -2.1638 -0.9675 -0.6207 -0.6389 3070694 BCB03_000608 COc1ccc(cn1)c2cc3CO[Si](C(C)C)(C(C)C)c3c(Cc4ccccc4)n2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 O16 compound treatment 10.6608 1.2305 0.6661 11.2441 1.424 0.6367 0.9213 0.9997 3220739 BCB03_000609 COC(=O)c1c(CC[C@@H](CO)NC(=O)N[C@@H](Cc2ccccc2)Cn3cc(nn3)c4ccccn4)oc(C(=O)N5CCOCC5)c1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 O17 compound treatment 8.5692 -0.86113 -0.4662 11.3414 1.5213 0.6802 0.1514 0.1835 3070746 BCB03_000610 COc1c(C)cc(cc1C)c2cc3CO[Si](C(C)C)(C(C)C)c3c(Cc4ccccc4)n2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 O18 compound treatment 9.1106 -0.31967 -0.1731 10.3791 0.55903 0.25 0.0544 0.1789 3220741 BCB03_000611 COC(=O)c1c(CC[C@@H](CO)NC(=O)N[C@@H](Cc2ccccc2)Cn3cc(nn3)C4(O)CCCC4)oc(C(=O)N5CCOCC5)c1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 O19 compound treatment 9.9761 0.54582 0.2955 10.1076 0.28751 0.1286 0.2998 0.9305 3188534 BCB03_000612 COC(=O)[C@H](Cc1ccccc1)N2CC3=CCCC=C[C@@H]3[C@H]2[C@H](O)Cc4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 O20 compound treatment 8.923 -0.50726 -0.2746 11.1975 1.3774 0.6159 0.2413 0.3579 3220743 BCB03_000613 COCc1cn(C[C@H](Cc2ccccc2)NC(=O)N[C@H](CO)CCc3oc(C(=O)N4CCOCC4)c(C(=O)OC)c3C(=O)OC)nn1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 O21 compound treatment 12.2955 2.8652 1.5511 9.6185 -0.20161 -0.0901 1.033 0.6649 3188535 BCB03_000614 COC(=O)[C@H](Cc1ccccc1)N2CC(=C)[C@H](/C=C/C=C)[C@H]2[C@H](O)Cc3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 O22 compound treatment 9.9802 0.54989 0.2977 10.1383 0.31818 0.1423 0.3111 0.9429 3188660 BCB03_000615 COC(=O)[C@H](Cc1ccccc1)N[C@H](/C=C/C2CC2)[C@@H](O)Cc3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 O23 compound treatment 8.5028 -0.92747 -0.5021 10.4857 0.6656 0.2976 -0.1446 -0.2477 3188536 BCB03_000616 O=C1O[C@H](Cc2ccccc2)[C@H](/C=C/C3CC3)N(CC#C)[C@H]1Cc4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 O24 compound treatment 9.1659 -0.26438 -0.1431 12.043 2.2229 0.9939 0.6016 0.5991 3188661 BCB03_000617 COC(=O)[C@H](Cc1ccccc1)N(CC#C)[C@H](/C=C/C2CC2)[C@@H](O)Cc3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 P01 compound treatment 11.2218 1.7915 0.9698 10.1698 0.34967 0.1564 0.7963 0.8106 3071602 BCB03_000618 OCCCCCCO[C@H]1C[C@H]2C(=C[C@@H]1C(=O)[C@@]32CO3)I 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 P02 compound treatment 9.7874 0.35706 0.1933 12.0103 2.1902 0.9793 0.8292 0.8307 3071666 BCB03_000619 CCCC[C@H]1OB(O)C[C@@H]2[C@H]3[C@@H](CC(=C12)C)C(=O)N(Cc4ccccc4)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 P03 compound treatment 9.7573 0.32698 0.177 9.9774 0.15725 0.0703 0.1749 0.9182 3071603 BCB03_000620 OCCCCO[C@H]1C[C@H]2C(=C[C@@H]1C(=O)[C@@]32CO3)I 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 P04 compound treatment 10.1693 0.739 0.4001 11.0514 1.2313 0.5506 0.6722 0.9877 3071711 BCB03_000621 CCCC[C@H]1OB(O)C[C@@H]2[C@H]3[C@@H](CC(=C12)COC)C(=O)N(Cc4ccccc4)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 P05 compound treatment 11.0961 1.6658 0.9018 11.3379 1.5178 0.6787 1.1175 0.9902 3071604 BCB03_000622 CCCCO[C@H]1C[C@H]2C(=C[C@@H]1C(=O)[C@@]32CO3)I 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 P06 compound treatment 11.0302 1.5999 0.8661 9.5007 -0.31941 -0.1428 0.5115 0.5826 3071776 BCB03_000623 CCCC[C@H]1OB(O)C[C@@H]2[C@H]3[C@@H](CC(=C12)COc4ccccc4)C(=O)N(Cc5ccccc5)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 P07 compound treatment 9.8805 0.45021 0.2437 11.0474 1.2273 0.5487 0.5604 0.9333 3071651 BCB03_000624 IC1=C[C@H]2[C@H](C[C@@H]1[C@@]3(CO3)C2=O)c4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 P08 compound treatment 10.5681 1.1378 0.616 14.2024 4.3823 1.9595 1.8211 0.8866 3188405 BCB03_000625 CN1C(=O)[C@@H]2CC(=C3[C@@H](CCc4ccccc4)OB(O)C[C@@H]3[C@@H]2C1=O)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 P09 compound treatment 9.3999 -0.030403 -0.0165 9.4392 -0.38091 -0.1703 -0.1321 -0.7718 3071652 BCB03_000626 Cc1cccc(c1)[C@H]2C[C@H]3C(=C[C@@H]2C(=O)[C@@]43CO4)I 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 P10 compound treatment 9.7538 0.32346 0.1751 10.265 0.44488 0.1989 0.2645 0.998 3070929 BCB03_000627 COCC1=C2[C@@H](CCc3ccccc3)OB(O)C[C@@H]2[C@H]4[C@@H](C1)C(=O)N(C)C4=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 P11 mock treatment 9.1265 -0.30385 -0.1645 11.2852 1.4651 0.6551 0.3469 0.5136 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 P12 mock treatment 9.881 0.45069 0.244 9.3714 -0.44871 -0.2006 0.0307 0.097 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 P13 compound treatment 12.2255 2.7952 1.5132 10.9814 1.1613 0.5193 1.4372 0.8983 3071653 BCB03_000628 COc1ccc(cc1)[C@H]2C[C@H]3C(=C[C@@H]2C(=O)[C@@]43CO4)I 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 P14 compound treatment 10.0762 0.64589 0.3497 11.0021 1.182 0.5285 0.621 0.9799 3188406 BCB03_000629 CN1C(=O)[C@@H]2CC(=C3[C@@H](CCc4ccccc4)OB(O)C[C@@H]3[C@@H]2C1=O)COc5ccccc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 P15 compound treatment 8.7274 -0.70295 -0.3805 9.8763 0.056186 0.0251 -0.2513 -0.659 3188268 BCB03_000630 CCCCO[C@H]1C[C@H]2C(=C[C@]1(CO)C(=O)[C@@]32CO3)Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 P16 compound treatment 7.6613 -1.769 -0.9577 10.7892 0.96913 0.4333 -0.3708 -0.3527 3070998 BCB03_000631 CC1=C([C@H](O)CCc2ccccc2)[C@H](CO)[C@H]3[C@@H](C1)C(=O)N(Cc4ccccc4)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 P17 compound treatment 10.443 1.0127 0.5482 11.0045 1.1844 0.5296 0.7621 0.9999 3071714 BCB03_000632 OC[C@@]1(C=C(Br)[C@@H]2C[C@@H]1c3ccccc3)C(=O)[C@@]42CO4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 P18 compound treatment 10.8123 1.382 0.7481 14.1399 4.3198 1.9315 1.8948 0.9148 3188793 BCB03_000633 CCCC[C@@H](O)C1=C(C)C[C@@H]2[C@H]([C@H]1CO)C(=O)N(C)C2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 P19 compound treatment 9.6719 0.24159 0.1308 11.5747 1.7546 0.7845 0.6472 0.8138 3071715 BCB03_000634 Cc1cccc(c1)[C@H]2C[C@H]3C(=C[C@]2(CO)C(=O)[C@@]43CO4)Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 P20 compound treatment 10.3966 0.96631 0.5231 11.8777 2.0576 0.92 1.0205 0.9642 3071118 BCB03_000635 CCCC[C@@H](O)C1=C(COC)C[C@@H]2[C@H]([C@H]1CO)C(=O)N(C)C2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 P21 compound treatment 10.362 0.93165 0.5044 12.261 2.4409 1.0914 1.1284 0.9385 3071717 BCB03_000636 COc1ccc(cc1)[C@H]2C[C@H]3C(=C[C@]2(CO)C(=O)[C@@]43CO4)Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 P22 compound treatment 9.4164 -0.013848 -0.0075 10.6121 0.79201 0.3541 0.2451 0.692 3071120 BCB03_000637 CCCC[C@@H](O)C1=C(COc2ccccc2)C[C@@H]3[C@H]([C@H]1CO)C(=O)N(C)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 P23 compound treatment 11.502 2.0717 1.1215 10.2184 0.39829 0.1781 0.919 0.8093 3071720 BCB03_000638 BrC1=C[C@]23COC[C@H]3C[C@@H]1[C@@]4(CO4)C2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2282 P24 compound treatment 12.3099 2.8796 1.5589 10.3882 0.56811 0.254 1.2819 0.8116 3188808 BCB03_000639 CC1=C([C@H](O)CCc2ccccc2)[C@H](CO)n3n(C1)c(=O)n(c4ccccc4)c3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 A01 compound treatment 11.5364 1.5945 0.8632 12.6413 2.4358 1.0891 1.3805 0.9934 3635123 CMLD5_000001 COC(=O)c1nnc(C(=O)N(C)Cc2ccccc2)c3[nH]c4ccccc4c13 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 A02 compound treatment 11.7881 1.8461 0.9994 11.4179 1.2124 0.5421 1.09 0.9587 3635124 CMLD5_000002 COCC1=Cc2cc3OCOc3cc2C(C(C(=O)OC)C(=O)OC)N1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 A03 compound treatment 9.7367 -0.2052 -0.1111 10.4882 0.28278 0.1264 0.0109 0.0645 3635125 CMLD5_000003 COC(=O)[C@@H](O)CC[C@@H](C)Cc1c(OC)c(OC)c(C)c(OC)c1OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 A04 compound treatment 10.1362 0.19428 0.1052 11.002 0.79658 0.3562 0.3262 0.8784 3635127 CMLD5_000004 COC[C@H]1OC=C[C@@H](OC)[C@@H]1OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 A05 compound treatment 8.9236 -1.0184 -0.5513 11.948 1.7425 0.7791 0.1611 0.1688 3635129 CMLD5_000005 COC(=O)c1ccccc1C[C@@]2(C=C[C@H](C)[C@H](N2C(=O)C(F)(F)F)c3ccccc3)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 A06 compound treatment 9.4841 -0.45785 -0.2479 10.605 0.39955 0.1787 -0.0489 -0.1602 3635131 CMLD5_000006 COC(=O)/C(=C(/C)\NCc1ccccc1)/[C@@H](NC(=O)OCC=C)c2ccc3OCOc3c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 A07 compound treatment 10.0337 0.091733 0.0497 10.9877 0.78221 0.3498 0.2824 0.7995 3635133 CMLD5_000007 COC(=O)c1nnc(SC)nc1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 A08 compound treatment 10.7665 0.82457 0.4464 11.1556 0.95017 0.4249 0.6161 0.9997 3635134 CMLD5_000008 OP1(=O)Oc2c(cc3ccccc3c2-c4c(O1)c(cc5ccccc45)c6ccccc6)c7ccccc7 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 A09 compound treatment 42.3773 32.435 17.5591 40.5342 30.329 13.561 22.0053 0.9918 3635135 CMLD5_000009 CC(=O)O[C@@H]1C(=C(Br)C(=O)[C@@H]2O[C@@]21C)CO[Si](C)(C)C(C)(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 A10 compound treatment 12.536 2.5941 1.4043 11.0099 0.80441 0.3597 1.2473 0.8604 3635137 CMLD5_000010 C[C@H](O)CON1C(=O)c2ccccc2C1=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 A11 compound treatment 10.5893 0.64733 0.3504 9.3369 -0.86851 -0.3883 -0.0268 -0.0512 3011273 CMLD5_000011 C=CC(=O)N1C(=O)c2ccccc2S1(=O)=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 A12 compound treatment 37.883 27.941 15.1261 30.7053 20.5 9.1662 17.1773 0.9712 3556134 CMLD5_000012 COCOc1ccc(OC)cc1C(=O)/C=C/c2ccc(OC)c(Br)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 A13 mock treatment 10.738 0.79605 0.4309 9.5444 -0.66106 -0.2956 0.0957 0.1832 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 A14 mock treatment 9.4239 -0.518 -0.2804 10.2736 0.068122 0.0305 -0.1767 -0.6266 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 A15 compound treatment 12.2578 2.3159 1.2537 9.79 -0.41548 -0.1858 0.7551 0.5958 3635138 CMLD5_000013 COC(=O)N[C@@H](c1ccccc1)[C@](CC=C)(C(=O)C)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 A16 compound treatment 9.9923 0.050391 0.0273 12.0039 1.7984 0.8041 0.5879 0.7307 3635140 CMLD5_000014 C[C@@H](O)C#C[Si](C)(C)c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 A17 compound treatment 10.8425 0.90057 0.4875 9.8337 -0.37173 -0.1662 0.2272 0.4411 3635142 CMLD5_000015 COc1ccc(cc1)C(C)(O)CC=C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 A18 compound treatment 11.0916 1.1496 0.6224 13.4925 3.287 1.4697 1.4793 0.9269 3635143 CMLD5_000016 COC(=O)N[C@@H](/C=C/c1ccccc1)/C(=C(\C)/NCc2ccccc2)/C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 A19 compound treatment 9.3933 -0.54864 -0.297 9.4673 -0.73811 -0.33 -0.4434 -0.9986 3635145 CMLD5_000017 CCOC(=O)C(CC=C)Nc1ccc(OC)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 A20 compound treatment 11.2465 1.3045 0.7062 12.4164 2.211 0.9886 1.1984 0.9864 3635146 CMLD5_000018 COC(=O)N[C@H](C[N+](=O)[O-])C(C)(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 A21 compound treatment 14.4391 4.4972 2.4346 14.6694 4.464 1.996 3.1329 0.9951 3635148 CMLD5_000019 OC(CC=C)(C#Cc1ccccc1)c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 A22 compound treatment 12.7073 2.7654 1.497 10.5297 0.32425 0.145 1.1611 0.772 3635149 CMLD5_000020 O=C(/C=C/c1ccc2OCOc2c1)c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 A23 compound treatment 10.487 0.54506 0.2951 11.3514 1.1459 0.5124 0.571 0.9656 3635150 CMLD5_000021 Cc1ccc(/C=C/C2=C[C@]3(C)C[C@]2(C)[C@@H](CC3=O)c4ccc(C)cc4)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 A24 compound treatment 9.9361 -0.0058066 -0.0031 9.8305 -0.37495 -0.1677 -0.1208 -0.7202 3635152 CMLD5_000022 COC(=O)C1(CC2=CC[C@@H]3[C@H]([C@@H]2Cc4ccccc4[C@@H]1C[N+](=O)[O-])C(=O)N(C3=O)c5ccccc5)C(=O)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 B01 compound treatment 11.3039 1.362 0.7373 11.484 1.2786 0.5717 0.9256 0.9921 3635154 CMLD5_000023 COC(=O)c1nnc(C(=O)NCc2ccccc2)c3[nH]c4ccccc4c13 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 B02 compound treatment 9.6395 -0.30246 -0.1637 11.3297 1.1242 0.5027 0.2397 0.4533 3635155 CMLD5_000024 COC(=O)N1[C@H]2CC[C@@]3(C)C=C(C)O[C@]1(C)C3c4ccccc24 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 B03 compound treatment 9.6277 -0.31423 -0.1701 9.7572 -0.44825 -0.2004 -0.262 -0.9967 3635157 CMLD5_000025 C[C@H]1CC[C@@H]2N(C[C@@H](COCC=C)OC2=O)[C@@H]1c3ccc(Br)cc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 B04 compound treatment 10.1797 0.23779 0.1287 10.4638 0.25835 0.1155 0.1727 0.9985 3635158 CMLD5_000026 CC(C)OC(=O)[C@@H]1CC[C@H](C)[C@@H](CCC[C@@H]2CC=C[C@H](COS(=O)(=O)c3c(C)cc(C)cc3C)O2)O1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 B05 compound treatment 9.4038 -0.53812 -0.2913 10.1785 -0.026983 -0.0121 -0.2145 -0.7358 3635160 CMLD5_000027 COC(=O)C(=C)C[C@]1(C[C@]2(CC=C(C)C)C(=C(C(=O)CC(C)C)C(=O)C(CC=C(C)C)(C1)C2=O)O)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 B06 compound treatment 10.0434 0.10148 0.0549 10.6565 0.45108 0.2017 0.1815 0.8681 3635162 CMLD5_000028 COC(=O)/C(=C(/C)\NCc1ccccc1)/[C@@H](NC(=O)OCC=C)c2cccc(OC)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 B07 compound treatment 9.0846 -0.85732 -0.4641 11.8587 1.6532 0.7392 0.1945 0.2229 3635164 CMLD5_000029 CC(=O)C([C@H](NC(=O)OCC=C)c1ccco1)C(=O)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 B08 compound treatment 71.0359 61.094 33.0736 50.3137 40.108 17.9338 36.0677 0.9587 3635166 CMLD5_000030 COC(=O)C(=Cc1cc(Br)c(OC)c(Br)c1)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 B09 compound treatment 27.9653 18.023 9.757 24.7781 14.573 6.5159 11.5067 0.9807 3635167 CMLD5_000031 OCC1=C(Br)C2(OCCCO2)C=CC1=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 B10 compound treatment 10.4254 0.48344 0.2617 8.9405 -1.265 -0.5656 -0.2149 -0.3448 3635168 CMLD5_000032 C[C@@H]1C[C@@](C)(C=C1c2ccc3OCOc3c2)C(=O)c4ccc5OCOc5c4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 B11 compound treatment 27.117 17.175 9.2979 27.9671 17.762 7.9418 12.1903 0.9969 3635170 CMLD5_000033 COCOc1cc(OC)ccc1C(=O)/C=C/c2cccc(c2)C(F)(F)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 B12 compound treatment 11.7217 1.7798 0.9635 11.0477 0.84223 0.3766 0.9476 0.916 3635172 CMLD5_000034 COCOc1ccc(OC)cc1C(=O)[C@@H]2O[C@H]2c3ccc(OC)c(Br)c3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 B13 mock treatment 8.7147 -1.2272 -0.6644 9.6038 -0.60169 -0.269 -0.66 -0.9208 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 B14 mock treatment 9.1196 -0.82231 -0.4452 9.3702 -0.83526 -0.3735 -0.5789 -0.9962 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 B15 compound treatment 10.8451 0.90312 0.4889 10.3776 0.17212 0.077 0.4001 0.8085 3635174 CMLD5_000035 COC(=O)NC(C(=C)C(=O)OC)c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 B16 compound treatment 10.412 0.47011 0.2545 12.1925 1.987 0.8885 0.8082 0.8745 3635175 CMLD5_000036 CC(O)(CC=C)c1ccsc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 B17 compound treatment 13.4361 3.4941 1.8916 13.418 3.2126 1.4364 2.3533 0.9908 3635176 CMLD5_000037 FC(F)(F)c1cc(NC(=S)Nc2ccc3cc4ccccc4cc3c2)cc(c1)C(F)(F)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 B18 compound treatment 11.5862 1.6442 0.8901 10.8584 0.65294 0.292 0.8359 0.8923 3635177 CMLD5_000038 C[C@H](C=C)[C@](C)(O)c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 B19 compound treatment 9.8563 -0.085612 -0.0463 12.0885 1.883 0.842 0.5626 0.6672 3635179 CMLD5_000039 C[C@@H]1C[C@@](C)(C=C1c2ccco2)C(=O)c3ccco3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 B20 compound treatment 9.5127 -0.42927 -0.2324 10.3808 0.17538 0.0784 -0.1089 -0.4439 3635181 CMLD5_000040 COC(=O)NC(c1ccccc1)C2(C(=O)OC)C(=O)Cc3ccccc32 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 B21 compound treatment 12.8779 2.936 1.5894 10.3252 0.11972 0.0535 1.1617 0.7305 3635182 CMLD5_000041 COC(=O)N[C@@H](CCc1ccccc1)/C(=C(\C)/NCc2ccccc2)/C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 B22 compound treatment 10.2813 0.33936 0.1837 9.1612 -1.0442 -0.4669 -0.2003 -0.3991 3635184 CMLD5_000042 O=C(NCc1ccccc1)/C=C/c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 B23 compound treatment 57.3573 47.415 25.6687 59.0052 48.8 21.8201 33.5796 0.9967 3556292 CMLD5_000043 CC(=C)C(O)/C=C/c1ccc(Br)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 B24 compound treatment 11.3193 1.3773 0.7456 15.0757 4.8703 2.1777 2.0671 0.898 3635186 CMLD5_000044 COCC(=C)C1=CCC([C@@H](C[N+](=O)[O-])c2ccccc12)(C(=O)OC)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 C01 compound treatment 9.6191 -0.32281 -0.1748 8.9041 -1.3013 -0.5819 -0.535 -0.8806 3635188 CMLD5_000045 O=C(NCC1CCCCC1)c2nnc(C(=O)NCC3CCCCC3)c4c5ccccc5[nH]c24 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 C02 compound treatment 10.213 0.27103 0.1467 8.5083 -1.6971 -0.7588 -0.4328 -0.56 3635189 CMLD5_000046 COC(=O)CC1N(C(=O)OC)C(=Cc2ccccc12)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 C03 compound treatment 10.8579 0.91596 0.4959 11.7781 1.5726 0.7032 0.8478 0.9854 3635190 CMLD5_000047 COC(=O)[C@H]1O[C@H]([C@H](C)[C@H]2O[C@]21C)c3cc(OC)c(C)c(OC)c3OCc4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 C04 compound treatment 10.4947 0.55278 0.2993 9.0957 -1.1097 -0.4962 -0.1393 -0.2403 3635192 CMLD5_000048 CC(C)OC(=O)[C@@H]1CC[C@H](C)[C@@H](CCCC=O)O1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 C05 compound treatment 7.9987 -1.9433 -1.052 12.3588 2.1533 0.9628 -0.0631 -0.0442 3635194 CMLD5_000049 COC1=C(C(=O)c2ccccc2)C(=O)[C@]3(CC=C(C)C)C(=O)C1(CC=C(C)C)C[C@H](CCCC(F)(F)F)C3(C)C.COC1=C(C(=O)c2ccccc2)C(=O)C3(CC=C(C)C)C[C@H](C(=O)OCC(F)(F)F)C(C)(C)[C@@]1(CC=C(C)C)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 C06 compound treatment 14.9257 4.9837 2.698 10.3126 0.10714 0.0479 1.9416 0.7195 2102645 CMLD5_000050 CSc1nnc(SC)nn1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 C07 compound treatment 9.3296 -0.61234 -0.3315 9.9298 -0.27566 -0.1233 -0.3216 -0.9092 3635196 CMLD5_000051 COC(=O)C/C=C/[C@@H](C)[C@H](NC(=O)OCC(Cl)(Cl)Cl)c1ccc2ccccc2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 C08 compound treatment 9.8037 -0.13824 -0.0748 9.8024 -0.40302 -0.1802 -0.1803 -0.9242 3635198 CMLD5_000052 CC1(C)O[C@@H]2[C@@H](O1)C(OP(=O)(O)OC2(c3ccccc3)c4ccccc4)(c5ccccc5)c6ccccc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 C09 compound treatment 10.89 0.94803 0.5132 18.5467 8.3412 3.7297 3.0002 0.7969 3635200 CMLD5_000053 COC(=O)c1nnc(C(=O)NCc2ccccc2)c3[nH]c4ccc(OC)cc4c13 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 C10 compound treatment 9.4506 -0.49135 -0.266 10.3483 0.1429 0.0639 -0.1429 -0.5224 3635201 CMLD5_000054 CC(=C)C(=O)c1ccc(F)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 C11 mock treatment 10.3131 0.37121 0.201 9.8509 -0.35457 -0.1585 0.03 0.1172 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 C12 mock treatment 9.282 -0.65992 -0.3573 9.1982 -1.0073 -0.4504 -0.5711 -0.9934 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 C13 compound treatment 10.6498 0.70787 0.3832 8.0411 -2.1644 -0.9678 -0.4133 -0.3971 1060776 CMLD5_000055 COC(=O)C=P(c1ccccc1)(c2ccccc2)c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 C14 compound treatment 34.3736 24.432 13.2263 23.6922 13.487 6.0304 13.6165 0.9367 3635202 CMLD5_000056 COC(=O)C(C(NC(=O)OCC=C)c1ccc(F)c(F)c1)C(=O)CCl 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 C15 mock treatment 9.6958 -0.24617 -0.1333 32.2554 22.05 9.8593 6.8773 0.6975 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 C16 mock treatment 8.5089 -1.433 -0.7758 10.4505 0.24503 0.1096 -0.4711 -0.6013 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 C17 compound treatment 10.7404 0.79847 0.4323 10.3551 0.14962 0.0669 0.353 0.8069 3635203 CMLD5_000057 FC(F)(F)c1cc(NC(=S)NC2(CC3CC4CC(C3)C2)C4)cc(c1)C(F)(F)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 C18 compound treatment 9.736 -0.20591 -0.1115 11.3144 1.109 0.4959 0.2718 0.5348 3635204 CMLD5_000058 COCC(=O)C([C@H](CCc1ccccc1)NC(=O)OC)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 C19 compound treatment 10.9854 1.0435 0.5649 9.7572 -0.44824 -0.2004 0.2577 0.43 3635206 CMLD5_000059 CCOP(=O)(CC(=O)C(=C)C)OCC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 C20 compound treatment 10.4759 0.53396 0.2891 9.426 -0.77941 -0.3485 -0.042 -0.0928 3635207 CMLD5_000060 COC(=O)C1(C)C=C(Nc2ccc(OC)cc2)C(=O)N1c3ccc(OC)cc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 C21 compound treatment 11.0974 1.1554 0.6255 11.1119 0.90647 0.4053 0.7289 0.9779 3635208 CMLD5_000061 OC(C1=CCCC1=O)c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 C22 compound treatment 21.264 11.322 6.1293 20.5003 10.295 4.6032 7.589 0.99 3635209 CMLD5_000062 Nc1ccccc1C(=O)/C=C/c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 C23 compound treatment 32.3707 22.429 12.142 31.2897 21.084 9.4275 15.2519 0.9922 3635211 CMLD5_000063 C[Si](C)(C/C=C/CC[C@H](O)C1=CCCCC1=O)c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 C24 compound treatment 9.8917 -0.050224 -0.0272 11.2427 1.0372 0.4638 0.3087 0.6645 3635213 CMLD5_000064 COCC1=C2[C@H](CC3([C@@H](CNC3=O)c4ccccc24)C(=O)OC)n5n(C1)c(=O)n(c6ccccc6)c5=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 D01 compound treatment 10.4438 0.50184 0.2717 10.2358 0.030384 0.0136 0.2017 0.7415 3635215 CMLD5_000065 COC(=O)C1(CC2=CC(CC2=O)Cc3ccccc3[C@@H]1C[N+](=O)[O-])C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 D02 compound treatment 10.677 0.73504 0.3979 12.2312 2.0258 0.9058 0.9219 0.9318 3635217 CMLD5_000066 COC(=O)N1C(c2ccccc2C=C1c3ccccc3)C4(CCCC4=O)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 D03 compound treatment 10.3606 0.41863 0.2266 9.3003 -0.9051 -0.4047 -0.1259 -0.2715 3635218 CMLD5_000067 COC[C@H]1O[C@H]([C@H](OC)[C@@H](OC)[C@@H]1OC)c2c(OC)cc(OC)cc2OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 D04 compound treatment 11.4994 1.5575 0.8432 9.955 -0.25043 -0.112 0.517 0.6079 3635220 CMLD5_000068 CC(C)OC(=O)[C@@H]1CC[C@H](C)[C@@H](CCC[C@@H]2C[C@@H](O)C[C@H](CC#N)O2)O1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 D05 compound treatment 9.882 -0.059904 -0.0324 11.5434 1.338 0.5983 0.4001 0.6678 3635222 CMLD5_000069 COC(=O)[C@H]1CC2(CC=C(C)C)C(=O)[C@@](CC=C(C)C)(C(=O)C(=C2OC)C(=O)c3ccccc3)C1(C)C.COC1=C(C(=O)c2ccccc2)C(=O)C3(CC=C(C)C)C[C@H](C(=O)O)C(C)(C)[C@@]1(CC=C(C)C)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 D06 compound treatment 9.8086 -0.13334 -0.0722 10.8071 0.6017 0.269 0.1392 0.4997 3635224 CMLD5_000070 CC(=O)C([C@H](NC(=O)OCC=C)c1ccccc1)C(=O)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 D07 compound treatment 7.8798 -2.0621 -1.1163 10.1002 -0.10521 -0.047 -0.8226 -0.7363 3635226 CMLD5_000071 Cc1ccc(cc1)S(=O)(=O)N(c2ccccc2)S(=O)(=O)C(F)(F)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 D08 compound treatment 10.0342 0.092221 0.0499 10.4586 0.25313 0.1132 0.1153 0.9323 3635227 CMLD5_000072 OP1(=O)Oc2c(c(cc3ccccc23)c4ccccc4)-c5c(cc6ccccc6c5O1)c7ccccc7 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 D09 compound treatment 11.7881 1.8461 0.9994 10.4133 0.20784 0.0929 0.7724 0.7695 3635228 CMLD5_000073 COC(=O)C12CC3=CC(CC3=O)Cc4ccccc4[C@@H]2CNC1=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 D10 compound treatment 27.9879 18.046 9.7693 32.5217 22.316 9.9784 13.9637 0.9999 3635230 CMLD5_000074 CC(=C)C(=O)/C=C/c1ccc(Br)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 D11 mock treatment 10.5818 0.63986 0.3464 9.1997 -1.0057 -0.4497 -0.073 -0.1287 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 D12 mock treatment 9.2279 -0.71406 -0.3866 11.4183 1.2129 0.5423 0.1101 0.1654 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 D13 compound treatment 9.9968 0.054871 0.0297 10.17 -0.035473 -0.0159 0.0098 0.2907 3635232 CMLD5_000075 C/C=C(\C)/[C@H](O)C[Si](C)(C)c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 D14 compound treatment 9.8774 -0.064499 -0.0349 10.3987 0.1933 0.0864 0.0364 0.3908 3635234 CMLD5_000076 COc1ccc(cc1)C(O)C2=CCCC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 D15 mock treatment 9.9713 0.029363 0.0159 10.0095 -0.19598 -0.0876 -0.0507 -0.5695 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 D16 mock treatment 10.0076 0.065621 0.0355 8.5201 -1.6854 -0.7536 -0.5078 -0.673 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 D17 compound treatment 12.9985 3.0565 1.6547 11.7612 1.5557 0.6956 1.6619 0.9259 3635235 CMLD5_000077 FC(F)(F)c1cc(NC(=S)NC(c2ccccc2)c3ccccc3)cc(c1)C(F)(F)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 D18 compound treatment 9.6244 -0.31758 -0.1719 8.784 -1.4214 -0.6356 -0.571 -0.8672 3635236 CMLD5_000078 CCOC(=O)C(C)(O)CC=C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 D19 compound treatment 8.7795 -1.1624 -0.6293 9.9376 -0.26781 -0.1197 -0.5296 -0.8268 3635237 CMLD5_000079 CCOC(=O)C(=C)C(=O)c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 D20 compound treatment 10.9761 1.0342 0.5599 10.8058 0.60031 0.2684 0.5857 0.9433 3555865 CMLD5_000080 COC(=O)N[C@H](C(C(=O)C)C(=O)OC)c1cccc(C)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 D21 compound treatment 26.5605 16.619 8.9966 24.6036 14.398 6.4379 10.9139 0.9865 3635238 CMLD5_000081 CC(=O)C(=C)C(O)c1ccc2ccccc2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 D22 compound treatment 21.6501 11.708 6.3383 22.7581 12.553 5.6127 8.4506 0.9982 3635239 CMLD5_000082 COCOc1ccccc1C(=O)/C=C/c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 D23 compound treatment 10.4901 0.5482 0.2968 12.2471 2.0416 0.9129 0.8554 0.8911 3635241 CMLD5_000083 CC(=C)C(=O)/C=C/c1ccc(cc1)C(F)(F)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 D24 compound treatment 8.8635 -1.0784 -0.5838 10.8908 0.68537 0.3065 -0.1961 -0.2975 3635243 CMLD5_000084 COC(=O)C1(CC#CC)[C@@H](CNC1=O)c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 E01 mock treatment 9.6968 -0.24512 -0.1327 9.7402 -0.46527 -0.208 -0.2409 -0.9764 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 E02 mock treatment 10.6783 0.73634 0.3986 11.303 1.0975 0.4908 0.6289 0.9947 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 E03 compound treatment 13.1236 3.1817 1.7224 10.2768 0.071374 0.0319 1.2405 0.7201 3635245 CMLD5_000085 COC(=O)[C@H]1O[C@H]([C@H](C)[C@@H]2O[C@@]21C)c3cc(OC)c(C)c(OC)c3OCc4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 E04 compound treatment 10.8054 0.86344 0.4674 12.0121 1.8067 0.8078 0.9017 0.9662 3635246 CMLD5_000086 CO[C@@H](CCOCc1ccccc1)C[C@H]2O[C@@H](C=C[C@@H]2C)C(=O)OC(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 E05 compound treatment 9.1303 -0.81165 -0.4394 12.3826 2.1771 0.9735 0.3776 0.3536 3635248 CMLD5_000087 COCOc1cccc2c(OCOC)c3C4=C(CCCC4)/C(=N\NS(=O)(=O)c5ccc(C)cc5)/c3c(OCOC)c12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 E06 compound treatment 9.043 -0.89894 -0.4866 10.8054 0.59991 0.2682 -0.1544 -0.2779 3635250 CMLD5_000088 COC(=O)/C(=C(/C)\NCc1ccccc1)/[C@@H](NC(=O)OCC=C)c2cccc(c2)C(F)(F)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 E07 compound treatment 10.1556 0.21369 0.1157 10.9846 0.77915 0.3484 0.3281 0.8939 3635252 CMLD5_000089 CC(=O)C([C@@H](NC(=O)OCC=C)c1cccs1)C(=O)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 E08 compound treatment 10.7513 0.8094 0.4382 15.3479 5.1424 2.2994 1.9357 0.827 3635254 CMLD5_000090 OP1(=O)Oc2c(c(cc3ccc4ccccc4c23)c5ccccc5)-c6c(cc7ccc8ccccc8c7c6O1)c9ccccc9 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 E09 mock treatment 9.0755 -0.86643 -0.469 9.5665 -0.63894 -0.2857 -0.5337 -0.9717 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 E10 mock treatment 11.2649 1.323 0.7162 10.0785 -0.12698 -0.0568 0.4663 0.649 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 E11 compound treatment 8.4004 -1.5415 -0.8345 9.6915 -0.51397 -0.2298 -0.7526 -0.8695 3635255 CMLD5_000091 OC(C1CCCC1=O)c2ccc3ccccc3c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 E12 compound treatment 9.4789 -0.46301 -0.2507 11.2314 1.026 0.4588 0.1472 0.2815 3635256 CMLD5_000092 CC(=CCn1cnc2NCN/C(=N\OCc3ccccc3)/c21)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 E13 compound treatment 11.4552 1.5133 0.8192 8.1587 -2.0467 -0.9152 -0.0678 -0.0552 3635258 CMLD5_000093 C/C=C(\C)/C(=O)C[Si](C)(C)c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 E14 compound treatment 10.1906 0.2487 0.1346 10.9482 0.74276 0.3321 0.33 0.921 3635260 CMLD5_000094 CC(=O)C(=C)C(O)c1ccco1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 E15 compound treatment 11.0385 1.0966 0.5936 9.9375 -0.26791 -0.1198 0.3351 0.5533 3635261 CMLD5_000095 COC(=O)[C@](CC=C)([C@@H](NC(=O)OC(C)(C)C)c1ccccc1)C(=O)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 E16 compound treatment 9.368 -0.57389 -0.3107 13.1943 2.9889 1.3364 0.7253 0.5286 3635263 CMLD5_000096 CC(O)(CC=C)c1cccc(c1)C(F)(F)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 E17 mock treatment 9.4834 -0.45856 -0.2482 10.7492 0.54371 0.2431 -0.0036 -0.0105 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 E18 mock treatment 9.3728 -0.56917 -0.3081 10.0913 -0.1141 -0.051 -0.254 -0.8131 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 E19 compound treatment 10.8403 0.89839 0.4864 9.9286 -0.27681 -0.1238 0.2564 0.5109 3635264 CMLD5_000097 CC(=C)C(=O)C1CCCCC1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 E20 compound treatment 9.8743 -0.067682 -0.0366 9.8521 -0.35335 -0.158 -0.1376 -0.8486 3635265 CMLD5_000098 COC(=O)N[C@H]([C@@H](C)[N+](=O)[O-])c1cccc(C)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 E21 compound treatment 10.2726 0.33071 0.179 10.9919 0.78642 0.3516 0.3752 0.951 3635267 CMLD5_000099 C[C@]1(C[C@]2(C)[C@@H](CC1=O)c3ccc(F)cc3)C=C2/C=C/c4ccc(F)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 E22 compound treatment 9.9952 0.053258 0.0288 12.0904 1.885 0.8428 0.6164 0.7309 3635268 CMLD5_000100 COC(=O)NC(CCc1ccccc1)C(C(=O)C)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 E23 compound treatment 17.3967 7.4547 4.0357 11.7258 1.5204 0.6798 3.3344 0.8147 3635269 CMLD5_000101 CC1(CC2(C)[C@H](CCc3ccco3)CC1=O)C=C2/C=C/CCc4ccco4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 E24 compound treatment 10.1242 0.18229 0.0987 10.6401 0.43463 0.1943 0.2072 0.9506 3635271 CMLD5_000102 COCC1=C2[C@H](CC([C@@H](C[N+](=O)[O-])c3ccccc23)(C(=O)OC)C(=O)OC)n4n(C1)c(=O)n(c5ccccc5)c4=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 F01 mock treatment 11.648 1.706 0.9236 9.9199 -0.28559 -0.1277 0.5628 0.6036 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 F02 mock treatment 10.8809 0.93893 0.5083 9.368 -0.83746 -0.3745 0.0946 0.1499 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 F03 compound treatment 10.2491 0.30716 0.1663 9.9835 -0.22197 -0.0992 0.0474 0.2448 3635273 CMLD5_000103 C/C=C/C(=O)C[C@H]1CC[C@@H](C)[C@@H](CCO)O1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 F04 compound treatment 9.621 -0.32098 -0.1738 10.4306 0.22518 0.1007 -0.0517 -0.2573 3635275 CMLD5_000104 CC(C)OC(=O)[C@@H]1CC[C@H](C)[C@@H](CCC[C@@H]2CC=C[C@H](CC#N)O2)O1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 F05 compound treatment 10.7369 0.79496 0.4304 10.5298 0.32432 0.145 0.4069 0.8959 3635277 CMLD5_000105 COCOc1cccc2c(OCOC)c3C4=C(CCCC4)/C(=N\NS(=O)(=O)C)/c3c(OCOC)c12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 F06 compound treatment 9.7755 -0.16646 -0.0901 10.5169 0.31147 0.1393 0.0348 0.2095 3635279 CMLD5_000106 COC(=O)/C(=C(/C)\NCc1ccccc1)/[C@@H](NC(=O)OCC=C)c2ccc(C)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 F07 compound treatment 8.8733 -1.0686 -0.5785 9.5087 -0.69674 -0.3115 -0.6294 -0.9578 3635281 CMLD5_000107 COC(=O)C/C=C/[C@@H](C)[C@H](NC(=O)OCC(Cl)(Cl)Cl)c1cccc(OC)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 F08 compound treatment 33.5727 23.631 12.7927 32.4402 22.235 9.9419 16.0758 0.9922 3635283 CMLD5_000108 CCOC(=O)C1=NO[C@]2(C1)C=C(Br)C(=O)[C@H]3O[C@H]32 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 F09 mock treatment 11.0817 1.1397 0.617 8.8936 -1.3118 -0.5866 0.0215 0.0253 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 F10 mock treatment 10.3398 0.39782 0.2154 10.9479 0.74244 0.332 0.387 0.978 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 F11 compound treatment 25.5762 15.634 8.4637 26.3933 16.188 7.2382 11.1029 0.997 3011535 CMLD5_000109 COCOc1cc(OC)ccc1C(=O)/C=C/c2ccc3OCOc3c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 F12 compound treatment 12.0136 2.0717 1.1215 11.2148 1.0094 0.4513 1.1122 0.92 3635285 CMLD5_000110 O=C([C@@H]1O[C@H]1c2ccccc2)c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 F13 compound treatment 9.2449 -0.69702 -0.3773 9.3084 -0.89709 -0.4011 -0.5505 -0.9995 3635286 CMLD5_000111 Cc1cc(C)cc(c1)c2cc3CCCCc3c(c2O)c4c(O)c(cc5CCCCc45)c6cc(C)cc(C)c6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 F14 compound treatment 11.7609 1.8189 0.9847 10.2858 0.080372 0.0359 0.7217 0.7324 3635287 CMLD5_000112 CC(=O)C(=C)C(O)c1ccc(cc1)C(F)(F)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 F15 compound treatment 10.633 0.6911 0.3741 8.9148 -1.2907 -0.5771 -0.1435 -0.2087 3635288 CMLD5_000113 COC(=O)NC(c1c[nH]c2ccc(OC)cc12)c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 F16 compound treatment 9.4944 -0.44758 -0.2423 11.1181 0.91267 0.4081 0.1172 0.247 3635289 CMLD5_000114 CC(O)(CC=C)c1cccs1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 F17 mock treatment 10.6644 0.72243 0.3911 9.8981 -0.30734 -0.1374 0.1794 0.4327 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 F18 mock treatment 10.6356 0.69369 0.3755 11.0329 0.8275 0.37 0.5272 1.0 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 F19 compound treatment 11.186 1.244 0.6735 10.014 -0.19142 -0.0856 0.4157 0.6123 3635290 CMLD5_000115 [O-][N+](=O)C[C@@H](NC(=O)OCC=C)c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 F20 compound treatment 1.1432 -8.7987 -4.7633 7.2948 -2.9106 -1.3015 -4.2884 -0.8685 3635292 CMLD5_000116 CCC1CN2CCC1CC2[C@@H](NC(=S)Nc3cc(cc(c3)C(F)(F)F)C(F)(F)F)c4cccc5ccc(OC)cc45 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 F21 compound treatment 9.2529 -0.68907 -0.373 9.6127 -0.59278 -0.2651 -0.4512 -0.986 3635294 CMLD5_000117 COc1ccc(/C=C/C2=C[C@]3(C)C[C@]2(C)[C@@H](CC3=O)c4ccc(OC)cc4)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 F22 compound treatment 11.0243 1.0824 0.5859 9.7937 -0.41178 -0.1841 0.2841 0.4626 1003402 CMLD5_000118 OC(CC=C)c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 F23 compound treatment 9.5819 -0.35999 -0.1949 13.4953 3.2899 1.471 0.9024 0.6081 3635295 CMLD5_000119 C[C@]1(C[C@]2(C)[C@@H](CC1=O)c3ccc(cc3)C(F)(F)F)C=C2/C=C/c4ccc(cc4)C(F)(F)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 F24 compound treatment 9.7069 -0.23507 -0.1273 10.2317 0.026304 0.0118 -0.0817 -0.639 3635296 CMLD5_000120 COC(=O)C1(CC2=CCC3C(C2Cc4ccccc4[C@@H]1C[N+](=O)[O-])C(=O)N(C3=O)c5ccccc5)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 G01 compound treatment 10.0953 0.15336 0.083 12.2885 2.083 0.9314 0.7173 0.7671 3635298 CMLD5_000121 CCCCCCCC1=CC2=C(Cl)C(=O)C(C)(OC(=O)C)C(=O)C2=CO1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 G02 compound treatment 9.6711 -0.27081 -0.1466 10.3119 0.10642 0.0476 -0.07 -0.4543 3635299 CMLD5_000122 CCCCCCCC1=Cc2ccc(F)cc2C(C(C(=O)OC)C(=O)OC)N1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 G03 mock treatment 9.5221 -0.41986 -0.2273 9.3891 -0.81632 -0.365 -0.4188 -0.974 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 G04 mock treatment 10.7217 0.77974 0.4221 10.5347 0.32925 0.1472 0.4026 0.9005 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 G05 compound treatment 10.0733 0.13133 0.0711 9.3827 -0.82272 -0.3679 -0.2098 -0.5601 3635300 CMLD5_000123 CCOC(=O)N/N=C/c1ccccc1c2cc(OC)ccc2OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 G06 compound treatment 11.7437 1.8018 0.9754 11.0864 0.88094 0.3939 0.9682 0.9204 3635302 CMLD5_000124 COC(=O)[C@@H]1C[C@]2([C@H]3N(Cc4ccccc4)c5ccccc52)C(=CC(=C3C(=O)OC)C(=O)OC)N1C(=O)NCc6ccccc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 G07 compound treatment 9.7314 -0.21053 -0.114 9.9635 -0.24199 -0.1082 -0.1571 -0.9997 3635304 CMLD5_000125 COC(=O)C/C=C/[C@@H](C)[C@H](NC(=O)OCC(Cl)(Cl)Cl)c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 G08 compound treatment 9.811 -0.13089 -0.0709 11.0315 0.82608 0.3694 0.2111 0.5612 3635306 CMLD5_000126 C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc4c(=O)c(cn1c24)C(=O)NCc5ccco5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 G09 compound treatment 8.9714 -0.9705 -0.5254 10.4979 0.29243 0.1308 -0.279 -0.5154 3635308 CMLD5_000127 CC1(C)CCC(=CC1)O[Si](C)(c2ccccc2)c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 G10 compound treatment 8.646 -1.296 -0.7016 8.7222 -1.4832 -0.6632 -0.965 -0.9996 3131447 CMLD5_000128 O=C(OCc1ccccc1)C(C2CCCC(=O)C2)C(=O)OCc3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 G11 compound treatment 10.2243 0.28238 0.1529 11.865 1.6595 0.742 0.6328 0.8352 3635309 CMLD5_000129 CC1COc2ccccc2C1=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 G12 compound treatment 8.7259 -1.216 -0.6583 9.7992 -0.40629 -0.1817 -0.5939 -0.8697 3635310 CMLD5_000130 CC1(C)C[C@@](C)(C=C1c2ccccc2)C(=O)c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 G13 compound treatment 25.006 15.064 8.155 15.0225 4.8171 2.1539 7.2895 0.8642 3635312 CMLD5_000131 Oc1ccc2CCCCc2c1c3c(O)c(Br)cc4CCCCc34 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 G14 compound treatment 10.1022 0.16026 0.0868 11.8943 1.6888 0.7551 0.5953 0.7832 3635313 CMLD5_000132 CC(=O)C(=C)C(O)c1cccs1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 G15 compound treatment 9.2539 -0.68806 -0.3725 10.9431 0.73765 0.3298 -0.0302 -0.0606 3635314 CMLD5_000133 COC(=O)C([C@@H](NC(=O)OC(C)(C)C)c1ccccc1)C(=O)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 G16 compound treatment 9.3149 -0.627 -0.3394 10.9374 0.73198 0.3273 -0.0086 -0.0182 3635316 CMLD5_000134 CCC/C=C/C(C)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 G17 compound treatment 8.9105 -1.0314 -0.5584 10.1881 -0.017343 -0.0078 -0.4003 -0.7169 1026004 CMLD5_000135 COc1ccc2ccccc2c1c3c(OC)ccc4ccccc34 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 G18 compound treatment 9.8696 -0.072329 -0.0392 10.9661 0.76069 0.3401 0.2128 0.6216 3635318 CMLD5_000136 COC(=O)N[C@@H](CCc1ccccc1)[C@@]2(CCCC2=O)C(=O)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 G19 mock treatment 10.4002 0.4583 0.2481 10.1617 -0.043756 -0.0196 0.1616 0.6493 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 G20 mock treatment 8.6645 -1.2774 -0.6915 10.5739 0.36849 0.1648 -0.3725 -0.524 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 G21 compound treatment 9.2178 -0.72417 -0.392 9.1229 -1.0825 -0.484 -0.6195 -0.9945 3635320 CMLD5_000137 CC[C@]1(C[C@]2(CC)[C@@H](CC1=O)c3ccccc3)C=C2/C=C/c4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 G22 compound treatment 9.89 -0.051917 -0.0281 10.0102 -0.19521 -0.0873 -0.0816 -0.8898 3635321 CMLD5_000138 C[C@](O)(CC=C)c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 G23 compound treatment 12.3478 2.4058 1.3024 10.8515 0.6461 0.2889 1.1252 0.8435 3635322 CMLD5_000139 CC(=C)C(O)/C=C/c1ccc(cc1)C(F)(F)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 G24 compound treatment 9.406 -0.53595 -0.2901 8.587 -1.6184 -0.7237 -0.7169 -0.9195 3635324 CMLD5_000140 COC(=O)C1(C[C@H]2CON=C2[C@H]1c3ccccc3)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 H01 compound treatment 11.9306 1.9887 1.0766 10.4126 0.2072 0.0926 0.8268 0.7651 3635326 CMLD5_000141 CCCCCCCc1cc2=C(Cl)C(=O)C(C)(OC(=O)C)C(=c2cn1)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 H02 compound treatment 11.6809 1.7389 0.9414 11.0898 0.88434 0.3954 0.9453 0.9258 3635327 CMLD5_000142 COC(=O)N1C(CC(=O)C)c2ccccc2C=C1C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 H03 mock treatment 9.2593 -0.6826 -0.3695 9.6032 -0.60224 -0.2693 -0.4517 -0.9879 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 H04 mock treatment 9.5612 -0.38076 -0.2061 9.9043 -0.30111 -0.1346 -0.241 -0.9787 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 H05 compound treatment 34.0025 24.061 13.0253 32.5861 22.381 10.0072 16.2864 0.9915 3635328 CMLD5_000143 CO[C@H](Cc1ccccc1Br)[C@H](C)/C=C/CC(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 H06 compound treatment 9.4524 -0.48952 -0.265 10.6173 0.41188 0.1842 -0.0572 -0.1771 3635330 CMLD5_000144 CC(=O)C([C@@H](NC(=O)OCC=C)c1ccc(Br)cc1)C(=O)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 H07 compound treatment 8.7153 -1.2267 -0.6641 12.8941 2.6887 1.2022 0.3805 0.2771 3635332 CMLD5_000145 CC(=O)C([C@H](CCc1ccccc1)NC(=O)OCC=C)C(=O)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 H08 compound treatment 9.4007 -0.54122 -0.293 9.9148 -0.29069 -0.13 -0.2991 -0.9331 3635334 CMLD5_000146 COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)NCc4ccc5OCOc5c4)c2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 H09 compound treatment 9.5777 -0.36425 -0.1972 10.2526 0.047127 0.0211 -0.1245 -0.628 3635335 CMLD5_000147 CC(C1CCCC(=O)C1)[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 H10 compound treatment 9.4567 -0.48525 -0.2627 10.5689 0.36345 0.1625 -0.0708 -0.2293 3011274 CMLD5_000148 CC(C)OC(=O)CC(NC(=O)OC(C)(C)C)c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 H11 compound treatment 10.3883 0.44637 0.2416 13.2496 3.0442 1.3612 1.1334 0.8198 3635336 CMLD5_000149 Oc1c(CN2CCOCC2)cc3CCCCc3c1c4c(O)c(CN5CCOCC5)cc6CCCCc46 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 H12 compound treatment 12.8168 2.8748 1.5563 11.8294 1.6239 0.7261 1.6139 0.9398 3635337 CMLD5_000150 OC(C1=CCCC1=O)c2ccc(Cl)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 H13 compound treatment 10.5688 0.62687 0.3394 9.0212 -1.1843 -0.5295 -0.1345 -0.2138 3635208 CMLD5_000151 OC(C1=CCCC1=O)c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 H14 compound treatment 12.7071 2.7652 1.4969 14.093 3.8875 1.7383 2.2876 0.9972 3635338 CMLD5_000152 CC(=O)C(=C)C(O)c1ccc(Cl)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 H15 compound treatment 10.1277 0.1858 0.1006 10.3375 0.13208 0.0591 0.1129 0.9678 3635339 CMLD5_000153 C[C@@]1(CCC=C2[C@@H]1CCCC2=O)C=C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 H16 compound treatment 9.9948 0.052823 0.0286 9.3412 -0.8642 -0.3864 -0.253 -0.653 3635341 CMLD5_000154 CC(O)(CC=C)c1ccco1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 H17 compound treatment 10.0215 0.079536 0.0431 12.5707 2.3653 1.0576 0.7783 0.7353 3635342 CMLD5_000155 CC(C)(C)OC(=O)N1CCC[C@H]1C(O)(c2ccccc2)c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 H18 compound treatment 9.6932 -0.24869 -0.1346 10.2923 0.086817 0.0388 -0.0677 -0.4835 3635344 CMLD5_000156 COCC(=O)C(C(NC(=O)OCC=C)c1ccc(F)c(F)c1)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 H19 mock treatment 9.1041 -0.83785 -0.4536 9.8183 -0.3871 -0.1731 -0.4431 -0.9127 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 H20 mock treatment 9.6977 -0.2442 -0.1322 9.808 -0.39745 -0.1777 -0.2191 -0.9894 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 H21 compound treatment 9.5242 -0.41773 -0.2261 10.6286 0.4232 0.1892 -0.0261 -0.0885 3635322 CMLD5_000157 CC(=C)C(O)/C=C/c1ccc(cc1)C(F)(F)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 H22 compound treatment 9.8528 -0.089167 -0.0483 10.2305 0.025054 0.0112 -0.0262 -0.5289 3635345 CMLD5_000158 COC(=O)NC(C(C(=O)OC)C(=O)OC)c1ccc2OCOc2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 H23 compound treatment 10.3704 0.42847 0.232 10.1323 -0.073108 -0.0327 0.1409 0.6015 3635346 CMLD5_000159 Fc1cc(F)c(F)c(/C=C/NC=O)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 H24 compound treatment 10.2795 0.33761 0.1828 11.4522 1.2468 0.5575 0.5234 0.8922 3635348 CMLD5_000160 COC(=O)C1(C[C@@H]2CON=C2[C@H]1c3ccccc3)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 I01 compound treatment 9.6199 -0.32204 -0.1743 9.3766 -0.82886 -0.3706 -0.3853 -0.9408 3635349 CMLD5_000161 CCCCCCCC1=CC2=C(Cl)C(=O)C(C)(OC(=O)C)C(=O)C2=CN1C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 I02 compound treatment 10.195 0.25309 0.137 12.0432 1.8378 0.8217 0.6779 0.8138 3635350 CMLD5_000162 COC(=O)C(C1N(C(=O)OC)C(=Cc2ccccc12)C3CC3)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 I03 compound treatment 10.7222 0.7803 0.4224 10.1076 -0.097868 -0.0438 0.2678 0.6305 3635351 CMLD5_000163 COC[C@@H](O)[C@@H](OC)[C@H](OC)[C@H](Cc1c(OC)cc(OC)cc1OC)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 I04 compound treatment 9.0641 -0.87787 -0.4752 46.4097 36.204 16.1882 11.1107 0.6861 3635353 CMLD5_000164 CC(C)OC(=O)[C@@H]1CC[C@H](C)[C@@H](CCC[C@@H]2C[C@H](C[C@H](CC#N)O2)OC(=O)[C@@H](OC(=O)C)c3ccccc3)O1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 I05 mock treatment 8.2262 -1.7158 -0.9288 9.3375 -0.86791 -0.3881 -0.9312 -0.925 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 I06 mock treatment 9.6112 -0.33069 -0.179 10.7095 0.50403 0.2254 0.0328 0.1139 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 I07 compound treatment 9.8797 -0.062279 -0.0337 10.6102 0.40479 0.181 0.1041 0.5657 3635243 CMLD5_000165 COC(=O)C1(CC#CC)[C@@H](CNC1=O)c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 I08 compound treatment 10.7141 0.77214 0.418 11.0107 0.80529 0.3601 0.5502 0.9972 3635355 CMLD5_000166 COC(=O)/C(=N/O)/Cc1cc(Br)c(OC)c(Br)c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 I09 compound treatment 11.8572 1.9153 1.0369 10.0598 -0.14567 -0.0651 0.6871 0.6614 3635357 CMLD5_000167 CC(=C)C(=O)c1ccc2OCOc2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 I10 compound treatment 9.5697 -0.37228 -0.2015 10.2749 0.069437 0.031 -0.1206 -0.5912 3010142 CMLD5_000168 CC(C)[C@H](O)C1=CCCCC1=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 I11 compound treatment 10.8392 0.89722 0.4857 11.2438 1.0383 0.4643 0.6717 0.9997 3635358 CMLD5_000169 CC(=O)CCOC1CCCCO1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 I12 compound treatment 9.9026 -0.039324 -0.0213 11.3367 1.1312 0.5058 0.3426 0.6767 3635359 CMLD5_000170 CCOC(=O)/C=C/CCC\C=C\C(=O)C(=C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 I13 compound treatment 9.7422 -0.19977 -0.1081 8.9792 -1.2263 -0.5483 -0.4642 -0.8306 3635361 CMLD5_000171 CC(=O)C(=C)C(O)c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 I14 compound treatment 10.363 0.42104 0.2279 10.5349 0.32942 0.1473 0.2653 0.9777 3635362 CMLD5_000172 Fc1ccc(cc1F)C(NC(=O)OCC=C)S(=O)(=O)c2ccc(Cl)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 I15 compound treatment 9.5044 -0.43756 -0.2369 9.9424 -0.26305 -0.1176 -0.2507 -0.9478 3635363 CMLD5_000173 CC(CCC#N)[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 I16 compound treatment 9.916 -0.025904 -0.014 8.3898 -1.8156 -0.8118 -0.584 -0.7192 3635141 CMLD5_000174 CC(O)C#C[Si](C)(C)c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 I17 compound treatment 10.0525 0.1106 0.0599 10.329 0.12357 0.0553 0.0814 0.9992 3635364 CMLD5_000175 COC(=O)C(=C)Nc1ccc(OC)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 I18 compound treatment 9.447 -0.49494 -0.2679 11.5664 1.361 0.6085 0.2408 0.3622 3635365 CMLD5_000176 C[C@@H](C=C)[C@](C)(O)c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 I19 compound treatment 10.3148 0.37284 0.2018 11.8984 1.693 0.757 0.678 0.8654 3635366 CMLD5_000177 Cc1nc2ccccc2oc1=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 I20 compound treatment 9.8642 -0.077692 -0.0421 9.6701 -0.53536 -0.2394 -0.199 -0.8188 3635367 CMLD5_000178 COC(=O)NC(c1ccccc1)C2(C(=O)OCC=C)C(=O)Cc3ccccc32 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 I21 mock treatment 10.5915 0.64957 0.3516 10.9516 0.7462 0.3337 0.4846 0.9997 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 I22 mock treatment 10.1279 0.18599 0.1007 12.2281 2.0226 0.9044 0.7107 0.781 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 I23 compound treatment 8.8544 -1.0876 -0.5888 10.4787 0.27327 0.1222 -0.3299 -0.5487 3635368 CMLD5_000179 COC(=O)C([C@@H](NC=O)c1ccccc1)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 I24 compound treatment 11.3098 1.3679 0.7405 10.7361 0.5307 0.2373 0.6914 0.8892 3635370 CMLD5_000180 COC(=O)C1(CC(CO)C(=O)[C@H]1c2ccccc2)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 J01 compound treatment 12.9924 3.0505 1.6514 10.471 0.26552 0.1187 1.2517 0.756 3635372 CMLD5_000181 CCCCCCCC1=CC2=C(Cl)C(=O)C(C)(OC(=O)C)C(=O)C2=CN1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 J02 compound treatment 9.013 -0.92888 -0.5029 8.8996 -1.3059 -0.5839 -0.7685 -0.9972 3635373 CMLD5_000182 CCCCCCCC1=Cc2ccc(F)cc2C(C(C(=O)C)C(=O)OC)N1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 J03 compound treatment 12.608 2.6661 1.4433 11.6913 1.4859 0.6644 1.4903 0.938 3635190 CMLD5_000183 COC(=O)[C@H]1O[C@H]([C@H](C)[C@H]2O[C@]21C)c3cc(OC)c(C)c(OC)c3OCc4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 J04 compound treatment 10.8141 0.87213 0.4721 10.1032 -0.10224 -0.0457 0.3015 0.6357 3635374 CMLD5_000184 CC(C)OC(=O)[C@H]1O[C@H](CCCCOCc2ccccc2)[C@@H](C)[C@H]3O[C@H]31 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 J05 mock treatment 10.4307 0.48873 0.2646 9.8254 -0.38001 -0.1699 0.0669 0.2129 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 J06 mock treatment 10.5555 0.6136 0.3322 11.266 1.0606 0.4742 0.5702 0.9848 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 J07 compound treatment 10.5595 0.61755 0.3343 9.1056 -1.0999 -0.4918 -0.1113 -0.1872 3635376 CMLD5_000185 COC(=O)C1(CC2=CC[C@H]3[C@@H]([C@@H]2Cc4ccccc4[C@@H]1C[N+](=O)[O-])C(=O)N(C3=O)c5ccccc5)C(=O)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 J08 compound treatment 41.965 32.023 17.3359 42.5431 32.338 14.4593 22.4826 0.9959 3555609 CMLD5_000186 CC(C)(C)OC(=O)C1=NOC2(C1)C=CC(=O)C=C2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 J09 compound treatment 10.9935 1.0516 0.5693 8.8638 -1.3417 -0.5999 -0.0217 -0.0262 3635377 CMLD5_000187 C/C(=C\CO)/CCO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 J10 compound treatment 10.1044 0.16246 0.0879 11.28 1.0746 0.4805 0.4019 0.8229 3131710 CMLD5_000188 CCOC(=O)CC(C1CCCCC1=O)C(=O)OCC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 J11 compound treatment 11.0766 1.1347 0.6143 10.7769 0.57142 0.2555 0.615 0.9244 3635234 CMLD5_000189 COc1ccc(cc1)C(O)C2=CCCC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 J12 compound treatment 8.8685 -1.0734 -0.5811 10.1573 -0.048098 -0.0215 -0.4261 -0.7328 3635379 CMLD5_000190 COc1ccc2CCCCc2c1c3c(OC)c(Br)cc4CCCCc34 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 J13 compound treatment 10.4619 0.51997 0.2815 11.7172 1.5118 0.676 0.677 0.9246 3635344 CMLD5_000191 COCC(=O)C(C(NC(=O)OCC=C)c1ccc(F)c(F)c1)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 J14 compound treatment 12.6803 2.7383 1.4824 14.5415 4.3361 1.9388 2.4192 0.9912 3635380 CMLD5_000192 COc1cccc(c1)C(O)C(=C)C(=O)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 J15 compound treatment 10.4774 0.53547 0.2899 11.2194 1.0139 0.4534 0.5256 0.9767 3635381 CMLD5_000193 Cc1ccc(cc1)C(O)C2=CCCC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 J16 compound treatment 10.4588 0.51686 0.2798 10.4034 0.19798 0.0885 0.2604 0.8875 2069487 CMLD5_000194 COc1ccc(/N=C/c2ccccc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 J17 compound treatment 9.4809 -0.46107 -0.2496 9.9151 -0.29039 -0.1298 -0.2683 -0.9536 3635382 CMLD5_000195 O[C@H]([C@@H](O)C(=O)OCC(F)(F)F)C(=O)OCC(F)(F)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 J18 compound treatment 9.1676 -0.77434 -0.4192 9.704 -0.50145 -0.2242 -0.455 -0.957 3635384 CMLD5_000196 CCOC(=O)C(CC=C)(Nc1ccc(OC)cc1)c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 J19 compound treatment 10.1706 0.22865 0.1238 11.1276 0.92217 0.4123 0.3791 0.8806 3635385 CMLD5_000197 COC(=O)N[C@H](C[N+](=O)[O-])/C=C/c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 J20 compound treatment 8.4179 -1.524 -0.825 10.4715 0.26607 0.119 -0.4993 -0.5989 3635387 CMLD5_000198 O=C1NC[C@@H](N1)c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 J21 mock treatment 11.2514 1.3095 0.7089 10.9039 0.69841 0.3123 0.7221 0.9322 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 J22 mock treatment 10.158 0.21602 0.1169 9.6947 -0.51075 -0.2284 -0.0788 -0.3071 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 J23 compound treatment 10.8718 0.92986 0.5034 9.8192 -0.38622 -0.1727 0.2338 0.4394 3635388 CMLD5_000199 COC(=O)C([C@@H](NC(=O)OCc1ccccc1)c2ccccc2)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 J24 compound treatment 11.0908 1.1488 0.6219 11.8716 1.6661 0.745 0.9666 0.996 3635390 CMLD5_000200 COCC1=C2C(CC([C@@H](C[N+](=O)[O-])c3ccccc23)(C(=O)OC)C(=O)OC)C4C(C1)C(=O)N(C4=O)c5ccccc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 K01 compound treatment 10.2178 0.27591 0.1494 10.3564 0.15095 0.0675 0.1533 0.9356 3635392 CMLD5_000201 COC(=O)C([C@@H]1O[C@]23COC=C[C@]3(C)[C@H]2c4ccccc14)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 K02 compound treatment 11.0965 1.1546 0.625 12.837 2.6315 1.1766 1.274 0.9562 3635394 CMLD5_000202 COC(=O)C(C1N(C(=O)OC)C(=Cc2ccccc12)/C=C/C)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 K03 compound treatment 10.9106 0.96866 0.5244 9.6759 -0.52958 -0.2368 0.2034 0.3534 3635396 CMLD5_000203 OC[C@@H](O)[C@@H](O)CCc1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 K04 compound treatment 10.1044 0.16242 0.0879 10.2498 0.044312 0.0198 0.0762 0.8453 3635398 CMLD5_000204 CO[C@@H](CCO)C[C@H]1O[C@@H](CC[C@@H]1C)C(=O)OC(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 K05 compound treatment 8.7029 -1.239 -0.6708 10.0841 -0.12133 -0.0543 -0.5127 -0.7618 3635400 CMLD5_000205 CO[C@H]1[C@H](C)/C(=C/CCOC(=O)C\C=C\c2ccccc2)/c3ccc(F)cc13 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 K06 compound treatment 8.5941 -1.3478 -0.7296 9.7783 -0.42716 -0.191 -0.651 -0.8631 3635402 CMLD5_000206 COC(=O)/C(=C(/C)\NCc1ccccc1)/[C@H](Cc2ccccc2)NC(=O)OCC=C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 K07 mock treatment 8.5695 -1.3724 -0.743 9.5152 -0.6902 -0.3086 -0.7436 -0.9243 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 K08 mock treatment 9.4863 -0.45561 -0.2466 12.0251 1.8197 0.8136 0.4009 0.4716 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 K09 compound treatment 8.1533 -1.7886 -0.9683 9.5872 -0.61827 -0.2765 -0.8802 -0.8741 3635404 CMLD5_000207 O=C(Oc1ccccc1)[C@H]2O[C@@H]2c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 K10 compound treatment 22.5086 12.567 6.803 20.1931 9.9877 4.4658 7.9683 0.9792 3635405 CMLD5_000208 CC(=C)C(=O)/C=C/C=C/c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 K11 compound treatment 11.5378 1.5959 0.864 9.5087 -0.6967 -0.3115 0.3906 0.4253 1069385 CMLD5_000209 Cc1ccc(cc1)S(=O)(=O)OCCc2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 K12 compound treatment 19.0612 9.1192 4.9368 17.8239 7.6185 3.4065 5.8996 0.9836 3635407 CMLD5_000210 Brc1ccc2n(CC3CO3)c4ccc(Br)cc4c2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 K13 compound treatment 10.2685 0.32661 0.1768 8.6612 -1.5442 -0.6905 -0.3632 -0.5096 3635408 CMLD5_000211 COC(=O)C(C(NC(=O)OCC=C)c1ccc(F)c(F)c1)C(=O)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 K14 compound treatment 14.9705 5.0285 2.7222 14.9804 4.775 2.1351 3.4346 0.9928 3635409 CMLD5_000212 CC(=O)C(=C)C(O)c1cccc(Br)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 K15 mock treatment 9.2946 -0.64734 -0.3504 10.8665 0.66102 0.2956 -0.0388 -0.0846 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 K16 mock treatment 9.4669 -0.47507 -0.2572 11.6794 1.474 0.6591 0.2842 0.4017 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 K17 compound treatment 10.6637 0.7218 0.3907 11.2891 1.0837 0.4845 0.6189 0.9943 3635410 CMLD5_000213 O[C@H]([C@@H](O)C(=O)OCC=C)C(=O)OCC=C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 K18 compound treatment 11.1211 1.1791 0.6383 13.7384 3.533 1.5797 1.5684 0.9205 3635412 CMLD5_000214 COC(=O)C(C(Cc1cc(F)cc(F)c1F)NC=O)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 K19 compound treatment 9.4678 -0.47415 -0.2567 9.6822 -0.52326 -0.234 -0.3469 -0.9989 3635413 CMLD5_000215 COC(=O)NC(C(=O)OC)(C(=O)OC)c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 K20 compound treatment 10.3196 0.37763 0.2044 10.7705 0.56509 0.2527 0.3232 0.9945 3635414 CMLD5_000216 COC(=O)/C(=N\c1ccc(OC)cc1)/CC(NC(=O)OCC=C)c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 K21 compound treatment 9.9377 -0.0042691 -0.0023 10.0232 -0.18227 -0.0815 -0.0593 -0.7269 3635416 CMLD5_000217 COc1ccc(NC2=CC(N(C2=O)c3ccc(OC)cc3)c4ccccc4)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 K22 compound treatment 10.8848 0.94285 0.5104 9.7805 -0.42495 -0.19 0.2266 0.416 3635417 CMLD5_000218 COC(=O)N[C@H](C(C(=O)C)C(=O)OC)c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 K23 mock treatment 10.1075 0.16558 0.0896 10.9689 0.76341 0.3413 0.3048 0.8635 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 K24 mock treatment 10.5759 0.634 0.3432 8.77 -1.4355 -0.6419 -0.2112 -0.2901 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 L01 compound treatment 9.7807 -0.16119 -0.0873 10.2857 0.080289 0.0359 -0.0363 -0.3849 3635419 CMLD5_000219 COC(=O)N1[C@H]2CC[C@@]3(C)CC(=O)C[C@]1(C)C3c4ccccc24 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 L02 compound treatment 9.8367 -0.10521 -0.057 12.4852 2.2797 1.0194 0.6805 0.6666 3635421 CMLD5_000220 COC(=O)C(C1N(C(=O)OC)C(=Cc2ccccc12)C)c3ccc(OC)c(OC)c3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 L03 compound treatment 10.6683 0.72636 0.3932 11.376 1.1706 0.5234 0.6481 0.9901 3635422 CMLD5_000221 COc1cc(OC)c([C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(OC)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 L04 compound treatment 10.1564 0.21448 0.1161 10.4863 0.28081 0.1256 0.1709 0.9992 3635424 CMLD5_000222 CCCCCCCc1cc2ccccc2c(=O)o1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 L05 compound treatment 8.2453 -1.6966 -0.9185 8.677 -1.5284 -0.6834 -1.1327 -0.9894 3635425 CMLD5_000223 CO[C@@H]([C@H](C)/C=C/CC(=O)OC)c1c2OCOc2ccc1Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 L06 compound treatment 8.8449 -1.0971 -0.5939 9.3779 -0.82752 -0.37 -0.6816 -0.9741 3635427 CMLD5_000224 COC(=O)/C(=C(/C)\NCc1ccccc1)/[C@@H](NC(=O)OCC=C)c2ccc(Br)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 L07 mock treatment 9.9274 -0.014499 -0.0078 10.6397 0.43423 0.1942 0.1317 0.678 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 L08 mock treatment 10.6647 0.72275 0.3913 10.9327 0.72725 0.3252 0.5066 0.9958 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 L09 compound treatment 10.8622 0.92022 0.4982 10.824 0.61854 0.2766 0.5478 0.9614 3635429 CMLD5_000225 COc1ccc(cc1)C(=O)[C@@]2(C)C[C@@H](C)C(=C2)c3ccc(OC)cc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 L10 compound treatment 9.6367 -0.30524 -0.1652 10.8029 0.59747 0.2672 0.0721 0.2294 3635431 CMLD5_000226 CC1(C)OCC(CO1)[C@H](O)C2=CCCCC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 L11 compound treatment 9.1006 -0.84129 -0.4554 8.876 -1.3294 -0.5944 -0.7424 -0.9914 3635432 CMLD5_000227 CCOC(=O)/C=C/CCCC=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 L12 compound treatment 11.6914 1.7495 0.9471 13.8059 3.6004 1.6099 1.808 0.968 3635434 CMLD5_000228 CCOC(=O)/C=C/CCC\C=C\C(=O)c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 L13 compound treatment 9.9401 -0.0018641 -0.001 9.249 -0.9564 -0.4276 -0.3031 -0.7088 3635436 CMLD5_000229 CC(C)(O)C(=O)C(=C)C(O)c1ccc(cc1)[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 L14 compound treatment 8.4216 -1.5204 -0.8231 10.5581 0.35269 0.1577 -0.4705 -0.5614 3635437 CMLD5_000230 CC(=O)C(=C)C(O)/C=C/c1ccco1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 L15 mock treatment 10.0887 0.14677 0.0795 10.455 0.24956 0.1116 0.1351 0.9861 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 L16 mock treatment 9.1434 -0.79853 -0.4323 9.3876 -0.8178 -0.3657 -0.5642 -0.9965 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 L17 compound treatment 9.5281 -0.4138 -0.224 9.7112 -0.49427 -0.221 -0.3147 -1.0 3635439 CMLD5_000231 CCOC(=O)C([C@H](CCc1ccccc1)NC(=O)OC)C(=O)c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 L18 compound treatment 9.3422 -0.59971 -0.3247 8.0728 -2.1327 -0.9536 -0.9039 -0.8973 3635441 CMLD5_000232 CC(O)(CC=C)/C=C/c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 L19 compound treatment 8.5769 -1.365 -0.739 11.0041 0.79862 0.3571 -0.27 -0.329 3635443 CMLD5_000233 COC(=O)C(C(=O)OC)c1ccccc1[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 L20 compound treatment 10.024 0.082098 0.0444 9.4305 -0.77499 -0.3465 -0.2136 -0.6114 3635444 CMLD5_000234 COC(=O)NC(/C=C/c1ccccc1)C(C(=O)C)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 L21 compound treatment 10.0625 0.12059 0.0653 11.7143 1.5088 0.6747 0.5232 0.7719 3635446 CMLD5_000235 CC(O)(CC=C)C#Cc1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 L22 compound treatment 10.5713 0.62938 0.3407 8.8188 -1.3866 -0.62 -0.1975 -0.2792 3635447 CMLD5_000236 COC(=O)NC(c1c[nH]c2ccccc12)c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 L23 mock treatment 12.4275 2.4856 1.3456 9.5388 -0.66661 -0.2981 0.7407 0.5374 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 L24 mock treatment 10.151 0.20907 0.1132 11.0907 0.88528 0.3958 0.3599 0.8743 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 M01 compound treatment 10.7988 0.85684 0.4639 9.029 -1.1764 -0.526 -0.044 -0.0627 3635448 CMLD5_000237 COC(=O)CC1N(C(=O)OC)C(=Cc2ccccc12)C3CC3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 M02 compound treatment 11.5787 1.6367 0.886 10.2862 0.080729 0.0361 0.6521 0.7353 3635449 CMLD5_000238 COC(=O)N1C(C/C(=C/C(=O)C)/C)c2ccccc2C=C1C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 M03 compound treatment 9.7907 -0.15126 -0.0819 9.6164 -0.589 -0.2634 -0.2441 -0.8852 3635451 CMLD5_000239 COC(=O)[C@H]1O[C@@H](CCOc2ccccc2)[C@@H](C)C=C1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 M04 compound treatment 10.7709 0.82894 0.4488 11.1474 0.94194 0.4212 0.6151 0.9995 3635453 CMLD5_000240 C/C=C/C1=CC2=CC(=O)C(C)(OC(=O)c3c(C)cc(O)cc3O)C(=O)C2=CO1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 M05 compound treatment 10.777 0.83512 0.4521 10.5282 0.32273 0.1443 0.4217 0.8886 3635455 CMLD5_000241 COC(=O)C/C=C/[C@@H](C)[C@H](O)c1ccccc1Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 M06 compound treatment 10.6611 0.7192 0.3893 9.6111 -0.59433 -0.2657 0.0874 0.1854 3635457 CMLD5_000242 COC(=O)[C@H](Cc1c[nH]c2ccccc12)Nc3nnc(C(=O)OC)c(n3)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 M07 compound treatment 7.8418 -2.1001 -1.1369 9.1179 -1.0876 -0.4863 -1.1478 -0.9282 3635459 CMLD5_000243 COC(=O)C1(CC=CCc2ccccc2[C@@H]1C[N+](=O)[O-])C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 M08 compound treatment 9.5875 -0.35446 -0.1919 8.5256 -1.6798 -0.7511 -0.6668 -0.8601 3635461 CMLD5_000244 C[C@H]1/C=C/CC(=O)NCc2cccc(CNC(=O)N[C@H]1c3ccccc3)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 M09 mock treatment 8.4209 -1.5211 -0.8234 9.4359 -0.76954 -0.3441 -0.8256 -0.9251 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 M10 mock treatment 9.1593 -0.78265 -0.4237 10.1989 -0.0064982 -0.0029 -0.3017 -0.7119 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 M11 compound treatment 10.3515 0.40957 0.2217 10.8733 0.66783 0.2986 0.3679 0.9893 1039317 CMLD5_000245 O=C1CCCC(=C1)c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 M12 compound treatment 8.3363 -1.6057 -0.8692 10.2746 0.069152 0.0309 -0.5928 -0.6815 3635463 CMLD5_000246 OC(C[N+](=O)[O-])c1ccc(cc1)[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 M13 mock treatment 8.486 -1.456 -0.7882 12.8753 2.6699 1.1938 0.2868 0.2005 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 M14 mock treatment 10.1885 0.2466 0.1335 8.2808 -1.9247 -0.8606 -0.5141 -0.5904 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 M15 compound treatment 13.7375 3.7955 2.0547 10.8764 0.67093 0.3 1.665 0.8018 3635464 CMLD5_000247 C=C[C@H]1CCC=C2[C@@H]1CCCC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 M16 compound treatment 8.85 -1.092 -0.5911 10.2096 0.0041443 0.0019 -0.4167 -0.7049 3635466 CMLD5_000248 CC(O)(CC=C)c1cccc(Br)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 M17 compound treatment 10.1496 0.20766 0.1124 10.7899 0.58449 0.2613 0.2643 0.929 3635467 CMLD5_000249 CCOC(=O)/C(=N/NC(=O)C)/C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 M18 compound treatment 14.1861 4.2441 2.2976 10.6139 0.40843 0.1826 1.7538 0.7609 3635469 CMLD5_000250 OC1(CC=C)CCOc2ccccc21 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 M19 compound treatment 8.8592 -1.0828 -0.5862 9.9622 -0.2432 -0.1087 -0.4914 -0.8242 3555939 CMLD5_000251 COC(=O)N[C@H](C(C(=O)C)C(=O)OC)c1cccc(F)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 M20 compound treatment 10.5497 0.60774 0.329 10.2443 0.038899 0.0174 0.2449 0.7435 3635470 CMLD5_000252 COC(=O)N[C@H](C(C(=O)OC)C(=O)OC)c1ccc(Br)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 M21 compound treatment 13.6861 3.7442 2.0269 11.2012 0.99574 0.4452 1.7481 0.8423 3635472 CMLD5_000253 COC(=O)N[C@H]([C@@H](C)[N+](=O)[O-])c1cccc(F)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 M22 compound treatment 9.7967 -0.14519 -0.0786 11.884 1.6785 0.7505 0.4751 0.6296 3635474 CMLD5_000254 COC(=O)NC1C=CCCC1C(=O)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 M23 compound treatment 12.4795 2.5375 1.3737 11.6256 1.4201 0.635 1.4204 0.9385 3635475 CMLD5_000255 CCOC(=O)C(C)(CC=C)Nc1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 M24 compound treatment 12.3856 2.4436 1.3229 10.6095 0.40405 0.1807 1.0632 0.7963 3635476 CMLD5_000256 COC(=O)C1(CC2=C[C@H](CC2=O)Cc3ccccc3[C@@H]1C[N+](=O)[O-])C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 N01 compound treatment 9.9372 -0.0047641 -0.0026 10.9512 0.74574 0.3334 0.234 0.7016 3635477 CMLD5_000257 CCCCCCCC1Cc2ccccc2C(C(C(=O)OC)C(=O)OC)N1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 N02 compound treatment 10.4093 0.46739 0.253 9.1469 -1.0585 -0.4733 -0.1558 -0.2902 3635478 CMLD5_000258 CC(C)OC(=O)[C@@H]1CC[C@H](C)[C@@H](CCCCO)O1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 N03 compound treatment 11.025 1.0831 0.5863 15.9408 5.7353 2.5645 2.228 0.8469 3635480 CMLD5_000259 COC(=O)C1=C(C)[C@@H](O)[C@@H](C)[C@@](C)(O1)c2cc(OC)c(C)c(OC)c2COc3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 N04 compound treatment 10.2111 0.26921 0.1457 19.578 9.3726 4.1908 3.0664 0.7313 3635482 CMLD5_000260 Cc1cc(O)cc(O)c1C(=O)OC2(C)C(=O)C=C3C=C(OC=C3C2=O)/C=C/C(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 N05 compound treatment 11.9248 1.9829 1.0735 11.3448 1.1393 0.5094 1.1193 0.942 3635483 CMLD5_000261 CO[C@H]1[C@H](C)/C(=C/CC(=O)OC)/c2ccc3OCOc3c12 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 N06 compound treatment 10.8355 0.8936 0.4838 10.5456 0.34014 0.1521 0.4496 0.8866 3635485 CMLD5_000262 CC(=O)C([C@H](NC(=O)OCC=C)c1cccc(c1)C(F)(F)F)C(=O)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 N07 compound treatment 9.333 -0.60896 -0.3297 9.5853 -0.62016 -0.2773 -0.4292 -0.9963 3635487 CMLD5_000263 COC(=O)C1(C/C=C\C/C=C\c2ccccc2C1C[N+](=O)[O-])C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 N08 compound treatment 9.9703 0.028328 0.0153 9.3005 -0.90493 -0.4046 -0.2753 -0.6798 3635489 CMLD5_000264 CC(C)CCNC(=O)[C@H](C)[C@@H]1CC[C@@]2(C)C=CC(=O)C(=C2[C@H]1O)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 N09 mock treatment 10.7098 0.76783 0.4157 10.7765 0.57108 0.2553 0.4745 0.9726 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 N10 mock treatment 10.9437 1.0017 0.5423 11.4628 1.2573 0.5622 0.781 0.9998 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 N11 compound treatment 15.043 5.101 2.7615 19.2262 9.0208 4.0335 4.8048 0.9829 3011353 CMLD5_000265 Oc1ccccc1C(=O)/C=C/c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 N12 compound treatment 8.9585 -0.98342 -0.5324 8.4867 -1.7188 -0.7685 -0.9199 -0.9839 3635491 CMLD5_000266 CC(=C)C(=O)c1cccs1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 N13 mock treatment 9.9407 -0.0012091 -7.0E-4 8.9105 -1.295 -0.579 -0.4099 -0.7079 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 N14 mock treatment 9.6745 -0.26742 -0.1448 8.7228 -1.4826 -0.6629 -0.5711 -0.8417 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 N15 compound treatment 10.2787 0.33678 0.1823 9.0361 -1.1694 -0.5229 -0.2408 -0.4349 3635492 CMLD5_000267 C/C(=C\C[Si](C)(C)C)/CC[C@H](O)C1=CCCCC1=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 N16 compound treatment 11.9028 1.9609 1.0615 10.1257 -0.079781 -0.0357 0.7254 0.683 3635494 CMLD5_000268 C[C@H](OC(=O)C)C#C[Si](C)(C)c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 N17 compound treatment 9.2401 -0.70184 -0.3799 8.4129 -1.7926 -0.8015 -0.8354 -0.9418 3635145 CMLD5_000269 CCOC(=O)C(CC=C)Nc1ccc(OC)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 N18 compound treatment 10.6988 0.75684 0.4097 10.8476 0.64218 0.2871 0.4928 0.9849 3635496 CMLD5_000270 COC(=O)C(O)(CC=C)c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 N19 compound treatment 10.178 0.23607 0.1278 10.3041 0.098612 0.0441 0.1215 0.8991 3635497 CMLD5_000271 C[C@H]([C@@H](NC(=O)OCC=C)c1ccccc1)[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 N20 compound treatment 16.116 6.174 3.3424 18.2113 8.0059 3.5797 4.8946 0.9994 3635499 CMLD5_000272 OC(CC=C)(/C=C/c1ccccc1)c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 N21 compound treatment 13.2859 3.3439 1.8103 15.3249 5.1195 2.2891 2.8987 0.9932 3132532 CMLD5_000273 Nc1ccccc1C(=O)/C=C/c2ccc3OCOc3c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 N22 compound treatment 10.6601 0.71815 0.3888 11.6071 1.4017 0.6267 0.7181 0.9736 3635501 CMLD5_000274 O[C@@H](CCOC(c1ccccc1)(c2ccccc2)c3ccccc3)C4=CCCCC4=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 N23 compound treatment 11.7073 1.7654 0.9557 9.2299 -0.97556 -0.4362 0.3673 0.3497 3635502 CMLD5_000275 CCC(=O)C([C@H](CCc1ccccc1)NC(=O)OC)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 N24 compound treatment 8.8155 -1.1264 -0.6098 10.3741 0.16863 0.0754 -0.3779 -0.615 3635504 CMLD5_000276 COC(=O)C1(C/C=C\C/C=C\c2ccccc2[C@@H]1C[N+](=O)[O-])C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 O01 compound treatment 9.5956 -0.34633 -0.1875 9.3934 -0.81201 -0.3631 -0.3893 -0.9527 3635505 CMLD5_000277 COC(=O)N1C(CC(=O)C)c2ccccc2C=C1C3CC3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 O02 compound treatment 10.3265 0.38462 0.2082 9.945 -0.26045 -0.1165 0.0649 0.272 3635506 CMLD5_000278 CC(C)OC(=O)[C@H]1O[C@H](CCCCOCc2ccccc2)[C@@H](C)C=C1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 O03 compound treatment 9.8966 -0.045354 -0.0246 9.8793 -0.32617 -0.1458 -0.1205 -0.8147 3635508 CMLD5_000279 Cc1ccc(cc1)C(=O)OC[C@H]2O[C@H](Cl)C[C@@H]2OC(=O)c3ccc(C)cc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 O04 compound treatment 9.3648 -0.57717 -0.3125 12.7849 2.5795 1.1534 0.5946 0.4976 3635509 CMLD5_000280 Cc1cc(O)cc(O)c1C(=O)OC2(C)C(=O)C=C3C=C(OC=C3C2=O)/C=C/CO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 O05 compound treatment 8.7742 -1.1677 -0.6321 9.8384 -0.36707 -0.1641 -0.563 -0.8621 3635271 CMLD5_000281 COCC1=C2[C@H](CC([C@@H](C[N+](=O)[O-])c3ccccc23)(C(=O)OC)C(=O)OC)n4n(C1)c(=O)n(c5ccccc5)c4=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 O06 compound treatment 10.0018 0.059876 0.0324 10.8723 0.66689 0.2982 0.2338 0.7794 3635511 CMLD5_000282 COC(=O)/C(=C(/C)\NCc1ccccc1)/[C@H](CC(C)C)NC(=O)OCC=C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 O07 compound treatment 11.8573 1.9154 1.0369 10.9799 0.77443 0.3463 0.9781 0.8947 3635513 CMLD5_000283 COC(=O)C1(Cc2conc2[C@H]1c3ccccc3)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 O08 compound treatment 9.8768 -0.065139 -0.0353 10.6345 0.42905 0.1918 0.1107 0.5676 3635515 CMLD5_000284 O=C1N[C@H](Cc2ccccc2)C(=O)N1Cc3cccc4ccccc34 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 O09 compound treatment 10.9487 1.0068 0.545 9.6244 -0.58108 -0.2598 0.2017 0.334 3635517 CMLD5_000285 C[C@@H]1C[C@@](C)(C=C1c2ccc3ccccc3c2)C(=O)c4ccc5ccccc5c4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 O10 compound treatment 10.0955 0.15352 0.0831 11.8724 1.6669 0.7453 0.5858 0.7811 3011264 CMLD5_000286 CCOC(=O)CC(CC(=O)C)C(=O)OCC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 O11 mock treatment 9.5977 -0.34419 -0.1863 8.8347 -1.3708 -0.6129 -0.5652 -0.8822 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 O12 mock treatment 10.0182 0.076263 0.0413 9.7305 -0.47493 -0.2124 -0.121 -0.5592 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 O13 compound treatment 26.4692 16.527 8.9472 25.8332 15.628 6.9877 11.2677 0.9925 3635519 CMLD5_000287 CC(=O)C(=C)C(O)c1ccc(cc1)[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 O14 compound treatment 9.8157 -0.12619 -0.0683 9.2856 -0.91988 -0.4113 -0.3391 -0.8134 3635520 CMLD5_000288 C/C(=C\C[Si](C)(C)C)/CCC=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 O15 compound treatment 9.992 0.050101 0.0271 10.8545 0.64903 0.2902 0.2244 0.7698 3635522 CMLD5_000289 CC(C)(C(O)c1ccc(cc1)[N+](=O)[O-])[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 O16 compound treatment 11.2565 1.3145 0.7116 9.1721 -1.0333 -0.462 0.1765 0.208 1019983 CMLD5_000290 CC(O)(CC=C)c1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 O17 compound treatment 10.7105 0.76852 0.416 10.4508 0.24537 0.1097 0.3718 0.864 3635523 CMLD5_000291 COC(=O)N[C@@H](CCc1ccccc1)[C@@]2(CCCC2=O)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 O18 compound treatment 11.9897 2.0478 1.1086 11.8256 1.6201 0.7244 1.2961 0.9787 3635525 CMLD5_000292 COc1cccc(c1)c2coc3ccc(Br)cc3c2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 O19 compound treatment 9.4716 -0.4703 -0.2546 8.5863 -1.6191 -0.724 -0.6919 -0.9016 3635526 CMLD5_000293 COC(=O)N[C@H](C[N+](=O)[O-])c1cccc(C)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 O20 compound treatment 9.8407 -0.10119 -0.0548 10.9433 0.73781 0.3299 0.1945 0.5817 3635528 CMLD5_000294 COC(=O)NC(CCc1ccccc1)C(C(=O)OC)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 O21 compound treatment 10.7382 0.79626 0.4311 11.4758 1.2704 0.568 0.7065 0.9907 1913672 CMLD5_000295 [O-][N+](=O)c1cccc(/C=C/C(=O)c2ccccc2)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 O22 compound treatment 8.7803 -1.1616 -0.6289 10.6098 0.40431 0.1808 -0.3168 -0.4842 3635529 CMLD5_000296 OC(C1=CCCC1=O)c2ccc3OCOc3c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 O23 compound treatment 10.5303 0.5884 0.3185 9.3052 -0.90028 -0.4025 -0.0594 -0.1157 3635513 CMLD5_000297 COC(=O)C1(Cc2conc2[C@H]1c3ccccc3)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 O24 compound treatment 10.822 0.88009 0.4764 10.6642 0.45874 0.2051 0.4819 0.9291 3635459 CMLD5_000298 COC(=O)C1(CC=CCc2ccccc2[C@@H]1C[N+](=O)[O-])C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 P01 compound treatment 12.9643 3.0224 1.6362 9.7506 -0.45484 -0.2034 1.0131 0.6145 3635530 CMLD5_000299 COC(=O)CC1N(C(=O)OC)C(=C(Cc2ccc3OCOc3c2)c4ccccc14)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 P02 compound treatment 11.0856 1.1437 0.6191 11.0849 0.87948 0.3932 0.7159 0.976 3635531 CMLD5_000300 COC(=O)C1=C(C)[C@H](O)[C@@H](C)[C@@](C)(O1)c2cc(OC)c(C)c(OC)c2COc3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 P03 compound treatment 11.397 1.4551 0.7877 10.5422 0.33675 0.1506 0.6635 0.8273 3635532 CMLD5_000301 COC(=O)[C@H]1O[C@H]([C@H](C)[C@@H](O)[C@H]1C)c2cc(OC)c(C)c(OC)c2O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 P04 compound treatment 13.7648 3.8229 2.0695 12.6346 2.4292 1.0862 2.2314 0.9547 3635534 CMLD5_000302 COC(=O)[C@@]1(Cc2ccccc2c3ccco3)C=C[C@H](C)[C@H](N1C(=O)C(F)(F)F)c4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 P05 compound treatment 11.271 1.3291 0.7195 9.5948 -0.61067 -0.2731 0.3157 0.4102 3635536 CMLD5_000303 COC(=O)C1(CC(=CCc2ccccc2[C@@H]1C[N+](=O)[O-])C=C)C(=O)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 P06 compound treatment 11.5658 1.6239 0.8791 9.9847 -0.22078 -0.0987 0.5518 0.6238 3635538 CMLD5_000304 COC(=O)/C(=C(/C)\NCc1ccccc1)/[C@@H](NC(=O)OCC=C)c2cccc(F)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 P07 compound treatment 10.0451 0.10313 0.0558 9.8035 -0.40192 -0.1797 -0.0876 -0.4655 1026004 CMLD5_000305 COc1ccc2ccccc2c1c3c(OC)ccc4ccccc34 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 P08 compound treatment 11.9698 2.0279 1.0978 12.2819 2.0765 0.9285 1.4328 0.9965 3635540 CMLD5_000306 C[C@@]12O[C@H]2[C@@H](O)C(=C(CO)[C@H]1O)Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 P09 compound treatment 9.9404 -0.0015641 -8.0E-4 10.9093 0.70385 0.3147 0.2219 0.7052 3635542 CMLD5_000307 COc1ccc(cc1)C(=O)C(=C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 P10 compound treatment 11.4446 1.5027 0.8135 10.3598 0.15434 0.069 0.624 0.7643 3635543 CMLD5_000308 CC1(CC2(C)[C@@H](CC1=O)c3ccc(Br)cc3)C=C2/C=C/c4ccc(Br)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 P11 mock treatment 9.5154 -0.42656 -0.2309 13.2204 3.0149 1.3481 0.7899 0.5776 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 P12 mock treatment 11.4359 1.494 0.8088 10.8862 0.68072 0.3044 0.7871 0.9109 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 P13 compound treatment 9.0316 -0.9103 -0.4928 9.7957 -0.40977 -0.1832 -0.478 -0.9092 3011405 CMLD5_000309 OC(CCc1ccccc1)C2=CCCC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 P14 compound treatment 10.7512 0.80928 0.4381 9.175 -1.0305 -0.4608 -0.016 -0.0252 3635545 CMLD5_000310 C[C@@]1(CC[C@H](O)[C@@H]2[C@@H]1CCCC2=O)C=C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 P15 compound treatment 11.4308 1.4889 0.806 10.6647 0.45924 0.2053 0.7152 0.8598 3635547 CMLD5_000311 ClC1NC=Nc2c1ncn2CCC#N 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 P16 compound treatment 17.1584 7.2165 3.9067 16.3942 6.1887 2.7672 4.7191 0.9857 3635548 CMLD5_000312 FC(F)(F)c1cc(NC(=S)Nc2ccc3ccccc3c2)cc(c1)C(F)(F)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 P17 compound treatment 12.4584 2.5164 1.3623 11.8887 1.6832 0.7526 1.4955 0.9609 3635549 CMLD5_000313 CC(O)(CCc1ccccc1)CC=C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 P18 compound treatment 11.3253 1.3834 0.7489 11.0429 0.83741 0.3744 0.7943 0.9487 3635550 CMLD5_000314 CCOC(=O)[C@](C)(CC=C)Nc1ccc(OC)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 P19 compound treatment 11.5623 1.6203 0.8772 11.2992 1.0937 0.489 0.9661 0.9619 3635552 CMLD5_000315 COC(=O)N[C@@H](/C=C/c1ccccc1)[C@@H](C)[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 P20 compound treatment 10.5537 0.61179 0.3312 10.951 0.74551 0.3333 0.4699 1.0 3635554 CMLD5_000316 CCOC(=O)C(C)(CC=C)NCc1ccccc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 P21 compound treatment 12.2172 2.2753 1.2317 11.2829 1.0775 0.4818 1.2116 0.9161 3635555 CMLD5_000317 COCOc1cc(OC)ccc1C(=O)/C=C/c2ccc(cc2)[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 P22 compound treatment 12.136 2.194 1.1878 13.4626 3.2572 1.4564 1.8697 0.9949 3635557 CMLD5_000318 C[C@]1(C[C@]2(C)[C@@H](CC1=O)c3ccccc3)C=C2/C=C/c4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 P23 compound treatment 13.639 3.6971 2.0014 8.9275 -1.278 -0.5714 1.0112 0.4858 3635536 CMLD5_000319 COC(=O)C1(CC(=CCc2ccccc2[C@@H]1C[N+](=O)[O-])C=C)C(=O)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2413 P24 compound treatment 11.3521 1.4101 0.7634 10.8774 0.67196 0.3005 0.7523 0.9169 3635559 CMLD5_000320 COC(=O)C12CC3=C[C@H](CC3=O)Cc4ccccc4[C@@H]2CNC1=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 A01 compound treatment 12.7729 2.8489 1.5423 7.6962 -1.9134 -0.8555 0.4856 0.2753 3186890 PK04Pur_000001 CN(C)C(=O)[C@@]1(CC=C)N=C(O[C@H]1c2ccccc2)c3ccc(OCCCO)cc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 A02 compound treatment 15.4902 5.5663 3.0133 10.3144 0.7048 0.3151 2.3536 0.7768 3068561 PK04Pur_000002 CCCNC(=O)[C@H]1[C@@H](N(CC2(CC3CC4CC(C3)C2)C4)C(=O)c5ccccc15)c6ccc(CO)cc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 A03 compound treatment 8.8714 -1.0525 -0.5698 8.2448 -1.3647 -0.6102 -0.8344 -0.9994 3186896 PK04Pur_000003 NC(=O)[C@]1(Cc2ccccc2N=[N+]=[N-])N=C(O[C@@H]1c3ccccc3)c4ccc(OCCCO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 A04 compound treatment 10.4694 0.54548 0.2953 11.1798 1.5703 0.7021 0.7053 0.9259 3187175 PK04Pur_000004 COc1ccccc1CN2[C@H]([C@H](C(=O)NCCCN(C)C)c3ccccc3C2=O)c4ccc(CO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 A05 compound treatment 10.1186 0.19463 0.1054 8.424 -1.1855 -0.5301 -0.3003 -0.5557 3187450 PK04Pur_000005 OCCCOc1ccc(cc1)C2=N[C@](CCS(=O)(=O)c3ccccc3)(CO2)C(=O)N4CCCCC4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 A06 compound treatment 9.0233 -0.90065 -0.4876 10.2797 0.67018 0.2997 -0.1329 -0.2322 3068144 PK04Pur_000006 COc1ccccc1CN2[C@@H](c3ccc(CO)cc3)[C@@](Cc4ccccc4I)(C(=O)NCc5ccccc5)c6ccccc6C2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 A07 compound treatment 12.3206 2.3967 1.2974 9.7007 0.091176 0.0408 0.9463 0.729 3068375 PK04Pur_000007 OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3N=[N+]=[N-])([C@H](O2)c4ccccc4N=[N+]=[N-])C(=O)NCC(O)CO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 A08 compound treatment 11.0321 1.1082 0.5999 13.7677 4.1582 1.8593 1.7389 0.8901 3068239 PK04Pur_000008 Cc1ccc(S[C@@]2(CC(=O)N([C@@H]2c3ccc(CO)cc3I)C4CCCCC4)C(=O)NCC(F)(F)F)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 A09 compound treatment 11.9212 1.9973 1.0812 10.3784 0.76888 0.3438 1.0077 0.8881 3068054 PK04Pur_000009 COCCCNC(=O)[C@@]1(Cc2ccccc2N=[N+]=[N-])N=C(O[C@H]1c3ccccc3)c4ccc(OCCCO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 A10 compound treatment 10.7557 0.8318 0.4503 9.5725 -0.037022 -0.0166 0.3067 0.6807 3186711 PK04Pur_000010 CN(C)CCCNC(=O)[C@]1(CC(=O)N([C@@H]1c2ccc(CO)cc2I)C3CCCCC3)Sc4ccc(C)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 A11 compound treatment 12.1452 2.2213 1.2025 13.2901 3.6806 1.6457 2.014 0.9881 3068573 PK04Pur_000011 OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3N=[N+]=[N-])(CO2)C(=O)N4CCCCC4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 A12 compound treatment 9.3959 -0.528 -0.2858 10.7195 1.11 0.4963 0.1488 0.2598 3068424 PK04Pur_000012 CC(C)CNC(=O)[C@H]1[C@@H](N(Cc2cc(cc(c2)C(F)(F)F)C(F)(F)F)C(=O)c3ccccc13)c4ccc(CO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 A13 mock treatment 9.7643 -0.15961 -0.0864 16.1112 6.5017 2.9071 1.9946 0.6858 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 A14 mock treatment 9.6753 -0.24862 -0.1346 10.6036 0.99407 0.4445 0.2191 0.4718 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 A15 compound treatment 9.8352 -0.088722 -0.048 10.7158 1.1063 0.4947 0.3158 0.6355 3186516 PK04Pur_000013 OCCCOc1ccc(cc1)C2=N[C@@](Cc3ccccc3CN=[N+]=[N-])([C@@H](O2)c4ccccc4N=[N+]=[N-])C(=O)NCC(O)CO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 A16 compound treatment 12.3518 2.4279 1.3144 8.1581 -1.4515 -0.649 0.4705 0.3209 3187316 PK04Pur_000014 COC(=O)C1=CN(C)C(C=C(C=C1C(=O)OC)c2ccc(CO)cc2)C3CC3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 A17 compound treatment 12.348 2.424 1.3123 10.9294 1.3198 0.5901 1.3452 0.9349 3186909 PK04Pur_000015 OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3N=[N+]=[N-])([C@H](O2)c4ccccc4N=[N+]=[N-])C(=O)N5CCOCC5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 A18 compound treatment 12.3233 2.3993 1.2989 11.8047 2.1951 0.9815 1.6125 0.9905 3188492 PK04Pur_000016 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(C)c6c3cc(C)cc6Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 A19 compound treatment 10.1092 0.18525 0.1003 10.2784 0.66886 0.2991 0.2824 0.8952 3187431 PK04Pur_000017 CC(C)NC(=O)[C@]1(C)[C@@H](N(Cc2cc(cc(c2)C(F)(F)F)C(F)(F)F)C(=O)c3ccccc31)c4ccc(CO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 A20 compound treatment 8.6126 -1.3114 -0.7099 10.488 0.87842 0.3928 -0.2243 -0.2764 3189028 PK04Pur_000018 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(C)c6c3cc(C)cc6Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 A21 compound treatment 10.5986 0.67462 0.3652 9.2766 -0.33298 -0.1489 0.153 0.3878 3187364 PK04Pur_000019 C[C@]1([C@@H](N(Cc2cc(F)cc(c2)C(F)(F)F)C(=O)c3ccccc31)c4ccc(CO)cc4)C(=O)NCc5ccccc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 A22 compound treatment 12.6052 2.6812 1.4515 11.2986 1.6891 0.7552 1.5604 0.9537 3188638 PK04Pur_000020 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4ccc(cc4)N5CCCCC5=O)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 A23 mock treatment 12.5086 2.5847 1.3993 11.0897 1.4801 0.6618 1.4574 0.9415 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 A24 compound treatment 9.7091 -0.21483 -0.1163 10.1163 0.50676 0.2266 0.078 0.3062 3176044 PK04Pur_000021 CC(C)C[C@@H]1NC(=O)[C@@H]2C[C@@H]([C@@H](N2C1=O)c3cccc(OCCO)c3)C(=O)NCCCC[N+](C)(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 B01 compound treatment 11.9625 2.0385 1.1036 10.0165 0.40691 0.1819 0.909 0.8127 3052536 PK04Pur_000022 CC(=O)NCCCC[C@@H]1NC(=O)[C@@H]2C[C@@H]([C@@H](N2C1=O)c3cccc(OCCO)c3)C(=O)OCCOc4ccc(cc4)[C@@H]5N6[C@H]([C@H](C(=O)OCC=C)[C@@]57C(=O)Nc8ccccc87)C(=O)O[C@H]([C@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 B02 compound treatment 10.5501 0.62618 0.339 10.945 1.3355 0.5971 0.6619 0.964 2065570 PK04Pur_000023 O=C(NCc1ccccc1)C(COCc2ccccc2)OC(=O)c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 B03 compound treatment 9.6836 -0.24031 -0.1301 7.9399 -1.6697 -0.7466 -0.6199 -0.818 3052754 PK04Pur_000024 CC(=O)NCCCC[C@@H]1NC(=O)[C@@H]2C[C@@H]([C@@H](N2C1=O)c3ccc(O)cc3)C(=O)OCCOc4ccc(cc4)[C@@H]5N6[C@H]([C@H](C(=O)OCC=C)[C@@]57C(=O)Nc8ccccc87)C(=O)O[C@H]([C@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 B04 compound treatment 10.3037 0.37973 0.2056 10.3237 0.71415 0.3193 0.3712 0.9773 3562136 PK04Pur_000025 COC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2OC(CSc3nc4ccccc4s3)CC(O2)c5ccccc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 B05 compound treatment 11.2819 1.3579 0.7351 9.4823 -0.12725 -0.0569 0.4796 0.6504 3052527 PK04Pur_000026 CN(C)CCCCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3cccc(OCCO)c3)C(=O)[C@H](CCCCNC(=O)C)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 B06 compound treatment 13.3115 3.3876 1.8339 9.8805 0.27098 0.1212 1.3824 0.7522 3561841 PK04Pur_000027 COc1ccc(CN2[C@@H]3C(=O)N(Cc4ccccc4)CC=C[C@]53O[C@@H]6/C=C/CCC(=O)N(C)[C@H](C)[C@H](OC(=O)[C@@H]6[C@H]5C2=O)c7ccccc7)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 B07 compound treatment 10.1412 0.21724 0.1176 7.9486 -1.661 -0.7427 -0.442 -0.5878 3188502 PK04Pur_000028 CSc1ccc(NC(=O)O[C@H]([C@@H](C)C=C)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 B08 compound treatment 14.3828 4.4589 2.4138 11.5063 1.8968 0.8481 2.3065 0.9015 3188011 PK04Pur_000029 O=C1C=C(C(=O)c2ccc(cc12)[C@H]3Oc4ccccc4S(=O)(=O)N5CCC[C@@H]35)c6ccccc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 B09 compound treatment 9.2816 -0.64232 -0.3477 8.196 -1.4135 -0.632 -0.6928 -0.9604 3221285 PK04Pur_000030 COC(=O)c1ccc(cc1)[C@@H]2C[C@H](OCCCCO)OC(=C2)C(=O)NCCCCCCO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 B10 compound treatment 9.4941 -0.42979 -0.2327 9.268 -0.34157 -0.1527 -0.2725 -0.9792 3188523 PK04Pur_000031 CCCC[C@H]1OB(O)C[C@@H]2[C@H]3[C@@H](CC(=C12)COc4ccccc4)C(=O)N(C)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 B11 compound treatment 10.3972 0.47324 0.2562 10.1586 0.54902 0.2455 0.3547 0.9998 3211804 PK04Pur_000032 COc1ccc(NC(=O)O[C@@H](CCCO)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 B12 compound treatment 11.1478 1.2239 0.6626 10.1658 0.55622 0.2487 0.6444 0.9105 3071001 PK04Pur_000033 COC(=O)[C@@H]1N[C@H]2[C@@H](COc3ccccc23)[C@@H]1C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 B13 mock treatment 11.0925 1.1686 0.6326 8.8453 -0.7642 -0.3417 0.2057 0.2861 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 B14 mock treatment 8.8612 -1.0627 -0.5753 8.8613 -0.7482 -0.3345 -0.6434 -0.9667 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 B15 compound treatment 9.5417 -0.38228 -0.2069 8.8945 -0.71505 -0.3197 -0.3724 -0.9778 3052931 PK04Pur_000034 NCCCC[C@@H]1NC(=O)[C@@H]2C[C@@H]([C@@H](N2C1=O)c3ccc(O)cc3)C(=O)NCc4ccc(F)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 B16 mock treatment 9.5277 -0.39626 -0.2145 10.41 0.80049 0.3579 0.1014 0.243 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 B17 compound treatment 12.1045 2.1805 1.1804 9.1141 -0.49543 -0.2215 0.6781 0.5646 3176437 PK04Pur_000035 CN(C)CCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3ccc(O)cc3)C(=O)[C@H](CCCCNC(=O)C)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 B18 mock treatment 10.8712 0.94729 0.5128 8.3777 -1.2319 -0.5508 -0.0269 -0.0357 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 B19 mock treatment 10.0404 0.11643 0.063 9.1814 -0.42816 -0.1914 -0.0908 -0.4505 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 B20 mock treatment 9.6298 -0.29416 -0.1592 8.507 -1.1026 -0.493 -0.4612 -0.8902 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 B21 mock treatment 10.5187 0.59478 0.322 7.7822 -1.8274 -0.8171 -0.3501 -0.3986 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 B22 mock treatment 10.4969 0.57294 0.3102 8.9224 -0.68719 -0.3073 0.0021 0.0047 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 B23 mock treatment 10.4613 0.53739 0.2909 9.5297 -0.079799 -0.0357 0.1805 0.6158 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 B24 mock treatment 10.6521 0.7282 0.3942 9.5445 -0.065064 -0.0291 0.2582 0.6531 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 C01 compound treatment 10.4626 0.53869 0.2916 8.6381 -0.97145 -0.4344 -0.1009 -0.1929 3187103 PK04Pur_000036 COC(=O)[C@H]1N=C(O[C@H]1c2ccccc2CN=[N+]=[N-])c3ccc(OCCCO)cc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 C02 compound treatment 11.6199 1.696 0.9181 11.4008 1.7912 0.8009 1.2155 0.9977 3068587 PK04Pur_000037 COc1ccc(CCNC(=O)[C@H]2[C@@H](N(CC3(CC4CC5CC(C4)C3)C5)C(=O)c6ccccc26)c7ccc(CO)cc7)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 C03 compound treatment 8.6106 -1.3134 -0.711 8.757 -0.8526 -0.3812 -0.7723 -0.9573 3068190 PK04Pur_000038 CN(C)C(=O)[C@@]1(Cc2ccccc2N=[N+]=[N-])N=C(O[C@H]1c3ccccc3)c4ccc(OCCCO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 C04 compound treatment 10.4648 0.54088 0.2928 11.217 1.6074 0.7187 0.7153 0.9216 3187360 PK04Pur_000039 C[C@]1([C@@H](N(Cc2ccc(OC(F)(F)F)cc2)C(=O)c3ccccc31)c4ccc(CO)cc4)C(=O)NCc5ccccc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 C05 compound treatment 10.8033 0.87937 0.4761 10.2221 0.6126 0.2739 0.5303 0.9655 3187531 PK04Pur_000040 COCCCNC(=O)[C@@]1(Cc2ccccc2N=[N+]=[N-])COC(=N1)c3ccc(OCCCO)cc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 C06 compound treatment 11.1877 1.2638 0.6842 10.7607 1.1512 0.5147 0.8477 0.9902 3068263 PK04Pur_000041 COc1ccc(CCNC(=O)[C@]2(CC(=O)N(C(C)C)[C@@H]2c3ccc(CO)cc3I)Sc4ccc(C)cc4)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 C07 compound treatment 12.5419 2.618 1.4173 10.3436 0.73409 0.3282 1.2343 0.8484 3068380 PK04Pur_000042 OCCCOc1ccc(cc1)C2=N[C@@](Cc3ccccc3)([C@@H](O2)c4ccccc4N=[N+]=[N-])C(=O)NCC(O)CO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 C08 compound treatment 10.0949 0.17099 0.0926 7.5082 -2.1013 -0.9396 -0.5989 -0.6344 3186709 PK04Pur_000043 Cc1ccc(S[C@@]2(CC(=O)N([C@@H]2c3ccc(CO)cc3I)C4CCCCC4)C(=O)NCc5ccccc5)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 C09 compound treatment 12.1723 2.2484 1.2172 10.1882 0.57866 0.2587 1.0436 0.8387 3186514 PK04Pur_000044 OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3N=[N+]=[N-])(CO2)C(=O)NCC(O)CO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 C10 compound treatment 9.576 -0.34794 -0.1884 8.5574 -1.0522 -0.4705 -0.4659 -0.9193 3186712 PK04Pur_000045 COCCCNC(=O)[C@]1(CC(=O)N([C@@H]1c2ccc(CO)cc2I)C3CCCCC3)Sc4ccc(C)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 C11 mock treatment 11.2391 1.3151 0.7119 9.8732 0.26362 0.1179 0.5868 0.8131 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 C12 mock treatment 9.7913 -0.13263 -0.0718 10.0397 0.4302 0.1924 0.0852 0.4152 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 C13 compound treatment 9.6627 -0.26121 -0.1414 10.6072 0.99769 0.4461 0.2155 0.4604 3187014 PK04Pur_000046 OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3N=[N+]=[N-])([C@H](O2)c4ccccc4)C(=O)NCC(O)CO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 C14 compound treatment 9.6401 -0.28379 -0.1536 8.6035 -1.0061 -0.4499 -0.4267 -0.8977 3068643 PK04Pur_000047 COCCCNC(=O)[C@]1(C)[C@@H](N(Cc2cc(F)cc(c2)C(F)(F)F)C(=O)c3ccccc31)c4ccc(CO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 C15 mock treatment 10.8889 0.96494 0.5224 10.3584 0.74881 0.3348 0.6061 0.9769 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 C16 mock treatment 11.2531 1.3291 0.7195 9.3666 -0.24291 -0.1086 0.432 0.5936 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 C17 compound treatment 12.2827 2.3588 1.2769 9.9584 0.34881 0.156 1.0132 0.7876 3186921 PK04Pur_000048 CN(C)C(=O)[C@@]1(Cc2ccccc2N=[N+]=[N-])COC(=N1)c3ccc(OCCCO)cc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 C18 mock treatment 7.8606 -2.0634 -1.117 9.6302 0.020683 0.0092 -0.7833 -0.7012 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 C19 compound treatment 10.3789 0.45495 0.2463 10.3865 0.77697 0.3474 0.4198 0.9858 3068604 PK04Pur_000049 CCCNC(=O)[C@]1(C)[C@@H](N(Cc2ccc(OC(F)(F)F)cc2)C(=O)c3ccccc31)c4ccc(CO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 C20 compound treatment 8.3789 -1.545 -0.8364 8.791 -0.81852 -0.366 -0.8502 -0.9313 3188093 PK04Pur_000050 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4ccccc4)c5ccc(cc53)N6CCCCC6=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 C21 compound treatment 9.8021 -0.12187 -0.066 9.7982 0.18869 0.0844 0.013 0.1214 3187362 PK04Pur_000051 COCCCNC(=O)[C@]1(C)[C@@H](N(Cc2ccc(OC(F)(F)F)cc2)C(=O)c3ccccc31)c4ccc(CO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 C22 compound treatment 9.4791 -0.44482 -0.2408 8.2445 -1.365 -0.6104 -0.6019 -0.9173 3189141 PK04Pur_000052 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(CC=C)c4ccc(cc43)N5CCCCC5=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 C23 mock treatment 9.3169 -0.60701 -0.3286 8.6347 -0.97481 -0.4359 -0.5406 -0.9903 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 C24 compound treatment 9.0114 -0.91255 -0.494 7.7854 -1.8242 -0.8156 -0.9261 -0.9711 3052639 PK04Pur_000053 C[N+](C)(C)CCCCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3cccc(OCCO)c3)C(=O)[C@@H]4CCCN4C2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 D01 compound treatment 12.1738 2.2499 1.218 10.625 1.0154 0.454 1.1823 0.9096 3176202 PK04Pur_000054 OCCOc1cccc(c1)[C@H]2[C@H](C[C@@H]3N2C(=O)[C@@H]4CCCN4C3=O)C(=O)OCCOc5ccc(cc5)[C@@H]6N7[C@H]([C@H](C(=O)OCC=C)[C@@]68C(=O)Nc9ccccc98)C(=O)O[C@H]([C@H]7c%10ccccc%10)c%11ccccc%11 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 D02 compound treatment 11.7057 1.7817 0.9646 8.9904 -0.61919 -0.2769 0.4863 0.4846 3561947 PK04Pur_000055 CCOC(=O)/C=C/c1c(OC)cccc1OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 D03 compound treatment 10.8378 0.91384 0.4947 11.0392 1.4297 0.6392 0.8018 0.992 3176441 PK04Pur_000056 CC(=O)NCCCC[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3ccc(O)cc3)C(=O)NCCCCCCNC(=O)CS 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 D04 compound treatment 9.4678 -0.45616 -0.2469 10.5553 0.94572 0.4229 0.1244 0.254 3561878 PK04Pur_000057 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2CC(CSc3nc(c(o3)c4ccccc4)c5ccccc5)OC(O2)c6ccccc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 D05 compound treatment 8.385 -1.539 -0.8331 10.5325 0.923 0.4127 -0.2973 -0.3198 3176510 PK04Pur_000058 CC(C)C[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3ccc(O)cc3)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccc(I)cc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 D06 compound treatment 11.3084 1.3844 0.7495 9.4747 -0.13486 -0.0603 0.4873 0.6481 3562044 PK04Pur_000059 CC(C)(C)N1[C@@H](C(=O)N(CC=C)Cc2ccccc2)[C@]3(O[C@H]4C=C3)[C@H]([C@@H]4C(=O)O)C1=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 D07 compound treatment 13.1158 3.1918 1.7279 8.4469 -1.1627 -0.5199 0.8542 0.4734 3069414 PK04Pur_000060 CSc1ccc(NC(=O)O[C@H]([C@H](C)C=C)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 D08 compound treatment 11.7329 1.809 0.9793 10.3456 0.73601 0.3291 0.9252 0.8955 3188138 PK04Pur_000061 Cc1ccc(cc1)S(=O)(=O)N(CCC=C)CC#C[C@H]2Oc3ccccc3S(=O)(=O)N4CCC[C@@H]24 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 D09 compound treatment 7.9043 -2.0196 -1.0933 10.8496 1.2401 0.5545 -0.381 -0.3108 2019311 PK04Pur_000062 COC(CN(C)C(=O)C1=C[C@@H](C[C@H](OCCCCO)O1)c2ccc(cc2)C(=O)OC)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 D10 compound treatment 10.3396 0.41568 0.225 8.4096 -1.2 -0.5365 -0.2203 -0.3786 3188538 PK04Pur_000063 CCCC[C@H]1OB(O)C[C@H]2C1=C(C)Cn3n2c(=O)n(c4ccccc4)c3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 D11 mock treatment 10.0405 0.11658 0.0631 9.2406 -0.36897 -0.165 -0.072 -0.4078 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 D12 mock treatment 10.6209 0.69693 0.3773 9.5827 -0.026872 -0.012 0.2583 0.6842 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 D13 compound treatment 9.9552 0.031233 0.0169 10.2384 0.62883 0.2812 0.2108 0.7483 3052831 PK04Pur_000064 CN(C)CCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3ccc(O)cc3)C(=O)[C@@H]4CCCN4C2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 D14 mock treatment 8.6157 -1.3083 -0.7082 10.7213 1.1117 0.4971 -0.1493 -0.1725 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 D15 mock treatment 10.0164 0.092488 0.0501 8.9328 -0.67675 -0.3026 -0.1786 -0.5822 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 D16 mock treatment 9.2747 -0.64921 -0.3515 9.4916 -0.11792 -0.0527 -0.2858 -0.8042 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 D17 compound treatment 9.6084 -0.31557 -0.1708 9.9258 0.31625 0.1414 -0.0208 -0.0938 3176382 PK04Pur_000065 CN(C)CCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3cccc(OCCO)c3)C(=O)[C@H](CCCCN)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 D18 mock treatment 9.1767 -0.74722 -0.4045 10.3229 0.71337 0.319 -0.0605 -0.1174 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 D19 mock treatment 9.542 -0.38191 -0.2068 9.6171 0.0075285 0.0034 -0.1438 -0.6955 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 D20 mock treatment 11.9396 2.0157 1.0912 10.2747 0.66518 0.2974 0.9819 0.8682 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 D21 mock treatment 9.5405 -0.38342 -0.2076 8.2322 -1.3773 -0.6158 -0.5822 -0.8959 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 D22 mock treatment 9.3266 -0.59734 -0.3234 9.3342 -0.27533 -0.1231 -0.3157 -0.9124 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 D23 mock treatment 10.0823 0.15833 0.0857 9.035 -0.57453 -0.2569 -0.121 -0.447 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 D24 mock treatment 10.3694 0.44549 0.2412 9.9863 0.37675 0.1685 0.2896 0.9846 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 E01 mock treatment 8.9523 -0.97162 -0.526 10.706 1.0965 0.4903 -0.0253 -0.0351 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 E02 mock treatment 8.7443 -1.1796 -0.6386 10.248 0.63843 0.2855 -0.2497 -0.357 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 E03 compound treatment 10.7544 0.83049 0.4496 9.5442 -0.065364 -0.0292 0.2972 0.6597 3187011 PK04Pur_000066 OCCCOc1ccc(cc1)C2=N[C@@](Cc3ccccc3)([C@@H](O2)c4ccccc4)C(=O)NCC(O)CO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 E04 compound treatment 18.3106 8.3867 4.5402 16.8982 7.2886 3.259 5.5149 0.9868 3186424 PK04Pur_000067 OCc1ccc([C@H]2N(CC3(CC4CC5CC(C4)C3)C5)C(=O)C[C@@]2(C(=O)NCCN6CCOCC6)c7ccc(cc7)[N+](=O)[O-])c(I)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 E05 compound treatment 10.037 0.11303 0.0612 9.0425 -0.56704 -0.2535 -0.136 -0.5215 3186300 PK04Pur_000068 OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3N=[N+]=[N-])([C@H](O2)c4ccccc4)C(=O)NCCN5CCOCC5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 E06 compound treatment 17.278 7.354 3.9812 16.1299 6.5204 2.9155 4.8767 0.9883 3186792 PK04Pur_000069 Cc1ccc(S[C@@]2(CC(=O)N(Cc3ccccc3C(F)(F)F)[C@@H]2c4ccc(CO)cc4I)C(=O)NCCN5CCOCC5)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 E07 compound treatment 9.3707 -0.55325 -0.2995 10.1802 0.57068 0.2552 -0.0313 -0.0797 3068465 PK04Pur_000070 OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3)(CO2)C(=O)N4CCCCC4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 E08 compound treatment 36.8429 26.919 14.5728 36.0231 26.414 11.8104 18.6557 0.9946 3186802 PK04Pur_000071 Cc1ccc(S[C@@]2(CC(=O)N(Cc3ccccc3)[C@@H]2c4ccc(CO)cc4I)C(=O)NCCN5CCOCC5)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 E09 mock treatment 11.3249 1.4009 0.7584 8.9708 -0.63878 -0.2856 0.3343 0.4125 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 E10 mock treatment 9.5574 -0.36652 -0.1984 9.7034 0.093826 0.042 -0.1106 -0.5455 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 E11 compound treatment 9.6833 -0.24064 -0.1303 10.0075 0.39792 0.1779 0.0337 0.1528 3186738 PK04Pur_000072 OCCCOc1ccc(cc1)C2=N[C@@](CCS(=O)(=O)c3ccccc3)([C@@H](O2)c4ccccc4N=[N+]=[N-])C(=O)NCC(O)CO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 E12 compound treatment 10.918 0.99409 0.5382 8.8329 -0.77662 -0.3473 0.135 0.2108 3187274 PK04Pur_000073 OCc1ccc(cc1)[C@H]2[C@H](C(=O)NC3CC3)c4ccccc4C(=O)N2CC5(CC6CC7CC(C6)C5)C7 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 E13 compound treatment 9.2141 -0.70988 -0.3843 10.9419 1.3324 0.5958 0.1495 0.2109 3068081 PK04Pur_000074 OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3N=[N+]=[N-])(CO2)C(=O)NCCN4CCOCC4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 E14 compound treatment 9.4073 -0.51666 -0.2797 9.4545 -0.15509 -0.0693 -0.2468 -0.8565 3187119 PK04Pur_000075 CN1C(=O)C2C(C3C(C4CC4)N(Cc5cccc(OC(F)(F)F)c5)C2C=C3CCCO)C1=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 E15 compound treatment 10.3544 0.43043 0.233 7.9234 -1.6862 -0.754 -0.3684 -0.4668 3186576 PK04Pur_000076 OCCCOc1ccc(cc1)C2=N[C@@](Cc3ccccc3N=[N+]=[N-])([C@@H](O2)c4ccccc4)C(=O)NCCN5CCOCC5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 E16 compound treatment 7.3611 -2.5628 -1.3874 19.2755 9.666 4.322 2.0751 0.4571 3189668 PK04Pur_000077 OCCCC1=CC(N(Cc2sc3ccccc3c2Cl)/C(=N\P(=O)(Oc4ccccc4)Oc5ccccc5)/C1)c6ccc(CN7CCCC7)cc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 E17 mock treatment 9.2254 -0.69859 -0.3782 9.9135 0.30395 0.1359 -0.1713 -0.4263 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 E18 mock treatment 9.9704 0.046493 0.0252 9.3308 -0.27877 -0.1246 -0.0703 -0.5532 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 E19 compound treatment 14.1951 4.2712 2.3122 10.4474 0.83781 0.3746 1.8999 0.8111 3068588 PK04Pur_000078 OCc1ccc(cc1)[C@H]2[C@H](C(=O)NCc3ccccc3)c4ccccc4C(=O)N2CC5(CC6CC7CC(C6)C5)C7 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 E20 compound treatment 9.6386 -0.2853 -0.1545 10.1954 0.58588 0.262 0.076 0.25 3069307 PK04Pur_000079 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4ccccc4)c5ccc(cc53)N6CCOC6=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 E21 compound treatment 9.5498 -0.37409 -0.2025 10.3274 0.71787 0.321 0.0838 0.2207 3187164 PK04Pur_000080 OCc1ccc(cc1)[C@H]2[C@H](C(=O)NCc3ccccc3)c4ccccc4C(=O)N2Cc5cc(F)cc(c5)C(F)(F)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 E22 compound treatment 10.0907 0.16677 0.0903 10.478 0.86847 0.3883 0.3384 0.8489 3189149 PK04Pur_000081 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4cccc(c4)N5CCCCC5=O)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 E23 mock treatment 10.1429 0.21893 0.1185 9.5516 -0.057909 -0.0259 0.0655 0.5399 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 E24 compound treatment 9.3469 -0.577 -0.3124 9.407 -0.20255 -0.0906 -0.2849 -0.876 3176042 PK04Pur_000082 CC(C)C[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCO)c3)C(=O)NCCCCCC[N+](C)(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 F01 mock treatment 8.5682 -1.3557 -0.7339 11.9364 2.3268 1.0404 0.2167 0.1702 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 F02 mock treatment 10.454 0.53001 0.2869 10.6615 1.0519 0.4704 0.5355 0.9719 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 F03 compound treatment 10.931 1.0071 0.5452 9.4802 -0.12932 -0.0578 0.3446 0.6286 3176636 PK04Pur_000083 Oc1ccc(cc1)[C@H]2[C@H](C[C@@H]3N2C(=O)[C@@H]4CCCN4C3=O)C(=O)OCCOc5ccc(cc5)[C@H]6N7[C@@H]([C@@H](C(=O)OCC=C)[C@]68C(=O)Nc9ccccc98)C(=O)O[C@@H]([C@@H]7c%10ccccc%10)c%11ccccc%11 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 F04 compound treatment 12.3073 2.3834 1.2902 11.5951 1.9856 0.8878 1.5401 0.9834 3561927 PK04Pur_000084 OC(CSc1nc(c(o1)c2ccccc2)c3ccccc3)CC(O)c4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 F05 compound treatment 9.3766 -0.54731 -0.2963 9.3989 -0.21066 -0.0942 -0.2761 -0.8881 3176118 PK04Pur_000085 C[N+](C)(C)CCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3cccc(OCCO)c3)C(=O)[C@H](Cc4ccccc4)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 F06 compound treatment 9.7878 -0.1361 -0.0737 12.8298 3.2203 1.4399 0.9661 0.67 3562085 PK04Pur_000086 CCOC(=O)[C@@H]1[C@H]2O[C@@]3(C=C2)[C@@H](N(CCCCCCO)C(=O)[C@@H]13)C(=O)NCc4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 F07 compound treatment 11.4042 1.4803 0.8013 9.2303 -0.37926 -0.1696 0.4467 0.5454 3069707 PK04Pur_000087 CSc1ccc(NC(=O)O[C@@H](CC=C)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 F08 compound treatment 9.5087 -0.41519 -0.2248 12.4312 2.8217 1.2617 0.7332 0.5721 3071655 PK04Pur_000088 CN1C(=O)C2CC=C(CC2C1=O)C3=CCO[C@@H]3[C@H]4CCCN4S(=O)(=O)c5ccccc5[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 F09 mock treatment 8.9302 -0.99372 -0.538 9.7837 0.17416 0.0779 -0.3253 -0.5985 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 F10 mock treatment 10.2834 0.35943 0.1946 9.0362 -0.5733 -0.2563 -0.0437 -0.1357 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 F11 compound treatment 10.8823 0.95836 0.5188 9.1305 -0.47905 -0.2142 0.2154 0.3837 3211815 PK04Pur_000089 COc1ccc(NC(=O)O[C@H]([C@H](C)C=C)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 F12 mock treatment 9.9808 0.056841 0.0308 9.9427 0.33316 0.149 0.1271 0.8355 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 F13 compound treatment 8.8873 -1.0366 -0.5612 9.9056 0.29605 0.1324 -0.3032 -0.5259 3176195 PK04Pur_000090 OCCOc1cccc(c1)[C@@H]2[C@@H](C[C@H]3N2C(=O)[C@@H]4CCCN4C3=O)C(=O)NCc5ccc(F)cc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 F14 mock treatment 9.5449 -0.37901 -0.2052 10.8782 1.2686 0.5673 0.256 0.4244 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 F15 compound treatment 10.4973 0.57332 0.3104 12.1725 2.563 1.146 1.0298 0.8674 3176330 PK04Pur_000091 CN(C)CCCC[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCO)c3)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccccc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 F16 mock treatment 8.7642 -1.1597 -0.6278 9.9999 0.39036 0.1745 -0.3205 -0.4919 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 F17 mock treatment 10.5189 0.59493 0.3221 9.5617 -0.047887 -0.0214 0.2126 0.6586 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 F18 mock treatment 10.6055 0.68156 0.369 10.9102 1.3006 0.5815 0.6721 0.9759 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 F19 mock treatment 9.6878 -0.23613 -0.1278 8.5716 -1.0379 -0.4641 -0.4185 -0.8695 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 F20 mock treatment 10.3287 0.40478 0.2191 8.6049 -1.0046 -0.4492 -0.1627 -0.3255 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 F21 mock treatment 8.6199 -1.304 -0.7059 9.4244 -0.18515 -0.0828 -0.5577 -0.7847 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 F22 mock treatment 10.7231 0.79913 0.4326 10.0474 0.43788 0.1958 0.4443 0.9358 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 F23 mock treatment 10.3248 0.40088 0.217 10.2601 0.65058 0.2909 0.3592 0.9896 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 F24 mock treatment 10.6933 0.76941 0.4165 9.9641 0.35455 0.1585 0.4066 0.9124 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 G01 compound treatment 11.9953 2.0714 1.1214 8.8802 -0.72939 -0.3261 0.5623 0.4815 3187109 PK04Pur_000092 COC(=O)[C@@]1(Cc2ccccc2CN=[N+]=[N-])N=C(O[C@H]1c3ccccc3N=[N+]=[N-])c4ccc(OCCCO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 G02 compound treatment 10.5101 0.58611 0.3173 10.9005 1.2909 0.5772 0.6325 0.9603 3068596 PK04Pur_000093 CC(C)N1[C@@H](c2ccc(CO)cc2)[C@@](C)(C(=O)NCC(F)(F)F)c3ccccc3C1=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 G03 mock treatment 10.935 1.011 0.5473 9.4272 -0.18236 -0.0815 0.3294 0.5952 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 G04 mock treatment 10.4313 0.50739 0.2747 9.7671 0.15753 0.0704 0.244 0.8606 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 G05 compound treatment 10.5078 0.58389 0.3161 8.9556 -0.65391 -0.2924 0.0168 0.0389 3186312 PK04Pur_000094 OCCCOc1ccc(cc1)C2=N[C@](CCS(=O)(=O)c3ccccc3)(CO2)C(=O)NCc4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 G06 compound treatment 10.1479 0.22397 0.1212 11.6643 2.0548 0.9188 0.7354 0.7935 3068151 PK04Pur_000095 CC(C)NC(=O)[C@]1(Cc2ccccc2I)[C@@H](N(Cc3ccccc3C(F)(F)F)C(=O)c4ccccc41)c5ccc(CO)cc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 G07 compound treatment 9.1692 -0.75472 -0.4086 9.8249 0.21532 0.0963 -0.2208 -0.5261 3187380 PK04Pur_000096 COCCCNC(=O)[C@]1(Cc2ccccc2N=[N+]=[N-])N=C(O[C@@H]1c3ccccc3N=[N+]=[N-])c4ccc(OCCCO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 G08 compound treatment 9.4881 -0.43584 -0.2359 11.7401 2.1305 0.9526 0.5068 0.5164 3068141 PK04Pur_000097 OCc1ccc(cc1)[C@@H]2N(C3CCCCC3)C(=O)c4ccccc4[C@]2(Cc5ccccc5I)C(=O)NCc6ccccc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 G09 compound treatment 9.8043 -0.11966 -0.0648 9.2475 -0.36208 -0.1619 -0.1603 -0.9192 3068070 PK04Pur_000098 CN(C)C(=O)[C@@]1(Cc2ccccc2N=[N+]=[N-])N=C(O[C@H]1c3ccccc3N=[N+]=[N-])c4ccc(OCCCO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 G10 compound treatment 58.9188 48.995 26.5237 69.4966 59.887 26.7776 37.6897 1.0 3068311 PK04Pur_000099 CN(C)CCCNC(=O)[C@]1(CC(=O)N(Cc2ccccc2C(F)(F)F)[C@@H]1c3ccc(CO)cc3I)Sc4ccc(C)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 G11 compound treatment 10.9248 1.0009 0.5419 8.2461 -1.3634 -0.6096 -0.0479 -0.0588 3067982 PK04Pur_000100 OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3N=[N+]=[N-])(CO2)C(=O)NCc4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 G12 compound treatment 10.621 0.69703 0.3773 10.827 1.2174 0.5444 0.6517 0.984 3068634 PK04Pur_000101 CC(C)CNC(=O)[C@]1(C)[C@@H](N(Cc2cc(F)cc(c2)C(F)(F)F)C(=O)c3ccccc31)c4ccc(CO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 G13 compound treatment 9.7278 -0.19609 -0.1062 9.7133 0.10373 0.0464 -0.0423 -0.3649 3187018 PK04Pur_000102 OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3N=[N+]=[N-])([C@H](O2)c4ccccc4)C(=O)N5CCCCC5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 G14 compound treatment 9.0927 -0.83123 -0.45 9.3648 -0.24476 -0.1094 -0.3956 -0.8542 3187214 PK04Pur_000103 COc1cc2CCN(Cc3sc4ccccc4c3Cl)C(c5cccs5)c2cc1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 G15 compound treatment 9.0412 -0.88272 -0.4779 9.972 0.36248 0.1621 -0.2233 -0.4425 3068126 PK04Pur_000104 OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3)(CO2)C(=O)NCC(O)CO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 G16 compound treatment 9.9843 0.060356 0.0327 9.0951 -0.51444 -0.23 -0.1395 -0.6006 3187850 PK04Pur_000105 OCCCC1=CC(C2CC2)N(Cc3cccc(OC(F)(F)F)c3)CC1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 G17 compound treatment 9.5967 -0.3272 -0.1771 8.5845 -1.025 -0.4583 -0.4493 -0.9145 3068038 PK04Pur_000106 OCCCOc1ccc(cc1)C2=N[C@@](Cc3ccccc3N=[N+]=[N-])([C@@H](O2)c4ccccc4)C(=O)N5CCCCC5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 G18 compound treatment 9.6306 -0.29334 -0.1588 8.7975 -0.81207 -0.3631 -0.369 -0.9312 3188493 PK04Pur_000107 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4cccc(c4)N5CCCCC5=O)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 G19 mock treatment 10.2826 0.35865 0.1942 8.9718 -0.63773 -0.2852 -0.0643 -0.1865 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 G20 mock treatment 9.6212 -0.30277 -0.1639 10.1934 0.58385 0.2611 0.0687 0.2229 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 G21 mock treatment 9.9878 0.063813 0.0345 10.4286 0.81902 0.3662 0.2834 0.7704 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 G22 compound treatment 10.3694 0.44549 0.2412 10.5065 0.89697 0.4011 0.4541 0.9704 3189151 PK04Pur_000108 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(nn4)[C@H](O)c5ccccc5)C(=O)N(Cc6cccc(c6)N7CCOC7=O)c8ccccc83 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 G23 mock treatment 10.0074 0.083486 0.0452 10.9115 1.302 0.5822 0.4436 0.7597 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 G24 compound treatment 11.5473 1.6234 0.8788 8.8344 -0.7751 -0.3466 0.3764 0.3984 3052589 PK04Pur_000109 C[N+](C)(C)CCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3cccc(OCCO)c3)C(=O)[C@H](Cc4ccccc4)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 H01 compound treatment 7.861 -2.0629 -1.1168 12.5199 2.9103 1.3013 0.1305 0.0761 3176558 PK04Pur_000110 NCCCCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3ccc(O)cc3)C(=O)[C@H](Cc4ccccc4)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 H02 compound treatment 9.3237 -0.60021 -0.3249 9.4244 -0.18518 -0.0828 -0.2883 -0.8598 3561958 PK04Pur_000111 O=C1CS(=O)(=O)C(N1c2ccc(cc2)c3ccccc3)c4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 H03 mock treatment 10.8125 0.88858 0.481 9.1834 -0.42615 -0.1905 0.2054 0.397 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 H04 mock treatment 9.5383 -0.38563 -0.2088 9.5637 -0.045862 -0.0205 -0.1621 -0.7728 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 H05 compound treatment 12.6402 2.7162 1.4704 9.0548 -0.55478 -0.2481 0.8644 0.5796 3052597 PK04Pur_000112 OCCOc1cccc(c1)[C@@H]2[C@@H](C[C@H]3N2C(=O)[C@@H]4CCCN4C3=O)C(=O)NCCCCCCNC(=O)CS 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 H06 compound treatment 9.7103 -0.2136 -0.1156 9.9987 0.38914 0.174 0.0413 0.1975 3000754 PK04Pur_000113 CCOC(=O)/C=C/c1cccc(OC)c1O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 H07 compound treatment 9.4846 -0.43939 -0.2379 9.9292 0.31968 0.1429 -0.0671 -0.2419 3188898 PK04Pur_000114 CO[C@H](C=C)[C@H](OC(=O)Nc1ccc(SC)cc1)c2ccc(OCCO)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 H08 compound treatment 8.9423 -0.98161 -0.5314 8.589 -1.0205 -0.4563 -0.6984 -0.9971 3561974 PK04Pur_000115 Brc1c[n+](Cc2ccccc2)cc3ccccc13 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 H09 compound treatment 10.2836 0.35965 0.1947 10.1653 0.55574 0.2485 0.3134 0.9927 2019470 PK04Pur_000116 OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)O)c2coc3ccccc3c2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 H10 compound treatment 8.1059 -1.818 -0.9842 9.2682 -0.34132 -0.1526 -0.8038 -0.8071 3215882 PK04Pur_000117 CCCC[C@H]1OB(O)C[C@H]2C1=C(COC)Cn3n2c(=O)n(c4ccccc4)c3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 H11 compound treatment 10.0877 0.16373 0.0886 10.053 0.44349 0.1983 0.2029 0.9341 3080225 PK04Pur_000118 COc1ccc(NC(=O)O[C@H]([C@@H](C)CCO)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 H12 mock treatment 9.4175 -0.50647 -0.2742 8.831 -0.77857 -0.3481 -0.44 -0.993 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 H13 compound treatment 10.3558 0.43184 0.2338 10.1048 0.49526 0.2214 0.3219 0.9996 3176736 PK04Pur_000119 CN(C)CCCC[C@@H]1NC(=O)[C@@H]2C[C@@H]([C@@H](N2C1=O)c3ccc(O)cc3)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccccc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 H14 mock treatment 9.5839 -0.34001 -0.1841 9.7528 0.14326 0.0641 -0.0849 -0.4354 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 H15 compound treatment 10.7237 0.79974 0.4329 10.6918 1.0822 0.4839 0.6483 0.9985 3052741 PK04Pur_000120 C[N+](C)(C)CCCC[C@@H]1NC(=O)[C@@H]2C[C@@H]([C@@H](N2C1=O)c3cccc(OCCO)c3)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccccc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 H16 mock treatment 11.0189 1.095 0.5928 10.1321 0.52256 0.2337 0.5844 0.9172 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 H17 compound treatment 8.6524 -1.2715 -0.6884 10.4945 0.88493 0.3957 -0.207 -0.2607 3176383 PK04Pur_000121 NCCCCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3cccc(OCCO)c3)C(=O)[C@H](CCCCN)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 H18 mock treatment 9.9345 0.010541 0.0057 8.0331 -1.5765 -0.7049 -0.4944 -0.7014 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 H19 mock treatment 10.2343 0.31036 0.168 7.9043 -1.7052 -0.7625 -0.4203 -0.5384 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 H20 mock treatment 10.6729 0.74898 0.4055 8.9921 -0.61744 -0.2761 0.0915 0.1865 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 H21 mock treatment 9.7884 -0.13558 -0.0734 9.6906 0.081076 0.0363 -0.0263 -0.3208 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 H22 mock treatment 10.7142 0.7903 0.4278 10.2657 0.65616 0.2934 0.51 0.9831 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 H23 mock treatment 10.4206 0.49662 0.2689 9.4531 -0.15645 -0.07 0.1406 0.5063 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 H24 mock treatment 9.1136 -0.81033 -0.4387 9.5812 -0.028304 -0.0127 -0.3191 -0.7272 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 I01 compound treatment 9.0603 -0.86364 -0.4675 10.6686 1.059 0.4735 0.0042 0.0064 3187110 PK04Pur_000122 OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3)(CO2)C(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 I02 compound treatment 10.7451 0.82119 0.4446 8.8008 -0.80871 -0.3616 0.0587 0.1024 3187273 PK04Pur_000123 CC(C)CNC(=O)[C@H]1[C@@H](N(CC2(CC3CC4CC(C3)C2)C4)C(=O)c5ccccc15)c6ccc(CO)cc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 I03 compound treatment 10.895 0.97101 0.5257 8.9221 -0.68741 -0.3074 0.1544 0.2535 3187104 PK04Pur_000124 OCCCOc1ccc(cc1)C2=N[C@@](Cc3ccccc3N=[N+]=[N-])([C@@H](O2)c4ccccc4)C(=O)NCc5ccccc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 I04 compound treatment 12.4342 2.5103 1.359 11.1739 1.5644 0.6995 1.4555 0.9523 3068591 PK04Pur_000125 OCc1ccc(cc1)[C@H]2[C@H](C(=O)NCC(F)(F)F)c3ccccc3C(=O)N2CC4(CC5CC6CC(C5)C4)C6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 I05 mock treatment 8.2334 -1.6905 -0.9152 9.6879 0.078386 0.035 -0.6224 -0.6795 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 I06 mock treatment 9.6496 -0.27431 -0.1485 10.9169 1.3074 0.5846 0.3084 0.5112 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 I07 compound treatment 8.2792 -1.6447 -0.8904 7.9937 -1.6159 -0.7225 -1.1405 -0.9946 3187463 PK04Pur_000126 OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3CN=[N+]=[N-])(CO2)C(=O)NCC(O)CO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 I08 compound treatment 14.2629 4.3389 2.3489 10.8208 1.2112 0.5416 2.0439 0.8479 3186634 PK04Pur_000127 CC(C)N1C(=O)[C@]2(Cc3ccccc13)[C@@H](N(Cc4ccccc4C(F)(F)F)C(=O)c5ccccc52)c6ccc(CO)cc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 I09 compound treatment 9.5864 -0.33749 -0.1827 9.7242 0.11469 0.0513 -0.0929 -0.4897 3068075 PK04Pur_000128 OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3N=[N+]=[N-])(CO2)C(=O)N4CCOCC4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 I10 compound treatment 10.9777 1.0537 0.5705 11.5954 1.9858 0.8879 1.0312 0.9771 3186643 PK04Pur_000129 Cc1ccc(S[C@@]2(CC(=O)N([C@@H]2c3ccc(CO)cc3I)C4CCCCC4)C(=O)NC5CC5)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 I11 compound treatment 10.5672 0.64328 0.3482 9.3187 -0.29083 -0.13 0.1543 0.4151 3186908 PK04Pur_000130 OCCCOc1ccc(cc1)C2=N[C@@](Cc3ccccc3N=[N+]=[N-])([C@@H](O2)c4ccccc4)C(=O)N5CCOCC5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 I12 compound treatment 10.3289 0.40492 0.2192 10.2312 0.62167 0.278 0.3516 0.9931 3067975 PK04Pur_000131 CC(C)NC(=O)[C@]1(CC(=O)N(CC2(CC3CC4CC(C3)C2)C4)[C@@H]1c5ccc(CO)cc5)c6ccc(cc6)[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 I13 compound treatment 9.2291 -0.69489 -0.3762 11.6159 2.0063 0.8971 0.3683 0.3786 3186448 PK04Pur_000132 OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3N=[N+]=[N-])([C@H](O2)c4ccccc4N=[N+]=[N-])C(=O)NCCN5CCOCC5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 I14 compound treatment 11.0625 1.1386 0.6164 10.9977 1.3881 0.6207 0.8747 1.0 3068945 PK04Pur_000133 COC(=O)C1=CN(Cc2cccc(OC(F)(F)F)c2)C(C=C(CCCO)C=C1C(=O)OC)c3cccs3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 I15 compound treatment 9.5364 -0.38756 -0.2098 10.8774 1.2679 0.5669 0.2525 0.4177 3186742 PK04Pur_000134 OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3CN=[N+]=[N-])(CO2)C(=O)NCc4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 I16 compound treatment 9.878 -0.045982 -0.0249 10.9357 1.3262 0.593 0.4017 0.6768 3187856 PK04Pur_000135 OCCCC1=CC(N(Cc2cccc(OC(F)(F)F)c2)CC1)c3cccs3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 I17 compound treatment 9.3699 -0.55403 -0.2999 13.1976 3.5881 1.6044 0.9224 0.5651 3187015 PK04Pur_000136 OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3N=[N+]=[N-])([C@H](O2)c4ccccc4)C(=O)N5CCOCC5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 I18 compound treatment 9.0232 -0.90073 -0.4876 10.485 0.8754 0.3914 -0.068 -0.1088 3069412 PK04Pur_000137 COc1ccc(cc1)C(=O)Nc2ccc3N(CC=C)C(=O)[C@@]4(O[C@@H](CCn5cc(CCO)nn5)[C@@H]([C@H]4C)[Si](C)(C)c6ccc(OC)cc6)c3c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 I19 compound treatment 9.6929 -0.23102 -0.1251 8.7681 -0.84143 -0.3762 -0.3545 -0.8941 3068649 PK04Pur_000138 COCCCNC(=O)[C@]1(C)[C@@H](N(Cc2cc(cc(c2)C(F)(F)F)C(F)(F)F)C(=O)c3ccccc31)c4ccc(CO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 I20 compound treatment 10.1826 0.25867 0.14 9.1518 -0.45774 -0.2047 -0.0457 -0.1843 3069396 PK04Pur_000139 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(CC=C)c4ccc(NC(=O)[C@H](C)O)cc43 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 I21 mock treatment 9.882 -0.041907 -0.0227 10.6847 1.0751 0.4807 0.3239 0.673 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 I22 mock treatment 11.0066 1.0827 0.5861 9.1354 -0.47416 -0.212 0.2645 0.4244 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 I23 mock treatment 10.3645 0.44056 0.2385 9.6993 0.089781 0.0401 0.197 0.8147 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 I24 compound treatment 12.2669 2.3429 1.2684 10.602 0.99245 0.4438 1.2107 0.901 3176117 PK04Pur_000140 C[N+](C)(C)CCCCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3cccc(OCCO)c3)C(=O)[C@H](Cc4ccccc4)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 J01 compound treatment 10.6873 0.76338 0.4133 11.66 2.0505 0.9168 0.9405 0.9352 3052795 PK04Pur_000141 NCCCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3ccc(O)cc3)C(=O)[C@H](Cc4ccccc4)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 J02 compound treatment 9.7196 -0.20432 -0.1106 10.3143 0.70472 0.3151 0.1446 0.433 3561990 PK04Pur_000142 CCCNC(=O)Cc1ccc(cc1)N2C(c3ccccc3)S(=O)(=O)CC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 J03 compound treatment 8.6039 -1.3201 -0.7146 10.5121 0.90252 0.4035 -0.22 -0.268 3174822 PK04Pur_000143 CC(=O)NCCCC[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCO)c3)C(=O)NCCCCCCNC(=O)CS 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 J04 compound treatment 10.8828 0.95884 0.5191 7.5475 -2.0621 -0.922 -0.2849 -0.2693 3561930 PK04Pur_000144 OC(CSc1ccccn1)CC(O)c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 J05 mock treatment 8.4134 -1.5106 -0.8178 9.2661 -0.34345 -0.1536 -0.6868 -0.8255 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 J06 mock treatment 10.1663 0.24236 0.1312 10.7042 1.0946 0.4894 0.4389 0.8661 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 J07 compound treatment 9.3432 -0.58077 -0.3144 9.4642 -0.14533 -0.065 -0.2683 -0.8356 3188901 PK04Pur_000145 CSc1ccc(NC(=O)O[C@H](CC=C)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 J08 compound treatment 10.3456 0.42164 0.2283 8.4298 -1.1797 -0.5275 -0.2116 -0.3681 2129057 PK04Pur_000146 COc1cc(CO)cc(I)c1O[C@H]2C=C(C[C@@H](NC[C@@H]3CCCO3)[C@@H]2O)C(=O)NCCO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 J09 compound treatment 7.8072 -2.1167 -1.1459 9.6388 0.029226 0.0131 -0.801 -0.699 3221347 PK04Pur_000147 COc1ccc(CN2CCc3cc(OC)c(O)cc3C2C#Cc4ccccc4)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 J10 compound treatment 9.1866 -0.73732 -0.3992 9.5529 -0.056649 -0.0253 -0.3002 -0.7505 3187877 PK04Pur_000148 CC(C)C[C@@H]1NC(=O)[C@@]2(C3[C@H](Cc4ccccc4)NC2=O)C(/C=C/CC\C=C\CNC(=O)[C@@H](C)NC1=O)[C@@H]5O[C@]5(C)[C@H]3C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 J11 compound treatment 9.0843 -0.83962 -0.4545 9.0437 -0.5659 -0.253 -0.5003 -0.9618 3211816 PK04Pur_000149 COc1ccc(NC(=O)O[C@H]([C@H](C)CCO)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 J12 mock treatment 9.1462 -0.77771 -0.421 11.4884 1.8788 0.8401 0.2963 0.3153 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 J13 compound treatment 8.9242 -0.99976 -0.5412 8.7259 -0.88363 -0.3951 -0.6621 -0.988 3052793 PK04Pur_000150 CN(C)CCCCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3ccc(O)cc3)C(=O)[C@H](Cc4ccccc4)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 J14 mock treatment 9.8708 -0.053147 -0.0288 9.6489 0.039363 0.0176 -0.0079 -0.2342 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 J15 compound treatment 9.3805 -0.54339 -0.2942 9.2035 -0.40606 -0.1816 -0.3364 -0.9731 3176788 PK04Pur_000151 CN(C)CCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3ccc(O)cc3)C(=O)[C@H](CCCCN)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 J16 mock treatment 10.023 0.099088 0.0536 9.9735 0.36394 0.1627 0.153 0.8929 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 J17 compound treatment 8.624 -1.2999 -0.7037 9.8763 0.26676 0.1193 -0.4133 -0.579 3176205 PK04Pur_000152 CN(C)CCCCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3cccc(OCCO)c3)C(=O)CNC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 J18 mock treatment 10.0614 0.1375 0.0744 7.1562 -2.4534 -1.097 -0.7231 -0.6576 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 J19 mock treatment 9.5002 -0.42378 -0.2294 7.4787 -2.1308 -0.9528 -0.8359 -0.853 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 J20 mock treatment 9.2424 -0.68156 -0.369 10.2105 0.60098 0.2687 -0.0709 -0.1553 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 J21 mock treatment 10.6878 0.76382 0.4135 8.3271 -1.2824 -0.5734 -0.1131 -0.1599 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 J22 mock treatment 8.8411 -1.0828 -0.5862 7.9026 -1.7069 -0.7632 -0.9542 -0.9915 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 J23 mock treatment 9.7409 -0.18306 -0.0991 9.7534 0.1439 0.0643 -0.0246 -0.208 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 J24 mock treatment 10.0706 0.14669 0.0794 9.8731 0.26351 0.1178 0.1395 0.9816 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 K01 compound treatment 9.6673 -0.25664 -0.1389 9.3653 -0.24428 -0.1092 -0.1755 -0.9929 3187196 PK04Pur_000153 COC(=O)[C@@H]1N=C(O[C@@H]1c2ccccc2)c3ccc(OCCCO)cc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 K02 compound treatment 10.4816 0.55768 0.3019 11.5997 1.9901 0.8899 0.8427 0.8968 3186420 PK04Pur_000154 OCc1ccc([C@H]2N(C3CCCCC3)C(=O)C[C@@]2(C(=O)NCC(F)(F)F)c4ccc(cc4)[N+](=O)[O-])c(I)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 K03 compound treatment 11.3867 1.4628 0.7919 10.3226 0.71306 0.3188 0.7854 0.92 3187105 PK04Pur_000155 OCCCOc1ccc(cc1)C2=N[C@](CCS(=O)(=O)c3ccccc3)(CO2)C(=O)NCC(O)CO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 K04 compound treatment 10.5116 0.58767 0.3181 9.36 -0.24956 -0.1116 0.1461 0.4332 3187437 PK04Pur_000156 CC(C)NC(=O)[C@]1(C)[C@@H](N(Cc2ccccc2)C(=O)c3ccccc31)c4ccc(CO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 K05 compound treatment 9.6894 -0.23455 -0.127 9.6893 0.079788 0.0357 -0.0646 -0.4895 3186992 PK04Pur_000157 COCCCNC(=O)[C@@]1(Cc2ccccc2N=[N+]=[N-])N=C(O[C@H]1c3ccccc3N=[N+]=[N-])c4ccc(OCCCO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 K06 compound treatment 63.7416 53.818 29.1346 68.9423 59.333 26.5298 39.3606 0.9989 3068273 PK04Pur_000158 CN(C)CCCNC(=O)[C@]1(CC(=O)N(C2Cc3ccccc3C2)[C@@H]1c4ccc(CO)cc4I)Sc5ccc(C)cc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 K07 mock treatment 10.2264 0.30243 0.1637 9.8663 0.25677 0.1148 0.197 0.9849 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 K08 mock treatment 9.5612 -0.36275 -0.1964 8.4313 -1.1783 -0.5269 -0.5114 -0.9095 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 K09 compound treatment 10.7809 0.85693 0.4639 11.0623 1.4528 0.6496 0.7874 0.9864 3068113 PK04Pur_000159 OCCCOc1ccc(cc1)C2=N[C@](CCS(=O)(=O)c3ccccc3)([C@H](O2)c4ccccc4N=[N+]=[N-])C(=O)NCC(O)CO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 K10 compound treatment 62.0578 52.134 28.223 67.3012 57.692 25.796 38.1972 0.999 3186725 PK04Pur_000160 Cc1ccc(S[C@@]2(CC(=O)N(Cc3ccccc3Cl)[C@@H]2c4ccc(CO)cc4I)C(=O)NCCN5CCOCC5)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 K11 compound treatment 10.9019 0.97796 0.5294 10.289 0.67942 0.3038 0.5892 0.9652 3068033 PK04Pur_000161 NC(=O)[C@@]1(CC=C)COC(=N1)c2ccc(OCCCO)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 K12 compound treatment 9.191 -0.73298 -0.3968 8.4622 -1.1474 -0.513 -0.6434 -0.9919 3187433 PK04Pur_000162 CCCNC(=O)[C@]1(C)[C@@H](N(Cc2ccccc2)C(=O)c3ccccc31)c4ccc(CO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 K13 compound treatment 9.7025 -0.22148 -0.1199 10.4691 0.8595 0.3843 0.187 0.4644 3186452 PK04Pur_000163 OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3N=[N+]=[N-])([C@H](O2)c4ccccc4)C(=O)NCc5ccccc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 K14 compound treatment 9.6484 -0.27558 -0.1492 9.505 -0.10454 -0.0467 -0.1385 -0.8862 3187223 PK04Pur_000164 OCCCC1=CC(N(Cc2cc3OCOc3cc2Br)/C(=N\P(=O)(Oc4ccccc4)Oc5ccccc5)/C1)c6cccs6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 K15 mock treatment 8.5128 -1.4112 -0.7639 8.8274 -0.78219 -0.3497 -0.7875 -0.9373 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 K16 mock treatment 8.9747 -0.94923 -0.5139 8.6854 -0.9241 -0.4132 -0.6555 -0.9942 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 K17 compound treatment 9.0235 -0.90047 -0.4875 8.6201 -0.98948 -0.4424 -0.6575 -0.9988 3187016 PK04Pur_000165 OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3CN=[N+]=[N-])(CO2)C(=O)N4CCCCC4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 K18 compound treatment 10.9877 1.0638 0.5759 8.9982 -0.61132 -0.2733 0.2139 0.3356 3069507 PK04Pur_000166 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N(CCO)Cc4ccccc4)C(=O)N(C)c5ccccc53 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 K19 compound treatment 9.8727 -0.051282 -0.0278 10.2154 0.60582 0.2709 0.1719 0.6313 3187170 PK04Pur_000167 CCCNC(=O)[C@H]1[C@@H](N(Cc2ccccc2OC)C(=O)c3ccccc13)c4ccc(CO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 K20 compound treatment 9.8319 -0.092002 -0.0498 8.8073 -0.80227 -0.3587 -0.2889 -0.7976 3188486 PK04Pur_000168 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(CC=C)c4ccc(cc43)N5CCCCC5=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 K21 mock treatment 9.0695 -0.85445 -0.4626 8.6899 -0.9197 -0.4112 -0.6179 -0.9983 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 K22 compound treatment 16.4111 6.4872 3.5119 12.1321 2.5225 1.1279 3.2808 0.8895 3189280 PK04Pur_000169 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4ccccc4)c5ccc(cc53)N6CCCCC6=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 K23 mock treatment 8.74 -1.1839 -0.6409 7.5583 -2.0512 -0.9172 -1.1017 -0.9846 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 K24 mock treatment 11.3253 1.4014 0.7586 10.6359 1.0263 0.4589 0.8609 0.971 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 L01 compound treatment 9.3176 -0.60632 -0.3282 18.7537 9.1442 4.0887 2.659 0.6483 3052595 PK04Pur_000170 NCCCCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3cccc(OCCO)c3)C(=O)[C@@H]4CCCN4C2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 L02 compound treatment 9.772 -0.15195 -0.0823 8.3213 -1.2882 -0.576 -0.4655 -0.8 3562057 PK04Pur_000171 O=C1CS(=O)(=O)CN1c2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 L03 compound treatment 11.7759 1.8519 1.0026 9.3445 -0.26504 -0.1185 0.6251 0.6192 3052874 PK04Pur_000172 Oc1ccc(cc1)[C@@H]2[C@@H](C[C@H]3N2C(=O)CNC3=O)C(=O)OCCOc4ccc(cc4)[C@@H]5N6[C@H]([C@H](C(=O)OCC=C)[C@@]57C(=O)Nc8ccc(I)cc87)C(=O)O[C@H]([C@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 L04 compound treatment 10.609 0.68509 0.3709 9.6237 0.014138 0.0063 0.2667 0.7191 3562041 PK04Pur_000173 COc1cc2CCN(CC=C)C(C#Cc3ccccc3)c2cc1OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 L05 compound treatment 10.6734 0.74949 0.4057 11.6647 2.0551 0.9189 0.9367 0.9325 3188230 PK04Pur_000174 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(Cc6cccc(I)c6)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 L06 compound treatment 10.9741 1.0501 0.5685 9.3229 -0.28667 -0.1282 0.3113 0.5343 3093843 PK04Pur_000175 CCOC(=O)C1=CC[C@@H]2[C@H]1C(=O)N(C2=O)c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 L07 mock treatment 8.5885 -1.3355 -0.723 8.1161 -1.4934 -0.6678 -0.9834 -0.9992 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 L08 mock treatment 10.3266 0.40265 0.218 10.4999 0.89039 0.3981 0.4356 0.9598 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 L09 compound treatment 11.3587 1.4347 0.7767 10.1233 0.51378 0.2297 0.7117 0.8786 3069417 PK04Pur_000176 C[C@H](C=C)[C@H](O)c1ccc(OCCO)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 L10 compound treatment 10.227 0.30304 0.1641 8.7083 -0.90127 -0.403 -0.169 -0.3883 3188275 PK04Pur_000177 CC(C)C[C@H]1NC(=O)[C@H](C)NC(=O)[C@@]2(C3[C@H](Cc4ccccc4)NC2=O)C(/C=C/C\C=C/CNC1=O)[C@@H]5O[C@]5(C)[C@H]3C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 L11 compound treatment 8.2301 -1.6938 -0.9169 8.7124 -0.89713 -0.4011 -0.932 -0.9312 3080189 PK04Pur_000178 CO[C@H](CCO)[C@H](OC(=O)Nc1ccc(SC)cc1)c2ccc(OC)c(O)c2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 L12 mock treatment 8.6547 -1.2692 -0.6871 9.3959 -0.21368 -0.0955 -0.5534 -0.7978 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 L13 compound treatment 9.2104 -0.71356 -0.3863 9.9163 0.30672 0.1371 -0.1762 -0.4298 3052886 PK04Pur_000179 CN(C)CCCC[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3ccc(O)cc3)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccccc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 L14 mock treatment 9.4164 -0.50751 -0.2747 11.0238 1.4142 0.6324 0.2529 0.3668 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 L15 mock treatment 10.3713 0.44732 0.2422 8.2867 -1.3229 -0.5915 -0.247 -0.3865 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 L16 mock treatment 8.7798 -1.1442 -0.6194 10.4213 0.81173 0.363 -0.1813 -0.2526 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 L17 compound treatment 9.9274 0.0034759 0.0019 8.5214 -1.0881 -0.4865 -0.3427 -0.7044 3176125 PK04Pur_000180 CN(C)CCCCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3cccc(OCCO)c3)C(=O)[C@@H]4CCCN4C2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 L18 mock treatment 8.889 -1.0349 -0.5603 7.5571 -2.0524 -0.9177 -1.0451 -0.972 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 L19 mock treatment 10.4284 0.50448 0.2731 10.1248 0.51527 0.2304 0.356 0.9964 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 L20 mock treatment 8.8207 -1.1032 -0.5972 7.9533 -1.6562 -0.7406 -0.946 -0.9943 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 L21 mock treatment 9.0064 -0.91758 -0.4967 8.4897 -1.1199 -0.5007 -0.7053 -1.0 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 L22 mock treatment 8.4665 -1.4575 -0.789 9.4523 -0.15721 -0.0703 -0.6076 -0.7671 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 L23 mock treatment 9.9016 -0.022304 -0.0121 11.0081 1.3986 0.6253 0.4336 0.6933 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 L24 mock treatment 8.0009 -1.923 -1.041 7.7692 -1.8404 -0.8229 -1.318 -0.9932 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 M01 compound treatment 11.3504 1.4265 0.7722 11.0432 1.4337 0.641 0.9993 0.9957 3187197 PK04Pur_000181 OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3N=[N+]=[N-])([C@H](O2)c4ccccc4)C(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 M02 compound treatment 10.7767 0.85281 0.4617 8.9645 -0.64506 -0.2884 0.1225 0.225 3186421 PK04Pur_000182 CN(C)CCCNC(=O)[C@]1(CC(=O)N([C@@H]1c2ccc(CO)cc2I)C3CCCCC3)c4ccc(cc4)[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 M03 compound treatment 9.7887 -0.13528 -0.0732 10.7405 1.1309 0.5057 0.3058 0.5985 3068361 PK04Pur_000183 COCCCNC(=O)[C@]1(Cc2ccccc2N=[N+]=[N-])N=C(O[C@@H]1c3ccccc3)c4ccc(OCCCO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 M04 compound treatment 9.3459 -0.578 -0.3129 9.8246 0.21508 0.0962 -0.1533 -0.4682 3187588 PK04Pur_000184 CC(C)N1[C@@H](c2ccc(CO)cc2)[C@@](C)(C(=O)O)c3ccccc3C1=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 M05 compound treatment 10.4956 0.57165 0.3095 10.1277 0.51811 0.2317 0.3826 0.9898 3187094 PK04Pur_000185 OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3CN=[N+]=[N-])([C@H](O2)c4ccccc4N=[N+]=[N-])C(=O)NCC(O)CO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 M06 compound treatment 12.6336 2.7096 1.4669 15.7823 6.1728 2.7601 2.9889 0.9562 3068238 PK04Pur_000186 COc1ccc(CCNC(=O)[C@]2(CC(=O)N([C@@H]2c3ccc(CO)cc3I)C4CCCCC4)Sc5ccc(C)cc5)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 M07 compound treatment 9.8032 -0.12077 -0.0654 9.2659 -0.3437 -0.1537 -0.1549 -0.9275 3067963 PK04Pur_000187 OCCCOc1ccc(cc1)C2=N[C@@](Cc3ccccc3N=[N+]=[N-])([C@@H](O2)c4ccccc4N=[N+]=[N-])C(=O)NCCN5CCOCC5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 M08 compound treatment 9.9945 0.070536 0.0382 9.8971 0.28753 0.1286 0.1179 0.8792 3186710 PK04Pur_000188 CC(C)NC(=O)[C@]1(CC(=O)N([C@@H]1c2ccc(CO)cc2I)C3CCCCC3)Sc4ccc(C)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 M09 mock treatment 9.9092 -0.014769 -0.008 10.3469 0.73737 0.3297 0.2275 0.6898 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 M10 mock treatment 9.1022 -0.82173 -0.4448 9.4644 -0.14512 -0.0649 -0.3604 -0.8018 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 M11 compound treatment 10.1107 0.18676 0.1011 9.4319 -0.17769 -0.0795 0.0153 0.1191 3186922 PK04Pur_000189 CN(C)C(=O)[C@]1(Cc2ccccc2N=[N+]=[N-])N=C(O[C@@H]1c3ccccc3)c4ccc(OCCCO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 M12 compound treatment 8.3512 -1.5728 -0.8514 9.8515 0.24194 0.1082 -0.5256 -0.6123 3187438 PK04Pur_000190 CN(C)CCCNC(=O)[C@]1(C)[C@@H](N(Cc2ccccc2)C(=O)c3ccccc31)c4ccc(CO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 M13 mock treatment 7.8858 -2.0382 -1.1034 8.3473 -1.2623 -0.5644 -1.1793 -0.9515 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 M14 mock treatment 9.9407 0.016748 0.0091 10.5287 0.91913 0.411 0.297 0.7225 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 M15 compound treatment 8.5813 -1.3426 -0.7268 8.8864 -0.72319 -0.3234 -0.7426 -0.9335 3186822 PK04Pur_000191 CC(C)(C)OC(=O)CC[C@@]1(COC(=N1)c2ccc(OCCCO)cc2)C(=O)NCCN3CCOCC3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 M16 compound treatment 8.0865 -1.8375 -0.9947 9.8451 0.23559 0.1053 -0.6289 -0.6287 3188232 PK04Pur_000192 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(c5ccccc53)c6ccccc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 M17 compound treatment 10.8864 0.96242 0.521 11.2999 1.6903 0.7558 0.9028 0.9835 3187434 PK04Pur_000193 CC(C)CNC(=O)[C@]1(C)[C@@H](N(Cc2ccccc2)C(=O)c3ccccc31)c4ccc(CO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 M18 compound treatment 10.8735 0.9496 0.5141 9.4228 -0.1867 -0.0835 0.3045 0.5846 3188770 PK04Pur_000194 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N(CCO)Cc4ccccc4)C(=O)N(c5ccccc53)c6ccccc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 M19 compound treatment 7.3445 -2.5795 -1.3964 10.2415 0.63191 0.2825 -0.7876 -0.5528 3068422 PK04Pur_000195 CN(C)CCCNC(=O)[C@H]1[C@@H](N(Cc2ccccc2)C(=O)c3ccccc13)c4ccc(CO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 M20 compound treatment 11.6649 1.7409 0.9425 8.8941 -0.71542 -0.3199 0.4402 0.4423 3188495 PK04Pur_000196 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(CC=C)c4ccc(cc43)N5CCOC5=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 M21 mock treatment 8.0318 -1.8922 -1.0243 8.7253 -0.88428 -0.3954 -1.0039 -0.9143 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 M22 compound treatment 10.1845 0.26051 0.141 8.5817 -1.0279 -0.4596 -0.2253 -0.4686 3070287 PK04Pur_000197 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCO)C(=O)N(Cc4ccc(cc4)N5CCCCC5=O)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 M23 mock treatment 10.1819 0.25796 0.1396 10.6155 1.006 0.4498 0.4168 0.885 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 M24 compound treatment 9.9868 0.062866 0.034 8.3234 -1.2861 -0.5751 -0.3826 -0.6641 3052798 PK04Pur_000198 C[N+](C)(C)CCCCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3ccc(O)cc3)C(=O)[C@H](Cc4ccccc4)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 N01 compound treatment 10.6545 0.73058 0.3955 10.116 0.50645 0.2265 0.4398 0.965 3052585 PK04Pur_000199 NCCCCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3cccc(OCCO)c3)C(=O)[C@H](Cc4ccccc4)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 N02 compound treatment 10.4367 0.51279 0.2776 9.9558 0.34623 0.1548 0.3058 0.962 3561931 PK04Pur_000200 [O-][N+](=O)c1ccccc1/C=C/c2ccncc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 N03 compound treatment 8.8223 -1.1016 -0.5964 8.7352 -0.87437 -0.391 -0.6981 -0.979 3176114 PK04Pur_000201 OCCOc1cccc(c1)[C@@H]2[C@@H](C[C@H]3N2C(=O)[C@H](Cc4ccccc4)NC3=O)C(=O)NCCCCCCNC(=O)CS 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 N04 compound treatment 9.4445 -0.47945 -0.2596 10.1572 0.54763 0.2449 -0.0104 -0.0291 3561853 PK04Pur_000202 Brc1ccc(CN(C(C(=O)NCc2ccccc2)c3ccco3)C(=O)Cc4ccccc4)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 N05 compound treatment 10.0481 0.12418 0.0672 10.5408 0.93128 0.4164 0.342 0.8108 3188231 PK04Pur_000203 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(Cc5ccc(I)cc5)c6ccccc63 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 N06 compound treatment 9.2633 -0.66064 -0.3576 9.6718 0.062221 0.0278 -0.2332 -0.6501 3092870 PK04Pur_000204 CCOC(=O)C1=CC[C@H](N(C1)S(=O)(=O)c2ccc(C)cc2)c3ccccc3C(F)(F)F 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 N07 compound treatment 10.4011 0.47716 0.2583 10.1511 0.54154 0.2421 0.3539 0.9995 3069421 PK04Pur_000205 CO[C@@H](C=C)[C@@H](OC(=O)Nc1ccc(SC)cc1)c2ccc(OCCO)cc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 N08 compound treatment 10.3581 0.4342 0.2351 9.9731 0.3636 0.1626 0.2812 0.9838 2129067 PK04Pur_000206 COc1cc(CO)cc(I)c1O[C@H]2C=C(C[C@@H](NCc3ccccc3F)[C@@H]2O)C(=O)NCCO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 N09 mock treatment 12.9585 3.0346 1.6428 9.8275 0.21792 0.0974 1.2305 0.7477 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 N10 mock treatment 9.6908 -0.2331 -0.1262 10.0893 0.47973 0.2145 0.0624 0.2509 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 N11 compound treatment 10.9908 1.0669 0.5776 9.518 -0.091524 -0.0409 0.3795 0.6554 3052645 PK04Pur_000207 CN(C)CCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3cccc(OCCO)c3)C(=O)CNC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 N12 mock treatment 10.2832 0.35927 0.1945 10.9989 1.3894 0.6212 0.5768 0.8861 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 N13 mock treatment 10.012 0.088098 0.0477 9.7772 0.16766 0.075 0.0867 0.9762 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 N14 mock treatment 9.6864 -0.23758 -0.1286 11.1215 1.5119 0.676 0.3871 0.5625 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 N15 compound treatment 9.7364 -0.18756 -0.1015 13.9905 4.3809 1.9589 1.3133 0.6696 3176789 PK04Pur_000208 NCCCCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3ccc(O)cc3)C(=O)[C@H](CCCCN)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 N16 mock treatment 9.7975 -0.12642 -0.0684 9.521 -0.088512 -0.0396 -0.0764 -0.9661 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 N17 compound treatment 10.4047 0.48078 0.2603 9.7306 0.12104 0.0541 0.2223 0.8363 3052740 PK04Pur_000209 C[N+](C)(C)CCCC[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCO)c3)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccccc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 N18 mock treatment 12.162 2.2381 1.2116 10.584 0.97441 0.4357 1.1648 0.9047 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 N19 mock treatment 12.3638 2.4398 1.3208 8.233 -1.3766 -0.6155 0.4987 0.3422 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 N20 mock treatment 11.6476 1.7237 0.9331 9.6686 0.059013 0.0264 0.6785 0.7268 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 N21 mock treatment 10.1015 0.17756 0.0961 8.7094 -0.90011 -0.4025 -0.2166 -0.5235 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 N22 mock treatment 10.0111 0.087138 0.0472 9.4289 -0.18063 -0.0808 -0.0238 -0.254 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 N23 mock treatment 10.2937 0.36971 0.2001 9.3682 -0.24138 -0.1079 0.0652 0.2868 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 N24 mock treatment 11.3142 1.3902 0.7526 10.2514 0.6418 0.287 0.7351 0.9126 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 O01 compound treatment 10.0976 0.17363 0.094 9.0853 -0.52428 -0.2344 -0.0993 -0.3932 3187371 PK04Pur_000210 COC(=O)[C@H]1N=C(O[C@H]1c2ccccc2)c3ccc(OCCCO)cc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 O02 compound treatment 10.5897 0.66576 0.3604 10.8765 1.267 0.5665 0.6554 0.9762 3067973 PK04Pur_000211 OCc1ccc(cc1)[C@H]2N(CC3(CC4CC5CC(C4)C3)C5)C(=O)C[C@@]2(C(=O)NCCN6CCOCC6)c7ccc(cc7)[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 O03 compound treatment 10.9293 1.0054 0.5443 11.2444 1.6348 0.731 0.9017 0.9894 3187295 PK04Pur_000212 OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3)([C@H](O2)c4ccccc4N=[N+]=[N-])C(=O)NCC(O)CO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 O04 compound treatment 10.3322 0.40822 0.221 10.6723 1.0628 0.4752 0.4923 0.9393 3186714 PK04Pur_000213 CC(C)NC(=O)[C@]1(CC(=O)N(C(C)C)[C@@H]1c2ccc(CO)cc2I)Sc3ccc(C)cc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 O05 compound treatment 10.1316 0.20769 0.1124 10.4067 0.79717 0.3564 0.3315 0.8871 3187101 PK04Pur_000214 OCCCOc1ccc(cc1)C2=N[C@](CC=C)([C@H](O2)c3ccccc3)C(=O)NCC(O)CO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 O06 compound treatment 9.3005 -0.62347 -0.3375 13.6167 4.0071 1.7917 1.0283 0.564 3186642 PK04Pur_000215 CCCNC(=O)[C@]1(CC(=O)N([C@@H]1c2ccc(CO)cc2I)C3CCCCC3)Sc4ccc(C)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 O07 compound treatment 9.0684 -0.85553 -0.4631 10.6377 1.0282 0.4597 -0.0024 -0.0037 3186376 PK04Pur_000216 OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3N=[N+]=[N-])([C@H](O2)c4ccccc4N=[N+]=[N-])C(=O)NCc5ccccc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 O08 compound treatment 70.3274 60.403 32.6998 78.0191 68.41 30.5883 44.7515 0.9994 3186789 PK04Pur_000217 CN(C)CCCNC(=O)[C@]1(CC(=O)N(Cc2ccccc2Cl)[C@@H]1c3ccc(CO)cc3I)Sc4ccc(C)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 O09 compound treatment 9.4707 -0.45328 -0.2454 8.4148 -1.1948 -0.5342 -0.5513 -0.9377 3186584 PK04Pur_000218 OCCCOc1ccc(cc1)C2=N[C@@](CC=C)([C@@H](O2)c3ccccc3)C(=O)N4CCCCC4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 O10 compound treatment 9.2227 -0.7012 -0.3796 9.2325 -0.37702 -0.1686 -0.3876 -0.9332 3068608 PK04Pur_000219 CC(C)NC(=O)[C@]1(C)[C@@H](N(Cc2ccc(OC(F)(F)F)cc2)C(=O)c3ccccc31)c4ccc(CO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 O11 mock treatment 10.0109 0.086918 0.0471 9.625 0.015448 0.0069 0.0382 0.8023 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 O12 mock treatment 10.7301 0.80613 0.4364 9.4195 -0.19002 -0.085 0.2485 0.5589 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 O13 compound treatment 9.5748 -0.34914 -0.189 10.3162 0.7066 0.3159 0.0898 0.2438 3068067 PK04Pur_000220 OCCCOc1ccc(cc1)C2=N[C@](CC=C)(CO2)C(=O)NCC(O)CO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 O14 compound treatment 9.9862 0.062248 0.0337 10.7854 1.1758 0.5257 0.3956 0.7509 3187302 PK04Pur_000221 CN1C(=O)C2C(C3C(C4CC4)N(Cc5sc6ccccc6c5Cl)C2C=C3c7ccc(CO)cc7)C1=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 O15 compound treatment 7.5929 -2.331 -1.2619 8.4349 -1.1746 -0.5252 -1.2637 -0.9245 3186825 PK04Pur_000222 OCCCOc1ccc(cc1)C2=N[C@@](Cc3ccccc3N=[N+]=[N-])([C@@H](O2)c4ccccc4N=[N+]=[N-])C(=O)NCC(O)CO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 O16 compound treatment 8.6232 -1.3008 -0.7042 10.2589 0.64932 0.2903 -0.2926 -0.3842 3069444 PK04Pur_000223 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N(CCO)Cc4ccccc4)C(=O)N(C)c5ccccc53 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 O17 compound treatment 10.3436 0.41969 0.2272 10.9794 1.3698 0.6125 0.5938 0.9089 3186422 PK04Pur_000224 CCCNC(=O)[C@]1(CC(=O)N(CC2(CC3CC4CC(C3)C2)C4)[C@@H]1c5ccc(CO)cc5I)c6ccc(cc6)[N+](=O)[O-] 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 O18 compound treatment 8.4642 -1.4598 -0.7902 9.4399 -0.16967 -0.0759 -0.6124 -0.7714 3189015 PK04Pur_000225 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4CCC[C@H]4CO)C(=O)N(C)c5c3cc(C)cc5Br 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 O19 compound treatment 9.3076 -0.61634 -0.3337 8.299 -1.3106 -0.586 -0.6503 -0.9644 3187428 PK04Pur_000226 C[C@]1([C@@H](N(Cc2cc(cc(c2)C(F)(F)F)C(F)(F)F)C(=O)c3ccccc31)c4ccc(CO)cc4)C(=O)NC5CC5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 O20 compound treatment 11.5167 1.5927 0.8622 10.8466 1.2371 0.5531 1.0008 0.977 3188629 PK04Pur_000227 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCO)C(=O)N(Cc4ccccc4)c5ccc(cc53)N6CCOC6=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 O21 mock treatment 9.6352 -0.28873 -0.1563 8.4478 -1.1617 -0.5194 -0.4778 -0.8809 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 O22 compound treatment 10.2455 0.32153 0.1741 9.0113 -0.5983 -0.2675 -0.0661 -0.2071 3176043 PK04Pur_000228 CC(C)C[C@@H]1NC(=O)[C@@H]2C[C@@H]([C@@H](N2C1=O)c3cccc(OCCO)c3)C(=O)NCCCCCC[N+](C)(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 O23 mock treatment 10.4455 0.52157 0.2824 10.2492 0.63968 0.286 0.4019 1.0 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 O24 mock treatment 11.4818 1.5579 0.8434 9.8916 0.28206 0.1261 0.6855 0.8039 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 P01 compound treatment 10.4634 0.53948 0.2921 9.59 -0.019594 -0.0088 0.2003 0.6856 3176207 PK04Pur_000229 NCCCCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3cccc(OCCO)c3)C(=O)CNC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 P02 compound treatment 10.0047 0.080756 0.0437 9.9411 0.3316 0.1483 0.1358 0.8782 3562135 PK04Pur_000230 COC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2OC(CSc3ccccn3)CC(O2)c4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 P03 compound treatment 8.8828 -1.0412 -0.5637 9.264 -0.34554 -0.1545 -0.5078 -0.8689 3052544 PK04Pur_000231 CC(C)C[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCO)c3)C(=O)NCCCC[N+](C)(C)C 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 P04 compound treatment 10.0745 0.15052 0.0815 12.3228 2.7132 1.2132 0.9155 0.7529 3561861 PK04Pur_000232 CCOC(=O)C1C2OC3(C=C2)C(N(Cc4ccccc4)C(=O)C13)C(=O)NCc5ccccc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 P05 compound treatment 11.324 1.4001 0.758 9.9146 0.30506 0.1364 0.6324 0.8212 3069399 PK04Pur_000233 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4Cc5ccccc5C[C@H]4CO)C(=O)N(Cc6ccc(I)cc6)c7ccccc73 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 P06 compound treatment 10.6988 0.77484 0.4195 9.4154 -0.19414 -0.0868 0.2352 0.5491 3561916 PK04Pur_000234 COCCCN(CC(O)CO)C[C@]1(O)CCC2[C@]1(C)CCC3[C@@]4(C)CC[C@H](O)C[C@@]54C=C[C@]23C(=C5)C(=O)c6ccc(OC)cc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 P07 compound treatment 9.4651 -0.45887 -0.2484 10.0444 0.4349 0.1945 -0.0382 -0.1209 2019458 PK04Pur_000235 OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)Nc2ccccc2O)c3coc4ccccc4c3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 P08 compound treatment 9.9991 0.075136 0.0407 9.347 -0.26251 -0.1174 -0.0542 -0.4366 3071461 PK04Pur_000236 CC(=C)C/1CN([C@H](CO)c2ccccc2)C(=O)\C1=C/c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 P09 compound treatment 11.4185 1.4945 0.8091 11.4354 1.8259 0.8164 1.1494 1.0 3080226 PK04Pur_000237 COc1ccc(NC(=O)O[C@@H]([C@@H](C)CCO)c2ccc(OCCO)cc2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 P10 compound treatment 9.3233 -0.60068 -0.3252 10.8309 1.2214 0.5461 0.1562 0.2458 3070944 PK04Pur_000238 O/N=C(\Cc1ccccc1)/C(=O)NCCCCCNC(=O)OCc2ccccc2 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 P11 mock treatment 9.022 -0.90194 -0.4883 11.1599 1.5503 0.6932 0.1449 0.1709 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 P12 mock treatment 10.6989 0.77493 0.4195 9.5989 -0.010632 -0.0048 0.2933 0.699 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 P13 compound treatment 10.6242 0.70024 0.3791 9.5322 -0.077364 -0.0346 0.2436 0.6399 3052888 PK04Pur_000239 CN(C)CCCCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3ccc(O)cc3)C(=O)[C@H](CCCC[N+](C)(C)C)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 P14 mock treatment 9.247 -0.67695 -0.3665 13.1161 3.5066 1.5679 0.8496 0.5276 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 P15 compound treatment 10.0761 0.15215 0.0824 16.2137 6.6041 2.9529 2.1463 0.7265 3052794 PK04Pur_000240 CN(C)CCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3ccc(O)cc3)C(=O)[C@H](Cc4ccccc4)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 P16 mock treatment 10.8331 0.90915 0.4922 10.8915 1.282 0.5732 0.7534 0.9971 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 P17 compound treatment 10.7327 0.80877 0.4378 9.4652 -0.14439 -0.0646 0.2639 0.5964 3052799 PK04Pur_000241 C[N+](C)(C)CCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3ccc(O)cc3)C(=O)[C@H](Cc4ccccc4)NC2=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 P18 mock treatment 11.3043 1.3804 0.7473 8.9216 -0.688 -0.3076 0.3109 0.3847 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 P19 mock treatment 9.1868 -0.73716 -0.3991 11.1149 1.5054 0.6731 0.1938 0.2476 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 P20 mock treatment 9.4063 -0.51768 -0.2803 8.4487 -1.1608 -0.5191 -0.5652 -0.9582 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 P21 mock treatment 9.3564 -0.56753 -0.3072 9.3603 -0.2492 -0.1114 -0.296 -0.9058 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 P22 mock treatment 9.7933 -0.13067 -0.0707 9.277 -0.33252 -0.1487 -0.1552 -0.9423 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 P23 mock treatment 11.1719 1.2479 0.6756 10.0424 0.43287 0.1936 0.6146 0.8745 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2449 P24 mock treatment 12.0443 2.1204 1.1479 11.2657 1.6561 0.7405 1.3353 0.9775 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 A01 compound treatment 10.6737 0.53761 0.291 10.6614 0.59813 0.2674 0.3949 0.9991 3186439 PK04Pur_000242 CCCN1C(=O)[C@]2(CCS(=O)(=O)c3ccccc3)N=C(O[C@@H]2c4ccccc14)c5ccc(OCCCO)cc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 A02 compound treatment 10.1666 0.030508 0.0165 11.5987 1.5355 0.6866 0.4972 0.7239 2143237 PK04Pur_000243 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccc(OCCO)cc4)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)NC[C@H](O)c7ccccc7)c8cc(C#Cc9ccc(OC)cc9)ccc18 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 A03 compound treatment 8.9603 -1.1758 -0.6365 11.0531 0.98986 0.4426 -0.1371 -0.1769 3186457 PK04Pur_000244 CCCN1C(=O)[C@]2(CCC(=O)OC(C)(C)C)N=C(O[C@@H]2c3ccccc13)c4ccc(OCCCO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 A04 compound treatment 9.8261 -0.30995 -0.1678 11.1865 1.1232 0.5022 0.2365 0.4466 2144457 PK04Pur_000245 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccc(O)cc4)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCc8cc(OC)c(OC)cc8C7)c9cc(C#CC%10=CCCCC%10)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 A05 compound treatment 9.4011 -0.73497 -0.3979 9.8229 -0.24031 -0.1074 -0.3573 -0.867 3186522 PK04Pur_000246 OCCCOc1ccc(cc1)C2=N[C@@]3(CO2)Cc4ccccc4CN(Cc5ccccc5)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 A06 compound treatment 10.2213 0.085218 0.0461 14.987 4.9238 2.2016 1.5894 0.7218 2142097 PK04Pur_000247 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(OCCO)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCc8cc(OC)c(OC)cc8C7)c9cc(C#CCC(C(=O)OC)C(=O)OC)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 A07 compound treatment 11.1845 1.0484 0.5676 11.8841 1.8209 0.8142 0.977 0.9844 3186732 PK04Pur_000248 CN1C(=O)[C@]2(CCS(=O)(=O)c3ccccc3)N=C(O[C@@H]2c4ccccc14)c5ccc(OCCCO)cc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 A08 compound treatment 11.2508 1.1147 0.6035 9.9226 -0.14063 -0.0629 0.3823 0.63 2143945 PK04Pur_000249 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccccc4OCCO)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)NCC=C)c7cc(C#CCCO)ccc17 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 A09 compound treatment 10.7082 0.5721 0.3097 11.5496 1.4863 0.6646 0.6889 0.9396 3068183 PK04Pur_000250 OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3N=[N+]=[N-])(CO2)C(=O)O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 A10 compound treatment 12.828 2.6919 1.4573 8.9864 -1.0768 -0.4815 0.69 0.4496 2144817 PK04Pur_000251 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccc(OCCO)cc4)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)Nc7nc8ccccc8s7)c9ccccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 A11 compound treatment 10.1132 -0.02286 -0.0124 13.0398 2.9766 1.3309 0.9324 0.7005 3187290 PK04Pur_000252 OCCCOc1ccc(cc1)C2=N[C@]3(CC=C)[C@H](O2)c4ccccc4N(CC=C)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 A12 compound treatment 11.735 1.5989 0.8656 11.623 1.5598 0.6974 1.1052 0.9943 2144053 PK04Pur_000253 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccccc4OCCO)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCN(CC7)c8ncccn8)c9cc(C#CC%10(O)CCCCCC%10)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 A13 mock treatment 11.6434 1.5073 0.816 10.8956 0.83232 0.3722 0.8401 0.9368 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 A14 mock treatment 11.6134 1.4773 0.7997 10.213 0.14979 0.067 0.6129 0.7637 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 A15 compound treatment 13.4998 3.3637 1.8209 10.9782 0.91493 0.4091 1.5769 0.8449 3068605 PK04Pur_000254 OCCCOc1ccc(cc1)C2=N[C@]3(Cc4ccccc4)[C@H](O2)c5ccccc5N(CC=C)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 A16 compound treatment 11.1271 0.99101 0.5365 8.5454 -1.5178 -0.6787 -0.1005 -0.1162 2144025 PK04Pur_000255 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccccc4OCCO)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)NCC=C)c7cc(C#CC8(O)CCCCCC8)ccc17 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 A17 compound treatment 11.3003 1.1642 0.6303 11.9746 1.9114 0.8546 1.05 0.9888 3067972 PK04Pur_000256 OCCCOc1ccc(cc1)C2=N[C@]3(Cc4ccccc4CN(CC=C)C3=O)[C@H](O2)c5ccccc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 A18 compound treatment 10.3519 0.21586 0.1169 10.5455 0.48231 0.2157 0.2351 0.9586 2143969 PK04Pur_000257 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccccc4OCCO)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)Nc7nc8ccccc8s7)c9cc(C#CCCO)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 A19 mock treatment 10.7123 0.57621 0.3119 11.9329 1.8696 0.836 0.8117 0.9097 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 A20 mock treatment 11.0374 0.90134 0.4879 11.1431 1.0799 0.4828 0.6865 1.0 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 A21 mock treatment 12.1912 2.0551 1.1125 9.9826 -0.080629 -0.0361 0.7612 0.6838 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 A22 mock treatment 9.2778 -0.85826 -0.4646 10.6285 0.56522 0.2527 -0.1498 -0.2833 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 A23 mock treatment 10.6505 0.51443 0.2785 10.1762 0.11301 0.0505 0.2327 0.822 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 A24 mock treatment 11.0114 0.87535 0.4739 11.5698 1.5066 0.6736 0.8114 0.9852 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 B01 compound treatment 8.9011 -1.235 -0.6686 10.8242 0.761 0.3403 -0.2322 -0.3095 2141420 PK04Pur_000258 COc1ccc(C#Cc2ccc3NC(=O)[C@@]4([C@H]([C@H]5N([C@H]4c6ccc(O)cc6)[C@@H]([C@@H](OC5=O)c7ccccc7)c8ccccc8)C(=O)Nc9nc%10ccccc%10s9)c3c2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 B02 compound treatment 10.6998 0.56368 0.3051 11.1768 1.1136 0.4979 0.5679 0.9724 3000708 PK04Pur_000259 CO[C@H]1O[C@H](CO)[C@@H](OC(=O)Nc2cccc(F)c2)[C@H](OC(=O)Nc3ccccc3)[C@H]1OC(=O)Nc4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 B03 compound treatment 10.1402 0.0041327 0.0022 9.5488 -0.51446 -0.23 -0.1611 -0.7002 2141142 PK04Pur_000260 NC(=O)NCC#Cc1ccc2NC(=O)[C@]3([C@@H]([C@@H]4N([C@@H]3c5ccc(O)cc5)[C@H]([C@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)O)c2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 B04 compound treatment 10.9796 0.84356 0.4567 8.9527 -1.1106 -0.4966 -0.0282 -0.0418 3089664 PK04Pur_000261 CCOC(=O)c1ccc(NC(=O)O[C@@H]2[C@@H](CO)O[C@H](OC)[C@H](OC(=O)Nc3ccc4OCOc4c3)[C@H]2OC(=O)Nc5ccc6OCOc6c5)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 B05 compound treatment 8.8649 -1.2712 -0.6882 9.4634 -0.59978 -0.2682 -0.6763 -0.9156 2141453 PK04Pur_000262 COC(=O)C(CC#Cc1ccc2NC(=O)[C@@]3([C@H]([C@H]4N([C@H]3c5ccc(O)cc5)[C@@H]([C@@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)Nc8nc9ccccc9s8)c2c1)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 B06 compound treatment 13.1723 3.0362 1.6437 11.5902 1.527 0.6828 1.645 0.9243 3089768 PK04Pur_000263 CCOC(=O)c1ccc(NC(=O)O[C@@H]2[C@@H](CO)O[C@H](OC)[C@@H](OC(=O)Nc3ccccc3)[C@H]2OC(=O)Nc4ccccc4)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 B07 compound treatment 9.1789 -0.95722 -0.5182 9.2132 -0.85 -0.3801 -0.6352 -0.9884 2143973 PK04Pur_000264 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccccc4OCCO)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCN(CC7)c8ncccn8)c9cc(C#CCCO)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 B08 compound treatment 10.6129 0.47683 0.2581 8.1795 -1.8837 -0.8423 -0.4131 -0.4689 3089773 PK04Pur_000265 CO[C@H]1O[C@H](CO)[C@@H](OC(=O)Nc2ccc3OCOc3c2)[C@H](OC(=O)Nc4ccc5OCOc5c4)[C@@H]1OC(=O)Nc6ccc7OCOc7c6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 B09 compound treatment 12.3912 2.2551 1.2208 13.4804 3.4172 1.528 1.9437 0.9938 2144373 PK04Pur_000266 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccc(O)cc4)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCN(CC7)c8ncccn8)c9cc(C#CC%10(O)CCCCCC%10)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 B10 compound treatment 10.5175 0.38146 0.2065 10.4095 0.34632 0.1549 0.2555 0.9899 3001180 PK04Pur_000267 CO[C@H]1O[C@H](CO)[C@@H](OC(=O)Nc2ccc3OCOc3c2)[C@H](OC(=O)Nc4ccccc4c5ccccc5)[C@@H]1OC(=O)Nc6ccccc6c7ccccc7 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 B11 compound treatment 11.7621 1.626 0.8802 10.2204 0.15721 0.0703 0.6721 0.7612 2144881 PK04Pur_000268 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccccc4OCCO)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCCCCCC7)c8ccccc18 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 B12 compound treatment 11.784 1.648 0.8921 9.456 -0.60723 -0.2715 0.4388 0.4706 2141882 PK04Pur_000269 OCCOc1ccccc1[C@@H]2N3[C@H]([C@H](C(=O)Nc4nc5ccccc5s4)[C@@]26C(=O)Nc7ccccc76)C(=O)O[C@H]([C@H]3c8ccccc8)c9ccccc9 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 B13 mock treatment 10.9453 0.80925 0.4381 10.409 0.34582 0.1546 0.4191 0.9021 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 B14 mock treatment 10.7674 0.63134 0.3418 11.3217 1.2584 0.5627 0.6396 0.9714 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 B15 compound treatment 10.8638 0.72777 0.394 8.1749 -1.8883 -0.8443 -0.3184 -0.3418 2143929 PK04Pur_000270 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccccc4OCCO)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)Nc7nc8ccccc8s7)c9cc(C#CCNC(=O)N)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 B16 compound treatment 10.4147 0.27864 0.1508 11.5273 1.4641 0.6546 0.5696 0.8478 2141904 PK04Pur_000271 OCCOc1ccc(cc1)[C@H]2N3[C@@H]([C@@H](C(=O)Nc4nc5ccccc5s4)[C@]26C(=O)Nc7ccccc76)C(=O)O[C@@H]([C@@H]3c8ccccc8)c9ccccc9 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 B17 compound treatment 11.5562 1.4201 0.7688 10.6016 0.53834 0.2407 0.7138 0.8861 2141834 PK04Pur_000272 Oc1ccc(cc1)[C@H]2N3[C@@H]([C@@H](C(=O)N4CCCCCCC4)[C@]25C(=O)Nc6ccc(C#CC7=CCCCC7)cc65)C(=O)O[C@@H]([C@@H]3c8ccccc8)c9ccccc9 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 B18 compound treatment 10.8241 0.68803 0.3725 11.2636 1.2004 0.5367 0.6429 0.9841 2141108 PK04Pur_000273 NC(=O)NCC#Cc1ccc2NC(=O)[C@@]3([C@H]([C@H]4N([C@H]3c5ccccc5OCCO)[C@@H]([C@@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)O)c2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 B19 compound treatment 9.6098 -0.52627 -0.2849 9.113 -0.95019 -0.4249 -0.5019 -0.9811 2141530 PK04Pur_000274 OCCOc1ccc(cc1)[C@H]2N3[C@@H]([C@@H](C(=O)Nc4nc5ccccc5s4)[C@]26C(=O)Nc7ccc(C#CCCO)cc76)C(=O)O[C@@H]([C@@H]3c8ccccc8)c9ccccc9 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 B20 compound treatment 11.3325 1.1964 0.6477 10.8927 0.82949 0.3709 0.7202 0.965 2141222 PK04Pur_000275 OCCOc1ccc(cc1)[C@@H]2N3[C@H]([C@H](C(=O)Nc4nc5ccccc5s4)[C@@]26C(=O)Nc7ccc(C#CC8=CCCCC8)cc76)C(=O)O[C@H]([C@H]3c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 B21 mock treatment 9.3909 -0.7452 -0.4034 8.62 -1.4432 -0.6453 -0.7416 -0.9744 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 B22 mock treatment 10.634 0.49787 0.2695 10.0329 -0.030326 -0.0136 0.181 0.6707 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 B23 mock treatment 10.5318 0.39567 0.2142 9.1986 -0.86459 -0.3866 -0.1219 -0.2758 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 B24 mock treatment 10.4682 0.33215 0.1798 10.3601 0.29684 0.1327 0.221 0.9888 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 C01 compound treatment 10.897 0.76092 0.4119 11.2181 1.1549 0.5164 0.6564 0.9937 3068022 PK04Pur_000276 CCCN1C(=O)[C@]2(Cc3ccccc13)N=C(O[C@@H]2c4ccccc4)c5ccc(OCCCO)cc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 C02 compound treatment 10.1316 -0.0045098 -0.0024 10.346 0.28278 0.1264 0.0877 0.6933 2144193 PK04Pur_000277 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccc(O)cc4)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCCCCCC7)c8cc(C#Cc9ccc(OC)cc9)ccc18 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 C03 compound treatment 9.3221 -0.81397 -0.4406 12.4964 2.4332 1.088 0.4577 0.3899 3068062 PK04Pur_000278 CCCN1C(=O)[C@@]2(CC=C)N=C(O[C@H]2c3ccccc13)c4ccc(OCCCO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 C04 compound treatment 14.244 4.1079 2.2239 12.3153 2.252 1.007 2.2845 0.9358 2143985 PK04Pur_000279 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccccc4OCCO)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)NCC=C)c7cc(C#CCC(C(=O)OC)C(=O)OC)ccc17 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 C05 compound treatment 12.9836 2.8475 1.5415 10.6425 0.57926 0.259 1.2732 0.8145 3068116 PK04Pur_000280 CCCN1C(=O)[C@]2(Cc3ccccc3)N=C(O[C@@H]2c4ccccc14)c5ccc(OCCCO)cc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 C06 compound treatment 7.7484 -2.3877 -1.2926 8.8871 -1.1762 -0.5259 -1.2859 -0.9215 2144905 PK04Pur_000281 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccccc4OCCO)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCc8cc(OC)c(OC)cc8C7)c9ccccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 C07 compound treatment 8.977 -1.159 -0.6275 8.5205 -1.5428 -0.6898 -0.9315 -0.9989 3186733 PK04Pur_000282 CCCN1C(=O)[C@@]2(Cc3ccccc13)N=C(O[C@H]2c4ccccc4)c5ccc(OCCCO)cc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 C08 compound treatment 9.3598 -0.77629 -0.4203 9.8126 -0.25065 -0.1121 -0.3764 -0.8654 2144737 PK04Pur_000283 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccccc4OCCO)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)Nc7nc8ccccc8s7)c9ccccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 C09 compound treatment 8.3739 -1.7622 -0.954 10.627 0.5638 0.2521 -0.4963 -0.503 3068274 PK04Pur_000284 COC(=O)[C@]1(CCC(=O)OC(C)(C)C)N=C(O[C@@H]1c2ccccc2N=[N+]=[N-])c3ccc(OCCCO)cc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 C10 compound treatment 9.4269 -0.70917 -0.3839 9.4841 -0.57915 -0.259 -0.4546 -0.9816 2143225 PK04Pur_000285 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccc(OCCO)cc4)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)NCC=C)c7cc(C#Cc8ccc(OC)cc8)ccc17 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 C11 mock treatment 9.1967 -0.93934 -0.5085 10.295 0.23176 0.1036 -0.2863 -0.5517 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 C12 mock treatment 11.1927 1.0566 0.572 9.8815 -0.18169 -0.0812 0.347 0.6007 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 C13 compound treatment 10.8814 0.74535 0.4035 10.4371 0.37387 0.1672 0.4035 0.9239 3187457 PK04Pur_000286 OCCCOc1ccc(cc1)C2=N[C@]3(CC=C)[C@H](O2)c4ccccc4N(CCS(=O)(=O)c5ccccc5)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 C14 compound treatment 9.9529 -0.18319 -0.0992 8.8709 -1.1923 -0.5331 -0.4471 -0.8245 2142957 PK04Pur_000287 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(O)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)NC[C@H](O)c7ccccc7)c8cc(C#CCNC(=O)N)ccc18 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 C15 mock treatment 10.7409 0.60482 0.3274 9.401 -0.66222 -0.2961 0.0221 0.0502 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 C16 mock treatment 10.6135 0.47744 0.2585 9.9236 -0.13962 -0.0624 0.1386 0.5213 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 C17 mock treatment 10.2322 0.096118 0.052 9.6756 -0.38763 -0.1733 -0.0858 -0.4739 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 C18 compound treatment 10.4179 0.28184 0.1526 11.0365 0.97327 0.4352 0.4156 0.9012 2141464 PK04Pur_000288 Oc1ccc(cc1)[C@@H]2N3[C@H]([C@H](C(=O)Nc4nc5ccccc5s4)[C@@]26C(=O)Nc7ccc(C#CC8(O)CCCCCC8)cc76)C(=O)O[C@H]([C@H]3c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 C19 mock treatment 10.502 0.3659 0.1981 9.6534 -0.40986 -0.1833 0.0105 0.0388 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 C20 mock treatment 8.5998 -1.5363 -0.8317 10.679 0.61572 0.2753 -0.3934 -0.4491 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 C21 mock treatment 9.9449 -0.19115 -0.1035 9.0881 -0.97512 -0.436 -0.3815 -0.8513 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 C22 mock treatment 9.779 -0.35709 -0.1933 9.0589 -1.0043 -0.4491 -0.4542 -0.9291 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 C23 mock treatment 9.1396 -0.99649 -0.5395 9.6783 -0.38492 -0.1721 -0.5032 -0.8886 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 C24 mock treatment 12.8887 2.7526 1.4902 11.0247 0.9615 0.4299 1.3577 0.8754 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 D01 compound treatment 12.4992 2.3631 1.2793 9.4389 -0.62438 -0.2792 0.7072 0.5401 2141445 PK04Pur_000289 COc1cc2CCN(Cc2cc1OC)C(=O)[C@H]3[C@H]4N([C@@H](c5ccc(O)cc5)[C@]36C(=O)Nc7ccc(C#CCCO)cc76)[C@@H]([C@@H](OC4=O)c8ccccc8)c9ccccc9 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 D02 compound treatment 11.4802 1.3441 0.7276 10.2443 0.18107 0.081 0.5718 0.781 3089333 PK04Pur_000290 CO[C@H]1O[C@H](CO)[C@@H](OC(=O)Nc2ccc(OC)cc2)[C@H](OC(=O)Nc3ccccc3)[C@H]1OC(=O)Nc4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 D03 compound treatment 12.8802 2.7441 1.4855 8.9829 -1.0803 -0.483 0.7089 0.4538 2141179 PK04Pur_000291 OCCOc1ccc(cc1)[C@@H]2N3[C@H]([C@H](C(=O)N4CCN(CC4)c5ncccn5)[C@@]26C(=O)Nc7ccc(C#CCCO)cc76)C(=O)O[C@H]([C@H]3c8ccccc8)c9ccccc9 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 D04 compound treatment 10.9217 0.78563 0.4253 10.5925 0.52924 0.2366 0.4681 0.9617 3000714 PK04Pur_000292 CO[C@H]1O[C@H](CO)[C@@H](OC(=O)Nc2ccc(cc2)C(F)(F)F)[C@H](OC(=O)Nc3ccc4OCOc4c3)[C@H]1OC(=O)Nc5ccc6OCOc6c5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 D05 compound treatment 9.4641 -0.67199 -0.3638 9.7745 -0.2887 -0.1291 -0.3485 -0.9029 2141541 PK04Pur_000293 COC(=O)C(CC#Cc1ccc2NC(=O)[C@]3([C@@H]([C@@H]4N([C@@H]3c5ccc(OCCO)cc5)[C@H]([C@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)Nc8nc9ccccc9s8)c2c1)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 D06 compound treatment 9.7798 -0.35625 -0.1929 9.7468 -0.31641 -0.1415 -0.2364 -0.9884 3089764 PK04Pur_000294 CO[C@H]1O[C@H](CO)[C@@H](OC(=O)Nc2c(C)cccc2OC)[C@H](OC(=O)Nc3ccccc3)[C@@H]1OC(=O)Nc4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 D07 compound treatment 9.3364 -0.79964 -0.4329 10.2347 0.17148 0.0767 -0.2519 -0.5729 2144657 PK04Pur_000295 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(OCCO)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)Nc7nc8ccccc8s7)c9ccccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 D08 compound treatment 10.0162 -0.11986 -0.0649 9.0622 -1.0011 -0.4476 -0.3624 -0.8012 3089774 PK04Pur_000296 CO[C@H]1O[C@H](CO)[C@@H](OC(=O)Nc2ccccc2c3ccccc3)[C@H](OC(=O)Nc4ccc5OCOc5c4)[C@@H]1OC(=O)Nc6ccc7OCOc7c6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 D09 compound treatment 9.6343 -0.50183 -0.2717 10.1565 0.093291 0.0417 -0.1626 -0.5916 2143037 PK04Pur_000297 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(O)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)NC[C@H](O)c7ccccc7)c8cc(C#CCC(C(=O)OC)C(=O)OC)ccc18 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 D10 compound treatment 8.0381 -2.098 -1.1358 10.0401 -0.023151 -0.0104 -0.8104 -0.7135 3001092 PK04Pur_000298 CO[C@H]1O[C@H](CO)[C@@H](OC(=O)Nc2ccccc2c3ccccc3)[C@H](OC(=O)Nc4ccccc4c5ccccc5)[C@@H]1OC(=O)Nc6ccccc6c7ccccc7 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 D11 mock treatment 8.6876 -1.4485 -0.7842 9.6261 -0.4371 -0.1954 -0.6927 -0.8571 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 D12 mock treatment 11.0112 0.8751 0.4737 9.9008 -0.16239 -0.0726 0.2836 0.5918 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 D13 compound treatment 10.4516 0.31555 0.1708 11.8139 1.7506 0.7828 0.6743 0.8416 2143325 PK04Pur_000299 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccc(OCCO)cc4)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N)c7cc(C#CCCO)ccc17 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 D14 compound treatment 10.6317 0.49565 0.2683 8.6227 -1.4406 -0.6441 -0.2657 -0.3808 2141706 PK04Pur_000300 OCCOc1ccccc1[C@H]2N3[C@@H]([C@@H](C(=O)Nc4nc5ccccc5s4)[C@]26C(=O)Nc7ccc(C#CCCO)cc76)C(=O)O[C@@H]([C@@H]3c8ccccc8)c9ccccc9 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 D15 mock treatment 9.3416 -0.79453 -0.4301 9.0214 -1.0419 -0.4658 -0.6335 -0.9992 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 D16 mock treatment 10.1072 -0.028882 -0.0156 12.1835 2.1202 0.948 0.6593 0.6954 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 D17 compound treatment 9.8451 -0.29101 -0.1575 11.157 1.0938 0.4891 0.2344 0.4562 2141376 PK04Pur_000301 OCCOc1ccccc1[C@@H]2N3[C@H]([C@H](C(=O)Nc4nc5ccccc5s4)[C@@]26C(=O)Nc7ccc(C#CC8(O)CCCCCC8)cc76)C(=O)O[C@H]([C@H]3c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 D18 compound treatment 8.4982 -1.6379 -0.8867 8.319 -1.7443 -0.7799 -1.1785 -0.998 2141703 PK04Pur_000302 OCCOc1ccccc1[C@H]2N3[C@@H]([C@@H](C(=O)NC[C@H](O)c4ccccc4)[C@]25C(=O)Nc6ccc(C#CCCO)cc65)C(=O)O[C@@H]([C@@H]3c7ccccc7)c8ccccc8 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 D19 compound treatment 10.3091 0.17298 0.0936 10.7805 0.71725 0.3207 0.293 0.877 2143965 PK04Pur_000303 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccccc4OCCO)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N)c7cc(C#CCCO)ccc17 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 D20 compound treatment 11.2453 1.1092 0.6005 8.4336 -1.6297 -0.7287 -0.0907 -0.096 2141524 PK04Pur_000304 OCCOc1ccc(cc1)[C@H]2N3[C@@H]([C@@H](C(=O)NCC=C)[C@]24C(=O)Nc5ccc(C#CCCO)cc54)C(=O)O[C@@H]([C@@H]3c6ccccc6)c7ccccc7 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 D21 mock treatment 9.4549 -0.68122 -0.3688 9.0752 -0.98799 -0.4418 -0.5731 -0.996 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 D22 mock treatment 10.7566 0.62047 0.3359 10.1798 0.11653 0.0521 0.2744 0.8071 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 D23 mock treatment 9.7899 -0.34619 -0.1874 10.0765 0.013256 0.0059 -0.1283 -0.6844 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 D24 mock treatment 8.2175 -1.9186 -1.0386 10.2114 0.14822 0.0663 -0.6876 -0.6606 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 E01 mock treatment 9.8595 -0.27655 -0.1497 10.2196 0.15638 0.0699 -0.0564 -0.3414 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 E02 mock treatment 11.2925 1.1564 0.626 11.8845 1.8212 0.8143 1.0185 0.9916 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 E03 compound treatment 10.7423 0.60618 0.3282 9.9736 -0.089601 -0.0401 0.2037 0.6162 3186505 PK04Pur_000305 OCCCOc1ccc(cc1)C2=N[C@@]3(Cc4ccccc4N(Cc5ccccc5)C3=O)[C@@H](O2)c6ccccc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 E04 compound treatment 9.8193 -0.31674 -0.1715 9.4189 -0.64435 -0.2881 -0.325 -0.9693 2142633 PK04Pur_000306 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccccc4OCCO)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCCCCCC7)c8cc(C#CCNC(=O)N)ccc18 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 E05 compound treatment 8.9689 -1.1672 -0.6318 9.6379 -0.4253 -0.1902 -0.5813 -0.8809 3068117 PK04Pur_000307 CCCN1C(=O)[C@]2(CC=C)N=C(O[C@@H]2c3ccccc13)c4ccc(OCCCO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 E06 compound treatment 10.9362 0.80013 0.4332 10.6917 0.62845 0.281 0.505 0.978 2143169 PK04Pur_000308 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(O)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)Nc7nc8ccccc8s7)c9cc(C#CC%10=CCCCC%10)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 E07 compound treatment 11.6981 1.562 0.8456 11.7554 1.6922 0.7566 1.1329 0.9985 3068669 PK04Pur_000309 CCOC(=O)N1C(N=C(N1C(=O)OCC)c2ccc(OCCCO)cc2)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 E08 compound treatment 9.2561 -0.88 -0.4764 10.1391 0.075854 0.0339 -0.3129 -0.6551 2142677 PK04Pur_000310 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccccc4OCCO)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)NC[C@H](O)c7ccccc7)c8cc(C#CCCO)ccc18 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 E09 mock treatment 9.5421 -0.59395 -0.3215 11.387 1.3238 0.5919 0.1912 0.2838 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 E10 mock treatment 9.4725 -0.6636 -0.3592 10.808 0.74473 0.333 -0.0186 -0.0379 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 E11 compound treatment 11.1575 1.0214 0.5529 10.2015 0.13828 0.0618 0.4347 0.7813 3187293 PK04Pur_000311 OCCCOc1ccc(cc1)C2=N[C@]3(Cc4ccccc4)[C@H](O2)c5ccccc5N(CCS(=O)(=O)c6ccccc6)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 E12 compound treatment 9.5234 -0.61271 -0.3317 11.9261 1.8629 0.833 0.3544 0.3953 2144037 PK04Pur_000312 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccccc4OCCO)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)NC[C@H](O)c7ccccc7)c8cc(C#CC9(O)CCCCCC9)ccc18 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 E13 compound treatment 9.2858 -0.85025 -0.4603 9.9542 -0.10905 -0.0488 -0.36 -0.7777 3068518 PK04Pur_000313 OCCCOc1ccc(cc1)C2=N[C@]3(Cc4ccccc4N(CCS(=O)(=O)c5ccccc5)C3=O)[C@H](O2)c6ccccc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 E14 compound treatment 11.7951 1.659 0.8981 9.9877 -0.075559 -0.0338 0.6112 0.68 2143297 PK04Pur_000314 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccc(OCCO)cc4)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCc8cc(OC)c(OC)cc8C7)c9cc(C#CCNC(=O)N)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 E15 compound treatment 11.0845 0.94842 0.5134 10.7357 0.67252 0.3007 0.5757 0.9675 3186298 PK04Pur_000315 OCCCOc1ccc(cc1)C2=N[C@@]3(Cc4ccccc4N(CC=C)C3=O)[C@@H](O2)c5ccccc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 E16 compound treatment 9.4953 -0.64082 -0.3469 8.9515 -1.1117 -0.4971 -0.5968 -0.9845 2144197 PK04Pur_000316 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccc(O)cc4)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)NC[C@H](O)c7ccccc7)c8cc(C#Cc9ccc(OC)cc9)ccc18 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 E17 mock treatment 8.8116 -1.3244 -0.717 8.4482 -1.615 -0.7221 -1.0176 -1.0 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 E18 mock treatment 9.6939 -0.44218 -0.2394 9.8399 -0.2233 -0.0998 -0.2399 -0.9248 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 E19 mock treatment 9.9112 -0.22487 -0.1217 9.3934 -0.66986 -0.2995 -0.2979 -0.9213 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 E20 mock treatment 10.5046 0.36851 0.1995 10.0267 -0.036494 -0.0163 0.1295 0.6471 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 E21 mock treatment 9.9869 -0.14923 -0.0808 9.7033 -0.3599 -0.1609 -0.1709 -0.9492 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 E22 mock treatment 10.756 0.61995 0.3356 10.2763 0.21309 0.0953 0.3047 0.8733 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 E23 mock treatment 11.0328 0.89672 0.4854 8.393 -1.6702 -0.7468 -0.1848 -0.2075 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 E24 mock treatment 9.1336 -1.0025 -0.5427 10.0627 -4.9353E-4 -2.0E-4 -0.3839 -0.7074 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 F01 mock treatment 12.081 1.945 1.0529 9.8079 -0.25534 -0.1142 0.6638 0.6268 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 F02 mock treatment 12.1973 2.0613 1.1159 11.3311 1.2678 0.5669 1.1899 0.9507 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 F03 compound treatment 9.0292 -1.1069 -0.5992 10.356 0.29272 0.1309 -0.3312 -0.5399 2141805 PK04Pur_000317 COC(=O)C(CC#Cc1ccc2NC(=O)[C@]3([C@@H]([C@@H]4N([C@@H]3c5ccc(O)cc5)[C@H]([C@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)Nc8nc9ccccc9s8)c2c1)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 F04 compound treatment 10.2683 0.13226 0.0716 10.5538 0.49062 0.2194 0.2057 0.8916 3089662 PK04Pur_000318 CO[C@H]1O[C@H](CO)[C@@H](OC(=O)Nc2ccccc2c3ccccc3)[C@H](OC(=O)Nc4ccc5OCOc5c4)[C@H]1OC(=O)Nc6ccc7OCOc7c6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 F05 compound treatment 8.1167 -2.0194 -1.0932 10.2436 0.18032 0.0806 -0.716 -0.6532 2141134 PK04Pur_000319 NC(=O)NCC#Cc1ccc2NC(=O)[C@]3([C@@H]([C@@H]4N([C@@H]3c5ccccc5OCCO)[C@H]([C@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)O)c2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 F06 compound treatment 8.6427 -1.4934 -0.8085 9.9094 -0.15388 -0.0688 -0.6203 -0.7645 3089769 PK04Pur_000320 CO[C@H]1O[C@H](CO)[C@@H](OC(=O)Nc2ccccc2)[C@H](OC(=O)Nc3ccc4OCOc4c3)[C@@H]1OC(=O)Nc5ccc6OCOc6c5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 F07 compound treatment 9.9103 -0.2258 -0.1222 8.5314 -1.5319 -0.685 -0.5708 -0.8203 2144825 PK04Pur_000321 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccc(OCCO)cc4)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCc8cc(OC)c(OC)cc8C7)c9ccccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 F08 compound treatment 9.926 -0.2101 -0.1137 10.3255 0.26225 0.1173 0.0025 0.0152 3089775 PK04Pur_000322 CO[C@H]1O[C@H](CO)[C@@H](OC(=O)Nc2ccc(Oc3ccccc3)cc2)[C@H](OC(=O)Nc4ccc5OCOc5c4)[C@@H]1OC(=O)Nc6ccc7OCOc7c6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 F09 mock treatment 10.7719 0.63581 0.3442 9.4599 -0.60336 -0.2698 0.0526 0.1203 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 F10 mock treatment 10.7455 0.60942 0.3299 10.0427 -0.020531 -0.0092 0.2268 0.6872 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 F11 compound treatment 9.2993 -0.83673 -0.453 10.7798 0.71658 0.3204 -0.0937 -0.1689 2143405 PK04Pur_000323 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccc(OCCO)cc4)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N)c7cc(C#CC8(O)CCCCCC8)ccc17 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 F12 compound treatment 10.2973 0.16117 0.0873 11.4755 1.4123 0.6315 0.5082 0.7972 2141372 PK04Pur_000324 OCCOc1ccccc1[C@@H]2N3[C@H]([C@H](C(=O)N4CCCCCCC4)[C@@]25C(=O)Nc6ccc(C#CC7(O)CCCCCC7)cc65)C(=O)O[C@H]([C@H]3c8ccccc8)c9ccccc9 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 F13 compound treatment 10.736 0.59989 0.3248 10.0451 -0.018111 -0.0081 0.2239 0.6893 2142773 PK04Pur_000325 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccccc4OCCO)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCN(CC7)c8ncccn8)c9cc(C#CC%10(O)CCCCCC%10)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 F14 compound treatment 9.8948 -0.24129 -0.1306 11.7226 1.6593 0.742 0.4323 0.5738 2141167 PK04Pur_000326 NC(=O)NCC#Cc1ccc2NC(=O)[C@@]3([C@H]([C@H]4N([C@H]3c5ccc(OCCO)cc5)[C@@H]([C@@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)Nc8nc9ccccc9s8)c2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 F15 compound treatment 12.2977 2.1616 1.1702 11.1552 1.092 0.4883 1.1727 0.9249 2142745 PK04Pur_000327 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccccc4OCCO)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)NCC=C)c7cc(C#CC8(O)CCCCCC8)ccc17 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 F16 compound treatment 9.2489 -0.88714 -0.4803 9.0845 -0.97877 -0.4376 -0.6491 -0.9989 2141117 PK04Pur_000328 OCCC#Cc1ccc2NC(=O)[C@@]3([C@H]([C@H]4N([C@H]3c5ccc(O)cc5)[C@@H]([C@@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)O)c2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 F17 mock treatment 10.4832 0.34711 0.1879 11.2664 1.2032 0.538 0.5133 0.9007 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 F18 mock treatment 9.9672 -0.16886 -0.0914 11.7086 1.6454 0.7357 0.4556 0.6145 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 F19 compound treatment 9.8722 -0.26387 -0.1428 10.6025 0.53927 0.2411 0.0695 0.248 2142065 PK04Pur_000329 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(OCCO)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)NCC=C)c7cc(C#CCC(C(=O)OC)C(=O)OC)ccc17 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 F20 compound treatment 13.0991 2.963 1.604 9.4722 -0.59103 -0.2643 0.9473 0.5828 2141354 PK04Pur_000330 OCCOc1ccccc1[C@@H]2N3[C@H]([C@H](C(=O)Nc4nc5ccccc5s4)[C@@]26C(=O)Nc7ccc(C#CCCO)cc76)C(=O)O[C@H]([C@H]3c8ccccc8)c9ccccc9 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 F21 mock treatment 11.3179 1.1818 0.6398 8.6694 -1.3939 -0.6232 0.0117 0.0131 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 F22 mock treatment 10.5804 0.44432 0.2405 8.4908 -1.5725 -0.7031 -0.3271 -0.4402 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 F23 mock treatment 9.4051 -0.73102 -0.3957 10.2207 0.15745 0.0704 -0.2301 -0.5723 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 F24 mock treatment 10.7063 0.57026 0.3087 9.9532 -0.11003 -0.0492 0.1835 0.587 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 G01 compound treatment 11.269 1.133 0.6133 12.3071 2.2439 1.0033 1.1432 0.9721 3186440 PK04Pur_000331 CCCN1C(=O)[C@@]2(CCS(=O)(=O)c3ccccc3)N=C(O[C@H]2c4ccccc14)c5ccc(OCCCO)cc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 G02 compound treatment 9.3238 -0.81227 -0.4397 10.3809 0.31762 0.142 -0.2105 -0.4556 2142117 PK04Pur_000332 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(OCCO)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)NC[C@H](O)c7ccccc7)c8cc(C#CC9(O)CCCCCC9)ccc18 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 G03 mock treatment 11.0209 0.88481 0.479 8.2311 -1.8321 -0.8192 -0.2406 -0.2535 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 G04 mock treatment 10.2461 0.11001 0.0596 11.0253 0.96202 0.4302 0.3463 0.7974 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 G05 compound treatment 9.3696 -0.76647 -0.4149 9.0101 -1.0531 -0.4709 -0.6264 -0.998 3186590 PK04Pur_000333 OCCCOc1ccc(cc1)C2=N[C@@]3(CO2)Cc4ccccc4N(C(=O)c5ccccc5)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 G06 compound treatment 10.7704 0.63431 0.3434 9.9332 -0.13 -0.0581 0.2017 0.5792 2143073 PK04Pur_000334 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(O)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCCCCCC7)c8cc(C#CC9(O)CCCCCC9)ccc18 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 G07 compound treatment 8.9573 -1.1787 -0.6381 10.1827 0.11945 0.0534 -0.4135 -0.6457 3068670 PK04Pur_000335 COCCCNC(=O)C1ON(C(=N1)c2ccc(OCCCO)cc2)c3ccccc3 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 G08 compound treatment 10.9651 0.82905 0.4488 9.0697 -0.99356 -0.4443 0.0032 0.0051 2144209 PK04Pur_000336 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccc(O)cc4)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)Nc7nc8ccccc8s7)c9cc(C#Cc%10ccc(OC)cc%10)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 G09 compound treatment 10.4392 0.30311 0.1641 9.0313 -1.0319 -0.4614 -0.2102 -0.4293 3068314 PK04Pur_000337 OCCCOc1ccc(cc1)C2=N[C@]3(CCS(=O)(=O)c4ccccc4)[C@H](O2)c5ccccc5N(CCS(=O)(=O)c6ccccc6)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 G10 compound treatment 10.1093 -0.026785 -0.0145 9.8238 -0.23939 -0.107 -0.0859 -0.7956 2144185 PK04Pur_000338 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccc(O)cc4)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)NCC=C)c7cc(C#Cc8ccc(OC)cc8)ccc17 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 G11 compound treatment 9.6254 -0.5107 -0.2765 9.7043 -0.35891 -0.1605 -0.309 -0.9665 3187373 PK04Pur_000339 CC(C)(C)OC(=O)CC[C@]12N=C(O[C@@H]2c3ccccc3N(CC=C)C1=O)c4ccc(OCCCO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 G12 compound treatment 9.0444 -1.0916 -0.591 9.1643 -0.89892 -0.4019 -0.7021 -0.9824 2143253 PK04Pur_000340 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccc(OCCO)cc4)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCN(CC7)c8ncccn8)c9cc(C#Cc%10ccc(OC)cc%10)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 G13 compound treatment 10.1459 0.0098627 0.0053 9.025 -1.0383 -0.4642 -0.3245 -0.6989 3068543 PK04Pur_000341 OCCCOc1ccc(cc1)C2=N[C@]3(Cc4ccccc4N(Cc5ccccc5)C3=O)[C@H](O2)c6ccccc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 G14 compound treatment 10.3178 0.18175 0.0984 10.1848 0.12156 0.0544 0.108 0.9609 2142017 PK04Pur_000342 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(OCCO)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCc8cc(OC)c(OC)cc8C7)c9cc(C#CCNC(=O)N)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 G15 compound treatment 11.0594 0.92334 0.4999 9.2243 -0.83894 -0.3751 0.0882 0.1411 3186313 PK04Pur_000343 OCCCOc1ccc(cc1)C2=N[C@@]3(Cc4ccccc4N(CCS(=O)(=O)c5ccccc5)C3=O)[C@@H](O2)c6ccccc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 G16 compound treatment 9.1909 -0.9452 -0.5117 9.2989 -0.76434 -0.3418 -0.6035 -0.9807 2142125 PK04Pur_000344 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(OCCO)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N)c7cc(C#CC8(O)CCCCCC8)ccc17 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 G17 mock treatment 8.8709 -1.2652 -0.6849 9.2389 -0.82434 -0.3686 -0.7449 -0.9578 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 G18 compound treatment 9.651 -0.48504 -0.2626 10.6927 0.62949 0.2815 0.0134 0.0347 2144013 PK04Pur_000345 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccccc4OCCO)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCN(CC7)c8ncccn8)c9cc(C#CCC(C(=O)OC)C(=O)OC)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 G19 mock treatment 9.1059 -1.0302 -0.5577 8.8533 -1.2099 -0.541 -0.7769 -0.9999 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 G20 mock treatment 10.2897 0.15361 0.0832 9.1202 -0.94301 -0.4217 -0.2394 -0.5569 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 G21 mock treatment 9.5407 -0.59541 -0.3223 10.3686 0.30534 0.1365 -0.1314 -0.3753 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 G22 mock treatment 9.5923 -0.54375 -0.2944 9.2412 -0.82206 -0.3676 -0.4681 -0.9939 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 G23 mock treatment 10.3065 0.17041 0.0923 9.7945 -0.26876 -0.1202 -0.0197 -0.1303 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 G24 mock treatment 10.9769 0.84079 0.4552 12.9004 2.8372 1.2686 1.2189 0.9044 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 H01 compound treatment 9.5484 -0.58769 -0.3181 10.5566 0.49342 0.2206 -0.069 -0.1781 2141552 PK04Pur_000346 OCCOc1ccc(cc1)[C@H]2N3[C@@H]([C@@H](C(=O)Nc4nc5ccccc5s4)[C@]26C(=O)Nc7ccc(C#CC8(O)CCCCCC8)cc76)C(=O)O[C@@H]([C@@H]3c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 H02 compound treatment 9.6887 -0.44742 -0.2422 8.6356 -1.4276 -0.6383 -0.6226 -0.912 3089363 PK04Pur_000347 CO[C@H]1O[C@H](CO)[C@@H](OC(=O)Nc2ccc3OCOc3c2)[C@H](OC(=O)Nc4ccccc4)[C@H]1OC(=O)Nc5ccccc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 H03 mock treatment 8.8869 -1.2492 -0.6763 10.1272 0.063999 0.0286 -0.458 -0.6766 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 H04 mock treatment 9.6556 -0.48047 -0.2601 8.7801 -1.2832 -0.5737 -0.5896 -0.936 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 H05 compound treatment 8.6705 -1.4656 -0.7934 9.9241 -0.13914 -0.0622 -0.605 -0.7602 2143933 PK04Pur_000348 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccccc4OCCO)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCN(CC7)c8ncccn8)c9cc(C#CCNC(=O)N)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 H06 compound treatment 10.6307 0.49464 0.2678 10.1975 0.13427 0.06 0.2318 0.8447 3089770 PK04Pur_000349 CCc1cccc(NC(=O)O[C@@H]2[C@@H](CO)O[C@H](OC)[C@@H](OC(=O)Nc3ccc4OCOc4c3)[C@H]2OC(=O)Nc5ccc6OCOc6c5)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 H07 compound treatment 10.45 0.31397 0.17 9.8163 -0.24691 -0.1104 0.0421 0.2078 2142833 PK04Pur_000350 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccccc4OCCO)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCCCCCC7)c8cc(C#CC9=CCCCC9)ccc18 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 H08 compound treatment 12.0271 1.891 1.0237 11.4103 1.3471 0.6023 1.1498 0.968 3089828 PK04Pur_000351 CO[C@H]1O[C@H](CO)[C@@H](OC(=O)Nc2ccccc2)[C@H](OC(=O)Nc3ccccc3c4ccccc4)[C@@H]1OC(=O)Nc5ccccc5c6ccccc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 H09 compound treatment 8.7036 -1.4325 -0.7755 10.3679 0.30469 0.1362 -0.452 -0.5741 2142913 PK04Pur_000352 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(O)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCCCCCC7)c8cc(C#Cc9ccc(OC)cc9)ccc18 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 H10 compound treatment 8.7073 -1.4288 -0.7735 9.9188 -0.14439 -0.0646 -0.5926 -0.7635 3001093 PK04Pur_000353 CO[C@H]1O[C@H](CO)[C@@H](OC(=O)Nc2ccc(Oc3ccccc3)cc2)[C@H](OC(=O)Nc4ccccc4c5ccccc5)[C@@H]1OC(=O)Nc6ccccc6c7ccccc7 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 H11 compound treatment 10.4985 0.36246 0.1962 11.9965 1.9333 0.8644 0.75 0.8461 2142929 PK04Pur_000354 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(O)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)Nc7nc8ccccc8s7)c9cc(C#Cc%10ccc(OC)cc%10)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 H12 compound treatment 9.9802 -0.15587 -0.0844 8.4419 -1.6214 -0.725 -0.5723 -0.7841 2141344 PK04Pur_000355 NC(=O)NCC#Cc1ccc2NC(=O)[C@@]3([C@H]([C@H]4N([C@H]3c5ccccc5OCCO)[C@@H]([C@@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)N8CCN(CC8)c9ncccn9)c2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 H13 compound treatment 12.4768 2.3407 1.2672 10.8658 0.80256 0.3589 1.1498 0.873 2144305 PK04Pur_000356 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccc(O)cc4)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)NCC=C)c7cc(C#CCC(C(=O)OC)C(=O)OC)ccc17 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 H14 compound treatment 11.4276 1.2915 0.6991 12.2923 2.2291 0.9967 1.1991 0.985 2141178 PK04Pur_000357 OCCOc1ccc(cc1)[C@@H]2N3[C@H]([C@H](C(=O)Nc4nc5ccccc5s4)[C@@]26C(=O)Nc7ccc(C#CCCO)cc76)C(=O)O[C@H]([C@H]3c8ccccc8)c9ccccc9 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 H15 compound treatment 8.8603 -1.2758 -0.6907 10.1094 0.046166 0.0206 -0.4738 -0.6857 2142729 PK04Pur_000358 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccccc4OCCO)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)Nc7nc8ccccc8s7)c9cc(C#CCC(C(=O)OC)C(=O)OC)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 H16 compound treatment 10.7586 0.62247 0.337 10.199 0.13576 0.0607 0.2812 0.8213 2141838 PK04Pur_000359 Oc1ccc(cc1)[C@H]2N3[C@@H]([C@@H](C(=O)Nc4nc5ccccc5s4)[C@]26C(=O)Nc7ccc(C#CC8=CCCCC8)cc76)C(=O)O[C@@H]([C@@H]3c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 H17 compound treatment 9.9866 -0.14945 -0.0809 10.1658 0.10259 0.0459 -0.0248 -0.2664 2141728 PK04Pur_000360 OCCOc1ccccc1[C@H]2N3[C@@H]([C@@H](C(=O)Nc4nc5ccccc5s4)[C@]26C(=O)Nc7ccc(C#CC8(O)CCCCCC8)cc76)C(=O)O[C@@H]([C@@H]3c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 H18 compound treatment 10.5448 0.40874 0.2213 8.6842 -1.3791 -0.6166 -0.2796 -0.4267 2141782 PK04Pur_000361 NC(=O)NCC#Cc1ccc2NC(=O)[C@]3([C@@H]([C@@H]4N([C@@H]3c5ccc(O)cc5)[C@H]([C@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)N)c2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 H19 mock treatment 9.5042 -0.63189 -0.3421 9.4686 -0.59462 -0.2659 -0.4299 -0.9922 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 H20 mock treatment 10.4785 0.34237 0.1853 9.6932 -0.37006 -0.1655 0.0141 0.0566 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 H21 mock treatment 8.5895 -1.5466 -0.8372 10.1946 0.13136 0.0587 -0.5505 -0.6559 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 H22 mock treatment 8.9425 -1.1936 -0.6461 9.1851 -0.87815 -0.3927 -0.7345 -0.9715 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 H23 mock treatment 10.2522 0.11613 0.0629 11.3248 1.2615 0.5641 0.4433 0.7811 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 H24 mock treatment 10.5847 0.44864 0.2429 10.8176 0.75441 0.3373 0.4103 0.987 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 I01 compound treatment 9.4282 -0.70784 -0.3832 10.1058 0.042571 0.019 -0.2575 -0.6712 3068024 PK04Pur_000362 OCCCOc1ccc(cc1)C2=N[C@]3(CCS(=O)(=O)c4ccccc4)[C@H](O2)c5ccccc5N(Cc6ccccc6)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 I02 compound treatment 9.4096 -0.72647 -0.3933 9.6143 -0.44892 -0.2007 -0.42 -0.9513 2141945 PK04Pur_000363 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(OCCO)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)NCC=C)c7cc(C#Cc8ccc(OC)cc8)ccc17 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 I03 compound treatment 10.2599 0.12384 0.067 10.685 0.62174 0.278 0.244 0.8532 3068063 PK04Pur_000364 OCCCOc1ccc(cc1)C2=N[C@@]3(CO2)Cc4ccccc4N(Cc5ccccc5)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 I04 compound treatment 10.7629 0.62683 0.3393 9.4113 -0.6519 -0.2915 0.0338 0.0756 2142689 PK04Pur_000365 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccccc4OCCO)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)Nc7nc8ccccc8s7)c9cc(C#CCCO)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 I05 mock treatment 9.621 -0.51511 -0.2789 10.1423 0.079094 0.0354 -0.1722 -0.6125 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 I06 mock treatment 9.0808 -1.0553 -0.5713 10.9443 0.88111 0.394 -0.1254 -0.1807 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 I07 compound treatment 9.9741 -0.16203 -0.0877 10.6031 0.53987 0.2414 0.1087 0.4231 3067927 PK04Pur_000366 OCCCOc1ccc(cc1)C2=NC(ON2c3ccccc3)C(=O)NCC(O)CO 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 I08 compound treatment 10.8926 0.75649 0.4095 12.9655 2.9022 1.2977 1.2072 0.8871 2144745 PK04Pur_000367 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccccc4OCCO)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCc8cc(OC)c(OC)cc8C7)c9ccccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 I09 compound treatment 11.3816 1.2456 0.6743 9.6073 -0.45592 -0.2039 0.3327 0.4722 3068365 PK04Pur_000368 OCCCOc1ccc(cc1)C2=N[C@@]3(CC=C)[C@@H](O2)c4ccccc4N(CCS(=O)(=O)c5ccccc5)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 I10 compound treatment 9.5648 -0.57128 -0.3093 9.7824 -0.28086 -0.1256 -0.3075 -0.9212 2144897 PK04Pur_000369 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccccc4OCCO)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)Nc7nc8ccccc8s7)c9ccccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 I11 compound treatment 12.1742 2.0382 1.1034 9.9404 -0.12282 -0.0549 0.7414 0.6711 3068460 PK04Pur_000370 OCCCOc1ccc(cc1)C2=N[C@@]3(CCS(=O)(=O)c4ccccc4)[C@@H](O2)c5ccccc5N(CC=C)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 I12 compound treatment 9.9059 -0.23018 -0.1246 9.9648 -0.098474 -0.044 -0.1192 -0.9023 2143957 PK04Pur_000371 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccccc4OCCO)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)NC[C@H](O)c7ccccc7)c8cc(C#CCCO)ccc18 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 I13 compound treatment 9.4109 -0.72513 -0.3926 9.8398 -0.22347 -0.0999 -0.3482 -0.8597 3187540 PK04Pur_000372 CC(C)(C)OC(=O)CC[C@]12N=C(O[C@@H]2c3ccccc3N(CCS(=O)(=O)c4ccccc4)C1=O)c5ccc(OCCCO)cc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 I14 compound treatment 10.9538 0.81768 0.4427 9.0638 -0.99942 -0.4469 -0.003 -0.0047 2142105 PK04Pur_000373 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(OCCO)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)NCC=C)c7cc(C#CC8(O)CCCCCC8)ccc17 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 I15 compound treatment 11.017 0.88093 0.4769 8.5521 -1.5112 -0.6757 -0.1406 -0.17 3186316 PK04Pur_000374 OCCCOc1ccc(cc1)C2=N[C@@]3(CC=C)[C@@H](O2)c4ccccc4N(CC=C)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 I16 compound treatment 10.6722 0.53615 0.2902 9.9793 -0.083961 -0.0375 0.1787 0.6106 2144233 PK04Pur_000375 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccc(O)cc4)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCCCCCC7)c8cc(C#CCNC(=O)N)ccc18 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 I17 mock treatment 11.5045 1.3684 0.7408 10.0677 0.004439 0.002 0.5252 0.709 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 I18 compound treatment 10.2542 0.11814 0.064 9.9331 -0.13013 -0.0582 0.0041 0.0472 2141332 PK04Pur_000376 COc1ccc(C#Cc2ccc3NC(=O)[C@@]4([C@H]([C@H]5N([C@H]4c6ccccc6OCCO)[C@@H]([C@@H](OC5=O)c7ccccc7)c8ccccc8)C(=O)Nc9nc%10ccccc%10s9)c3c2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 I19 mock treatment 10.3929 0.25685 0.139 10.6403 0.57703 0.258 0.2808 0.9579 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 I20 mock treatment 9.5549 -0.58114 -0.3146 10.2231 0.1599 0.0715 -0.1719 -0.5328 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 I21 mock treatment 11.293 1.157 0.6263 12.1223 2.0591 0.9207 1.0939 0.9824 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 I22 mock treatment 10.4904 0.35437 0.1918 8.9619 -1.1014 -0.4925 -0.2126 -0.4022 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 I23 mock treatment 12.589 2.4529 1.3279 10.6491 0.58583 0.2619 1.1242 0.8306 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 I24 mock treatment 10.4749 0.33879 0.1834 10.4762 0.41297 0.1847 0.2603 1.0 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 J01 compound treatment 9.403 -0.73305 -0.3968 8.8086 -1.2547 -0.561 -0.6773 -0.9856 2141816 PK04Pur_000377 Oc1ccc(cc1)[C@H]2N3[C@@H]([C@@H](C(=O)Nc4nc5ccccc5s4)[C@]26C(=O)Nc7ccc(C#CC8(O)CCCCCC8)cc76)C(=O)O[C@@H]([C@@H]3c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 J02 compound treatment 11.2022 1.0661 0.5772 9.4173 -0.64595 -0.2888 0.2039 0.3159 3089657 PK04Pur_000378 CO[C@H]1O[C@H](CO)[C@@H](OC(=O)Nc2ccccc2)[C@H](OC(=O)Nc3ccc4OCOc4c3)[C@H]1OC(=O)Nc5ccc6OCOc6c5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 J03 compound treatment 10.9893 0.85318 0.4619 9.9822 -0.081039 -0.0362 0.301 0.6496 2141717 PK04Pur_000379 COC(=O)C(CC#Cc1ccc2NC(=O)[C@]3([C@@H]([C@@H]4N([C@@H]3c5ccccc5OCCO)[C@H]([C@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)Nc8nc9ccccc9s8)c2c1)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 J04 compound treatment 10.3889 0.25283 0.1369 12.3022 2.239 1.0011 0.8047 0.7964 3000914 PK04Pur_000380 CO[C@H]1O[C@H](CO)[C@@H](OC(=O)Nc2ccccc2)[C@H](OC(=O)Nc3ccccc3)[C@@H]1OC(=O)Nc4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 J05 mock treatment 11.3117 1.1756 0.6364 8.8904 -1.1728 -0.5244 0.0792 0.096 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 J06 mock treatment 10.689 0.55294 0.2993 10.3708 0.30761 0.1375 0.3089 0.9378 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 J07 compound treatment 9.2263 -0.90977 -0.4925 10.9614 0.89812 0.4016 -0.0643 -0.1012 2142765 PK04Pur_000381 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccccc4OCCO)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N)c7cc(C#CC8(O)CCCCCC8)ccc17 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 J08 compound treatment 10.6576 0.52151 0.2823 9.6713 -0.39193 -0.1752 0.0757 0.2279 3001020 PK04Pur_000382 CCc1cccc(NC(=O)O[C@@H]2[C@@H](CO)O[C@H](OC)[C@@H](OC(=O)Nc3ccccc3c4ccccc4)[C@H]2OC(=O)Nc5ccccc5c6ccccc6)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 J09 compound treatment 9.8414 -0.29464 -0.1595 9.4826 -0.58058 -0.2596 -0.2964 -0.9726 2143925 PK04Pur_000383 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccccc4OCCO)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N)c7cc(C#CCNC(=O)N)ccc17 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 J10 compound treatment 10.5112 0.37514 0.2031 10.1375 0.074294 0.0332 0.1671 0.812 3186916 PK04Pur_000384 CO[C@H]1O[C@H](CO)[C@@H](OC(=O)Nc2ccc(Br)cc2)[C@@H]3OC(=O)[C@@H](Cc4ccccc4)C/C=C/C[C@H](Cc5ccccc5)C(=O)O[C@@H]13 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 J11 compound treatment 9.8597 -0.27639 -0.1496 9.5266 -0.5366 -0.2399 -0.2755 -0.9742 2143377 PK04Pur_000385 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccc(OCCO)cc4)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCc8cc(OC)c(OC)cc8C7)c9cc(C#CCC(C(=O)OC)C(=O)OC)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 J12 compound treatment 13.3796 3.2435 1.7559 9.5242 -0.53901 -0.241 1.0712 0.6044 2065845 PK04Pur_000386 NC(=O)NCC#Cc1ccc2NC(=O)[C@]3([C@@H]([C@@H]4N([C@@H]3c5ccc(OCCO)cc5)[C@H]([C@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)O)c2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 J13 compound treatment 9.0782 -1.0579 -0.5727 9.5765 -0.48675 -0.2176 -0.5589 -0.9122 2144009 PK04Pur_000387 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccccc4OCCO)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)Nc7nc8ccccc8s7)c9cc(C#CCC(C(=O)OC)C(=O)OC)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 J14 compound treatment 10.7402 0.60409 0.327 10.0957 0.032466 0.0145 0.2415 0.7378 2141519 PK04Pur_000388 NC(=O)NCC#Cc1ccc2NC(=O)[C@]3([C@@H]([C@@H]4N([C@@H]3c5ccc(OCCO)cc5)[C@H]([C@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)Nc8nc9ccccc9s8)c2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 J15 compound treatment 11.34 1.2039 0.6517 10.1796 0.11641 0.052 0.4976 0.7612 2144273 PK04Pur_000389 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccc(O)cc4)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCCCCCC7)c8cc(C#CCCO)ccc18 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 J16 compound treatment 10.4379 0.30181 0.1634 9.6536 -0.40966 -0.1832 -0.014 -0.057 2141427 PK04Pur_000390 NC(=O)NCC#Cc1ccc2NC(=O)[C@@]3([C@H]([C@H]4N([C@H]3c5ccc(O)cc5)[C@@H]([C@@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)N8CCCCCCC8)c2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 J17 compound treatment 10.0876 -0.04849 -0.0263 9.005 -1.0582 -0.4732 -0.3531 -0.7452 2141107 PK04Pur_000391 COc1ccc(C#Cc2ccc3NC(=O)[C@@]4([C@H]([C@H]5N([C@H]4c6ccccc6OCCO)[C@@H]([C@@H](OC5=O)c7ccccc7)c8ccccc8)C(=O)O)c3c2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 J18 compound treatment 10.8525 0.7164 0.3878 8.5573 -1.5059 -0.6734 -0.2019 -0.2598 2141172 PK04Pur_000392 OCCOc1ccc(cc1)[C@@H]2N3[C@H]([C@H](C(=O)NCC=C)[C@@]24C(=O)Nc5ccc(C#CCCO)cc54)C(=O)O[C@H]([C@H]3c6ccccc6)c7ccccc7 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 J19 compound treatment 10.6598 0.52372 0.2835 8.5532 -1.51 -0.6752 -0.277 -0.3782 2142697 PK04Pur_000393 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccccc4OCCO)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCc8cc(OC)c(OC)cc8C7)c9cc(C#CCCO)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 J20 compound treatment 11.4056 1.2695 0.6873 8.3464 -1.7168 -0.7677 -0.0569 -0.0552 2141189 PK04Pur_000394 COC(=O)C(CC#Cc1ccc2NC(=O)[C@@]3([C@H]([C@H]4N([C@H]3c5ccc(OCCO)cc5)[C@@H]([C@@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)Nc8nc9ccccc9s8)c2c1)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 J21 mock treatment 9.7534 -0.38264 -0.2071 10.7529 0.68971 0.3084 0.0716 0.1927 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 J22 mock treatment 10.389 0.2529 0.1369 11.3929 1.3296 0.5945 0.5172 0.8478 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 J23 mock treatment 10.8112 0.67507 0.3655 9.492 -0.57127 -0.2554 0.0778 0.1745 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 J24 mock treatment 9.1176 -1.0185 -0.5514 10.9991 0.93583 0.4184 -0.094 -0.1358 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 K01 compound treatment 11.3571 1.221 0.661 10.8262 0.76293 0.3411 0.7086 0.9527 3186455 PK04Pur_000395 CN1C(=O)[C@@]2(CCC(=O)OC(C)(C)C)N=C(O[C@H]2c3ccccc13)c4ccc(OCCCO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 K02 compound treatment 9.6497 -0.48637 -0.2633 10.3627 0.29947 0.1339 -0.0915 -0.3097 2143145 PK04Pur_000396 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(O)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)NCC=C)c7cc(C#CC8=CCCCC8)ccc17 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 K03 compound treatment 8.8708 -1.2653 -0.685 10.9968 0.93352 0.4174 -0.1892 -0.2359 3068064 PK04Pur_000397 CC(C)(C)OC(=O)CC[C@]12N=C(O[C@@H]2c3ccccc3N(Cc4ccccc4)C1=O)c5ccc(OCCCO)cc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 K04 compound treatment 10.755 0.61889 0.335 10.2476 0.18441 0.0825 0.2952 0.8556 2142905 PK04Pur_000398 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(O)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)NCC=C)c7cc(C#Cc8ccc(OC)cc8)ccc17 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 K05 compound treatment 7.3783 -2.7578 -1.4929 8.7055 -1.3577 -0.6071 -1.4849 -0.9214 3068121 PK04Pur_000399 OCCCOc1ccc(cc1)C2=N[C@@]3(CO2)Cc4ccccc4CN(C(=O)c5ccccc5)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 K06 compound treatment 10.4006 0.26449 0.1432 8.6171 -1.4461 -0.6466 -0.356 -0.5375 2143913 PK04Pur_000400 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccccc4OCCO)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCCCCCC7)c8cc(C#CCNC(=O)N)ccc18 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 K07 mock treatment 8.1111 -2.025 -1.0962 12.0771 2.0138 0.9005 -0.1384 -0.0976 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 K08 mock treatment 10.1588 0.022675 0.0123 11.2651 1.2018 0.5374 0.3887 0.7231 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 K09 compound treatment 8.7909 -1.3452 -0.7282 10.4989 0.43568 0.1948 -0.3772 -0.5004 3187286 PK04Pur_000401 OCCCOc1ccc(cc1)C2=N[C@@]3(Cc4ccccc4)[C@@H](O2)c5ccccc5N(CC=C)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 K10 compound treatment 8.9336 -1.2025 -0.651 9.8695 -0.19375 -0.0866 -0.5216 -0.7942 2144721 PK04Pur_000402 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccccc4OCCO)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCCCCCC7)c8ccccc18 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 K11 compound treatment 10.5151 0.37906 0.2052 9.064 -0.99926 -0.4468 -0.1708 -0.3475 3187377 PK04Pur_000403 OCCCOc1ccc(cc1)C2=N[C@@]3(CO2)Cc4ccccc4N(CCS(=O)(=O)c5ccccc5)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 K12 compound treatment 9.2049 -0.93123 -0.5041 10.4629 0.39968 0.1787 -0.2301 -0.4302 2143889 PK04Pur_000404 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccccc4OCCO)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)Nc7nc8ccccc8s7)c9cc(C#Cc%10ccc(OC)cc%10)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 K13 compound treatment 9.8127 -0.32333 -0.175 10.6099 0.54667 0.2444 0.0491 0.1632 3187544 PK04Pur_000405 OCCCOc1ccc(cc1)C2=N[C@]3(Cc4ccccc4N(CC=C)C3=O)[C@H](O2)c5ccccc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 K14 compound treatment 8.7365 -1.3996 -0.7577 8.6342 -1.4291 -0.639 -0.9876 -0.9964 2143937 PK04Pur_000406 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccccc4OCCO)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCc8cc(OC)c(OC)cc8C7)c9cc(C#CCNC(=O)N)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 K15 mock treatment 9.7023 -0.43373 -0.2348 9.8442 -0.21908 -0.098 -0.2353 -0.9248 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 K16 mock treatment 9.7075 -0.42861 -0.232 8.3902 -1.673 -0.7481 -0.693 -0.8848 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 K17 mock treatment 9.7959 -0.34021 -0.1842 8.9366 -1.1267 -0.5038 -0.4865 -0.9069 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 K18 compound treatment 11.6738 1.5377 0.8325 9.783 -0.2802 -0.1253 0.5 0.594 3000699 PK04Pur_000407 CO[C@H]1O[C@H](CO)[C@@H](OC(=O)CCc2ccccc2)[C@H](OC(=O)c3cc4ccccc4[nH]3)[C@H]1OC(=O)c5cc6ccccc6[nH]5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 K19 mock treatment 8.5033 -1.6328 -0.8839 9.9061 -0.15711 -0.0702 -0.6747 -0.7609 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 K20 mock treatment 9.7604 -0.37569 -0.2034 10.6609 0.59764 0.2672 0.0451 0.1344 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 K21 mock treatment 10.0379 -0.098222 -0.0532 10.9636 0.90038 0.4026 0.2471 0.6084 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 K22 mock treatment 9.3688 -0.76726 -0.4154 9.1226 -0.94064 -0.4206 -0.5911 -1.0 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 K23 mock treatment 10.8042 0.6681 0.3617 9.2221 -0.84116 -0.3761 -0.0102 -0.0196 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 K24 mock treatment 9.5075 -0.62857 -0.3403 11.376 1.3127 0.587 0.1744 0.2571 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 L01 compound treatment 9.331 -0.80505 -0.4358 10.88 0.81679 0.3652 -0.0499 -0.0878 2141200 PK04Pur_000408 OCCOc1ccc(cc1)[C@@H]2N3[C@H]([C@H](C(=O)Nc4nc5ccccc5s4)[C@@]26C(=O)Nc7ccc(C#CC8(O)CCCCCC8)cc76)C(=O)O[C@H]([C@H]3c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 L02 compound treatment 9.2886 -0.84749 -0.4588 10.2851 0.22185 0.0992 -0.2543 -0.5417 3000713 PK04Pur_000409 CCc1cccc(NC(=O)O[C@@H]2[C@@H](CO)O[C@H](OC)[C@H](OC(=O)Nc3ccc4OCOc4c3)[C@H]2OC(=O)Nc5ccc6OCOc6c5)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 L03 compound treatment 10.3683 0.23223 0.1257 8.4738 -1.5895 -0.7107 -0.4137 -0.5731 2141365 PK04Pur_000410 COC(=O)C(CC#Cc1ccc2NC(=O)[C@@]3([C@H]([C@H]4N([C@H]3c5ccccc5OCCO)[C@@H]([C@@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)Nc8nc9ccccc9s8)c2c1)C(=O)OC 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 L04 compound treatment 10.5269 0.39081 0.2116 11.5644 1.5012 0.6712 0.6242 0.887 3089723 PK04Pur_000411 CCc1cccc(NC(=O)O[C@@H]2[C@@H](CO)O[C@H](OC)[C@@H](OC(=O)Nc3ccccc3)[C@H]2OC(=O)Nc4ccccc4)c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 L05 compound treatment 9.8396 -0.29649 -0.1605 9.8755 -0.18776 -0.084 -0.1729 -0.9543 2144045 PK04Pur_000412 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccccc4OCCO)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N)c7cc(C#CC8(O)CCCCCC8)ccc17 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 L06 compound treatment 9.0976 -1.0385 -0.5622 10.6569 0.59367 0.2655 -0.2098 -0.3375 3001007 PK04Pur_000413 CO[C@H]1O[C@H](CO)[C@@H](OC(=O)Nc2cccc(F)c2)[C@H](OC(=O)Nc3ccc4OCOc4c3)[C@@H]1OC(=O)Nc5ccc6OCOc6c5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 L07 mock treatment 9.4147 -0.72135 -0.3905 10.248 0.18476 0.0826 -0.2177 -0.5454 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 L08 mock treatment 10.0094 -0.12666 -0.0686 10.512 0.44875 0.2007 0.0934 0.4404 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 L09 compound treatment 9.1736 -0.96249 -0.5211 10.5281 0.46488 0.2079 -0.2215 -0.3948 2142649 PK04Pur_000414 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccccc4OCCO)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)Nc7nc8ccccc8s7)c9cc(C#CCNC(=O)N)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 L10 compound treatment 8.7025 -1.4336 -0.7761 9.6101 -0.45312 -0.2026 -0.692 -0.8628 1952975 PK04Pur_000415 CO[C@H]1O[C@H](CO)[C@@H](OC(=O)Nc2ccccc2)[C@@H]3OC(=O)[C@H](Cc4ccccc4)C/C=C/C[C@@H](Cc5ccccc5)C(=O)O[C@@H]13 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 L11 compound treatment 11.3602 1.2242 0.6627 9.5678 -0.49542 -0.2215 0.312 0.4465 2144237 PK04Pur_000416 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccc(O)cc4)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)NC[C@H](O)c7ccccc7)c8cc(C#CCNC(=O)N)ccc18 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 L12 compound treatment 9.071 -1.0651 -0.5766 10.9513 0.88802 0.3971 -0.1269 -0.1813 2141574 PK04Pur_000417 OCCOc1ccc(cc1)[C@H]2N3[C@@H]([C@@H](C(=O)Nc4nc5ccccc5s4)[C@]26C(=O)Nc7ccc(C#CC8=CCCCC8)cc76)C(=O)O[C@@H]([C@@H]3c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 L13 compound treatment 11.1288 0.99268 0.5374 10.5698 0.50653 0.2265 0.5401 0.9262 2144297 PK04Pur_000418 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccc(O)cc4)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCc8cc(OC)c(OC)cc8C7)c9cc(C#CCCO)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 L14 compound treatment 8.3181 -1.818 -0.9842 9.6904 -0.37279 -0.1667 -0.8138 -0.8153 2141772 PK04Pur_000419 COc1ccc(C#Cc2ccc3NC(=O)[C@]4([C@@H]([C@@H]5N([C@@H]4c6ccc(O)cc6)[C@H]([C@H](OC5=O)c7ccccc7)c8ccccc8)C(=O)Nc9nc%10ccccc%10s9)c3c2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 L15 mock treatment 8.4957 -1.6404 -0.888 10.1033 0.040081 0.0179 -0.6153 -0.6927 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 L16 mock treatment 10.3676 0.23156 0.1254 9.0422 -1.021 -0.4565 -0.2342 -0.4946 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 L17 compound treatment 10.1838 0.047683 0.0258 10.5136 0.45035 0.2014 0.1606 0.7913 2141394 PK04Pur_000420 OCCOc1ccccc1[C@@H]2N3[C@H]([C@H](C(=O)N4CCCCCCC4)[C@@]25C(=O)Nc6ccc(C#CC7=CCCCC7)cc65)C(=O)O[C@H]([C@H]3c8ccccc8)c9ccccc9 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 L18 compound treatment 9.9608 -0.17524 -0.0949 11.5032 1.44 0.6439 0.3882 0.5965 2141520 PK04Pur_000421 NC(=O)NCC#Cc1ccc2NC(=O)[C@]3([C@@H]([C@@H]4N([C@@H]3c5ccc(OCCO)cc5)[C@H]([C@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)N8CCN(CC8)c9ncccn9)c2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 L19 compound treatment 10.344 0.20797 0.1126 10.9184 0.85514 0.3824 0.35 0.878 2143373 PK04Pur_000422 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccc(OCCO)cc4)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCN(CC7)c8ncccn8)c9cc(C#CCC(C(=O)OC)C(=O)OC)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 L20 compound treatment 8.8352 -1.3009 -0.7042 9.3143 -0.7489 -0.3349 -0.7348 -0.9422 2141430 PK04Pur_000423 NC(=O)NCC#Cc1ccc2NC(=O)[C@@]3([C@H]([C@H]4N([C@H]3c5ccc(O)cc5)[C@@H]([C@@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)N)c2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 L21 mock treatment 9.6107 -0.52539 -0.2844 9.0446 -1.0187 -0.4555 -0.5232 -0.9743 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 L22 mock treatment 9.7764 -0.35967 -0.1947 10.8924 0.82919 0.3708 0.1245 0.2973 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 L23 mock treatment 11.2584 1.1223 0.6076 11.2208 1.1576 0.5176 0.7956 0.9968 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 L24 mock treatment 10.3251 0.18906 0.1023 9.8738 -0.18945 -0.0847 0.0125 0.0939 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 M01 compound treatment 8.9377 -1.1984 -0.6487 10.8609 0.79769 0.3567 -0.2065 -0.279 3186456 PK04Pur_000424 CCCN1C(=O)[C@@]2(CCC(=O)OC(C)(C)C)N=C(O[C@H]2c3ccccc13)c4ccc(OCCCO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 M02 compound treatment 10.82 0.6839 0.3702 10.0965 0.033261 0.0149 0.2723 0.7349 2142777 PK04Pur_000425 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccccc4OCCO)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCc8cc(OC)c(OC)cc8C7)c9cc(C#CC%10(O)CCCCCC%10)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 M03 compound treatment 7.7074 -2.4286 -1.3148 10.6601 0.59689 0.2669 -0.741 -0.5523 3068072 PK04Pur_000426 CN1C(=O)[C@]2(CCC(=O)OC(C)(C)C)N=C(O[C@@H]2c3ccccc13)c4ccc(OCCCO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 M04 compound treatment 9.1909 -0.9452 -0.5117 15.2179 5.1546 2.3048 1.2679 0.537 2142693 PK04Pur_000427 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccccc4OCCO)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCN(CC7)c8ncccn8)c9cc(C#CCCO)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 M05 compound treatment 11.217 1.0809 0.5852 10.8213 0.75808 0.339 0.6535 0.9663 3068122 PK04Pur_000428 CC(C)(C)OC(=O)CC[C@@]12N=C(O[C@H]2c3ccccc3N(Cc4ccccc4)C1=O)c5ccc(OCCCO)cc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 M06 compound treatment 9.5613 -0.57475 -0.3111 9.5765 -0.48675 -0.2176 -0.3739 -0.9847 2144453 PK04Pur_000429 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccc(O)cc4)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCN(CC7)c8ncccn8)c9cc(C#CC%10=CCCCC%10)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 M07 mock treatment 8.5484 -1.5877 -0.8595 10.8367 0.77345 0.3458 -0.3632 -0.392 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 M08 compound treatment 11.3161 1.18 0.6388 9.9655 -0.097704 -0.0437 0.4208 0.6572 2143257 PK04Pur_000430 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccc(OCCO)cc4)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCc8cc(OC)c(OC)cc8C7)c9cc(C#Cc%10ccc(OC)cc%10)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 M09 mock treatment 11.1154 0.97931 0.5302 9.9394 -0.12382 -0.0554 0.3357 0.6298 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 M10 mock treatment 9.9131 -0.22298 -0.1207 8.6293 -1.4339 -0.6412 -0.5387 -0.8257 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 M11 compound treatment 9.6459 -0.49017 -0.2654 10.9689 0.90566 0.405 0.0987 0.2039 3068470 PK04Pur_000431 OCCCOc1ccc(cc1)C2=N[C@@]3(CCS(=O)(=O)c4ccccc4)[C@@H](O2)c5ccccc5N(Cc6ccccc6)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 M12 compound treatment 9.1655 -0.97056 -0.5254 9.5255 -0.53775 -0.2404 -0.5416 -0.9372 2142733 PK04Pur_000432 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccccc4OCCO)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCN(CC7)c8ncccn8)c9cc(C#CCC(C(=O)OC)C(=O)OC)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 M13 mock treatment 9.2586 -0.87748 -0.475 9.9965 -0.066746 -0.0298 -0.357 -0.7501 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 M14 mock treatment 9.7258 -0.41029 -0.2221 11.3589 1.2957 0.5793 0.2526 0.4071 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 M15 compound treatment 8.9201 -1.216 -0.6583 9.3569 -0.70629 -0.3158 -0.6888 -0.9434 3186317 PK04Pur_000433 OCCCOc1ccc(cc1)C2=N[C@@]3(CO2)Cc4ccccc4N(CC=C)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 M16 compound treatment 10.0049 -0.13116 -0.071 10.9138 0.85058 0.3803 0.2187 0.5653 2142013 PK04Pur_000434 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(OCCO)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCN(CC7)c8ncccn8)c9cc(C#CCNC(=O)N)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 M17 mock treatment 10.2418 0.10568 0.0572 8.3603 -1.7029 -0.7614 -0.498 -0.6521 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 M18 mock treatment 10.9164 0.78035 0.4224 9.6798 -0.38347 -0.1715 0.1775 0.3893 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 M19 mock treatment 10.0368 -0.099317 -0.0538 8.8356 -1.2277 -0.5489 -0.4262 -0.7727 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 M20 mock treatment 10.3765 0.24043 0.1302 9.1223 -0.94091 -0.4207 -0.2055 -0.4665 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 M21 mock treatment 10.318 0.18194 0.0985 11.0567 0.99352 0.4442 0.3838 0.8434 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 M22 mock treatment 9.5306 -0.6055 -0.3278 11.2002 1.1369 0.5084 0.1277 0.2111 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 M23 mock treatment 9.9437 -0.19239 -0.1042 8.3752 -1.688 -0.7548 -0.6073 -0.7971 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 M24 mock treatment 10.3441 0.20805 0.1126 10.2771 0.21389 0.0956 0.1473 0.9967 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 N01 compound treatment 9.1108 -1.0253 -0.555 10.6863 0.62302 0.2786 -0.1955 -0.3148 2141926 PK04Pur_000435 OCCOc1ccccc1[C@H]2N3[C@@H]([C@@H](C(=O)Nc4nc5ccccc5s4)[C@]26C(=O)Nc7ccccc76)C(=O)O[C@@H]([C@@H]3c8ccccc8)c9ccccc9 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 N02 compound treatment 9.2377 -0.89833 -0.4863 9.7903 -0.27289 -0.122 -0.4302 -0.8579 3089658 PK04Pur_000436 CO[C@H]1O[C@H](CO)[C@@H](OC(=O)Nc2cccc(F)c2)[C@H](OC(=O)Nc3ccc4OCOc4c3)[C@H]1OC(=O)Nc5ccc6OCOc6c5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 N03 compound treatment 10.5782 0.44216 0.2394 8.2735 -1.7897 -0.8002 -0.3966 -0.4748 2141684 PK04Pur_000437 COc1ccc(C#Cc2ccc3NC(=O)[C@]4([C@@H]([C@@H]5N([C@@H]4c6ccccc6OCCO)[C@H]([C@H](OC5=O)c7ccccc7)c8ccccc8)C(=O)Nc9nc%10ccccc%10s9)c3c2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 N04 compound treatment 10.6188 0.4827 0.2613 12.7681 2.7049 1.2095 1.04 0.8405 3089724 PK04Pur_000438 CO[C@H]1O[C@H](CO)[C@@H](OC(=O)Nc2cccc(F)c2)[C@H](OC(=O)Nc3ccccc3)[C@@H]1OC(=O)Nc4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 N05 compound treatment 13.6208 3.4847 1.8865 11.9673 1.904 0.8514 1.9359 0.9354 2144377 PK04Pur_000439 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccc(O)cc4)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCc8cc(OC)c(OC)cc8C7)c9cc(C#CC%10(O)CCCCCC%10)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 N06 compound treatment 9.651 -0.48507 -0.2626 9.1613 -0.90194 -0.4033 -0.4709 -0.9784 3089771 PK04Pur_000440 CO[C@H]1O[C@H](CO)[C@@H](OC(=O)Nc2ccc(OC)cc2)[C@H](OC(=O)Nc3ccc4OCOc4c3)[C@@H]1OC(=O)Nc5ccc6OCOc6c5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 N07 compound treatment 10.3103 0.17423 0.0943 10.1974 0.13416 0.06 0.1091 0.9761 2142645 PK04Pur_000441 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccccc4OCCO)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N)c7cc(C#CCNC(=O)N)ccc17 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 N08 compound treatment 10.533 0.39695 0.2149 11.6273 1.564 0.6993 0.6465 0.8836 3089829 PK04Pur_000442 CO[C@H]1O[C@H](CO)[C@@H](OC(=O)Nc2cccc(F)c2)[C@H](OC(=O)Nc3ccccc3c4ccccc4)[C@@H]1OC(=O)Nc5ccccc5c6ccccc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 N09 mock treatment 11.9126 1.7765 0.9617 11.0869 1.0236 0.4577 1.0037 0.9424 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 N10 mock treatment 11.9431 1.807 0.9782 10.7208 0.6576 0.294 0.8996 0.8807 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 N11 compound treatment 8.7096 -1.4265 -0.7722 12.4469 2.3837 1.0658 0.2076 0.1577 2142993 PK04Pur_000443 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(O)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCCCCCC7)c8cc(C#CCCO)ccc18 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 N12 compound treatment 10.4053 0.26923 0.1458 11.2969 1.2337 0.5516 0.4931 0.8643 2141339 PK04Pur_000444 NC(=O)NCC#Cc1ccc2NC(=O)[C@@]3([C@H]([C@H]4N([C@H]3c5ccccc5OCCO)[C@@H]([C@@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)N8CCCCCCC8)c2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 N13 mock treatment 9.9823 -0.15377 -0.0832 9.599 -0.4642 -0.2076 -0.2056 -0.9195 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 N14 mock treatment 9.8645 -0.27163 -0.147 8.7618 -1.3014 -0.5819 -0.5155 -0.8588 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 N15 compound treatment 11.624 1.4879 0.8055 8.9265 -1.1367 -0.5083 0.2102 0.2207 2141133 PK04Pur_000445 COc1ccc(C#Cc2ccc3NC(=O)[C@]4([C@@H]([C@@H]5N([C@@H]4c6ccccc6OCCO)[C@H]([C@H](OC5=O)c7ccccc7)c8ccccc8)C(=O)O)c3c2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 N16 compound treatment 10.0078 -0.12831 -0.0695 9.8438 -0.21942 -0.0981 -0.1185 -0.9857 2141156 PK04Pur_000446 COc1ccc(C#Cc2ccc3NC(=O)[C@@]4([C@H]([C@H]5N([C@H]4c6ccc(OCCO)cc6)[C@@H]([C@@H](OC5=O)c7ccccc7)c8ccccc8)C(=O)Nc9nc%10ccccc%10s9)c3c2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 N17 compound treatment 10.7076 0.57153 0.3094 10.1552 0.092004 0.0411 0.2479 0.7941 2141442 PK04Pur_000447 OCCC#Cc1ccc2NC(=O)[C@@]3([C@H]([C@H]4N([C@H]3c5ccc(O)cc5)[C@@H]([C@@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)Nc8nc9ccccc9s8)c2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 N18 compound treatment 10.7418 0.60575 0.3279 10.5742 0.51092 0.2285 0.3934 0.9844 2141508 PK04Pur_000448 COc1ccc(C#Cc2ccc3NC(=O)[C@]4([C@@H]([C@@H]5N([C@@H]4c6ccc(OCCO)cc6)[C@H]([C@H](OC5=O)c7ccccc7)c8ccccc8)C(=O)Nc9nc%10ccccc%10s9)c3c2)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 N19 compound treatment 9.9469 -0.18913 -0.1024 9.2144 -0.84885 -0.3796 -0.3408 -0.8669 2143977 PK04Pur_000449 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccccc4OCCO)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCc8cc(OC)c(OC)cc8C7)c9cc(C#CCCO)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 N20 compound treatment 11.1212 0.9851 0.5333 9.3996 -0.66367 -0.2968 0.1673 0.2741 2141860 PK04Pur_000450 OCCOc1ccc(cc1)[C@@H]2N3[C@H]([C@H](C(=O)Nc4nc5ccccc5s4)[C@@]26C(=O)Nc7ccccc76)C(=O)O[C@H]([C@H]3c8ccccc8)c9ccccc9 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 N21 mock treatment 11.5976 1.4615 0.7912 10.2065 0.14325 0.0641 0.6048 0.7619 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 N22 mock treatment 11.7156 1.5795 0.8551 11.067 1.0038 0.4488 0.922 0.9547 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 N23 mock treatment 10.7297 0.59362 0.3214 9.3299 -0.73335 -0.3279 -0.0046 -0.0101 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 N24 mock treatment 9.3673 -0.76875 -0.4162 9.1181 -0.94509 -0.4226 -0.5931 -1.0 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 O01 compound treatment 10.274 0.13794 0.0747 9.3899 -0.67329 -0.3011 -0.1601 -0.5161 3068061 PK04Pur_000451 CCCN1C(=O)[C@@]2(Cc3ccccc3)N=C(O[C@H]2c4ccccc14)c5ccc(OCCCO)cc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 O02 compound treatment 10.6748 0.53875 0.2917 11.9934 1.9302 0.8631 0.8165 0.8963 2142133 PK04Pur_000452 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(OCCO)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCN(CC7)c8ncccn8)c9cc(C#CC%10(O)CCCCCC%10)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 O03 compound treatment 9.2066 -0.92952 -0.5032 10.8512 0.78793 0.3523 -0.1067 -0.1737 3186521 PK04Pur_000453 OCCCOc1ccc(cc1)C2=N[C@]3(Cc4ccccc4N(C(=O)c5ccccc5)C3=O)[C@H](O2)c6ccccc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 O04 compound treatment 9.5085 -0.6276 -0.3398 11.9496 1.8864 0.8435 0.3562 0.3917 2141957 PK04Pur_000454 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(OCCO)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)NC[C@H](O)c7ccccc7)c8cc(C#Cc9ccc(OC)cc9)ccc18 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 O05 compound treatment 10.0045 -0.13159 -0.0712 9.8223 -0.24089 -0.1077 -0.1265 -0.9799 3186666 PK04Pur_000455 OCCCOc1ccc(cc1)C2=N[C@@]3(Cc4ccccc4N(C(=O)c5ccccc5)C3=O)[C@@H](O2)c6ccccc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 O06 compound treatment 11.2871 1.151 0.6231 10.1973 0.13405 0.0599 0.483 0.7716 2144777 PK04Pur_000456 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(O)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)Nc7nc8ccccc8s7)c9ccccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 O07 compound treatment 9.2339 -0.90216 -0.4884 9.7006 -0.36259 -0.1621 -0.46 -0.8939 3067930 PK04Pur_000457 OCCCOc1ccc(cc1)C2=NC(ON2c3ccccc3)C(=O)N4CCCCC4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 O08 compound treatment 11.2903 1.1542 0.6248 10.7639 0.70071 0.3133 0.6634 0.949 2143413 PK04Pur_000458 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccc(OCCO)cc4)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCN(CC7)c8ncccn8)c9cc(C#CC%10(O)CCCCCC%10)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 O09 compound treatment 9.9462 -0.18992 -0.1028 11.2486 1.1854 0.53 0.3021 0.5595 3187289 PK04Pur_000459 CC(C)(C)OC(=O)CC[C@@]12N=C(O[C@H]2c3ccccc3N(CC=C)C1=O)c4ccc(OCCCO)cc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 O10 compound treatment 10.0895 -0.046565 -0.0252 9.2775 -0.78575 -0.3513 -0.2663 -0.7559 2141973 PK04Pur_000460 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(OCCO)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCN(CC7)c8ncccn8)c9cc(C#Cc%10ccc(OC)cc%10)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 O11 mock treatment 10.3372 0.20109 0.1089 8.7448 -1.3185 -0.5895 -0.3399 -0.5669 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 O12 mock treatment 11.6949 1.5588 0.8439 11.4957 1.4324 0.6405 1.0496 0.9907 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 O13 compound treatment 7.6786 -2.4575 -1.3304 11.0008 0.93753 0.4192 -0.6443 -0.4619 3068603 PK04Pur_000461 CC(C)(C)OC(=O)CC[C@@]12N=C(O[C@H]2c3ccccc3N(CCS(=O)(=O)c4ccccc4)C1=O)c5ccc(OCCCO)cc5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 O14 compound treatment 9.7331 -0.40296 -0.2181 8.815 -1.2482 -0.5581 -0.5489 -0.916 2141997 PK04Pur_000462 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(OCCO)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)NC[C@H](O)c7ccccc7)c8cc(C#CCNC(=O)N)ccc18 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 O15 compound treatment 8.4526 -1.6835 -0.9114 8.6178 -1.4454 -0.6463 -1.1015 -0.9858 3186365 PK04Pur_000463 OCCCOc1ccc(cc1)C2=N[C@]3(CCS(=O)(=O)c4ccccc4)[C@H](O2)c5ccccc5N(CC=C)C3=O 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 O16 compound treatment 9.6763 -0.45976 -0.2489 10.0502 -0.013039 -0.0058 -0.1801 -0.7235 2142953 PK04Pur_000464 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(O)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCCCCCC7)c8cc(C#CCNC(=O)N)ccc18 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 O17 mock treatment 9.2544 -0.8817 -0.4773 9.6893 -0.37394 -0.1672 -0.4557 -0.9011 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 O18 mock treatment 9.6937 -0.44242 -0.2395 9.7149 -0.34831 -0.1557 -0.2795 -0.9783 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 O19 mock treatment 9.5742 -0.56192 -0.3042 8.0479 -2.0154 -0.9011 -0.8523 -0.8961 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 O20 mock treatment 9.5657 -0.57043 -0.3088 8.9949 -1.0683 -0.4777 -0.5561 -0.9777 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 O21 mock treatment 9.3923 -0.7438 -0.4027 10.4835 0.42027 0.1879 -0.1518 -0.3417 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 O22 mock treatment 9.7578 -0.37831 -0.2048 7.9021 -2.1611 -0.9663 -0.8281 -0.8384 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 O23 mock treatment 9.3829 -0.75318 -0.4077 9.6114 -0.45178 -0.202 -0.4312 -0.9475 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 O24 mock treatment 9.6724 -0.46372 -0.251 10.5573 0.49404 0.2209 -0.0213 -0.0637 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 P01 compound treatment 10.6592 0.5231 0.2832 14.023 3.9597 1.7705 1.4522 0.8099 2141777 PK04Pur_000465 NC(=O)NCC#Cc1ccc2NC(=O)[C@]3([C@@H]([C@@H]4N([C@@H]3c5ccc(O)cc5)[C@H]([C@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)NCC=C)c2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 P02 compound treatment 9.744 -0.39207 -0.2122 9.5331 -0.53014 -0.237 -0.3177 -0.9985 3089659 PK04Pur_000466 CO[C@H]1O[C@H](CO)[C@@H](OC(=O)Nc2ccc(OC)cc2)[C@H](OC(=O)Nc3ccc4OCOc4c3)[C@H]1OC(=O)Nc5ccc6OCOc6c5 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 P03 compound treatment 11.8237 1.6876 0.9136 9.9859 -0.077351 -0.0346 0.6216 0.6799 2141174 PK04Pur_000467 OCCOc1ccc(cc1)[C@@H]2N3[C@H]([C@H](C(=O)N4CCCCCCC4)[C@@]25C(=O)Nc6ccc(C#CCCO)cc65)C(=O)O[C@H]([C@H]3c7ccccc7)c8ccccc8 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 P04 compound treatment 10.5299 0.39386 0.2132 9.5187 -0.54458 -0.2435 -0.0214 -0.0662 3000917 PK04Pur_000468 CO[C@H]1O[C@H](CO)[C@@H](OC(=O)Nc2ccc(OC)cc2)[C@H](OC(=O)Nc3ccccc3)[C@@H]1OC(=O)Nc4ccccc4 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 P05 compound treatment 10.9683 0.83218 0.4505 9.9101 -0.15313 -0.0685 0.2701 0.5928 2143265 PK04Pur_000469 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccc(OCCO)cc4)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)NCC=C)c7cc(C#CCNC(=O)N)ccc17 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 P06 compound treatment 9.1124 -1.0237 -0.5542 9.0826 -0.98065 -0.4385 -0.7019 -0.9933 3089776 PK04Pur_000470 CCOC(=O)c1ccc(NC(=O)O[C@@H]2[C@@H](CO)O[C@H](OC)[C@@H](OC(=O)Nc3ccc4OCOc4c3)[C@H]2OC(=O)Nc5ccc6OCOc6c5)cc1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 P07 compound treatment 10.1407 0.0046152 0.0025 9.0729 -0.99036 -0.4428 -0.3114 -0.7031 2142977 PK04Pur_000471 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(O)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCc8cc(OC)c(OC)cc8C7)c9cc(C#CCNC(=O)N)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 P08 compound treatment 9.2576 -0.87845 -0.4756 11.3409 1.2776 0.5713 0.0677 0.0911 3001022 PK04Pur_000472 CO[C@H]1O[C@H](CO)[C@@H](OC(=O)Nc2ccc(OC)cc2)[C@H](OC(=O)Nc3ccccc3c4ccccc4)[C@@H]1OC(=O)Nc5ccccc5c6ccccc6 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 P09 compound treatment 10.2192 0.083138 0.045 11.4726 1.4093 0.6302 0.4774 0.7557 2143397 PK04Pur_000473 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccc(OCCO)cc4)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)NC[C@H](O)c7ccccc7)c8cc(C#CC9(O)CCCCCC9)ccc18 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 P10 compound treatment 10.1638 0.02771 0.015 9.1654 -0.89779 -0.4014 -0.2732 -0.6802 2141463 PK04Pur_000474 NC(=O)[C@H]1[C@H]2N([C@@H](c3ccc(O)cc3)[C@]14C(=O)Nc5ccc(C#CC6(O)CCCCCC6)cc54)[C@@H]([C@@H](OC2=O)c7ccccc7)c8ccccc8 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 P11 mock treatment 9.9756 -0.16045 -0.0869 11.4858 1.4226 0.6361 0.3884 0.6049 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 P12 mock treatment 10.7772 0.64116 0.3471 10.3343 0.27102 0.1212 0.3311 0.9007 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 P13 compound treatment 9.5629 -0.57319 -0.3103 10.1008 0.037519 0.0168 -0.2076 -0.6679 2142217 PK04Pur_000475 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(OCCO)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCc8cc(OC)c(OC)cc8C7)c9cc(C#CC%10=CCCCC%10)ccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 P14 compound treatment 9.7592 -0.3769 -0.204 10.7669 0.70363 0.3146 0.0782 0.2085 2141794 PK04Pur_000476 OCCC#Cc1ccc2NC(=O)[C@]3([C@@H]([C@@H]4N([C@@H]3c5ccc(O)cc5)[C@H]([C@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)Nc8nc9ccccc9s8)c2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 P15 compound treatment 9.5988 -0.53732 -0.2909 9.4226 -0.64061 -0.2864 -0.4082 -1.0 2141695 PK04Pur_000477 NC(=O)NCC#Cc1ccc2NC(=O)[C@]3([C@@H]([C@@H]4N([C@@H]3c5ccccc5OCCO)[C@H]([C@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)Nc8nc9ccccc9s8)c2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 P16 compound treatment 9.7097 -0.42635 -0.2308 7.9291 -2.1341 -0.9542 -0.838 -0.8535 2141092 PK04Pur_000478 NC(=O)NCC#Cc1ccc2NC(=O)[C@@]3([C@H]([C@H]4N([C@H]3c5ccc(OCCO)cc5)[C@@H]([C@@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)O)c2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 P17 compound treatment 10.634 0.49787 0.2695 9.7348 -0.32845 -0.1469 0.0867 0.2826 2141147 PK04Pur_000479 OC(=O)[C@@H]1[C@@H]2N([C@H](c3ccc(O)cc3)[C@@]14C(=O)Nc5ccc(C#CC6=CCCCC6)cc54)[C@H]([C@H](OC2=O)c7ccccc7)c8ccccc8 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 P18 compound treatment 9.6528 -0.48326 -0.2616 8.6983 -1.3649 -0.6103 -0.6165 -0.9285 2141343 PK04Pur_000480 NC(=O)NCC#Cc1ccc2NC(=O)[C@@]3([C@H]([C@H]4N([C@H]3c5ccccc5OCCO)[C@@H]([C@@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)Nc8nc9ccccc9s8)c2c1 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 P19 compound treatment 9.1032 -1.0329 -0.5592 8.9301 -1.1332 -0.5067 -0.7537 -0.9988 2144665 PK04Pur_000481 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(OCCO)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCc8cc(OC)c(OC)cc8C7)c9ccccc19 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 P20 compound treatment 9.566 -0.57009 -0.3086 8.9259 -1.1374 -0.5086 -0.5778 -0.9714 2141486 PK04Pur_000482 Oc1ccc(cc1)[C@@H]2N3[C@H]([C@H](C(=O)Nc4nc5ccccc5s4)[C@@]26C(=O)Nc7ccc(C#CC8=CCCCC8)cc76)C(=O)O[C@H]([C@H]3c9ccccc9)c%10ccccc%10 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 P21 mock treatment 9.8486 -0.28752 -0.1556 11.0476 0.98437 0.4401 0.2012 0.4309 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 P22 mock treatment 8.6477 -1.4884 -0.8057 10.2126 0.14938 0.0668 -0.5225 -0.6463 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 P23 mock treatment 9.7905 -0.34554 -0.1871 10.3422 0.27893 0.1247 -0.0441 -0.1961 1152.0007 AvgIn(1152.0007) BetaCatenin 1152.0007.2450 P24 mock treatment 9.5081 -0.62794 -0.3399 9.1173 -0.94589 -0.4229 -0.5394 -0.9941